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Direct Dehydrative N-Pyridinylation of Amides, the Interrupted Bischler-Napieralski
Reaction, and the Enantioselective Total Synthesis and Arylative Dimerization of
Aspidosperma Alkaloids
by
Jonathan William Medley
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Organic Chemistry
ABSTRACT
I. Direct Dehydrative N-Pyridinylation of Amides
A method for the single-step N-pyridinylation of secondary amides is described. The
process involves electrophilic activation of secondary amides with trifluoromethanesulfonic
anhydride in the presence of 2-fluoropyridine followed by introduction of a pyridine N-oxide
derivative and warming to afford the corresponding N-pyridinyl tertiary amide derivatives. The
structure of activated amide intermediates is probed through in situ monitoring, and a
mechanism supported by in situ monitoring and deuterium labeling experiments is discussed.
II. Synthesis of Spirocyclic Indolines by Interruption of the Bischler-Napieralski Reaction
The development of a versatile method for the synthesis of spirocyclic
pyrrolidinoindolines is described. Treatment of N-acyltryptamines with trifluoromethanesulfonic
anhydride-2-chloropyridine reagent combination affords highly persistent spiroindoleninium
ions, which are selectively trapped intra- and intermolecularly by various nucleophiles.
III. A Concise and Versatile Double-Cyclization Strategy for the Highly Stereoselective
Synthesis and Novel Arylative Dimerization of Aspidosperma Alkaloids
A strategy for the concise, stereoselective synthesis of aspidosperma alkaloids and
related structures via a common putative diiminium ion intermediate is described. The approach
enables the dimerization of aspidosperma-type structures at the sterically hindered C2-position.
The diiminium intermediate is prepared in situ from an enantioenriched c-quaternary 2-
chlorotryptamine lactam through a stereoselective electrophilic double-cyclization cascade. The
key C5-quaternary stereocenter is secured via successive diastereoselective a-alkylations of
pseudoephenamine crotonamide.
Thesis Supervisor: Professor Mohammad Movassaghi
Title: Associate Professor of Chemistry
6
Table of Contents
I. Direct Dehydrative N-Pyridinylation of Amides
Introduction and Background 12
Results and Discussion 16
Conclusion 22
Experimental Section 27
II. Synthesis of Spirocyclic Indolines by Interruption of the Bischler-Napieralski Reaction
Introduction and Background 61
Results and Discussion 65
Conclusion 70
Experimental Section 74
III. A Concise and Versatile Double-Cyclization Strategy for the Highly Stereoselective
Synthesis and Novel Arylative Dimerization of Aspidosperma Alkaloids
Introduction and Background 97
Results and Discussion 103
Conclusion 110
Experimental Section 116
Appendix A: Spectra for Chapter I 170
Appendix B: Spectra for Chapter II 247
Appendix C: Spectra for Chapter III 317
Curriculum Vitae 382
7
Abbreviations
A
[a]
Ac
AIBN
Anis
app
aq
atm
Bn
Br
Bu
c
C
"C
CAM
cat.
2-ClPyr
cm
3-CNPyr
CNS
d
d
DART
DBU
4-DMAP
DMF
DMPU
DMSO
dr
EDC*HCl
ee
El
equiv
ESI
Et
2-FPyr
FT
g
gCOSY
gHMBC
h
angstrom
specific rotation
acetyl
2,2'-azobisisobutyronitrile
para-anisaldehyde
apparent
aqueous
atmosphere
benzyl
broad
butyl
centi
concentration
degree Celsius
ceric ammonium molybdate
catalyst
2-chloropyridine
centimeter
3-cyanopyridine
central nervous system
doublet
deuterium
parts per million
direct analysis in real time
1,8-diazabicyclo[5.4.0]undec-7-ene
4-dimethylaminopyridine
N,N-dimethylformamide
N,N-dimethylpropylene urea
dimethylsulfoxide
diastereomeric ratio
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrogen chloride
enantiomeric excess
electron ionization
equivalent
electronspray ionization
ethyl
2-fluoropyridine
Fourier transform
gram
gradient correlation spectroscopy
gradient heteronuclear multiple bond correlation
hour
8
HPLC high performance liquid chromatography
HRMS high resolution mass spectrometry
HSQC heteronuclear single quantum correlation
Hz Hertz
i iso
IR infrared
J coupling constant
Josiphos (R)- 1-[(Sp)-2-(di-tert-butylphosphino)ferrocenyl]ethylbis(2-
methylphenyl)phosphine
L liter
LDA lithium NN-diisopropylamide
LTMP lithium 2,2,6,6-tetramethylpiperidide
m medium
m multiplet
m milli
m meter
M molar
micro
Me methyl
MHz megahertz
min minute
mol mole
Ms methanesulfonyl
MS molecular sieves
MS mass spectrometry
m/z mass to charge ratio
n normal
N normal
NCS N-chlorosuccinimide
NMR nuclear magnetic resonance
NOESY nuclear Overhauser effect correlation spectroscopy
Nuc nucleophile
p para
Ph phenyl
PMA phosphomolybdic acid
ppm parts per million
Pr propyl
psi pounds per square inch
q quartet
ref. reference
R rectus
Rf retention factor
ROESY rotating-frame nuclear Overhauser effect correlation spectroscopy
9
ss
S
S
SFO
str
t
t
tBuBrettPhos
TES
Tf
THF
TLC
Ts
UV
w
singlet
strong
secondary
sinister
system fluidics organizer
stretch
triplet
tertiary
[3,6-Dimethoxy-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]bis(1,1-
dimethylethyl)phosphine
triethylsilyl
trifluoromethanesulfonyl
tetrahydrofuran
thin layer chromatography
para-toluenesulfonyl
ultraviolet
weak
10
Chapter I
Direct Dehydrative N-Pyridinylation of Amides
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Introduction and Background
Pyridin-2-ylated amides are key structural motifs in a wide variety of pharmaceutical
compounds and fine chemicals.1 Propiram2 (Figure 1) is a partial mu opioid receptor agonist and
weak mu antagonist analgesic that has been shown to be more effective and potent than codeine.
Eszopiclone 3 (Lunesta*), a CNS stimulant, is a short-acting, nonbenzodiazepine hypnotic agent
widely used for the treatment of chronic insomnia. Piketoprofen (Calmatel*) and piroxicam5
(Feldene*) are non-steroidal anti-inflammatory drugs, the latter of which is prescribed for the
relief of symptoms of rheumatoid and osteoarthritis. The pyridin-2-ylated amide structure is also
present in topical retinoids used for the treatment of psoriasis.6 Pirenzipine7 (Gastrozepin*) is an
Mi-selective antagonist used to treat peptic ulcers. The importance of pyridinylated amides
continues to inspire new methods for their syntheses.
Me
NN N
propiram eszopicione piketoprofen
analgesic CNS stimulant anti-inflammatory
ISO2
HO O Me Me Me O0 Me'N -N N OA
0 Me- N N 0
N 0 N 0  N N
0e MeH
piroxicam antipsoriatic pirenzepine
anti inflammatory anti-ulcer drug
Figure 1. Representative compounds containing a pyridin-2-ylated amide substructure.
Among the earliest methods for the introduction of a pyridin-2-yl substituent onto a
nitrogen atom was the reaction between sodamide and pyridine at elevated temperature reported
by Chichibabin and co-workers (Scheme 1).8 Addition of strongly basic sodamide into the
weakly electrophilic 2-position of pyridine, followed by loss of hydrogen gas, affords 2-
sodamidopyridine; acidification affords 2-aminopyridine. Recently, a milder set of conditions
has been reported by Yin and co-workers9 (Scheme 2), in which a pyridine N-oxide derivativelo
is activated with para-toluenesulfonic anhydride (Ts20) in the presence of excess tert-butyl
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amine to effect in situ formation of a 2-tert-butylamino pyridine derivative. Addition of
trifluoroacetic acid and heating affords the 2-aminopyridine product. While these methods
provide efficient access to 2-aminopyridines," they are not known to effect the N-pyridinylation
of amide substrates.
NH NH2  ~ NHNa NH 2NaNH2[Na H j-H2NN H2+N NH-~ -. N
N Nheat N N + NaH -2 NH
Scheme 1. The Chichibabin reaction.
- tB NH 1N H Bu N H 2
uN H2 N H Cu NH2O Ts2 0 TsO, :NH 2qu -2 TsOH 1 CF 3COOHN ~ N 1  LNO 0
_ PhCF3  TheatOR PC3 R TR 
-isobutylene
Scheme 2. Synthesis of 2-aminopyridines from pyridine N-oxides.
Metal-catalyzed cross-coupling reactions between nitrogen nucleophiles and aryl or
heteroaryl halides or sulfonates, such as the palladium- and copper-catalyzed methods reported
by Buchwald1 3 and the complementary palladium-catalyzed method reported by Hartwig, 4 have
proven to highly efficient and mild means for the N-arylation and N-heteroarylation of a variety
of nitrogen-containing compounds, including amines and amides (Scheme 3). Primary amide
substrates, in general, are efficiently substituted with a wide range of aryl and heteroaryl groups,
including pyridin-2-yl groups. Secondary lactams and sterically unhindered15 acyclic secondary
amides are also generally useful in these transformations, though sterically hindered acyclic
secondary amides represent a challenging substrate class, 16 and to date, methods for the
intermolecular cross-coupling of sterically hindered acyclic secondary amides and 2-
Buchwald:
o Pd(OAc) 2, tBuBrettPhos O NN K3PO4, H20
/ NH2 + *HO +C tBuOH, 110 *C O
0 C1 0e93%
Hartwig:
o CI Pd(OAc)2, Josiphos ONaO tBu
NNH2 + N * N N
1,2-DME, 70 *C H
99%
Scheme 3. N-pyridinylation of amides via the Buchwald-Hartwig reaction.
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halopyridines has not been reported.
In 1969, R. A. Abramovitch and co-workers reported a fascinating methodology for the
synthesis of N-pyridinyl amide derivatives via the nucleophilic addition of heteroaromatic N-
oxides to N-aryl and N-alkyl imidoyl chlorides or nitrilium salts at elevated temperature followed
by a thermal rearrangement (Scheme 4).17 Abramovitch's proposed mechanism was supported
by elegant mechanistic investigations, although the reversibility or irreversibility of the steps
involved was not determined. The reactions in general give good regioselectivity with respect to
site of substitution on the pyridine ring, typically affording the N-pyridin-2-yl amide product as
the only regioisomer. The high temperatures required for the reaction, the need for the synthesis
and isolation of sensitive imidoyl chlorides or nitrilium salts in a separate step, the failure of
electron-deficient N-oxides to undergo reaction, and the tendency for undesired side-product
formation represent drawbacks to the original methodology.
CI- +K>R Ci- 1
R 1 N'R + PhC N R -HCI 
R2
R [ R' N ' L 2  J
R2 
R
Scheme 4. The Abramovitch reaction.
Recently, more direct methods for the N-pyridinylation of amides through reaction with
pyridine N-oxide derivatives have been developed. Couturier and co-workers' 8 reported the N-
quinolinylation and N-isoquinolinylation of primary amides by in situ activation of the amide
with oxalyl chloride at elevated temperature to afford an N-acylisocyanate intermediate, which
undergoes trapping by a quinoline or isoquinoline N-oxide and subsequent thermal
rearrangement to afford a secondary N-quinolin-2-ylated or N-isoquinolin-1-ylated amide
product as single regioisomers (Scheme 5). Also, Bilodeau and co-workers19 reported a
modification of the Abramovitch reaction for the N-pyridinylation of secondary amides via in
situ activation of the amide substrate with oxalyl chloride in the presence of 2,6-lutidine (Scheme
6). Addition of a pyridine N-oxide derivative to the imidoyl chloride intermediate affords the N-
pyridinylated amide product. While this method allows for the direct N-pyridinylation of
sterically unhindered N-methyl and N-benzyl acetamides and benzamides, no successful
examples of the N-pyridinylation of sterically hindered amides were reported, and N-aryl amides
proved to be a highly recalcitrant substrate class. Given the importance of N-pyridinylated amide
14
products, we sought to develop a mild protocol that would expand the substrate scope of the
Abramovitch reaction.
0 (COCI)2
Me NH2 (CICH 2)2, reflux
-2 HCI, -CO [ H0N O H -NO -' ' -A C0 - . N N OMe N reflux Me O 83% Me N Ni O j H
Scheme 5. N-pyridinylation of primary amides via N-acylisocyanates.
0,+
O (COCI) 2 ' CI AM Me2,6-lutidine Bn Me N
Me kN ' M Me Nme-WH CH2CI2, O MC 0 - 23 C N
66% 6er
Scheme 6. A modified Abramovitch reaction.
Our laboratory has previously reported the use of 2-chloropyridine (2-ClPyr) with
trifluoromethanesulfonic anhydride 20 (Tf 2O) as a versatile reagent combination for the synthesis
of pyrimidine2 1 and pyridine derivatives (Scheme 7).2 These methodologies provide the desired
TfO- TfO-
R'J N ' - f0 : C CI +N '1,'_-_I-R
H 2-CIPyr R RN '''
_ TfO- H Tfo H
-2-CIPyrTfOH
R TR
-2-CIPyr-TfOH
-2-CiPyr-TfOH
I
R'
TfOH . N ' R
R NR
R4 TfO- R40
K j R2  R
R4
-R40H
R3
TfOH - '_-R
R1 N "
Scheme 7. Previous condensative heterocycle syntheses by Movassaghi et al.
azaheterocycles via electrophilic activation of secondary N-aryl or N-vinyl amides to enable
nucleophilic addition and annulation. Early spectroscopic studies indicated that activation of N-
15
]
aryl amides with our laboratory's reagent combination Tf2 O-2-ClPyr gives rise to 2-
chloropyridinium adducts, which were proposed to potentially be highly electrophilic species
that might enable reaction with the nucleophile. We envisioned that our laboratory's conditions
would serve well for a modified Abramovitch reaction (eq 1). In this chapter, we describe the N-
pyridinylation, N-isoquinolinylation and N-quinolinylation of various secondary amides and
discuss a plausible mechanism supported by deuterium labeling and in situ monitoring
experiments.
0
0 N' ,R2Ok -2  + Tf2O, 2-CiPyr, R' N
R1  ,R + O + No, CH(1H C 2C12R -78 - 23*C
Results and Discussion
Based off of our laboratory's previous results in the context of azaheterocycle synthesis,
we reasoned that N-aryl amide la would be competent for in situ electrophilic activation with 2-
ClPyr-Tf2O and subsequent reaction with N-oxide nucleophiles. Thus, amide la and
isoquinoline N-oxide (2a) served as substrates for our early exploration of this chemistry (Table
1). Interestingly, the use of 2-fluoropyridine (2-FPyr, 1.2 equiv) as a base additive afforded a
significant improvement in the reaction yield as compared to 2-ClPyr, furnishing amide 3aa in
99% yield (compare entries 1 and 11, Table 1). More nucleophilic and stronger base additives
generally gave poorer yields as compared to base additives with attenuated nucleophilicity and
basicity. These observations suggest that optimal conditions provide a balance between the need
for a base additive to promote electrophilic activation of the amide substrate while avoiding
nucleophilic inhibition of this reaction. Consistent with our earlier findings,2 1 2 2 both the
presence of the optimal base additive in excess or its absence led to a marked decrease in the
yield of the desired product (entries 3, 12 and 13, Table 1). The use of the Hendrickson reagent
((Ph 3P*)20-2TfO~)23 as the activating agent for this dehydrative N-pyridinylation reaction proved
less effective as compared to the optimal conditions described above (entry 16, Table 1). The
overall yield can be improved by use of excess 2a due to competitive N-oxide decomposition
(entry 2, Table 1).
We next examined the optimal conditions with a range of amide substrates with three
representative heteroaromatic N-oxides (Table 2). Isoquinolinylation of amides under our
conditions is highly efficient, giving good to excellent yields in all cases examined.
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Table 1. Optimization of Reaction Conditions.a
0
MeO N' .Ph
MeO H Tf20 (1.1 equiv) O
MeO 1 la base additive MeO N'Ph
0+
ON CH2CI2, 3 h MeO N
-78 - 23 'C 3aa
2aa
entry base additive base equiv N-oxide X equiv yield (%)b
1 2-Cl-pyridine 1.2 1.1 77
2 2-Cl-pyridine 1.2 2.0 81
3 None - 1.1 16
4 pyridine 1.2 1.1 10
5 Et3N 1.2 1.1 0
6 2-Br-pyridine 1.2 1.1 58
7 3-CI-pyridine 1.2 1.1 74
8 Ethyl Nicotinate 1.2 1.1 73
9 3-Br-pyridine 1.2 1.1 72
10 2,6-lutidine 1.2 1.1 55
11 2-F-pyridine 1.2 1.1 99
12 2-F-pyridine 2.0 1.1 88
13 2-F-pyridine 5.0 1.1 76
14 DIPEA 1.2 1.1 48
15 2,6-dichloropyridine 1.2 1.1 15
16 Hendrickson Reagentc 1.5 1.1 72
aConditions: Amide la, Tf2O (1.1 equiv), base additive,
CH 2C12, -78 -+ 0 'C; isoquinoline N-oxide, 0 -+ 23 *C,
3 h. blsolated yield. cHendrickson reagent
((Ph 3P') 20-2TfO-) was prepared (reference 23) and used
in place of Tf2O without base additive.
Isoquinolinylation of both N-alkyl benzamides (entries 3da, 3fa, and 3ga, Table 2), in addition to
N-aryl and N-vinyl amides (entries 3ca and 3ha, Table 2) were achieved in high yields under our
standard reaction conditions. The high efficiency of our reaction with sterically hindered amide
substrates (3fa, 3ga, and 3ha, Table 2) is notable. Electron rich benzamides notwithstanding
(entry 3aa, Table 2), the least efficient substrates in this series were N-aryl benzamides (entries
3ba and 3ea, Table 2). In all cases, completely regioselective isoquinolinylations proceeded at
the 1-position of the isoquinoline ring.17 -19
The use of quinoline N-oxide (2b, Table 2) and pyridine N-oxide (2c) as substrates also
gave completely regioselective acylamination, however, with reduced overall efficiency for the
formation of the desired products. This is due in part to the faster decomposition17b,c, 24 of N-
oxides 2b and 2c (as compared to 2a) under the electrophilic activation reaction conditions."
Interestingly, in reactions employing N-oxide 2c, amides that exhibited high reactivity in
17
Table 2. Direct Dehydrative N-Pyridinylation of Amides.a
0
R1  N'R2
1x H
+ 'N
2y R
N-oxide: 0 +
2a
0
Tf2O, 2-FPyr, CH2Cl2  R N'R2
-78--23'C N
3xy
R
06+
ON
2bI 2c
amide N-(isoquinolin-1 -yl) N-(quinolin-2-yl) N-(pyridin-2-yl)product 3 product 3 product 3
0
MeO N Ph
Me H 3aa: 9 9%b 3ab: 0%C 3ac: 41%
MeO 1 a
0
Ph N'Ph 3ba: 72% 3bb: 36% 3bc: 40%
lb H
0
Me N'Ph 3ca: 97% 3cb: 35% 3cc: 6 6%d
1c H
0
Ph N'Me 3da: 100% 3db: 60% 3dc: 67
%d
1d HyOMe
Br N 3ea: 74% 3eb: 42% 3ec: 37%
Irl H 0
N )r 3fa: 92% 3fb: 13% 3fc: 74%
0 I I H
0
MeO IN'r 3ga: 94% 3gb: 25% 3gc: 48%I H
MeO H
SBu N 3ha: 91% 3hb: 78% 3hc: 39 %de
1h H
a Isolated yields of products 3xy. Average of two experiments.
Conditions: Amide 1x (1 equiv), Tf2O (1.1 equiv), 2-FPyr (1.2
equiv), CH 2Cl2 , -78 - 0 'C; N-oxide 2y (2.0 equiv), 0 -+ 23 'C,
4 h. b N-oxide 2a (1.1 equiv), 3 h. c Decomposition of la
observed over 4 h. d 2,6-lutidine used as base. e Low yield due
to product decomposition.
isoquinolinylation reactions gave higher yields when 2,6-lutidinel9 was used in place of 2-FPyr
as the base additive (products 3cc, 3dc and 3hc Table 2), likely owing to slight suppression of N-
oxide decomposition. However, the use of 2,6-lutidine in place of 2-fluoropyridine with less
18
reactive N-aryl benzamides (1b and le, Table 2) resulted in significantly lower yields of the
desired products.
Attempts to N-quinolinylate amide la under our standard conditions gave no detectable
amount of the desired product 3ab. This is consistent with poor nucleophilic addition of 2b to
the activated intermediate allowing a competitive decomposition of amide la.26 Given that
nucleophilic base additives inhibit the desired reaction (Table 1), we conjectured that the N-
pyridinylated products formed may also play an inhibitory role. Activation of amide 1f followed
by sequential addition of N-pyridinylated amide 3fc (1.00 equiv) and pyridine N-oxide (2c) gave
a low 33% yield of the desired amide 3fc (eq 2),2 which is less than half the expected yield.
This suggests that product inhibition can be significant in these pyridinylation reactions.
However, activation of amide 1f under optimized conditions, followed by sequential addition of
o Tf20, 2-FPyr OCH2C 2, -78 - 0 *C; 'Pr
N i~r N Pr (2)
H 3fc (1.00 equiv)
0 2N 1f N-Oxide 2c (2.00 equiv) 02N N0 - 23 C 3fc
33%
O Tf20, 2-FPyr O
N' Pr CH 2Cl2 , -78 -+ 0 *C;" N'Pr (3)H 3fa (1.00 equiv)
0 2N if N-Oxide 2a (2.00 equiv) 0 2N N0 - 23 *C 3fa
92%
product 3fa (1.00 equiv) and isoquinoline N-oxide (2a) gave 92% yield of the desired N-
isoquinolinylated amide 3fa (eq 3),27 indicating no significant product inhibition in this reaction.
Furthermore, sequential activation of an enantiomerically enriched amide 1h22 under optimized
conditions followed by introduction of isoquinoline N-oxide (2a) provided the optically active N-
isoquinolinylated amide (+)-3ha without erosion of optical activity (eq 4).
O VT20, 2-FPyr; 0
Me N '0 N-oxide 2a Me N (4)Me NH (4)
MeH H2C12, 4h Me
-78 - 23 *C
1h, 98% ee 88% Z 1
(+)-3ha, 98% ee
Interestingly, while N-pyridinylation of amides was generally less efficient as compared to N-
isoquinolinylation, the use of both electron-rich and electron-poor 4-substituted pyridine N-
oxides 2d and 2e, respectively, gave good yields of the desired products (eqs 5 and 6). The
successful N-pyridinylation of amide Id with 4-nitropyridine N-oxide (2e) is notable, as its use
19
as a nucleophile for the Abramovitch reaction was previously reported to be unsuccessful, 17a,c
suggesting greater electrophilicity of the intermediate under the conditions described here.
O 0+ Tf2O, 2-FPyr O
Ph, NMe + N Ph Ne (5)
H OMe CH2C12, 4 h
-78 - 23 *CN
1d 2d 75% 3dd
OMe
o 0 Tf20, 2-FPyr O
Ph NMe + N Ph N'Me (6)Ph NO CH2C2, 4 h PhN
-78 - 23 C
1d 2e 67% 3de N02
NO 2
To gain better understanding of the intermediates involved in this transformation, a series
of in situ IR and NMR monitoring experiments were performed. The conversion of amide 1d to
N-isoquinolinylated amide 3da under optimized conditions was monitored by in situ IR analysis.
Addition of Tf2O to a mixture of amide ld and 2-FPyr resulted in complete consumption of the
amide absorption band (1668 cm- 1) and appearance of a persistent absorption at 2370 cm-1,
suggestive of a nitrilium ion intermediate.17c,28 Addition of isoquinoline N-oxide (2a) resulted in
immediate disappearance of the absorption at 2370 cm-1 and appearance of a persistent
absorption at 1691 cm-1, which was due to the protonated product 3da. Interestingly, the
activation of N-(4-methoxyphenyl)benzamide (i) with the reagent combination of 2-ClPyr and
Tf 2O did not lead to an observable absorption corresponding to a nitrilium ion, but instead gave
rise to a persistent absorption at 1600 cm-, suggestive of an amidinium intermediate. 2 These
observations suggest that while electrophilic activation of ld using 2-FPyr results in 5d (Scheme
8), similar activation of li using 2-ClPyr leads to predominant formation of 4i rather than 5i.
- R2 Tf2O Jn 1 =NR x+cR1 N' T X +N TfO - TfO-
H 2-XPyr R1  NH + TfO- H
1 4 2 5 6
X = CI, F 
-2-XPyr-HOTf R
R
R1 NR 2  O-N TfO- + -R
S R +- -O
N TfOH R' , H
3 TfO- R2 8 R 1 N
Sche R R2
Scheme 8. Mechanism for direct dehydrative N-pyridinylation of amides.
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To determine the degree to which the formation of a nitrilium ion depends on the nature
of the base additive and the amide structure itself, a series of in situ IR monitoring experiments
were carried out.27 For comparison, while activation of N-alkyl benzamide 1d under optimal
conditions resulted in an absorption suggesting a nitrilium ion (2370 cm-1),29 the activation of N-
aryl benzamides lb and 1i under the same conditions led to no detection of an IR absorption
consistent with a nitrilium ion, but instead resulted in the appearance of an IR absorption
suggesting an amidinium ion (1621 cm 1 in both cases). However, Tf 2O activation of the
electron-rich N-aryl benzamide la in the presence of either 2-FPyr or 2-CIPyr (1.2 equiv) indeed
resulted in an absorption at 2312 cm-1, suggesting a persistent nitrilium ion intermediate.
Interestingly, addition of extra equivalents of 2-ClPyr resulted in complete disappearance of this
absorption band and appearance of a persistent absorption at 1594 cm 1, consistent with the
formation of the previously observed amidinium ion.22  Even the electron-poor N-alkyl
benzamide 1f resulted in a lasting nitrilium ion (2354 cm 1) upon electrophilic activation in the
presence of either 2-FPyr or 2-ClPyr (1.2 equiv), although the presence of excess 2-ClPyr
resulted in disappearance of the absorption at 2354 cm-1 and the appearance of an absorption at
1609 cm .3 These observations suggest that activation of N-alkyl amides under these
conditions more readily results in persistent nitrilium ion formation, while N-aryl amides show
reluctance to form the corresponding nitrilium ion, likely owing to the inductive effect of the
nitrogen substituent.31 Only the particularly electron-rich N-aryl benzamide la resulted in any
observable nitrilium ion, perhaps due to greater stabilization by resonance contribution. These
differences in amide reactivity were further substantiated by in situ IH NMR monitoring of the
electrophilic activation step. Interestingly, amides that demonstrated the least propensity to form
a nitrilium ion upon activation under the optimal reaction conditions also gave the lowest yields
in reactions with isoquinoline N-oxide (e.g., entry 3ba, Table 2). Furthermore, reduced yield of
the desired product upon addition of excess base additive (or use of nucleophilic bases, Table 1)
is consistent with the observed disappearance of the nitrilium species during in situ monitoring
experiments.
Additional mechanistic insight was obtained using deuterated substrates 2a-d 2, 2c-d 2 and
2c-di (eqs 7 and 8). Electrophilic activation of N-alkyl benzamide 1f under optimal conditions
followed by introduction of excess 32 isoquinoline N-oxide (2a) and 1,3-dideuteroisoquinoline N-
oxide (2a-d2) provided a mixture of N-isoquinolinylated products 3fa and 3fa-di corresponding
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to kH:kD= 1.0:1.0 in 86% combined yield (eq 7).2 The same outcome was observed in a similar
experiment using excess 2c-d2 and 2c, resulting in a mixture of the N-pyridinylated products 3fc
and 3fc-di corresponding to kH:kD = 1.0:1.0 in a combined yield of 59% (eq 7). As another
mechanistic probe, activation of 1f under optimal conditions and the use of excess 2-
deuteropyridine N-oxide (2a-di) provided the expected N-pyridinylated amide 3fc as a mixture of
non-deuterated and monodeuterated derivatives (eq 8).27 Importantly, the ratio of 3fc-d and 3fc-
di was found to be 1.0:2.0, reflecting an observable primary kinetic isotope effect (kH:kD =
2.0:1.0).33 These observations suggest that addition 34 of the imidate nitrogen onto the pyridinium
ring is reversible, whereas nucleophilic addition of the N-oxide 2 to the nitrilium ion 5 (or
another electrophilic variant) is irreversible (Scheme 8).
D
0
o i 'Pr
Ie )Pr D T 2a-d 2 (2c-d2) 2 2-FPyr N Z - (7)
0 2 N if _ H CH2C12, 2 h O2-ON 
-78 -+ 23 *C R '
86% (59%) R = H, 3fa (3fc)
H2a (2c) kH:kD = 1.0:1.0 R = D, 3fa-d1 (3fc-d1)
0
o O+ Tf2O, 2-FPyr N Pr
.. N)Pr + * (8)
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Conclusion
We have presented a direct method for the dehydrative N-pyridinylation of amides under
electrophilic activation by the reagent combination of Tf2O and 2-FPyr. This method allows for
a highly effective activation of a variety of amide substrates, including sterically hindered and N-
aryl amides,' 9 without requiring the isolation of sensitive intermediates or the use of heavy metal
Lewis acid additives, allows for the use of electron-deficient pyridine N-oxide derivatives, and
proceeds in shortened reaction times without the need for elevated temperatures.' 7 Our in situ
monitoring experiments suggest greater propensity for the formation of persistent nitrilium ion
intermediates when N-alkyl amide substrates are used as compared to N-aryl amides. Our
studies with deuterated N-oxide substrates suggest an irreversible nucleophilic addition step and
a plausible interconversion of intermediates 7 and 8 based on the observed kinetic isotope effect.
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Experimental Section
General Procedures. All reactions were performed in oven-dried or flame-dried round bottomed
flasks, modified Schlenk (Kjeldahl shape) flasks or glass pressure vessels. The flasks were fitted
with rubber septa and reactions were conducted under a positive pressure of argon. Stainless steel
gas-tight syringes or cannulae were used to transfer air- and moisture-sensitive liquids. Flash column
chromatography was performed as described by Still et al. using silica gel (60 A pore size, 32-63 pm,
standard grade) or non-activated alumina (80-325 mesh, chromatographic grade).' Analytical thin-
layer chromatography was performed using glass plates pre-coated with 0.25 mm 230-400 mesh
silica gel or neutral alumina impregnated with a fluorescent indicator (254 nm). Thin layer
chromatography plates were visualized by exposure to ultraviolet light and/or by exposure to an
ethanolic phosphomolybdic acid (PMA), an acidic solution of p-anisaldehyde (anis), an aqueous
solution of ceric ammonium molybdate (CAM), an aqueous solution of potassium permanganate
(KMnO 4) or an ethanolic solution of ninhydrin followed by heating (<1 min) on a hot plate (-250
'C). Organic solutions were concentrated on rotary evaporators at -20 Torr (house vacuum) at 25-35
0C, then at -1 Torr (vacuum pump) unless otherwise indicated.
Materials. Commercial reagents and solvents were used as received with the following exceptions:
Dichloromethane, diethyl ether, tetrahydrofuran, acetonitrile, toluene, and triethylamine were
purchased from J.T. Baker (Cycletainer Tm ) and were purified by the method of Grubbs et al. under
positive argon pressure.2 2-Chloropyridine was distilled from calcium hydride and stored sealed
under an argon atmosphere. Secondary amides were prepared by acylation of the corresponding
primary amines3 or by previously reported copper-catalyzed C-N bond-forming reactions. 4
Instrumentation. Proton nuclear magnetic resonance ('H NMR) spectra were recorded with 300 and
500 MHz spectrometers. Chemical shifts are recorded in parts per million on the 6 scale and are
referenced from the residual protium in the NMR solvent (CHCl3: 6 7.27, C2D5HSO: 6 2.50). Data are
reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m =
multiplet), coupling constant(s) in Hertz, integration, assignment]. Carbon-13 nuclear magnetic
resonance (1 3 C NMR) spectra were recorded with 300 and 500 MHz spectrometers and are recorded in
parts per million on the 8 scale and are referenced from the carbon resonances of the solvent (CDCl 3:
6 77.2, (D3C)2SO: 6 39.5). Data are reported as follows: chemical shift [multiplicity (s = singlet, d =
doublet, t = triplet, q = quartet, m = multiplet), coupling constant(s) in Hertz, assignment]. Infrared
data were obtained with an FTIR and are reported as follows: [frequency of absorption (cm 1),
intensity of absorption (s = strong, m = medium, w = weak, br = broad), assignment]. In situ IR
reaction monitoring was performed with an in situ monitoring IR spectrometer.
1 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923.
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For the general procedure used for the synthesis of N-vinyl amides, see: Jiang, L.; Job, G. E.; Klapars, A.; Buchwald, S. L. Org. Lett.
2003, 5, 3667.
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0
MeO N Ph
MeO
la
Tf20, 2-FPyr, CH2CI2;
isoquinoline N-oxide
-78 -- 23 *C
99%
0
MeO N Ph
MeO N
3aa
N-(Isoguinolin-1-yl)-3,4-dimethoxy-N-phenylbenzamide (3aa, Table 2):
Trifluoromethanesulfonic anhydride (46.0 tL, 0.270 mmol, 1.10 equiv) was added via syringe
to a solution of 3,4-dimethoxy-N-phenylbenzamide 5 (1a, 63.0 mg, 0.245 mmol, 1 equiv) and 2-
fluoropyridine (25.3 tL, 0.294 mmol, 1.20 equiv) in dichloromethane (1.0 mL) at -78 'C. After 2
min, the reaction mixture was warmed to 0 'C. After 5 min, isoquinoline N-oxide (39.2 mg, 0.270
mmol, 1.10 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 3 h, triethylamine (100 tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (40 -- 60% ethyl acetate in
hexanes) to afford the amide 3aa (93.1 mg, 99%).
IH NMR (500 MHz, CDCl3, 20 'C) 6:
13C NMR (125 MHz, CDCl 3, 20 'C) 8:
FTIR (neat) cm-1:
HRMS (ESI):
8.37 (d, 1H, J= 5.6 Hz), 8.16 (dd, 1H, J= 8.5, 0.8 Hz),
7.86 (d, 1H, J= 8.3 Hz), 7.69-7.57 (m, 3H), 7.31 (t, 2H,
J= 8.0 Hz), 7.24 (d, 2H, J= 7.5 Hz), 7.20 (m, 2H), 7.07
(s, 1H), 6.64 (s, 1H), 3.82 (s, 3H), 3.58 (s, 3H).
171.1, 155.4, 151.0, 148.1, 143.5, 141.9, 138.4, 130.7,
129.3, 128.5, 128.0, 127.3, 126.5, 126.3, 125.7, 125.0,
123.0, 121.1, 112.1, 110.1, 55.9, 55.7.
3061 (w), 2936 (m), 1661 (s), 1516 (s), 1268 (s).
calc'd for C 2 4H 2 1N 2 0 3 [M+H]*: 385.1547,
found: 385.1551.
TLC (50% EtOAc in hexanes), Rf: 0.21 (UV).
5 Gore, V. G.; Narasimhan, N. S. J. Chem. Soc., Perkin Trans. 1 1988, 481.
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MeO N Ph
MeO
la
Tf20, 2-FPyr, CH2CI2;
pyridine N-oxide
-78 -- 23 'C
41%
0
MeO N 'Ph
MeO N
3ac
3,4-Dimethoxy-N-phenyl-N-(pyridin-2-yl)benzamide (3ac, Table 2):
Trifluoromethanesulfonic anhydride (38.2 [tL, 0.227 mmol, 1.10 equiv) was added via syringe
to a solution of 3,4-dimethoxy-N-phenylbenzamide 5 (1a, 52.7 mg, 0.206 mmol, 1 equiv) and 2-
fluoropyridine (21.2 [tL, 0.247 mmol, 1.20 equiv) in dichloromethane (1.0 mL) at -78 'C. After 2
min, the reaction mixture was warmed to 0 'C. After 5 min, pyridine N-oxide (39.2 mg, 0.412 mmol,
2.00 equiv) was added as a solid under an atmosphere of argon. After 5 min, the resulting mixture
was allowed to warm to 23 'C. After 3 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (40 -+ 60% ethyl acetate in
hexanes) to afford the amide 3ac (28.0 mg, 41%).
IH NMR (500 MHz, CDCl3 , 20 'C) 8: 8.43-8.42 (m, 1H), 7.67-7.64 (m, 1H), 7.35-7.32 (m,
2H), 7.24-7.21 (m, 2H), 7.18-7.10 (m, 4H), 7.03 (d, 1H,
J= 2.0 Hz), 6.70 (d, 1H, J= 8.0 Hz), 3.85 (s, 3H), 3.69
(s, 3H).
13C NMR (75 MHz, CDCl3, 20 'C) 8: 170.7, 157.0, 151.1, 149.3, 148.3,
128.0, 127.8, 126.8, 123.6, 122.2,
56.0, 55.9.
143.4, 138.0, 129.5,
121.4, 112.6, 110.2,
FTIR (neat) cm 1 3007 (w), 2936 (m), 1660 (s), 1585 (s), 1239 (s).
calc'd for C20H19N 203 [M+H]*: 335.1390,
found: 335.1381.
HRMS (ESI):
TLC (50% EtOAc in hexanes), Rf: 0.09 (UV).
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Ph N'Ph
H
lb
Tf20, 2-FPyr, CH2CI2;
isoquinoline N-oxide
-78 - 23 *C
74%
0
Ph N'Ph
N -
3ba
N-(Isoguinolin-1-yl)-N-phenylbenzamide 6 (3ba, Table 2):
Trifluoromethanesulfonic anhydride (49.2 tL, 0.292 mmol, 1.10 equiv) was added via syringe
to a solution of N-phenylbenzamide (1b, 52.3 mg, 0.265 mmol, 1 equiv) and 2-fluoropyridine (27.3
[tL, 0.318 mmol, 1.20 equiv) in dichloromethane (2.0 mL) at -78 'C. After 2 min, the resulting
mixture was warmed to 0 'C. After 5 min, isoquinoline N-oxide (77.0 mg, 0.530 mmol, 2.00 equiv)
was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was allowed to
warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the trifluoromethanesulfonate
salts, and the mixture was diluted by the addition of dichloromethane (10 mL). The reaction mixture
was washed with brine (10 mL), and the layers were separated. The aqueous layer was extracted with
dichloromethane (2 x 5 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The residue was purified by
flash column chromatography on silica gel
3ba6 (63.6 mg, 74%).
1 H NMR (500 MHz, (D3 C) 2SO, 20 'C) 6:
13C NMR (125 MHz, (D 3C) 2SO, 100 'C) 8:
FTIR (neat) cm 1:
HRMS (ESI):
(20 -- 30% ethyl acetate in hexanes) to afford the amide
8.34-8.28 (m, 1H), 8.22 (d, 1H, J= 8.3 Hz), 8.02 (d, 1H,
J= 8.2 Hz), 7.84-7.74 (m, 2H), 7.73-7.67 (m, 1H), 7.47
(s, 2H), 7.34-7.27 (in, 3H), 7.26-7.16 (m, 5H).
170.2, 153.8, 142.3, 140.8, 137.4, 135.7, 130.1, 129.7,
128.4, 128.0, 127.6, 127.3, 126.6, 126.1, 125.7, 124.4,
124.1, 120.5.
3059 (in), 1663 (s), 1584 (s), 1494 (s), 1386 (s).
calc'd for C22H17N20 [M+H]*: 325.1335,
found: 325.1345.
TLC (30% EtOAc in hexanes), Rf: 0.35 (UV).
6 Abrarnovitch, R. A.; Rogers, R. B.; Singer, G. M. J. Org. Chem. 1975, 40, 41.
30
0Ph N'Ph
H
lb
Tf2O, 2-FPyr, CH2Cl2;
quinoline N-oxide
-78 - 23 *C
35%
0
Ph )NPh
N
/ 3bb
N-(Quinolin-2-yl)-N-phenylbenzamide 6 (3bb, Table 2):
Trifluoromethanesulfonic anhydride (46.3 IAL, 0.275 mmol, 1.10 equiv) was added via syringe
to a solution of N-phenylbenzamide (1b, 49.0 mg, 0.250 mmol, 1 equiv) and 2-fluoropyridine (25.8
giL, 0.300 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 5 min, quinoline N-oxide (72.6 mg, 0.500 mmol, 2.00
equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was
allowed to warm to 23 'C. After 4 h, triethylamine (100 tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (20 -> 30% ethyl acetate in
hexanes) to afford the amide 3bb6 (28.2 mg, 35%).
'H NMR (300 MHz, CDCl3, 20 'C) 8:
13C NMR (125 MHz, CDCl 3, 20 'C) 8:
FTIR (neat) cm-1
HRMS (ESI):
8.09 (d, 1H, J= 8.7 Hz), 7.81-7.74 (m, 2H), 7.66-7.59
(m, 1H), 7.58-7.45 (m, 3H), 7.39-7.17 (m, 9H).
171.7, 155.6, 147.3, 142.7, 138.1, 136.4, 130.7, 130.0,
129.4, 129.3, 129.0, 128.1, 128.1, 127.5, 127.0, 126.6,
126.5, 120.0.
3062 (m), 1666 (s), 1594 (s), 1502 (s), 1301 (s).
calc'd for C22H17N20 [M+H]*: 325.1335,
found: 325.1343.
TLC (30% EtOAc in hexanes), Rf: 0.44 (UV).
31
0Ph N'Ph
H
1b
Tf20, 2-FPyr, CH2CI2;
pyridine N-oxide
-78 - 23 *C
40%
0
Ph N'Ph
N
3bc
N-(Pyridin-2-yl)-N-phenylbenzamide 7 (3be, Table 2):
Trifluoromethanesulfonic anhydride (48.1 [tL, 0.286 mmol, 1.10 equiv) was added via syringe
to a solution of N-phenylbenzamide (1b, 51.1 mg, 0.260 mmol, 1 equiv) and 2-fluoropyridine (26.8
tL, 0.312 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 5 min, pyridine N-oxide (49.5 mg, 0.520 mmol, 2.00
equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was
allowed to warm to 23 'C. After 4 h, triethylamine (100 tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (20 -> 50% ethyl acetate in
hexanes) to afford the amide 3bc 7 (28.4 mg, 40%).
'H NMR (500 MHz, CDCl 3, 20 'C) 8:
"C NMR (125 MHz, CDCl3, 20 'C) 8:
FTIR (neat) cm-1:
HRMS (ESI):
TLC (30% EtOAc in hexanes), Rf:
8.40 (d, 1H, J= 4.5 Hz), 7.65 (dt, 1H, J= 7.5, 2.0 Hz),
7.49 (d, 2H, J 6.0 Hz,), 7.36-7.29 (m, 3H), 7.28-7.20
(m, 4H), 7.18 (d, 2H, J= 7.5 Hz), 7.12-7.08 (m, 1H).
171.2, 156.6, 149.3, 142.9, 137.9, 136.2, 130.6, 129.4,
129.3, 128.2, 127.9, 127.0, 122.0, 121.5.
3060 (w), 1660 (s), 1582 (s), 1435 (m), 1348 (in).
calc'd for CI8H15N 20 [M+H]*: 275.1179,
found: 275.1185.
0.24 (UV).
7 Abramovitch, R. A.; Singer, G. M. J. Org. Chem. 1974, 39, 1795.
32
Tf2 0, 2-FPyr, CH 2 CI2 ;
isoquinoline N-oxide
-78 23 'C
99%
0
Me N'Ph
N 
10
3ca
N-(Isoguinolin-1-yl)-N-phenylacetamide (3ca, Table 2):
Trifluoromethanesulfonic anhydride (54.0 [tL, 0.321 mmol, 1.10 equiv) was added via syringe
to a solution of N-phenylacetamide (1c, 39.5 mg, 0.292 mmol, 1 equiv) and 2-fluoropyridine (30.2
[L, 0.351 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 5 min, isoquinoline N-oxide (84.8 mg, 0.584 mmol, 2.00
equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was
allowed to warm to 23 'C. After 4 h, triethylamine (100 RL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (30 -+ 50% ethyl acetate in
hexanes) to afford the amide 3ca (73.6 mg, 96%).
IH NMR (500 MHz, (D3C)2 SO, 80 OC)
13C NMR (125 MHz, (D 3C)2SO, 100 'C) 5:
FTIR (neat) cm-:
HRMS (ESI):
8.47 (d, 1H, J= 5.7 Hz), 8.18 (d, 1H, J = 8.4 Hz), 8.05
(d, 1H, J = 8.3 Hz), 7.89 (d, 1H, J= 5.7 Hz), 7.84-7.79
(m, 1H), 7.74-7.70 (m, LH), 7.46 (d, 2H, J = 7.8 Hz),
7.39-7.34 (m, 2H), 7.26-7.22 (m, 1H), 1.98 (s, 3H).
169.4, 153.4, 141.3, 141.0, 137.6, 130.3, 128.4, 128.1,
126.6, 126.2, 126.1, 124.6, 124.3, 120.9, 22.4.
3059 (m), 2932 (w), 1680 (s), 1495 (s), 1370 (s).
calc'd for C17H15N20 [M+H]*: 263.1179,
found: 263.1172.
TLC (50% EtOAc in hexanes), Rf: 0.24 (UV).
33
0
Me N'Ph
H
1iC
0Me N'Ph
H
1c
Tf20, 2-FPyr, CH2CI2;
quinoline N-oxide
-78 - 23 *C
33%
0
Me N'Ph
NA
| - 3cb
N-(Quinolin-2-yl)-N-phenylacetamide (3ch, Table 2):
Trifluoromethanesulfonic anhydride (57.7 [tL, 0.343 mmol, 1.10 equiv) was added via syringe
to a solution of N-phenylacetamide (1c, 42.1 mg, 0.311 mmol, 1 equiv) and 2-fluoropyridine (32.1
tL, 0.374 mmol, 1.20 equiv) in dichloromethane (1.75 mL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 5 min, quinoline N-oxide (90.4 mg, 0.623 mmol, 2.00
equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was
allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (20 -- 30% ethyl acetate in
hexanes) to afford the amide 3cb (26.7 mg, 33%).
H NMR (300 MHz, CDCl 3, 20 'C) 6: 8.13 (d, 1H, 8.7 Hz), 7.98 (d, 1H, 8.4 Hz), 7.80 (d,
= 7.8 Hz), 7.73-7.65 (m, 1H), 7.56-7.50 (m, 1H),
7.29 (m, 6H), 2.27 (s, 3H).
1H, J
7.46-
3 C NMR (75 MHz, CDCl 3, 20 'C) 8:
FTIR (neat) cm 1
HRMS (ESI):
171.6, 154.6, 147.1, 141.9, 138.2, 130.0, 129.6, 129.1,
128.6, 127.7, 127.5, 126.8, 126.7, 119.7, 24.7.
3062 (m), 2927 (w), 1682 (s), 1593 (s), 1501 (s), 1292
(s).
calc'd for C17Hi5N20 [M+H]*: 263.1179,
found: 263.1168.
TLC (70% EtOAc in hexanes), Rf: 0.64 (UV).
34
0Me N'Ph
H
1C
Tf20, 2,6-lut, CH 2CI 2;
pyridine N-oxide
-78 - 23 *C
67%
Me N'Ph
N-
3cc
N-(Pyridin-2-yl)-N-phenylacetamide 8 (3cc, Table 2):
Trifluoromethanesulfonic anhydride (48.3 [tL, 0.287 mmol, 1.10 equiv) was added via syringe
to a solution of N-phenylacetamide (1c, 35.3 mg, 0.261 mmol, 1 equiv) and 2,6-lutidine (36.5 [tL,
0.313 mmol, 1.20 equiv) in dichloromethane (1.75 mL) at -78 'C. After 2 min, the reaction mixture
was allowed to warm to 0 'C. After 5 min, pyridine N-oxide (49.7 mg, 0.522 mmol, 2.00 equiv) was
added as a solid under an argon atmosphere. After 5 min, the resulting mixture was allowed to warm
to 23 'C. After 4 h, triethylamine (100 tL) was added to quench the trifluoromethanesulfonate salts,
and the mixture was diluted by the addition of dichloromethane (10 mL). The reaction mixture was
washed with brine (10 mL), and the layers were separated. The aqueous layer was extracted with
dichloromethane (2 x 5 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The residue was purified by
flash column chromatography on silica
3cc 8 (42.1 mg, 67%).
H NMR (500 MHz, CDCl3, 20 'C) 5:
13C NMR (125 MHz, CDCl3, 20 'C) 8:
FTIR (neat) cm-1
HRMS (ESI):
TLC (70% EtOAc in hexanes), Rf:
gel (0 -- 50% ethyl acetate in hexanes) to afford the amide
8.44 (d, 1H, J= 5.0 Hz), 7.75-7.70 (m, 1H), 7.48 (d, 1H,
J= 7.5 Hz), 7.45-7.40 (m, 2H), 7.35 (d, 1H, J= 7.5 Hz),
7.32-7.29 (m, 2H), 7.16-7.12 (m, 1H), 2.12 (s, 3H,).
171.2, 155.4, 149.0, 142.2, 138.1, 129.7, 128.6, 127.8,
121.7, 121.4, 24.5.
3058 (w), 2920 (w), 1678 (s), 1585 (s), 1433 (s).
calc'd for C13H13N20 [M+H]*: 213.1022,
found: 213.1023.
0.35 (UV).
8 Manley, P. J.; Bilodeau, M. T. Org. Lett. 2002, 4, 3127.
35
0Ph N'Me
H
1d
Tf20, 2-FPyr, CH2CI2;
isoquinoline N-oxide
-78 - 23 'C
100%
0
Ph N'Me
N
3da
N-(Isoguinolin-1-yl)-N-methylbenzamide (3da, Table 2):
Trifluoromethanesulfonic anhydride (55.7 [tL, 0.331 mmol, 1.10 equiv) was added via syringe
to a solution of N-methylbenzamide (1d, 40.7 mg, 0.301 mmol, 1 equiv) and 2-fluoropyridine (31.0
[tL, 0.361 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 0C. After 2 min, the reaction
mixture was allowed to warm to 0 0C. After 5 min, isoquinoline N-oxide (87.4 mg, 0.602 mmol, 2.00
equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was
allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (30 -+ 50% ethyl acetate in
hexanes) to afford the amide 3da (79.0 mg, 100%).
'H NMR (300 MHz, CDCl3, 20 'C) 8:
3C NMR (75 MHz, CDCl3, 20 'C) 8:
FTIR (neat) cm-1:
HRMS (ESI):
8.31 (d, 1H, J= 5.5 Hz), 7.99 (d, 1H, J= 8.5 Hz), 7.78
(d, 1H, J= 8.5 Hz), 7.65-7.50 (m, 3H), 7.40-7.20 (m, 2
H), 7.15-6.90 (m, 3H), 3.63 (s, 3H).
171.8, 155.9, 141.5, 138.2, 136.2, 130.8, 130.0, 128.4,
128.1, 127.8, 127.3, 125.0, 124.5, 121.0, 37.2.
3058 (m), 2936 (w), 1651 (s), 1560 (s), 1363 (s).
calc'd for C17H 15N 20 [M+H]+: 263.1179,
found: 263.1179.
TLC (50% EtOAc in hexanes), Rf: 0.33 (UV).
36
0Ph N'Me
H
1d
Tf20, 2-FPyr, CH2CI2;
quinoline N-oxide
-78 - 23 *C
65%
0
Ph N'Me
S- 3db
N-(Quinolin-2-yl)-N-methylbenzamide (3db, Table 2):
Trifluoromethanesulfonic anhydride (41.9 tL, 0.249 mmol, 1.10 equiv) was added via syringe
to a solution of N-methylbenzamide (1d, 30.6 mg, 0.226 mmol, 1 equiv) and 2-fluoropyridine (23.4
[L, 0.272 mmol, 1.20 equiv) in dichloromethane (2.0 mL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 5 min, quinoline N-oxide (65.7 mg, 0.453 mmol, 2.00
equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was
allowed to warm to 23 'C. After 4 h, triethylamine (100 tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (10 -> 30% ethyl acetate in
hexanes) to afford the amide 3db (38.4 mg, 65%).
IH NMR (500 MHz, CDCl 3, 20 'C) 8:
13 C NMR (75 MHz, CDCl 3, 20 'C) 6:
FTIR (neat) cm-1
HRMS (ESI):
7.97 (d, 1H, J= 9.0 Hz), 7.84 (d, 1H, J= 9.0 Hz), 7.73-
7.69 (m, 2H), 7.52-7.48 (m, 1H), 7.45-7.42 (m, 2H),
7.35-7.31 (m, 1H), 7.25-7.21 (m, 2H), 6.91 (d, 1H, J=
9.0 Hz), 3.74 (s, 3H).
171.6, 156.0, 147.1, 137.1, 136.3, 130.7, 130.2, 128.9,
128.7, 128.4, 127.6, 126.5, 126.0, 120.3, 36.4.
3050 (m), 2918 (m), 1652 (s), 1595 (s), 1502 (m).
calc'd for C17Hi 5N20 [M+H]*: 263.1179,
found: 263.1182.
TLC (70% EtOAc in hexanes), Rf: 0.71 (UV).
37
0Ph N'Me
H
1d
Tf20, 2,6-lut, CH2CI2 ;
pyridine N-oxide
-78 - 23 'C
73%
0
Ph N'Me
N-
3dc
N-(Pyridin-2-yl)-N-methylbenzamide8 (3dc, Table 2):
Trifluoromethanesulfonic anhydride (48.1 tL, 0.286 mmol, 1.10 equiv) was added via syringe
to a solution of N-methylbenzamide (1d, 35.1 mg, 0.260 mmol, 1 equiv) and 2,6-lutidine (36.3 tL,
0.312 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2 min, the reaction mixture
was allowed to warm to 0 'C. After 5 min, pyridine N-oxide (49.4 mg, 0.519 mmol, 2.00 equiv) was
added as a solid under an argon atmosphere. After 5 min, the resulting mixture was allowed to warm
to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the trifluoromethanesulfonate salts,
and the mixture was diluted by the addition of dichloromethane (10 mL). The reaction mixture was
washed with brine (10 mL), and the layers were separated. The aqueous layer was extracted with
dichloromethane (2 x 5 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The residue was purified by
flash column chromatography on silica
3dC (40.4 mg, 73%).
IH NMR (500 MHz, CDCl3, 20 'C) 8:
13C NMR (125 MHz, CDCl3, 20 'C) 6:
FTIR (neat) cm 1
HRMS (ESI):
TLC (70% EtOAc in hexanes), Rf:
gel (0 -+ 50% ethyl acetate in hexanes) to afford the amide
8.46-8.44 (m, 1H), 7.46-7.42 (m, 1H), 7.36-7.29 (m,
3H), 7.25-7.20 (m, 2H), 7.06-7.02 (m, 1H), 6.81 (d, 1H,
J= 8.0 Hz), 3.60 (s, 3H).
171.2, 156.9, 148.9, 137.5, 136.2, 130.3, 128.7, 128.2,
121.8, 121.1, 36.2.
3058 (w), 2931 (w), 1651 (s), 1587 (s), 1359 (s).
calc'd for C13H 13N 20 [M+H]*: 213.1022,
found: 213.1022.
0.45 (UV).
38
o / OMe
NI H
Br
le
Tf20, 2-FPyr, CH2CI2;
isoquinoline N-oxide
-78 -+ 23 *C
77%
o / OMe
N
Br N
3ea
4
-Bromo-N-(isoquinolin-1-yl)-N-(4-methoxyphenyl)benzamide (3ea, Table 2):
Trifluoromethanesulfonic anhydride (32.0 [tL, 0.190 mmol, 1.10 equiv) was added via syringe
to a solution of 4-bromo-N-(4-methoxyphenyl)benzamide 9 (le, 52.9 mg, 0.173 mmol, 1 equiv) and 2-
fluoropyridine (17.9 iL, 0.208 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, isoquinoline N-oxide (50.2 mg,
0.346 mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (10 -- 50% ethyl acetate in
hexanes) to afford the amide 3ea (57.7 mg, 77%).
IH NMR (300 MHz, CDCl 3, 20 'C) 6:
13 C NMR (125 MHz, (D 3C) 2 SO, 20 'C) 8:
FTIR (neat) cm 1
HRMS (ESI):
TLC (50% EtOAc in hexanes), Rf:
8.34 (d, 1H, J= 4.8 Hz), 8.15 (d, 1H, J= 8.1 Hz), 7.85
(d, 1H, J= 8.1 Hz), 7.72-7.56 (m, 3H), 7.46-7.24 (in,
4H), 7.20 (d, 2H, J= 7.8 Hz), 6.83 (d, 2H, J= 8.7 Hz),
3.76 (s, 3H).
169.3, 157.4, 153.7, 140.8, 137.5, 135.0, 134.8, 130.4,
130.2, 129.5, 128.0, 127.5, 126.6, 124.2, 124.2, 123.2,
120.5, 114.0, 54.9.
3057 (m), 2933 (w), 1660 (s), 1509 (s), 1248 (s).
calc'd for C2 3Hi 8BrN2 0 2 [M+H]*: 433.0546,
found: 433.0545.
0.45 (UV).
9 Yang, K.; He, X.; Ha-soon, C.; Wang, Z.; Woodmansee, D. H.; Liu, H. Tetrahedron Lett. 2008, 49, 1725.
39
o EA OMe
N~
Br le
Tf20, 2-FPyr, CH2C2;
quinoline N-oxide
-78 - 23 'C
43%
o N OMe
NN
Br N
|./ 3eb
4
-Bromo-N-(guinolin-2-y)-N-(4-methoxyphenyl)benzamide (3eb, Table 2):
Trifluoromethanesulfonic anhydride (30.8 [tL, 0.183 mmol, 1.10 equiv) was added via syringe
to a solution of 4-bromo-N-(4-methoxyphenyl)benzamide 9 (1e, 51.0 mg, 0.167 mmol, 1 equiv) and 2-
fluoropyridine (17.2 tL, 0.200 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, quinoline N-oxide (48.3 mg,
0.333 mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column
hexanes) to afford the amide 3eb (30.7 mg,
IH NMR (500 MHz, CDCl 3, 20 'C) 6:
13C NMR (75 MHz, CDCl3, 20 'C) 8:
FTIR (neat) cm 1:
HRMS (ESI):
TLC (30% EtOAc in hexanes), Rf:
chromatography on silica gel (5 -- 30% ethyl acetate in
43%).
8.08 (d, 1H, J= Hz), 7.78-7.72 (m, 1H), 7.65-7.58 (in,
1H), 7.54-7.46 (m, 1H), 7.42-7.25 (m, 6H), 7.18-7.12
(m, 2H), 6.95-6.83 (m, 2H), 3.79 (s, 3H).
170.7, 158.6, 155.3, 147.1, 138.3, 135.4, 135.1, 131.4,
130.8, 130.1, 129.2, 129.0, 127.5, 126.7, 126.5, 125.0,
119.5, 114.8, 55.6.
3062 (w), 2956 (w), 1663 (s), 1509 (s), 1247 (s).
calc'd for C23H18BrN20 2 [M+H]*: 433.0546,
found: 433.0546.
0.39 (UV).
40
o OMe
* N4
Br
le
Tf2O, 2-FPyr, CH 2Cl 2;
pyridine N-oxide
-78 -- 23 *C
39%
o - OMe
Br N
3ec
4-Bromo-N-(pyridin-2-yl)-N-(4-methoxyphenyl)benzamide (3ec, Table 2):
Trifluoromethanesulfonic anhydride (37.4 tL, 0.222 mmol, 1.10 equiv) was added via syringe
to a solution of 4-bromo-N-(4-methoxyphenyl)benzamide 9 (le, 61.8 mg, 0.202 mmol, 1 equiv) and 2-
fluoropyridine (20.8 ptL, 0.242 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, pyridine N-oxide (38.4 mg,
0.404 mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (20 -- 30% ethyl acetate in
hexanes) to afford the amide 3ec (29.9 mg, 39%).
IH NMR (300 MHz, CDCl3, 20 'C) 8:
13C NMR (125 MHz, CDCl3, 20 'C) 8:
FTIR (neat) cm-1
HRMS (ESI):
TLC (30% EtOAc in hexanes), Rf:
8.39 (dd, 1H, J= 4.8, 1.5 Hz), 7.67 (dt, 1H, J= 8.1, 2.1
Hz), 7.40-7.32 (m, 4H), 7.24 (d, 1H, J= 8.1 Hz), 7.14-
7.07 (m, 3H), 6.85 (d, 2H, J= 8.7 Hz), 3.79 (s, 3H).
170.2, 158.5, 156.4, 149.2, 138.0, 135.3, 135.2, 131.4,
130.8, 129.1, 125.0, 121.5, 121.5, 114.8, 55.6.
3055 (m), 2933 (m), 1662 (s), 1509 (s), 1247 (s).
calc'd for C19HI 6BrN20 2 [M+H]*: 383.0390,
found: 383.0391.
0.14 (UV).
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0N'' PrI H
0 2 N i1f
Tf2O, 2-FPyr, CH2Cl2;
isoquinoline N-oxide
-78 - 23 *C
90%
0
N')Pr
O2N N
3fa
N-(Isoguinolin-1-yl)-N-isopropyl-4-nitrobenzamide (3fa, Table 2):
Trifluoromethanesulfonic anhydride (44.3 tL, 0.263 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-4-nitrobenzamidel (1f, 49.7 mg, 0.239 mmol, 1 equiv) and 2-
fluoropyridine (24.6 tL, 0.286 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, isoquinoline N-oxide (69.2 mg,
0.477 mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (10 -+ 20% ethyl acetate in
hexanes) to afford the amide 3fa (72.0 mg, 90%).
IH NMR (500 MHz, CDCl 3, 20 'C) 6:
13C NMR (125 MHz, CDC13, 20 'C) 6:
FTIR (neat) cm 1:
HRMS (ESI):
TLC (30% EtOAc in hexanes), Rf:
8.43 (d, 1H, J= 5.5 Hz), 7.92 (d, 1H, J= 8.5 Hz), 7.78
(d, 2H, J= 8.5 Hz), 7.72 (d, 1H, J= 8.0 Hz), 7.63-7.54
(m, 3H), 7.39 (d, 2H, J= 8.5 Hz), 5.15-5.05 (m, 1H),
1.65 (d, 3H, J= 6.5 Hz), 1.14 (d, 3H, J= 6.5 Hz).
168.8, 152.9, 147.9, 143.5, 141.5, 138.1, 131.0, 128.9,
128.6, 127.4, 127.2, 124.6, 122.8, 121.7, 50.9, 22.2,
19.7.
3057 (w), 2977 (m), 1651 (s), 1523 (s), 1346 (s).
calc'd for C19H18N30 3 [M+H]*: 336.1343,
found: 336.1353.
0.30 (UV).
to Van den Hoven, B. G.; Alper, H. J. Am. Chem. Soc. 2001, 123, 10214.
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0N Pr Tf20, 2-FPyr, CH 2 Cl2;
0 2 N& 3fc,if pyridine N-oxide
-78 - 23 *C
33%
0
O2N 
N'Pr
02N 3
3fc
N-(Pyridin-2-yl)-N-isopropyl-4-nitrobenzamide (3fc, Table 2):
Trifluoromethanesulfonic anhydride (45.1 tL, 0.268 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-4-nitrobenzamidel (If, 50.7 mg, 0.244 mmol, 1 equiv) and 2-
fluoropyridine (25.1 iL, 0.292 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, pyridine N-oxide (46.3 mg,
0.487 mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 ptL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (0 -> 20% ethyl acetate in
hexanes) to afford the amide 3fc (51.6 mg, 74%).
'H NMR (500 MHz, CDCl 3, 20 'C) 6:
13C NMR (125 MHz, CDCl3, 20 'C) 6:
FTIR (neat) cm-1:
HRMS (ESI):
TLC (30% EtOAc in hexanes), Rf:
8.47-8.43 (in, 1H), 8.01 (d, 2H, J= 8.4 Hz), 7.56-7.48
(in, 1H), 7.43 (d, 2H, J= 8.4 Hz), 7.16-7.10 (m, 1H),
6.86 (d, 1H, J= 8.1 Hz), 5.12-4.98 (m, 1H), 1.34 (d, 6H,
J= 6.9 Hz).
168.3, 153.7, 149.5, 148.0, 143.5, 138.0, 129.3, 124.8,
123.2, 122.9, 49.3, 21.1.
3075 (w), 2976 (m), 1651 (s), 1522 (s), 1346 (s).
calc'd for C15Hi 6N 30 3 [M+H]*: 286.1186,
found: 286.1182.
0.21 (UV).
43
0
MeO N iPr
MeO
ig
Tf20, 2-FPyr, CH2CI2;
isoquinoline N-oxide
-78 - 23 'C
95%
0
MeO N Pr
MeO N
N 
3ga
N-(Isoguinolin-1-yl)-N-isopropyl-3,4-dimethoxybenzamide (3ga, Table 2):
Trifluoromethanesulfonic anhydride (41.9 [tL, 0.249 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-3,4-dimethoxybenzamide 1 (1g, 50.5 mg, 0.226 mmol, 1 equiv) and 2-
fluoropyridine (23.3 [tL, 0.271 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at 0 'C. After 7 min,
isoquinoline N-oxide (65.7 mg, 0.452 mmol, 2.00 equiv) was added as a solid under an argon
atmosphere. After 5 min, the resulting mixture was allowed to warm to 23 'C. After 4 h,
triethylamine (100 tL) was added to quench the trifluoromethanesulfonate salts, and the mixture was
diluted by the addition of dichloromethane (10 mL). The reaction mixture was washed with brine (10
mL), and the layers were separated. The aqueous layer was extracted with dichloromethane (2 x 5
mL). The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and
were concentrated under reduced pressure. The residue was purified by flash column
chromatography on silica gel (50% ethyl acetate in hexanes) to afford the amide 3ga (75.3 mg, 95%).
'H NMR (500 MHz, CDCl3, 20 'C) 6:
13C NMR (125 MHz, CDCl3, 20 'C) 6:
FTIR (neat) cm 1:
HRMS (ESI):
TLC (70% EtOAc in hexanes), Rf:
8.45 ( d, 1H, J= 5.5 Hz), 7.93 (d, 1H, J= 8.5 Hz), 7.72
(d, 1H, J= 8.0 Hz), 7.59-7.53 (m, 2H), 7.51-7.46 (m,
1H), 6.91 (d, 1H, J= 8.5 Hz), 6.79 (s, 1H), 6.43 (d, 1H,
J = 8.5 Hz), 5.19-5.07 (m, 1H), 3.65 (s, 3H), 3.56 (s,
3H), 1.63 (br s, 3H), 1.13 (br s, 3H).
170.5, 154.6, 150.0, 147.7, 141.3, 138.1, 130.6, 130.0,
128.1, 127.5, 127.1, 125.3, 122.1, 121.1, 111.6, 109.9,
55.8, 55.8, 50.8, 22.5, 19.8.
3057 (w), 2971 (m), 2934 (m), 1640 (s), 1516 (s), 1264
(s).
calc'd for C 2 1H 2 3N 2 0 3 [M+H]*: 351.1703,
found: 351.1703.
0.46 (UV).
" AIjundi, F.; Hannig, E.; Boehm, R. Pharmazie 1973, 28, 362.
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0
MeO N Pr
MeO 1g
Tf20, 2-FPyr, CH2Cl2;
quinoline N-oxide
0 - 23 *C
30%
0
MeO I z N 'Pr
MeO N
/ 3gb
N-(Quinolin-2-yl)-N-isopropyl-3,4-dimethoxybenzamide (3gb, Table 2):
Trifluoromethanesulfonic anhydride (40.6 [tL, 0.241 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-3,4-dimethoxybenzamide" (1g, 49.0 mg, 0.219 mmol, 1 equiv) and 2-
fluoropyridine (22.6 [tL, 0.263 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at 0 'C. After 7 min,
quinoline N-oxide (63.7 mg, 0.439 mmol, 2.00 equiv) was added as a solid under an argon
atmosphere. After 5 min, the resulting mixture was allowed to warm to 23 'C. After 4 h,
triethylamine (100 [tL) was added to quench the trifluoromethanesulfonate salts, and the mixture was
diluted by the addition of dichloromethane (10 mL). The reaction mixture was washed with brine (10
mL), and the layers were separated. The aqueous layer was extracted with dichloromethane (2 x 5
mL). The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and
were concentrated under reduced pressure. The residue was purified by flash column
chromatography on silica gel (20 - 50% ethyl acetate in hexanes) to afford the amide 3gb (23.1 mg,
30%).
'H NMR (300 MHz, CDCl3, 20 'C) 8:
13C NMR (125 MHz, CDCl3, 20 'C) 8:
FTIR (neat) cm-1
HRMS (ESI):
8.03 (d, 1H, J= 9.0 Hz), 7.85 (d, 1H, J= 8.7 Hz), 7.76-
7.68 (m, 2H), 7.52 (dt, 1H, J= 6.9, 1.2 Hz), 6.98-6.89
(m, 2H), 6.80 (d, 1H, J= 8.7 Hz), 6.54 (d, 1H, J= 8.4
Hz), 5.25-5.15 (m, 1H), 3.75 (s, 3H), 3.56 (s, 3H), 1.43
(d, 6H, J= 6.9 Hz).
170.0, 155.2, 150.4, 148.2, 147.2, 137.2, 130.1, 129.6,
129.2, 127.5, 126.8, 126.3, 123.2, 122.8, 112.2, 110.1,
55.9, 55.8, 50.2, 21.3.
3063 (w), 2969 (m), 2934 (in), 1647 (s), 1594 (s), 1264
(s).
calc'd for C 2 1H 2 3N 2 0 3 [M+H]*: 351.1703,
found: 351.1702.
TLC (70% EtOAc in hexanes), Rf: 0.52 (UV).
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0
MeO N')Pr
I H
MeO
1g
Tf20, 2-FPyr, CH2CI2;
pyridine N-oxide
0 - 23 *C
48%
0
MeO N' Pr
MeO N
'3g
3gc
N-(Pyridin-2-yl)-N-isopropyl-3,4-dimethoxybenzamide (3gc, Table 2):
Trifluoromethanesulfonic anhydride (40.9 tL, 0.243 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-3,4-dimethoxybenzamide 1 (1g, 49.3 mg, 0.221 mmol, 1 equiv) and 2-
fluoropyridine (22.8 [L, 0.265 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at 0 'C. After 7 min,
pyridine N-oxide (42.0 mg, 0.442 mmol, 2.00 equiv) was added as a solid under an argon
atmosphere. After 5 min, the resulting mixture was allowed to warm to 23 'C. After 4 h,
triethylamine (100 [tL) was added to quench the trifluoromethanesulfonate salts, and the mixture was
diluted by the addition of dichloromethane (10 mL). The reaction mixture was washed with brine (10
mL), and the layers were separated. The aqueous layer was extracted with dichloromethane (2 x 5
mL). The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and
were concentrated under reduced pressure. The residue was purified by flash column
chromatography on alumina (30 -- 40% ethyl acetate in hexanes) to afford the amide 3gc (31.8 mg,
48%).
IH NMR (500 MHz, CDCl 3, 20 'C) b:
13C NMR (125 MHz, CDCl3, 20 'C) 8:
FTIR (neat) cm 1
HRMS (ESI):
8.54-8.47 (m, 1H), 7.51-7.44 (m, 1H), 7.13-7.07 (m,
1H), 6.91-6.83 (m, 2H), 6.75 (d, 1H, J= 8.4 Hz), 6.61
(d, 1H, J = 8.7 Hz), 5.13-5.00 (m, 1H), 3.80 (s, 3H),
3.70 (s, 3H), 1.34 (d, 6H, J= 7.2 Hz).
170.0, 155.7, 150.3, 149.0, 148.2, 137.7, 129.6, 125.2,
122.5, 121.9, 112.1, 110.1, 56.0, 55.9, 49.5, 21.2.
2970 (m), 2934 (m), 1643 (s), 1585 (s), 1270 (s).
calc'd for C 1 7H2 1N 2 0 3 [M+H]*: 301.1547,
found: 301.1534.
TLC (70% EtOAc in hexanes), Rf: 0.27 (UV).
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Tf20, 2-FPyr, CH2CI2;
isoquinoline N-oxide
-78 - 23 OC
93%
Me N
MeN
3ha
N-Cyclohexenyl-N-(isoguinolin-1-yl)-2-methylbutanamide (3ha, Table 2):
Trifluoromethanesulfonic anhydride (50.2 [tL, 0.298 mmol, 1.10 equiv) was added via syringe
to a solution of (±)-N-cyclohexenyl-2-methylbutanamide1 2 (1h, 49.1 mg, 0.271 mmol, 1 equiv) and 2-
fluoropyridine (27.9 iL, 0.325 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, isoquinoline N-oxide (78.7 mg,
0.542 mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 iL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (10 -+ 50% ethyl acetate in
hexanes) to afford the amide 3ha (77.7 mg, 93%).
IH NMR (500 MHz, (D 3C) 2SO, 100 'C) 6:
13C NMR (125 MHz, (D 3C)2 SO, 100 'C) 6:
FTIR (neat) cm-1
HRMS (ESI):
TLC (50% EtOAc in hexanes), Rf:
8.40 (d, 1H, J= 5.7 Hz), 8.06-7.96 (m, 2H), 7.85-7.76
(in, 2H), 7.74-7.67 (m, 1H), 5.67 (br s, 1H), 2.99 (br s,
1H), 2.51-2.20 (m, 3H), 2.12-1.83 (m, 2H), 1.75-1.25
(m, 5H), 1.06 (d, 3H, J = 6.4 Hz), 0.83 (t, 3H, J= 7.3
Hz).
175.7, 153.4, 140.8, 139.0, 137.3, 130.1, 128.7, 127.7,
126.6, 124.8, 124.2, 120.4, 27.9, 26.4, 24.8, 23.8, 22.0,
20.7, 17.0, 11.0.
3055 (w), 2964 (s), 1673 (s), 1461 (m), 1384 (s).
calc'd for C20H 25N 20 [M+H]*: 309.1961,
found: 309.1949.
0.61 (UV).
12 Movassaghi, M.; Hill, M. D.; Ahmad, 0. K. J. Am. Chem. Soc. 2007, 129, 10096.
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0
Me N
Me H
1h
Me N
Me
1h
Tf20, 2-FPyr, CH2CI2;
quinoline N-oxide
-78 - 23 *C
77% 3hb
N-Cyclohexenyl-2-methyl-N-(guinolin-2-yl)butanamide (3hb, Table 2):
Trifluoromethanesulfonic anhydride (51.3 tL, 0.3 05 mmol, 1.10 equiv) was added via syringe
to a solution of N-cyclohexenyl-2-methylbutanamide12 (1h, 50.2 mg, 0.277 mmol, 1 equiv) and 2-
fluoropyridine (28.5 tL, 0.332 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, quinoline N-oxide (80.4 mg,
0.554 mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (5 -- 30% ethyl acetate in
hexanes) to afford the amide 3hb as an equal mixture of atropisomers (65.7 mg, 77%).
H NMR (300 MHz, CDCl3, 20 'C, equal mixture of atropisomers) 8: 8.70 (d, 1H, J= 2.7 Hz), 8.12-
8.03 (m, 2H), 7.98-7.93 (m, 1H), 7.85-7.81 (m, 1H),
7.80-7.74 (m, 2H), 7.70-7.59 (m, 2H), 7.54-7.45 (m,
3H), 5.78-5.73 (m, 1H), 4.85-4.80 (m, 1H), 2.97-2.73
(m, 2H), 2.37-2.26 (m, 2H), 2.23-2.14 (m, 2H), 2.09-
2.00 (m, 2H), 1.97-1.40 (m, 14H), 1.33 (d, 3H, J= 6.9
Hz), 1.22 (d, 3H, J= 6.9 Hz), 1.03 (t, 3H, J= 7.5 Hz),
0.92 (t, 3H, J= 7.5 Hz).
13 C NMR (75 MHz, CDCl3, 20 'C, equal mixture of atropisomers) 6:
147.1, 146.9, 145.5, 142.7,
129.0, 128.7, 128.5, 127.7,
126.2, 126.0, 119.3, 108.4,
27.2, 25.1, 24.3, 23.0, 22.8,
12.4.
178.5, 164.8, 154.3, 147.4,
139.7, 137.6, 129.7, 129.2,
127.6, 127.4, 127.0, 126.5,
40.4, 35.8, 29.2, 29.1, 28.1,
22.4, 21.8, 19.1, 18.3, 12.7,
FTIR (neat) cm-1: 3060 (w), 2963 (s), 1683 (s), 1597 (s), 1502 (s), 1225
(s).
HRMS (ESI): calc'd for C20H25N20 [M+H]: 309.1961,
found: 309.1961.
TLC (30% EtOAc in hexanes), Rf: 0.67 (UV).
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0Me N
Me
1h
Tf20, 2,6-lut, CH 2CI2;
pyridine N-oxide
-78 - 23 'C
42%
Me N
Me
3hc
N-Cyclohexenyl-2-methyl-N-(pyridin-2-yl)butanamide (3hc, Table 2):
Trifluoromethanesulfonic anhydride (46.1 [tL, 0.274 mmol, 1.10 equiv) was added via syringe
to a solution of N-cyclohexenyl-2-methylbutanamide 2 (1h, 45.1 mg, 0.249 mmol, 1 equiv) and 2,6-
lutidine (34.8 [tL, 0.299 mmol, 1.20 equiv) in dichloromethane (1.75 mL) at -78 'C. After 2 min, the
reaction mixture was allowed to warm to 0 'C. After 5 min, pyridine N-oxide (47.3 mg, 0.498 mmol,
2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was
allowed to warm to 23 'C. After 4 h, triethylamine (100 tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (0 -> 30% ethyl acetate in
hexanes) to afford the amide 3hc (27.3 mg, 42%).
'H NMR (500 MHz, CDCl3, 20 'C) 8:
13C NMR (125 MHz, CDCl 3, 20 'C) 8:
FTIR (neat) cm 1
HRMS (ESI):
TLC (30% EtOAc in hexanes), Rf:
8.47-8.43 (in, 1H), 7.71-7.65 (m, 1H), 7.42 (d, 1H, J=
7.3 Hz), 7.14-7.09 (m, 1H), 5.77 (br s, 1H), 2.71 (br s,
1H), 2.19 (br s, 4H), 1.84-1.58 (m, 5H), 1.48-1.38 (m,
1H), 1.17 (d, 3H, J= 6.7 Hz), 0.92 (t, 3H, J= 7.4 Hz).
177.8, 154.8, 148.9, 139.4, 137.7, 127.5, 121.3, 121.1,
40.0, 29.1, 28.1, 25.1, 23.0, 21.8, 18.4, 12.4.
2933 (in), 2875 (w), 1667 (s), 1586 (s), 1432 (s).
calc'd for Ci 6H23N20 [M+H]*: 259.1805,
found: 259.1812.
0.25 (UV).
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Me Tf20, 2-FPyr, CH2CI2; Me N
Me isoquinoline N-oxide MeN
1h, 98% ee -78 - 23 
*
88% (+)-3ha, 98% ee
(S)-(+)-N-Cyclohexenyl-N-(isoquinolin-1-yl)-2-methylbutanamide ((+)-3ha, Equation 1):
Trifluoromethanesulfonic anhydride (44.1 [tL, 0.262 mmol, 1.10 equiv) was added via syringe
to a solution of (S)-N-cyclohexenyl-2-methylbutanamide 12 (1h, 43.2 mg, 0.238 mmol, 1 equiv) and 2-
fluoropyridine (24.6 tL, 0.286 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, isoquinoline N-oxide (69.2 mg,
0.477 mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (10 -+ 50% ethyl acetate in
hexanes) to afford the amide (+)-3ha (77.7 mg, 93%). The enantiomeric excess of the product amide
was determined to be 98% by chiral HPLC analysis [Whelk-O (R,R); 0.5 mL/min; 3% 'PrOH in
hexanes; tR (minor) = 69.3 min, tR (major) = 74.5 min]. The enantiomeric excess of the starting
material amide was determined to be 98% by chiral HPLC analysis [Whelk-O (S,S); 0.8 mL/min; 3%
'PrOH in hexanes; tR (major) = 37.7 min, tR (minor) = 42.3 min]. (S)-(+)-3ha: [a] 2 0 D = +98.3 (c 0.480,
CHCl3). See page 47 for complete characterization data for amide 3ha.
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Tf20, 2-FPyr, CH2CI2;
4-methoxypyridine
N-oxide
-78 - 23 *C
75%
0
Ph N'Me
PhN
OMe
3dd
N-(4-Methoxypyridin-2-yl)-N-methylbenzamide (3dd, Equation 2):
Trifluoromethanesulfonic anhydride (46.0 ItL, 0.273 mmol, 1.10 equiv) was added via syringe
to a solution of N-methylbenzamide (ld, 33.6 mg, 0.249 mmol, 1 equiv) and 2-fluoropyridine (25.6
iL, 0.298 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 5 min, 4-methoxypyridine N-oxide (62.2 mg, 0.497
mmol, 2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting
mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL) was added to quench the
trifluoromethanesulfonate salts, and the mixture was diluted by the addition of dichloromethane (10
mL). The reaction mixture was washed with brine (10 mL), and the layers were separated. The
aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on alumina (10 -+ 20% ethyl acetate in
hexanes) to afford the amide 3dd (44.9 mg, 75%).
IH NMR (500 MHz, CDCl3, 20 'C) 6:
13C NMR (125 MHz, CDCl 3, 20 'C) 6:
FTIR (neat) cm-1
HRMS (ESI):
TLC (50% EtOAc in hexanes), Rf:
8.22 (d, 1H, J = 6.0 Hz), 7.38-7.28 (m, 3H), 7.26-7.20
(m, 2H), 6.57 (dd, 1H, J= 6.0, 2.5 Hz), 6.28 (d, 1H, J=
2.5 Hz), 3.56 (s, 3H), 3.55 (s, 3H).
171.2, 166.6, 158.4, 149.6, 136.3, 130.3, 128.5, 128.2,
108.4, 107.3, 55.4, 36.1.
3061 (w), 2941 (w), 1652 (s), 1595 (s), 1362 (s).
calc'd for C 14Hi 5N2 0 2 [M+H]+: 243.1128,
found: 243.1133.
0.28 (UV).
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Ph N'Me
H
id
Tf20, 2-FPyr, CH2Cl2;
4-nitropyridine
N-oxide
-78 - 23 'C
67%
0
Ph N'Me
Ph N
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N-(4-Nitropyridin-2-yl)-N-methylbenzamide (3de, Equation 3):
Trifluoromethanesulfonic anhydride (44.1 [tL, 0.262 mmol, 1.10 equiv) was added via syringe
to a solution of N-methylbenzamide (1d, 32.2 mg, 0.238 mmol, 1 equiv) and 2-fluoropyridine (24.6
tL, 0.286 mmol, 1.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 5 min, 4-nitropyridine N-oxide (66.7 mg, 0.476 mmol,
2.00 equiv) was added as a solid under an argon atmosphere. After 5 min, the resulting mixture was
allowed to warm to 23 'C. After 4 h, triethylamine (100 ptL) was added to quench the
trifluoromethanesulfonate salts, and the resulting mixture was concentrated under reduced pressure.13
The residue was purified by flash column chromatography on silica gel (10 -+ 30% ethyl acetate in
hexanes) to afford the amide 3de (40.8 mg, 67%).
'H NMR (500 MHz, CDCl3, 20 'C) 8: 8.66 (d, 1H, J= 5.0 Hz), 7.93
7.71 (m, 1H), 7.46-7.40 (m,
3.62 (s, 3H).
(d, 1H, J= 1.5 Hz), 7.75-
3H), 7.38-7.33 (m, 2H),
13C NMR (125 MHz, CDCl 3, 20 C) 6:
FTIR (neat) cm :
HRMS (ESI):
171.9, 158.3, 154.5, 150.3, 135.6, 131.2, 128.8, 128.3,
113.2, 112.7, 36.6.
3090 (w), 2923 (w), 1663 (s), 1534 (s), 1356 (s).
calc'd for C13H12N 3 0 3 [M+H]*: 258.0873,
found: 258.0883.
TLC (30% EtOAc in hexanes), Rf: 0.38 (UV).
13 In the case of amide 3de, aqueous work-up resulted in a decreased isolated yield (60%).
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Product Inhibition Studies:
0 0
N'' Pr Tf20, 2-FPyr, CH2Cl2; N PrH
O2N 3fa' 0 2N N --if isoquinoline N-oxide
-78 -+ 23 *C
92% 3fa
N-(Isoguinolin-1-yl)-N-isopropyl-4-nitrobenzamide:
Trifluoromethanesulfonic anhydride (22.6 [tL, 0.134 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-4-nitrobenzamide 0 (If, 25.4 mg, 0.122 mmol, 1 equiv) and 2-
fluoropyridine (12.5 tL, 0.146 mmol, 1.20 equiv) in dichloromethane (0.75 mL) at -78 'C. After 2
min, the reaction mixture was warmed to 0 'C. After 5 minutes, a solution of amide 3fa (38.2 mg,
0.114 mmol, 1.00 equiv) in dichloromethane (0.75 mL) was added via cannula followed by addition
of isoquinoline N-oxide (35.4 mg, 0.244 mmol, 2.00 equiv) as a solid under an argon atmosphere.
After 5 min, the reaction mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 [tL)
was added to quench the trifluoromethanesulfonate salts, and the mixture was diluted by the addition
of dichloromethane (10 mL). The reaction mixture was washed with brine (10 mL), and the layers
were separated. The aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined
organic layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under
reduced pressure. The residue was purified by flash column chromatography on silica gel (10 -+
20% ethyl acetate in hexanes) to afford the amide 3fa (75.7 mg). This corresponded to 37.5 mg
(92%) of newly formed amide 3fa. See page 42 for complete characterization data for amide 3fa.
0 0
0 N Pr Tf20, 2-FPyr, CH2Cl2 O2 N N Pr
&2  - 3fc, &'.
1f pyridine N-oxide 0 2 N N
-78 - 23 C
33% 3fc
N-(Pyridin-2-yl)-N-isopropyl-4-nitrobenzamide:
Trifluoromethanesulfonic anhydride (33.5 [tL, 0.199 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-4-nitrobenzamidel 0 (If, 37.7 mg, 0.181 mmol, 1 equiv) and 2-
fluoropyridine (18.6 tL, 0.217 mmol, 1.20 equiv) in dichloromethane (0.75 mL) at -78 'C. After 2
min, the reaction mixture was warmed to 0 'C. After 5 minutes, a solution of amide 3fc (51.6 mg,
0.181 mmol, 1.00 equiv) in dichloromethane (1.0 mL) was added via cannula followed by addition of
pyridine N-oxide (34.4 mg, 0.362 mmol, 2.00 equiv) as a solid under an argon atmosphere. After 5
min, the reaction mixture was allowed to warm to 23 'C. After 4 h, triethylamine (100 tL) was
added to quench the trifluoromethanesulfonate salts, and the mixture was diluted by the addition of
dichloromethane (10 mL). The reaction mixture was washed with brine (10 mL), and the layers were
separated. The aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined
organic layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under
reduced pressure. The residue was purified by flash column chromatography on silica gel (15 ->
20% ethyl acetate in hexanes) to afford the amide 3fc (68.8 mg). This corresponded to 17.2 mg
(33%) of newly formed amide 3fc. See page 43 for complete characterization data for amide 3fc.
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React-IR Monitoring of Reactions:
All reactions were performed in a reaction vessel under an atmosphere of argon with the
React-IR probe completely submerged in the reaction mixture.
0 0
Ph N'Me Tf20, 2-FPyr, CH2C2 Ph N'MeH
1d isoquinoline N-oxide N
-78 - 23 C 
85% 3da
In situ IR Analysis of the Conversion of Amide ld to Amide 3da:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (70.0 tL, 0.416
mmol, 1.1 equiv) via syringe to a solution of N-methylbenzamide (1d, 51.1 mg, 0.378 mmol, 1 equiv)
and 2-fluoropyridine (39.0 [tL, 0.454 mmol, 1.2 equiv) in dichloromethane (4.5 mL) at 0 'C revealed
within 1 min complete consumption of the starting material amide (cm-1) and appearance of a
persistent absorption at 2370 cm I, corresponding to an activated compound. After 5 min,
isoquinoline N-oxide (109.8 mg, 0.756 mmol, 2.00 equiv) was added as a solid, resulting in
immediate consumption of the activated compound and appearance of a persistent absorption at 1691
cm , corresponding to a protonated amide 3da. After 3 h, triethylamine (100 iL) was added to
quench the trifluoromethanesulfonate salts, and the mixture was diluted by the addition of
dichloromethane (10 mL). The reaction mixture was washed with brine (10 mL), and the layers were
separated. The aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined
organic layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under
reduced pressure. The residue was purified by flash column chromatography on silica gel (30 -
50% ethyl acetate in hexanes) to afford the amide 3da (84.3 mg, 85%).
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React-IR Control Experiments:
Assignment of the 2-fluoropyridine and the 2-fluoropyridinium trifluoromethanesulfonate
characteristic stretches:
In situ IR monitoring of the addition of trifluoromethanesulfonic acid (26.8 [tL, 0.303 mmol,
1.00 equiv) to a solution of 2-fluoropyridine (26.0 RL, 0.303 mmol, 1 equiv, 1598 cm 1) in
dichloromethane (3.5 mL) at 0 'C resulted in formation of the expected 2-fluoropyridinium
trifluoromethanesulfonate salt (1632 cm ).
Assignment of the isoquinoline N-oxide and N-hydroxyisoquinolium trifluoromethanesulfonate
characteristic stretches.
In situ IR monitoring of the addition of trifluoromethanesulfonic acid (36.2 [tL, 0.409 mmol,
1.00 equiv) to a solution of isoquinoline N-oxide (59.3 mg, 0.409 mmol, 1 equiv, 1327 cm-1) in
dichloromethane (3.5 mL) at 0 'C resulted in formation of the expected N-hydroxyisoquinolium
trifluoromethanesulfonate salt (1309 cm-1).
Assignment of Protonated, Trifluoromethanesulfonate Salt Derivatives of N-(isoquinolin-1-yl)-N-
methylbenzamide 3da:
In situ IR monitoring of the addition of trifluoromethanesulfonic acid (28.1 [tL, 0.317 mmol,
1.00 equiv) to a solution of N-(isoquinolin-1-yl)-N-methylbenzamide (3da, 83.1 mg, 0.317 mmol, 1
equiv, 1648 cm-1) in dichloromethane (3.5 mL) at 0 'C resulted in consumption of the amide 3da and
formation of the expected trifluoromethanesulfonate salt (1649 cm-1). Further addition of
trifluoromethanesulfonic acid (28.1 [tL, 0.317 mmol, 1.00 equiv) resulted in disappearance of the
absorption at 1649 cm 1 and appearance of a strong absorption at 1691 cm-1, corresponding to the
doubly protonated amide ditrifluoromethanesulfonate salt.
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React-IR Monitoring of Activated Amides:
Activation of N-methylbenzamide and addition of 2-fluoropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (52.0 [tL, 0.309
mmol, 1.10 equiv) to a vigorously stirred solution of N-methylbenzamide (38.0 mg, 0.281 mmol, 1
equiv, 1668 cm1) in dichloromethane (2.5 mL) at 0 'C resulted in immediate consumption of the
starting material and appearance of a strong absorption consistent with a nitrilium
trifluoromethanesulfonate salt (2370 cm-1). Addition of 2-fluoropyridine (29.0 [tL, 0.337 mmol, 1.20
equiv) resulted in a drastic increase in the intensity of this absorption. Further addition of 2-
fluoropyridine (24.1 tL, 0.281 mmol, 1.00 equiv) had no significant effect on the intensity of this
absorption. Subsequent addition of 2-fluoropyridine (67.6 [tL, 0.787 mmol, 2.80 equiv) had no
significant effect on the intensity of the absorption at 2370 cm 1. Addition of triethylamine (47.0 [tL,
0.337 mmol, 1.20 equiv) resulted in a significant decrease in intensity of this absorption.
Activation of N-methylbenzamide and addition of 2-chloropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (67.1 [tL, 0.399
mmol, 1.10 equiv) to a vigorously stirred solution of N-methylbenzamide (49.0 mg, 0.363 mmol, 1
equiv, 1668 cm-1) in dichloromethane (2.5 mL) at 0 'C resulted in immediate consumption of the
starting material and appearance of a strong absorption consistent with a nitrilium
trifluoromethanesulfonate salt (2370 cm '). Addition of 2-chloropyridine (41.2 [tL, 0.435 mmol, 1.20
equiv) resulted in a drastic increase in the intensity of this absorption. Further addition of 2-
chloropyridine (34.3 tL, 0.363 mmol, 1.00 equiv) had no significant effect on the intensity of this
absorption. Subsequent addition of 2-chloropyridine (96.0 tL, 1.01 mmol, 2.80 equiv) had no
significant effect on the intensity of the absorption at 2370 cm- . Addition of triethylamine (60.6 tL,
0.435 mmol, 1.20 equiv) resulted in a significant decrease in intensity of this absorption.
Activation of N-phenylacetamide and addition of 2-fluoropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (55.6 tL, 0.330
mmol, 1.10 equiv) to a vigorously stirred solution of N-phenylacetamide (40.6 mg, 0.300 mmol, 1
equiv, 1695 cm-) in dichloromethane (2.5 mL) at 0 'C resulted in immediate consumption of the
starting material but did not result in appearance of an absorption consistent with a nitrilium
trifluoromethanesulfonate salt. Addition of 2-fluoropyridine (30.9 [tL, 0.360 mmol, 1.20 equiv)
resulted in appearance of a strong absorption consistent with a nitrilium trifluoromethanesulfonate
salt (2364 cm 1). Further addition of 2-fluoropyridine (25.8 tL, 0.300 mmol, 1.00 equiv) had no
significant effect on the intensity of this absorption. Subsequent addition of 2-fluoropyridine (72.3
[tL, 0.841 mmol, 2.80 equiv) had no significant effect on the intensity of the absorption at 2364 cm-1.
Addition of triethylamine (50.2 tL, 0.360 mmol, 1.20 equiv) resulted in a significant decrease in
intensity of this absorption.
Activation of N-isopropyl-4-nitrobenzamidel0 and addition of 2-fluoropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (66.7 pL, 0.396
mmol, 1.10 equiv) to a vigorously stirred solution of N-isopropyl-4-nitrobenzamide 10 (75.0 mg, 0.360
mmol, 1 equiv, 1668 cm-1) in dichloromethane (2.5 mL) at 0 'C resulted in immediate consumption
of the starting material and appearance of a strong absorption consistent with a nitrilium
trifluoromethanesulfonate salt (2354 cm 1). Addition of 2-fluoropyridine (37.1 [tL, 0.432 mmol, 1.20
equiv) resulted in a drastic increase in the intensity of this absorption. Further addition of 2-
fluoropyridine (30.9 ptL, 0.360 mmol, 1.00 equiv) had no significant effect on the intensity of this
absorption. Subsequent addition of 2-fluoropyridine (86.6 pL, 1.01 mmol, 2.80 equiv) had no
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significant effect on the intensity of the absorption at 2354 cm-'. Addition of triethylamine (60.3 [tL,
0.432 mmol, 1.20 equiv) resulted in a significant decrease in intensity of this absorption.
Activation of N-isopropyl-4-nitrobenzamide"0 and addition of 2-chloropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (66.7 tL, 0.396
mmol, 1.10 equiv) to a vigorously stirred solution of N-isopropyl-4-nitrobenzamide 10 (75.0 mg, 0.3 60
mmol, 1 equiv, 1668 cm-) in dichloromethane (2.5 mL) at 0 'C resulted in immediate consumption
of the starting material and appearance of a strong absorption consistent with a nitrilium
trifluoromethanesulfonate salt (2354 cm 1). Addition of 2-chloropyridine (40.9 tL, 0.432 mmol, 1.20
equiv) resulted in a drastic increase in the intensity of this absorption. Further addition of 2-
chloropyridine (34.1 tL, 0.360 mmol, 1.00 equiv) resulted in a drastic decrease in the intensity of this
absorption and the appearance of a strong absorption consistent with an amidinium
trifluoromethanesulfonate salt (1609 cm-'). Subsequent addition of 2-chloropyridine (95.5 tL, 1.01
mmol, 2.80 equiv) resulted in a further decrease in the intensity of the absorption at 2354 cm and an
increase in the intensity of the absorption at 1609 cm-1. Addition of triethylamine (60.3 tL, 0.432
mmol, 1.20 equiv) resulted in a further decrease in intensity of the absorption at 2354 cm and a
drastic decrease in the absorption at 1609 cm- 1.
Activation of 3,4-dimethoxy-N-phenylbenzamide 5 and addition of 2-fluoropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (36.0 [tL, 0.214
mmol, 1.10 equiv) to a vigorously stirred solution of 3,4-dimethoxy-N-phenylbenzamide 5 (50.1 mg,
0.195 mmol, 1 equiv, 1691 cm-1) in dichloromethane (2.5 mL) at 0 'C resulted in immediate
consumption of the starting material and appearance of a very weak absorption consistent with a
nitrilium trifluoromethanesulfonate salt (2312 cm-1). Addition of 2-fluoropyridine (20.1 [tL, 0.234
mmol, 1.20 equiv) resulted in a drastic increase in the intensity of this absorption. Further addition of
2-fluoropyridine (16.8 tL, 0.195 mmol, 1.00 equiv) had no significant effect on the intensity of this
absorption. Subsequent addition of 2-fluoropyridine (46.8 [tL, 0.545 mmol, 2.80 equiv) resulted in a
slight decrease in the intensity of the absorption at 2312 cm '. Addition of triethylamine (32.6 [tL,
0.234 mmol, 1.20 equiv) resulted in a drastic decrease in intensity of this absorption.
Activation of 3,4-dimethoxy-N-phenylbenzamide 5 and addition of 2-chloropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (44.6 tL, 0.265
mmol, 1.10 equiv) to a vigorously stirred solution of 3,4-dimethoxy-N-phenylbenzamide5 (62.0 mg,
0.241 mmol, 1 equiv, 1691 cm-1) in dichloromethane (2.5 mL) at 0 'C resulted in immediate
consumption of the starting material and appearance of a very weak absorption consistent with a
nitrilium trifluoromethanesulfonate salt (2312 cm-1). Addition of 2-chloropyridine (27.3 RL, 0.289
mmol, 1.20 equiv) resulted in a drastic increase in the intensity of this absorption and the appearance
of a strong absorption consistent with an amidinium trifluoromethanesulfonate salt (1594 cm ).
Further addition of 2-chloropyridine (22.8 [tL, 0.241 mmol, 1.00 equiv) resulted in a significant
decrease in the intensity of the absorption at 2312 cm-1 and an increase in the intensity of the
absorption at 1594 cm . Subsequent addition of 2-chloropyridine (63.9 [tL, 0.675 mmol, 2.80 equiv)
resulted in disappearance of the absorption at 2312 cm I and an increase in the intensity of the
absorption at 1594 cm 1. Addition of triethylamine (40.3 tL, 0.289 mmol, 1.20 equiv) resulted in
disappearance of the absorption at 1594 cm 1.
Activation of N-phenylbenzamide and addition of 2-fluoropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (44.1 [tL, 0.262
mmol, 1.10 equiv) to a vigorously stirred solution of N-phenylbenzamide (47.0 mg, 0.238 mmol, 1
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equiv, 1679 cm 1) in dichloromethane (2.5 mL) at 0 'C resulted in immediate consumption of the
starting material but did not result in appearance of an absorption consistent with a nitrilium
trifluoromethanesulfonate salt. Addition of 2-fluoropyridine (24.6 iL, 0.286 mmol, 1.20 equiv)
resulted in appearance of a strong absorption consistent with an amidinium trifluoromethanesulfonate
salt (1621 cm 1). Further addition of 2-fluoropyridine (20.4 ptL, 0.238 mmol, 1.00 equiv) resulted in
a slight increase in the intensity of this absorption. Subsequent addition of 2-fluoropyridine (57.3 [tL,
0.667 mmol, 2.80 equiv) resulted in an additional slight increase in the intensity of the absorption at
1621 cm-1. Addition of triethylamine (39.9 RL, 0.286 mmol, 1.20 equiv) resulted in a drastic
decrease in intensity of this absorption.
Activation of N-(4-methoxyphenyl)benzamide 4 and addition of 2-fluoropyridine:
In situ IR monitoring of the addition of trifluoromethanesulfonic anhydride (41.6 [tL, 0.247
mmol, 1.10 equiv) to a vigorously stirred solution of N-(4-methoxyphenyl)benzamide1 4 (51.0 mg,
0.224 mmol, 1 equiv, 1513 cm-1) in dichloromethane (2.5 mL) at 0 'C resulted in immediate
consumption of the starting material but did not result in appearance of an absorption consistent with
a nitrilium trifluoromethanesulfonate salt. Addition of 2-fluoropyridine (23.1 tL, 0.269 mmol, 1.20
equiv) resulted in appearance of a strong absorption consistent with an amidinium
trifluoromethanesulfonate salt (1621 cm-1). Further addition of 2-fluoropyridine (19.2 [tL, 0.224
mmol, 1.00 equiv) resulted in a slight increase in the intensity of this absorption. Subsequent
addition of 2-fluoropyridine (54.0 [tL, 0.628 mmol, 2.80 equiv) resulted in an additional slight
increase in the intensity of the absorption at 1621 cm-1. Addition of triethylamine (37.5 tL, 0.269
mmol, 1.20 equiv) resulted in a drastic decrease in intensity of this absorption.
Deuterium Labelling Studies:
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Reaction of N-isopropyl-4-nitrobenzamide"0 with a mixture of pyridine N-oxide and 2,6-
dideuteropyridine N-oxide:
Trifluoromethanesulfonic anhydride (45.1 tL, 0.268 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-4-nitrobenzamidel" (If, 50.7 mg, 0.244 mmol, 1 equiv) and 2-
fluoropyridine (25.1 tL, 0.292 mmol, 1.20 equiv) in dichloromethane (1.0 mL) at -78 'C. After 2
min, the reaction mixture was allowed to warm to 0 'C. After 5 min, a solution of 2,6-
dideuteropyridine N-oxide15 (2c-d 2, 105 mg, 1.08 mmol, 4.42 equiv) and pyridine N-oxide (2c, 110
mg, 1.15 mmol, 4.73 equiv) in dichloromethane (1.0 mL) was added via cannula. After 5 min, the
resulting mixture was allowed to warm to 23 'C. After 2 h, triethylamine (100 [tL) was added to
quench the trifluoromethanesulfonate salts, and the mixture was diluted by the addition of
dichloromethane (10 mL). The reaction mixture was washed with brine (10 mL), and the layers were
separated. The aqueous layer was extracted with dichloromethane (2 x 5 mL). The combined
organic layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under
reduced pressure. The residue was purified by flash column chromatography on silica gel (15
14 Movassaghi, M.; Hill, M. D. J. Am. Chem. Soc. 2006, 128, 14254.
15 Pavlik, J. W.; Laohhasurayotin, S. J. Heterocyclic Chem. 2007, 44, 1485.
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20% ethyl acetate in hexanes) to afford the amide 3fc (21.8 mg, 31%) and amide 3fc-di (19.4 mg,
28%) as a 1.1:1.0 mixture, indicating kH:kD= 1.0:1.0 based on the ratio of the respective starting
materials.
D
0 N 0
0 N Pr 2ad Tf20, 2-FPyr 02 PrI H + ad e
0 2N 1f _ H CH 2Cl 2  0 2N N0 + -78- 23 C R
'N '" " 86%
86% -R = H, 3fa
H kH:kD = 1.01.0 R = D, 3fa-d1
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Reaction of N-isopropyl-4-nitrobenzamide with a mixture of isoquinoline N-oxide and 1,3-
dideuteroisoquinoline N-oxide (equation 5):
Trifluoromethanesulfonic anhydride (24.9 tL, 0.148 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-4-nitrobenzamide 0 (If, 28.1 mg, 0.135 mmol, 1 equiv) and 2-
fluoropyridine (13.9 iL, 0.162 mmol, 1.20 equiv) in dichloromethane (0.8 mL) at 0 'C. After 7 min,
a solution of 1,3-dideuteroisoquinoline N-oxide 6'17 (2a-d2, 100 mg, 0.68 mmol, 5.0 equiv) and
isoquinoline N-oxide (2a, 98 mg, 0.68 mmol, 5.0 equiv) in dichloromethane (0.8 mL) was added via
cannula. After 5 min, the resulting mixture was allowed to warm to 23 'C. After 2 h, triethylamine
(100 tL) was added to quench the trifluoromethanesulfonate salts, and the mixture was diluted by the
addition of dichloromethane (10 mL). The reaction mixture was washed with brine (10 mL), and the
layers were separated. The aqueous layer was extracted with dichloromethane (2 x 5 mL). The
combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (0 --+ 20% ethyl acetate in hexanes) to afford the amide 3fa (20.7 mg, 46%) and amide 3fa-
di (18.3 mg, 40%) as a 1.1:1.0 mixture, indicating kH:kD = 10: 1.0. 0
O 0 + Tf20, 2-FPyr Pr
& N NPr + NII 
N
Pr + D CH2C 2,4h
0 2 N 
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Reaction of N-isopropyl-4-nitrobenzamide"0 with 2-deuteropyridine N-oxide (Equation 6):
Trifluoromethanesulfonic anhydride (24.7 [tL, 0.147 mmol, 1.10 equiv) was added via syringe
to a solution of N-isopropyl-4-nitrobenzamidel (If, 27.8 mg, 0.134 mmol, 1 equiv) and 2-
fluoropyridine (13.7 iL, 0.160 mmol, 1.20 equiv) in dichloromethane (1.0 mL) at 0 'C. After 7 min,
a solution of 2-deuteropyridine N-oxide (2c-di, 116 mg, 1.20 mmol, 9.00 equiv) in dichloromethane
(0.7 mL) was added via cannula. After 5 min, the resulting mixture was allowed to warm to 23 'C.
After 4 h, triethylamine (100 [tL) was added to quench the trifluoromethanesulfonate salts, and the
mixture was diluted by the addition of dichloromethane (10 mL). The reaction mixture was washed
with brine (10 mL), and the layers were separated. The aqueous layer was extracted with
dichloromethane (2 x 5 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The residue was purified by
flash column chromatography on silica gel (0 -- 50% ethyl acetate in hexanes) to afford the amide
3fc (3.81 mg, 10%) and amide 3fc-di (7.65 mg, 20%) as a 1.0:2.0 mixture, indicating kH:kD 2.0: 1.0.
16 Pavlik, J. W.; Laohhasurayotin, S. J. Heterocyclic Chem. 2007, 44, 1485.
17 The 1,3-dideuteroisoquinoline N-oxide employed contained 100% deuterium incorporation at the 1-position of the isoquinoline ring,
and 91% deuterium incorporation at the 3-position by 'H NMR. This incomplete isotopic enrichment was taken into account when
calculating kH:kD.
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Chapter II
Synthesis of Spirocyclic Indolines by Interruption of the
Bischler-Napieralski Reaction
60
Introduction and Background
Spirocyclic pyrrolidinoindolines are a ubiquitous substructure in nature, representing the
core of the aspidosperma, kopsia, and strychnos alkaloid families, and are prevalent also in
pharmaceutically active compounds and other fine chemicals (Figure 1).1 (-)-Vindoline2 is a
member of the aspidosperma alkaloid family with a complex pentacyclic core, while (-)-
kopsinine3 represents the kopsia alkaloids, a related family with a distinct cage substructure. (-)-
Strychnine4 is a potently poisonous glycine antagonist of the strychnos alkaloid family that
blocks postsynaptic inhibition in the spinal cord.5  The importance of the
spiropyrrolidinoindoline structural motif has motivated the development of a number of elegant
synthetic strategies in complex alkaloid synthesis. 6 Synthetic spiropyrrolidinoindolines display a
range of useful properties and include insecticidal compounds, d and sky kinase inhibitors. lh
N Me N N
OAc
OH N H -O
MeO N H C2Me N CO2Me O
(-)-vindoline (-)-kopsinine (-)-strychnine
,QNH
N H N (C
C NNC
sky kinase inhibitor insecticide
Figure 1. Representative spiropyrrolidinoindoline compounds.
A direct route to the valuable spiropyrrolidinoindoline substructure would involve
intramolecular electrophilic trapping of an appropriate tryptamine derivative at C3. Such an
approach finds plausibility in the Pictet-Spengler reaction,7 a common reaction in the synthesis
and biosynthesis of tetrahydro-p-carbolines from tryptamines. Numerous studies into the
mechanism of this reaction,8 most notably Bailey's elegant isotope labelling study,8c have shown
that the reaction proceeds by initial intramolecular electrophilic trapping of the 2H-indole
nucleus at C3 by a pendant iminium ion to afford a spiroindoleninium intermediate (Scheme 1).
Wagner-Meerwein rearrangement affords the C2-protonated tetrahydro-P-carboline, which
undergoes deprotonation to afford the tetrahydro-p-carboline product. It is known, however, that
the initial spirocyclization event is reversible, and it cannot be ruled out that the protonated
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tetrahydro-p-carboline is formed by eventual direct attack of C2 onto the iminium ion.9
Furthermore, kinetic isotope studies8e in a biological setting have shown the final deprotonation
event to be rate-limiting, suggesting that all three of the aforementioned intermediates may be in
or near equilibrium during the reaction.
H
NH2 R
2CHO + 2  RNH -H+ NH
2 2 H ~ H
eN H N CNH R 2  S R2
/Wagner-Merwein
NH rearrangement
~R1
Scheme 1. Mechanism of the Pictet-Spengler reaction.
The presence of spiroindoleninium ions during the course of the Pictet-Spengler reaction
suggests the feasibility of intercepting such intermediates en route to spiropyrrolidinoindoline
products; however, the inherent tendency of such 2H-indoleninium systems to undergo rapid
Wagner-Meerwein rearrangement (Scheme 1) makes such an approach difficult. Previously
reported methods6 d'6 1,'0 for such transformations overcome this problem by using strongly
nucleophilic intramolecular traps or by employing electron-withdrawing groups on the indole or
aliphatic nitrogen, or both, to minimize such rearrangements, which can still occur (Scheme 2).
An early and illustrative example was reported in 1971 by Btichi6d in his seminal total synthesis
of (±)-vindorosine: electrophilic activation of an N-acetyl vinylgous amide in boron trifluoride
diethyl etherate resulted in electrophilic trapping of the indole nucleus at C3, followed by
cyclizative trapping at C2 with a strongly nucleophilic boron trifluoride enolate to afford the
desired spirocyclic product in 38% yield en route to the natural product. However, the isolation
of the undesired tetrahydro-p-carboline side product in 20% yield demonstrates the difficulty of
kinetically outcompeting the Wagner-Meerwein rearrangement. In Corey's enantioselective
synthesis of (-)-aspidophytine, 61 a similar strategy employing a chiral dialdehyde with a highly
nucleophilic pendant allylic trimethylsilane allows for a remarkable condensative cascade
reaction with a tryptamine derivative, affording the pentacyclic core of the natural product in
66% yield. Their use of an elaborate alkene reflects the need to outcompete rearrangement, as a
simple vinyl group would have been an ideal synthon: manipulation of the exocyclic alkene in
their pentacyclic product to the endocyclic alkene in the natural product requires four extra steps.
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OHC SiMe3  MeCN;
NaBH3CN MeO
66%
N ~Me
OAcO'j OH
N H 'O 2 MeMe
(±)-vindorosine38
O'Pr
MeOf N HM I 
-Me
OMe
(-)-aspidophytine
OH
+ SMe
N- CF3C00H
NHloc CH2CI2N H 23 OC
70%
H Et
only observed product
Jackson and Biswas:
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Scheme 2. Representative examples of trapping spiropyrrolodinoindoleninium ions.
Heteroatom nucleophiles have also been used as nucleophilic traps, as seen in an example
reported by Nakagawa in which the nitrogen atom of a secondary carbamate serves as a trapping
moiety to afford a spirocyclic product in 70% yield. 10h Nonetheless, under their conditions, the
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Wagner-Meerwein rearrangement competes with trapping of the spirocyclic indoleninium, as
two diasteromeric tetrahydro-@-carboline products were isolated in a combined 29% yield. The
use of an intermolecular nucleophilic trap present during iminium formation was employed by
Bosch,10' who found that that the presence of an electron-withdrawing para-toluenesulfonyl
group on the indole nitrogen was essential to reduce the rate of Wagner-Meerwein
rearrangement relative to nucleophilic trapping by triethylsilane en route to their spirocyclic
product. The absence of such an electon-withdrawing group gave the tetrahydro-@-carboline
product under identical conditions.
While the vast majority of examples of interception of spiropyrrolidinoindoleninium ions
have been in the context of the Pictet-Spengler reaction, there have been reportsi Oa-d on the use
of carbon nucelophiles in such a strategy in the context of the related Bischler-Napieralski
reaction," which differs by employing electrophilically activated amide electrophiles in place of
iminium ions. Jacksonoasc and Biswas reported an example of a tryptamine derived secondary
amide bearing a highly nucleophilic dimethoxyphenyl group undergoing a
spirocyclization/intramolecular trapping sequence when treated with a large excess of
trifluoroacetic anhydride, affording the spirocyclic product in 95% yield. Notably, an electron-
withdrawing trifluroacetyl group was installed on both nitrogen atoms during the reaction; the
use of trichlorooxyphosphine as activating agent resulted in a mixture of spiroindoline and
dihydro-@-carboline products. Later, Biswas10d reported two examples of a less nucleophilic
phenyl group as a trap in a similar reaction. While doubly trifluoroacetylated spirocyclic
products were isolated in yields of 73-74%, together with singly trifluoroacetylated 1H-
spirocycles in yields of 8-9%, singly trifluoroacetylated products resulting from competetive
Wagner-Meerwein rearrangement were also isolated in yields of 3-5%, consistent with a need
for trifluoroacetylation of the indole nitrogen atom to enable trapping at C2 to sufficiently
outcompete rearrangement when less powerful nucleophiles are used as intramolecular traps.
Due to the importance of spiropyrrolidinoindoline compounds, our group is interested in
new methods for their synthesis. In this chapter, we report a method for the efficient synthesis of
spiropyrrolidinoindolines by interruption of the Bischler-Napieralski reaction of 2H-N-
acyltryptamines via spiroindoleninium intermediates with high resilience to Wagner-Meerwein
rearrangements (eq 1).
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Results and Discussion
Earlier, our laboratory reported the use of the reagent combination
trifluoromethanesulfonic anhydride (Tf2O)-2-chloropyridine (2-ClPyr)12 to effect the Bischler-
Napieralski reaction of secondary amides.13 Interestingly, exposure of amide la to Tf20 (1.1
equiv) in the presence of 2-ClPyr (1.2 equiv) followed by warming and addition of excess
triethylamine14 provided the expected Bischler-Napieralski product 2a (76%) along with the
unexpected spirocyclic side product (+)-3a in low yield (-5%, Scheme 3). The sulfonylation of
the amide nitrogen was easily rationalized by sulfonylation of a spirocyclic indoleninium
intermediate (±)-4a with the slight excess of Tf 2O used for amide activation to afford
spiroindoleninium (±)-5a. Consistent with N-sulfonylation of intermediate (±)-4a, the use of 2.1
equivalents of Tf 2O and 3.2 equivalents of 2-CIPyr greatly increased the yield of (±)-3a to 30%
together with a complex mixture of side products and none of the Bischler-Napieralski product
2a. The reduction at C2 of the indoline nucleus prompted further investigation to better
understand the reactivity of the intermediates. Given the propensity of
spiropyrrolidinoindoleninium intermediates to undergo Wagner-Meerwein rearrangement unless
a strongly nucleophilic trap present is prior to spirocyclization,6d,1,10 a-fh-k we hypothesized
0
e~N
Tf20O(X equiv) '~. H Me
2-CIPyr (Y equiv) Me
CH 2Cl2 (0.3 M) N
-78 - 23 *C 1a Me
.. 
- SO2CF3~
N me N Me
Tf20
-HOTf-2-CIPyr HM
TfO- Me 4a TfO- Me 5a
| Wagner-Meerwein reduction at C2 by |
rearrangement NEt3 (5.8 equiv) * SO 2CF3N Me
/N X, Y
1 N Me 76% ----- 1.1,1.2----- 5% 2 Me
Me Me 0% ----- 2.1, 3.2-----30% (* N
2S (±)-3a Me
Scheme 3. Mechanism of the Interrupted Bischler-Napieralski Reaction.
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that the reduction at C2 may have been the result of a rapid hydride transfer reaction between
two intermediates along the reaction pathway' 5 (Scheme 3). This, however, was ruled out with a
concise set of deuterium labeling studies. First, hexadeuterated amide la-d6 was subjected to the
reaction conditions. Spirocycle (±)-3a-d6 was isolated in 29% yield with complete deuterium
retention on the alkenyl methyl groups and no deuterium enrichment at C2 (eq 2). Furthermore,
when amide la was exposed to the reaction conditions with lithium aluminum deuteride used in
place of triethylamine as the quenching reagent, monodeuterated spirocycle (+)-3a-di was
isolated in 60% yield with incorporation of exactly one deuterium atom at C2 (eq 3, 6:1 dr at
C2). 16 This showed unequivocally that reduction at C2 does not occur until an exogenous
hydride source is introduced. We posited that triethylamine might be acting as a hydride
source1 and conjectured that the modest mass balance might be the result of
spiroindoleninium (+)-5a undergoing competitive decompostion. Notably, when lithium
aluminum hydride (eq 2) or lithium aluminum deuteride (eq 3, without warming to 23 'C) were
introduced just 5 min after warming the respective reactions to 0 *C, products (±)-3a-d and (I)-
3a-di were isolated in 95% and 96% yields, respectively.
o Tf20, 2-CIPyr SO2CF3
CH2Cl2, -78 *C; N CD3
H CD3  s (2)H r 3UAIH -C HCD3D3C LiAIH 4, THF, 0 C ' HN or N
1a-d 6 Me 23 *C, 3h; Et3N (±)-3a-d 6 Me No deuterium
95% (29%) incorporation at
S Tf20, 2-CIPyr N Me
N CH2CI2, -78 *C;H Me nH(3)
Me LiAID4, THF, 0 *C DN orN
la Me 23 *C, h; LAID 4  (±)-3a-d1 Me 1 deuterium atomTHE, 0 -C 96% (60%) at * (87:13 dr)
These results suggested that spirocyclic N-trifluoromethanesulfonyl indoleninium (±)-5a
was electrophilic at C2 but recalcitrant to undergo a Wagner-Meerwein rearrangement due to
deactivation of the trifluoromethanesulfonamide nitrogen lone pair. Electrophilic activation of
la followed by reduction with lithium aluminum hydride afforded spirocycle (+)-3a in excellent
yield (Table 1, entry 1, 98% yield). When a less potent hydride source, triethylsilane, was
introduced after activation and the resulting mixture warmed to ambient temperature, spirocycle
(±)-3a was afforded in just 55% yield (Table 1, entry 2). On the other hand, 1-methyl-N-
acetyltryptamine (1b), which bears no s-hydrogens, underwent highly efficient spirocyclization
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and reduction to afford spirocycle (+)-3b using triethylsilane (Table 1, entry 3, 97% yield),
lithium aluminum hydride (Table 1, entry 4, 92% yield), or triethylamine (Table 1, entry 5, 72%
yield) as reducing agent. Spirocyclization followed by reduction with triethylsilane proceeded
smoothly with 1-benzyl-N-acetyltryptamine (1c) and even with electron-deficient 1-para-
toluenesulfonyl-N-acetyltryptamine (1d), providing the corresponding spirocycles (±)-3c (Table
1, entry 6, 100% yield) and (±)-3d (Table 1, entry 7, 94% yield), respectively. Trapping the
spironindoleninium of amide lb at C2 with a carbon nucleophile, 1-methylindole, afforded the
Table 1. Spirocyclization and Reduction.
Tf2O (2.1equiv) SO2CF3
2-CIPyr (3.2 equiv) N R2
'. H R2  H2C12  R
R2 N2-78 C- temp.
time; Et3SiHla-id R (2 equiv), 23 *C, 3 h (±)-3a-3d R
entry amide R1  R2  temp. time yielda
1 la Me Me 0 *C 5 min 9 8%b
2 la Me Me 0OC 30 min 55%
3 lb Me H 0 *C 30 min 97%
4 lb Me H 0 *C 5 min 9 2%b
5 lb Me H 23 C 60 min 72%c
6 1c Bn H 0 *C 30 min 100%
7 ld Ts H 23 0C 30 min 94%
alsolated yield. bLiALH 4 (3.0 equiv) used as reducing
agent at 0 'C. cEt3N (5.0 equiv) used as reducing agent.
spirocyclic indole adduct (±)-6b in excellent overall yield (eq 4, 76%) as a single diastereomer.16
The stereochemical outcome of the reaction is consistent with approach of the 1-methylindole
nucleophile opposite the bulky and highly electronegative19 trifluoromethanesulfonamide
moiety.
SO2CF3O Tf20, 2-CIPyr N
Ne 1 -methylindole
| H CH2Cl2  NMe
1b Me -78-*23*C (±)-6b Me -
76%
In order to avoid N-trifluoromethanesulfonylation, we hypothesized that a rapid,
reversible nucleophilic trap at C2 with an oxygen nucleophile might give a persistent
intermediate that could be further derivatized. Thus, 1-methyltryptamine oxazolidinone urea 1i
was activated with Tf2O (1.1 equiv) and 2-ClPyr (2.2 equiv); introduction of 1-methyltryptamine
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and titanium tetrachloride followed by heating to 45 *C afforded 1-methyltryptamine adduct (±)-
6e in 83% yield as a single diastereomer 6 (eq 5) that was consistent with nucleophile approach
from the same face of the spiroindoleninium as seen with amide lb (eq 4). The use of titanium
tetrachloride was found to be essential to achieve C-C bond formation, consistent with
competitive nucleophilic inibition at C2 by the oxazolidinone oxygen atom.
0
0 Tf2O, 2-CIPyr N O
N O CH2CI2 NH N 4 10 (5)
O -78 -- 0 C; N / NMe
N 1-methylindole Me -le Me TiCl 4, 45 0C (*)-6eM
83%
Motivated by a desire to extend the range of diastereoselective trappings of
spiroindoleninium intermediates, we hypothesized that non-enolizable tertiary amides would,
upon activation with Tf20-2-ClPyr, undergo rapid spirocyclization to afford a persistent
diiminium dication resilient to Wagner-Meerwein rearrangement.20 To our delight, treatment of
tertiary pivalamide 1f with 1.1 equivalents of Tf2O-2-ClPyr at 0 *C in acetonitrile 21 and warming
to 23 *C, followed by sequential trapping with triethylsilane and lithium aluminum hydride,
afforded spirocyclic indoline (+)-7f as a single diastereomeri in 91% yield (eq 6), suggesting the
in situ formation of a putative persistent diiminium dication intermediate. The
diastereoselectivity is likely a result of the steric bulk of the arene, which blocks approach of
lithium aluminum hydride. Use of lithium aluminum deuteride in place of lithium aluminum
hydride afforded monodeuterated spirocyclic indoline (+)-7f-di, demonstrating the regioselective
trapping at C2 with triethylsilane. 16 Similarly, activation of lactam 1g followed by tandem
reduction with triethylsilane-lithium aluminum hydride afforded tetracyclic indoline (+)-7g in
quantitative yield as a single diastereomer16 (eq 7).
o 2-CIPyr, Tf20 NMe meMeCN
N Me -78 - 0 C; ..<M
MMe EtXS HeC2Me (6)
e N MMe Et3SiH, 2300C;
if Me LiAIX4, 0 "C Me
LiAIH4, X = H: (*)-7f, 91%
LiAID 4, X = D: (±)-7f-d1, 91%
o 2-CIPyr, Tf 20 NMe CH2CI2N Me -78 - 0 0C; ' Me (7)H Me (7
N Et3SiH, 23 *C;
ig Me LiAIH 4, 0 *C (,)-7g Me
100%
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Encouraged by the efficiency of the spirocyclization/intermolecular nucleophilic trapping
protocol, we envisaged a double-cyclization cascade making use of enolizable secondary amides
with pendant nucleophiles. To explore and optimize this reaction, 1-methyltryptamine
phenylacetamide (1h) was selected as substrate. Activation with a slight excess of Tf2O (2.1
equiv) in the presence of 2-ClPyr (3.2 equiv) in CH 2 Cl2 followed by warming to 23 *C provided
pentacycle (±)-8h in 40% yield (Scheme 4) accompanied with monocyclized side products and
no recovered starting material or Bischler-Napieralski products. Heating the reaction to 45 *C in
an oil bath afforded (±)-8h in excellent yield22 (Scheme 2, 91% yield), while brief heating in a
microwave 2 3 to 130 'C provided (±)-8h in quantitative yield. While similar cascades have been
reported previously, the lack of any requirement of large excesses of activating agentsI Oacd or
installation of an electron-withdwrawing group on N110iac and the ability to completely avoid
Wagner-Meerwein rearrangement'Od are specific advantages to our conditions, and highlight the
importance of nitrogen lone pair deactivation by the highly electronegative
trifluoromethanesulfonyl group. Not surprisingly, electron-rich 3,4-dimethoxyphenylacetamide
1i provided pentacycle (±)-8i in 98% yield as a single regio- and diastereomer' 6 under 45 *C
conditions on half-gram scale (Scheme 4). Even highly electron-deficient 4-
nitrophenylacetamide lj afforded pentacycle (±)-8j in moderate yield (53%) under microwave
heating conditions (130 *C, 10 min), and vinylacetamide 1k afforded tetracyclic spiroindoline
(±)-8k in 56% yield under 45 *C conditions.
SO 2CF3
0 Tf2O N
N R2  2-CiPyr R 6
'I CH2C12  O NHR
lh-k R1  (±)-8h-k R4
SO2CF 3  SO2CF3  SO2CF3  SO2CF3N N N N
NH NOMe
Me Me OMe SO2CF3  NO2  SO2CF3
(±)-8h 1 0 %a,b (±)-8i: 9 8 %* (±)-8j: 5 3 %f (±)-8k: 5 6 %9
91 %C
40%d
Scheme 4. Double-Cyclization Cascades. aIsolated yields of single diastereomers. bTf2O (2.1 equiv), 2-ClPyr
(3.2 equiv), 130 *C (microwave), 5 min. c45 *C, 3 h. d2 3 *C, 3 h. eTf 20 (2.1 equiv), 2-ClPyr (3.2 equiv), 45
*C, 3 h.
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The trifluoromethanesulfonyl group present in the spirocyclic indolines derived from
secondary amides is readily removed under reductive or eliminative conditions: desulfonylation
of pentacycle (±)-8i with sodium and ammonia in the presence of methanol provided pentacyclic
diamine (±)-9i in excellent yield (95%) as a single diastereomer 1 (eq 8), while
dehydrosulfinylation of tricycle (±)-3a is effected with 1,8-diazabicyclo[5.4.0]undec-7-ene
(DBU) in acetonitrile under microwave heating conditions (eq 9) to afford enimine (±)-10a in
71% yield.
SO2CF3  HN N
Na, NH3
s OMeMe T " FOMe (8)
"'~NH -78 OC K~N H
(*)-8i Me OMe (±).i Me OMe
95%
SO 2CF3N Me N
DBU
MN4Me *CMe (9)
K~.N MeCN, 125T N
(±)-3a Me (±)-10a Me
71%
Conclusion
We have presented a method for the efficient generation of distinctively persistent
spiroindoleninium intermediates from secondary and tertiary N-acyl tryptamines. The
exceptional resilience of these intermediates to Wagner-Meerwein rearrangement, determined
through mechanistic studies, allows for efficient intra- and intermolecular trapping with
nucleophiles, including weak nucleophiles such as deactivated arenes, which can be introduced
even after6 d,1,10a-f,h-k initial activation and spirocyclization. The use of oxazolidinone ureas and
tertiary amides under our conditions allows for the direct and highly diastereoselective synthesis
of spiropyrrolidinoindolines without competitive rearrangement 6d,I0a,c-e,h,k or the need for an
electron-withdrawing group d,10a,c,d,g,k on the aliphatic or indole nitrogen atoms.
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17 When the quench was carried out by adding potassium carbonate or 1,4-
diazabicyclo[2.2.2]octane, no trace of (t)-3a was detected.
18 Coquerel, Y.; Brdmond, P.; Rodriguez, J. J. Organomet. Chem. 2007, 692, 4805.
19 Chdrest, M.; Felkin, H.; Prudent, M. Tetrahedron Lett. 1968, 18, 2199.
20 For previous examples of activation conditions that result in Wagner-Meerwein
rearrangements in similar systems, see: (a) Desmaelee, D.; Mekouar, K.; d'Angelo, J. J Org.
Chem. 1997, 62, 3890. (b) Yasui, Y.; Takeda, H.; Takemoto, Y. Chem. Pharm. Bull. 2008, 56,
1567.
2 Acetonitrile was used as solvent due to the poor solubility of the activated intermediates in
dichloromethane in this case.
22 2-ClPyr was found to be the optimal base additive for this reaction; the use of 2-fluoropyridine
or 2,6-lutidine gave yields of 90% and 66%, respectively, of (±)-8h under 45 'C conditions.
23 (a) Hill, M. D.; Movassaghi, M. Tetrahedron Lett. 2008, 49, 4286. For related reviews, see: (b)
Caddick, S. Tetrahedron 1995, 51, 10403. (c) Lidstrom, P.; Tierney, J.; Wathey, B.; Westman, J.
Tetrahedron 2001, 57, 9225. (d) Kappe, C. 0. Angew. Chem., Int. Ed 2004, 43, 6250.
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Experimental Section
General Procedures. All reactions were performed in oven-dried or flame-dried round bottomed
flasks, modified Schlenk (Kjeldahl shape) flasks or glass pressure vessels. The flasks were fitted
with rubber septa and reactions were conducted under a positive pressure of argon. Stainless steel
gas-tight syringes or cannulae were used to transfer air- and moisture-sensitive liquids. Flash column
chromatography was performed as described by Still et al. using silica gel (60 A pore size, 32-63 pim,
standard grade) or non-activated alumina (80-325 mesh, chromatographic grade).' Analytical thin-
layer chromatography was performed using glass plates pre-coated with 0.25 mm 230-400 mesh
silica gel or neutral alumina impregnated with a fluorescent indicator (254 nm). Thin layer
chromatography plates were visualized by exposure to ultraviolet light and/or by exposure to an
aqueous solution of ceric ammonium molybdate (CAM) or an aqueous solution of potassium
permanganate (KMnO4) followed by heating (<1 min) on a hot plate (-250 C). Organic solutions
were concentrated on rotary evaporators at ~20 Torr (house vacuum) at 25-35 'C, then at -1 Torr
(vacuum pump) unless otherwise indicated.
Materials. Commercial reagents and solvents were used as received with the following exceptions:
Dichloromethane, diethyl ether, tetrahydrofuran, acetonitrile, toluene, and triethylamine were
purchased from J.T. Baker (CycletainerTM) and were purified by the method of Grubbs et al. under
positive argon pressure .2 2-Chloropyridine and NN-diisopropylamine were distilled from calcium
hydride and stored sealed under argon atmospheres. The molarity of n-butyllithium solutions was
determined by titration against diphenylacetic acid3  (average of three titrations).
Trifluoromethanesulfonic anhydride was purchased from Oakwood Products, Inc.; all other solvents
and chemicals were purchased from Sigma-Aldrich.
Instrumentation. All reaction conducted at 130 "C were performed in a CEM Discover Lab Mate
microwave reactor. Proton nuclear magnetic resonance ('H NMR) spectra were recorded with Varian
inverse probe INOVA-500 and Varian INOVA-500 spectrometers, are reported in parts per million
on the 6 scale, and are referenced from the residual protium in the NMR solvent (CDCl 3: 6 7.24
(CHCl 3), toluene-d: 6 2.09 (C6D5CD 2H)). Data are reported as follows: chemical shift [multiplicity
(s = singlet, d = doublet, t = triplet, q = quartet, sp = septet, m = multiplet, br = broad), coupling
constant(s) in Hertz, integration, assignment]. Carbon-13 nuclear magnetic resonance (13C NMR)
spectra were recorded with a Varian INOVA-500 spectrometer, are reported in parts per million on
the 6 scale, and are referenced from the carbon resonances of the solvent (CDCl 3: 6 77.23, toluene-d8 :
6 20.4). Data are reported as follows: chemical shift (assignment). Fluorine-19 nuclear magnetic
resonance (19F NMR) spectra were recorded with a Varian Mercury 300 spectrometer or a Varian
INOVA-500 spectrometer, are reported in parts per million on the 6 scale, and are referenced from
the fluorine resonance of neat trichlorofluoromethane (CFCl3: 6 0). Data are reported as follows:
chemical shift (assignment). Infrared data (IR) were obtained with a Perkin-Elmer 2000 FTIR, and
are reported as follows: frequency of absorption (cm-1), intensity of absorption (s = strong, m =
medium, w = weak, br = broad). Optical rotations were measured on a Jasco- 1010 polarimeter. We
1 W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923.
2 A. B. Pangborn, M. A. Giardello, R. H. Grubbs, R. K. Rosen, F. J. Timmers, Organometallics 1996, 15, 1518.
W. G. Kofron, L. M. Baclawski, J. Org. Chem. 1976, 41, 1879.
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are grateful to Dr. Li Li for obtaining the mass spectrometric data at the Department of Chemistry's
Instrumentation Facility, Massachusetts Institute of Technology. High resolution mass spectra
(HRMS) were recorded on a Bruker Daltonics APEXIV 4.7 Tesla FTICR-MS using a direct analysis
in real time (DART) ionization source.
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N-Isobutyryltryptamine (Sla) :4'
Isobutyryl chloride (1.96 mL, 18.7 mmol, 1.00 equiv) was added via syringe to a solution of
tryptamine (Si, 3.00 g, 18.7 mmol, 1 equiv) and triethylamine (2.87 mL, 20.6 mmol, 1.10 equiv) in
tetrahydrofuran (47.0 mL) at 23 'C. After 20 min, water was added, and the organic layer was
diluted with ethyl acetate (250 mL). The layers were separated, and the organic layer was washed
with aqueous hydrogen chloride solution (IN, 250 mL), saturated aqueous potassium carbonate
solution (250 mL), and brine (250 mL). The organic layer was dried over anhydrous sodium sulfate,
was filtered, and was concentrated under reduced pressure to afford N-isobutyryltryptamine (Sla,
3.56 g, 82.6%) as a tan powder. Structural assignments were made with additional information from
gCOSY data.
'H NMR (500 MHz, CDCl3, 20 *C):
13C NMR (125 MHz, CDCl3, 20 'C):
FTIR (neat) cm-1:
6 8.32-8.18 (br-s, 1H, NIH), 7.60 (dd, J= 1.0, 7.9, 1H,
C5H), 7.37 (d, J= 8.0, 1H, C8H), 7.19 (app-dt, J= 1.1,
7.6, lH, C7H), 7.11 (app-dt, J= 1.1, 7.5, 1H, C6H), 7.01
(d, J= 2.3, 1H, C2H), 5.61-5.46 (br-s, 1H, N12H), 3.58
(app-q, J= 6.7, 2H, CI1 H2), 2.96 (t, J= 6.7, 2H, C1oH 2 ),
2.24 (sp, J= 7.0, 1H, C14H), 1.09 (d, J= 7.0, 6H, CI5 H3,
Ci6 H 3).
8 177.4, 136.6, 127.5, 122.4, 122.1, 119.4, 118.7, 112.7,
111.6, 39.9, 35.7, 25.4, 19.7.
3286 (br-s), 2969 (in), 1652 (s),
1229 (in), 743 (s).
1529 (s), 1457 (m),
HRMS (DART): calc'd for C14Hi8N2NaO [M+Na]*: 253.1311,
found: 253.1314.
TLC (A120 3, 30% EtOAc in hexanes), Rf: 0.08 (UV, CAM, KMnO4).
4 The Cl 5,C 16-hexadeuterated isotopomer Sla-d was synthesized by dehydrative coupling of tryptamine (Si) with isobutyric acid-d6
ref. 5) in the presence of 1 -ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrogen chloride (EDC-HCI) in dichloromethane.
For a previous preparation of isobutyric acid-d6, see Semmelhack, M. F.; Bargar, T. J. Am. Chem. Soc. 1980, 102, 7765.
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1-Methyl-N-isobutyryltryptamine (1a) :6
Sodium hydride (60% dispersion in mineral oil, 564 mg, 14.1 mmol, 1.30 equiv) was added as
a solid under an argon atmosphere to a solution of N-isobutyryltryptamine (Sla, 2.50 g, 10.9 mmol, 1
equiv) in NN-dimethylformamide (27 mL) at 23 'C. After 55 min, iodomethane (901 piL, 14.4
mmol, 1.33 equiv) was added dropwise via syringe over 5 min. After 15 h, water (20 mL) was added
to quench the excess base. The resulting mixture was diluted with diethyl ether (300 mL), and the
organic layer was washed with brine (3 x 300 mL). The organic layer was dried over anhydrous
sodium sulfate, was filtered, and was concentrated under reduced pressure. The residue was purified
by flash column chromatography on alumina (0 -+ 20% ethyl acetate in hexanes) to afford 1-methyl-
N-isobutyryltryptamine (la, 1.64 g, 61.8%) as a tan powder. Structural assignments were made with
additional information from gCOSY data.
'H NMR (500 MHz, CDCl3, 20 'C):
13C NMR (125 MHz, CDC13, 20 'C):
8 7.59 (d, J= 7.9, 1H, C5H), 7.29 (d, J= 8.2, 1H, C8H),
7.23 (app-dt, J = 1.2, 7.7, 1H, C7 H), 7.10 (app-dt, J =
1.0, 7.5, 1H, C6H), 6.86 (s, 1H, C2 H), 5.58-5.43 (br-s,
1H, N12H), 3.74 (s, 3H, C17H3 ), 3.56 (app-q, J= 6.7, 2H,
C,H 2 ), 2.94 (t, J = 6.7, 2H, CioH 2), 2.23 (sp, J= 6.9,
1H, C14 H), 1.09 (d, J= 6.9, 6H, C15H 3, Ci6 H 3).
8 177.0, 137.2, 127.9, 126.9, 121.8, 119.0, 119.0, 111.7,
109.4, 39.9, 35.7, 32.7, 25.4, 19.7.
3301 (br-s), 2967 (m), 1646 (in),
1236 (m), 740 (m).
FTIR (neat) cm-1:
HRMS (DART):
1548 (in), 1472 (in),
calc'd for C15H20N2NaO [M+Na]*: 267.1468,
found: 267.1465.
TLC (A120 3, 30% EtOAc in hexanes): Rf: 0.21 (UV, CAM, KMnO4).
6 The C15,C16-hexadeuterated isotopomer la-d was synthesized by an analogous procedure starting from Sla-d6 .
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Spirocyclic indoline ()-3a:
Trifluoromethanesulfonic anhydride (62.8 p.L, 373 gmol, 2.10 equiv) was added via syringe to
a solution of 1-methyl-N-isobutyryltryptamine (1a, 43.4 mg, 178 pmol, 1 equiv) and 2-chloropyridine
(53.3 pL, 568 pmol, 3.20 equiv) in dichloromethane (1.8 mL) at -78 *C. After 5 min, the reaction
mixture was allowed to warm to 0 C.7 ,8 After 5 min, tetrahydrofuran (1.0 mL) was added via
syringe. After 30 sec, lithium aluminum hydride9 '10 '1 (20.2 mg, 533 pmol, 3.00 equiv) was added as
a solid under an argon atmophere. After 20 min, sodium sulfate decahydrate was added to quench the
unreacted aluminum hydride salts. The resulting suspension was filtered, and the filter cake was
extracted with ethyl acetate (20 mL). The combined filtrates were concentrated under reduced
pressure. The residue was purified by flash column chromatography on silica gel (0 -> 10% ethyl
acetate in hexanes) to afford spirocyclic indoline (±)-3a (62.7 mg, 97.9%) as a beige powder.
Structural assignments were made with additional information from gCOSY, HSQC, gHMBC, and
NOESY data.
1H NMR (500 MHz, CDCl 3, 20 *C):
13 C NMR (125 MHz, CDCl 3, 20 *C):
19F NMR (471 MHz, CDCl3, 20 'C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (30% EtOAc in hexanes), Rf:
8 7.11 (app-dt, J= 1.3, 7.7, 1H, C7H), 6.95 (dd, J= 0.8,
7.4, 1H, C5H), 6.68 (app-dt, J= 0.9, 7.4, 1H, C6H), 6.51
(d, J= 7.9, 1H, CsH), 3.75-3.60 (m, 2H, C1 1H2), 3.52
(d, J 9.3, 1H, C2 Ha), 3.38 (d, J= 9.3, 1H, C2Hb), 2.81
(s, 3H, C17H3), 2.38 (app-dt, J = 13.0, 6.5, 1H, CioHa),
2.13 (app-dt, J = 13.0, 6.7, 1H, CioHb), 1.86 (s, 3H,
C15H3), 1.41 (s, 3H, C16H3).
6 151.8 (C9 ), 135.6 (C4), 134.7 (C13), 130.1 (C14), 128.4
(C7 ), 122.4 (C5), 120.0 (q, J = 323.4, SO2CF 3), 118.6
(C), 107.6 (C8), 68.8 (C2 ), 53.0 (C3 ), 50.5 (C11), 43.9
(C10), 35.7 (C17), 23.5 (C15), 21.2 (C 16).
S-75.1
2860 (m), 1606 (m), 1493 (m), 1378 (s), 1223 (s), 1191
(s), 1024 (m), 738 (m).
calc'd for C16H20F3N20 2S [M+H]*: 361.1192,
found: 361.1184.
0.67 (UV, CAM, KMnO 4).
Warming to 23 *C followed by addition of triethylsilane affords spirocyclic indoline (±)-3a in 55% yield. Warming to 23 *C and
keeping the mixture at 23 'C for 4.5 h followed by addition of triethylamine affords spirocyclic indoline (+)-3a in 30% yield.
8 The use of Cl 5,C16-hexadeuterated analog la-d6 as substrate and addition of triethylamine after warming to 23 *C for 4.5 y affordsC15,CI6-hexadeuterated spirocyclic indoline (+)-3a-d in 29% yield (>99% deuterium incorporation at C15 and C16 by H NMR
analysis).
9 The use of the C15,C16-hexadeuterated isotopomer la-d6 as substrate affords C15,C16-hexadeuterated spirocyclic indoline (±)-3a-din 95% yield (>99% deuterium incorporation at C15 and C16 by 'H NMR analysis).
' The addition of lithium aluminum deuteride (98 atom% D) in place of lithium aluminum hydride affords C2-monodeuterated analog(±)-3a-di in 96% yield (;>98% deuterium incorporation at C2 [d.r. = 6:1] by 'H NMR analysis). The C2-deuterium bond in the major
diastereomer is syn to the C3-C 10 bond, as determined by 'H NMR analysis and NOESY correlations for spirocyclic indoline (±)-3a.
" The addition of lithium aluminum deuteride (98 atom% D) I h after allowing the reaction mixture to warm to 23 *C affords C2-
monodeuterated analog (±)-3a-dl in 60% yield (>98% deuterium incorporation at C2 [dr = 6:1] by 'H NMR analysis).
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Spirocyclic indoline ()-3b:
Trifluoromethanesulfonic anhydride (70.7 pL, 420 pmol, 2.10 equiv) was added via syringe to
a solution of 1-methyl-N-acetyltryptamine12 (1b, 43.3 mg, 200 pmol, 1 equiv) and 2-chloropyridine
(60.1 pL , 640 pmol, 3.20 equiv) in dichloromethane (500 pL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 25 min, triethylsilane13 (63.9 pL, 400 [tmol, 2.00 equiv)
was added via syringe. After 5 min, the reaction mixture was allowed to warm to 23 'C. After 3 h,
triethylamine (300 ptL) was added to neutralize the trifluoromethanesulfonate salts. Brine (10 mL)
was added, and the aqueous layer was extracted with dichloromethane (10 mL, 2 x 5 mL). The
combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (0 --+ 20% ethyl acetate in hexanes) to afford spirocyclic indoline (±)-3b (64.7 mg, 97.3%)
as an off-white powder. Structural assignments were made with additional information from gCOSY,
HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl 3, 20 'C):
13C NMR (125 MHz, CDCl 3, 20 'C):
19 F NMR (471 MHz, CDCl 3, 20 *C):
FTIR (neat) cm-:
HRMS (DART):
TLC (30% EtOAc in hexanes), Rf:
8 7.17 (app-dt, J= 1.3, 7.7, 1H, C7H), 6.99 (d, J= 7.4,
1H, C5 H), 6.75 (app-dt, J= 1.0, 7.5, 1H, C6H), 6.56 (d,
J 7.9, 1H, C8H), 5.25 (d, J= 2.4, 1H, C14Hz), 4.42 (d,
J 2.4, 1H, C14HE), 4.00 (app-dt, J = 2.5, 9.2, 1H,
CiiHa), 3.78 (app-dt, J= 6.6, 10.2, 1H, CI Hb), 3.36 (d,
J= 8.8, 1H, C2 Ha), 3.21 (d, J= 8.8, 1H, C2Hb), 2.77 (s,
3H, C15H3), 2.22 (ddd, J = 2.5, 6.6, 12.6, 1H, CioHa),
2.07 (ddd, J= 8.2, 10.2, 12.6, 1H, C1oHb).
5 153.2 (C9), 148.4 (C13), 132.1 (C4), 129.2
(C), 120.6 (q, J = 325.8, SO2 CF3 ), 118.8
(Cs), 94.8 (C14), 68.4 (C2 ), 55.6 (C13), 49.8
(C15 ), 35.1 (C10 ).
5 -74.0.
(C7 ), 123.5
(C6 ), 108.1
(C11 ), 35.9
2954 (w), 1657 (in), 1608 (m), 1492 (m), 1404
1383 (in), 1227 (s), 1198 (s), 1147 (s), 748 (in).
calc'd for C14H16F3N2 0 2 S [M+H]*: 333.0879,
found: 333.0872.
(in),
0.60 (UV, CAM, KMnO 4).
For previous preparations of amides 1b, 1c, and 1d, see Song, H.; Yang, J.; Chen, W.; Qin, Y. Org. Lett. 2006, 8, 6011.
" The addition of tetrahydrofuran and lithium aluminum hydride in place of triethylsilane affords spirocyclic indoline (±)-3b in 92%
yield. The addition of triethylamine in place of triethylsilane affords spirocyclic indoline (±)-3b in 72% yield.
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Spirocyclic indoline (W)-3c:
Trifluoromethanesulfonic anhydride (154 pL, 916 ptmol, 2.10 equiv) was added via syringe to
a solution of 1-benzyl-N-acetyltryptamine12 (1c, 128 mg, 436 pmol, 1 equiv) and 2-chloropyridine
(131 pL, 1.40 mmol, 3.20 equiv) in dichloromethane (1.5 mL) at -78 'C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 25 min, triethylsilane (63.9 pL, 400 pimol, 2.00 equiv)
was added via syringe. After 5 min, the reaction mixture was allowed to warm to 23 'C. After 3 h,
triethylamine (500 pL) was added to neutralize the trifluoromethanesulfonate salts. Brine (15 mL)
was added, and the aqueous layer was extracted with dichloromethane (3 x 15 mL). The combined
organic layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under
reduced pressure. The residue was purified by flash column chromatography on silica gel (0 -+ 5%
ethyl acetate in hexanes) to afford spirocyclic indoline (±)-3c (128 mg, 99.5%) as a viscous, colorless
oil. Structural assignments were made with additional information from gCOSY, HSQC, gHMBC,
and NOESY data.
'H NMR (500 MHz, CDCl3, 20 *C):
"C NMR (125 MHz, CDCl 3, 20 'C):
19F NMR (282 MHz, CDCl3, 20 *C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (20% EtOAc in hexanes), Rf:
6 7.44-7.38 (m, 2H, C18H, C20H), 7.44-7.38 (in, 2H,
CI7 H, C2 1H), 7.44-7.38 (m, 1H, C19H), 7.20 (app-dt, J=
1.2, 7.7, 1H, C7H), 7.07 (dd, J= 1.2, 7.5, 1H, C5H), 6.81
(app-dt, J = 0.8, 7.4, 1H, C6H), 6.65 (d, J = 7.9, 1H,
C8H), 5.30 (d, J= 2.3, 1H, CI4Hz), 4.49 (d, J= 2.3, 1H,
C14HE), 4.43 (d, J 14.8, 1H, C15Ha), 4.25 (d, J= 14.8,
1H, C15Hb), 4.06-3.97 (m, 1H, CiHa), 3.82-3.70 (m,
1H, C11Hb), 3.38 (d, J= 9.2, 1H, C2Ha), 3.33 (d, J= 9.2,
1H, C2Hb), 2.27-2.09 (m, 2H, CoH2).
6 152.3 (C9 ), 148.6 (C13), 137.8 (C16), 131.9 (C4), 129.3
(C 7), 128.8 (C, 8 , C20), 127.9 (C17, C2 1), 127.6 (C19),
123.8 (C5), 120.6 (q, J = 325.3, SO2 CF3), 118.9 (C6),
108.0 (C), 94.8 (C14), 66.1 (C2 ), 55.4 (C3 ), 53.0 (C15),
49.7 (C1), 35.5 (C10).
6-74.0.
2831 (m), 1656 (in), 1606 (m), 1489 (s), 1404 (s), 1382
(s), 1228 (s), 1198 (s), 1029 (m), 742 (m).
calc'd for C20H20F3N20 2S [M+H]*: 409.1192,
found: 409.1178.
0.67 (UV, CAM, KMnO 4).
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Spirocyclic indoline (W)-3d:
Trifluoromethanesulfonic anhydride (64.9 gL, 386 gmol, 2.10 equiv) was added via syringe to
a solution of 1-(p-toluenesulfonyl)-N-acetyltryptamine1 (Id, 65.5 mg, 184 ptmol, 1 equiv) and 2-
chloropyridine (55.2 p.L, 588 pmol, 3.20 equiv) in dichloromethane (1.0 mL) at -78 'C. After 2 min,
the reaction mixture was allowed to warm to 0 'C. After 10 min, the reaction mixture was allowed to
warm to 23 'C. After 30 min, triethylsilane (58.7 [tL, 368 pmol, 2.00 equiv) was added via syringe.
After 3 h, triethylamine (300 pL) was added to neutralize the trifluoromethanesulfonate salts. Brine
(15 mL) was added, and the aqueous layer was extracted with dichloromethane (3 x 15 mL). The
combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (0 -- 10% ethyl acetate in hexanes) to afford spirocyclic indoline (±)-3d (81.2 mg, 93.5%)
as a white powder. Structural assignments were made with additional information from gCOSY,
HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl 3, 20 'C):
3 C NMR (125 MHz, CDCl3, 20 0C):
19F NMR (282 MHz, CDC13, 20 'C):
FTIR (neat) cm1:
HRMS (DART):
TLC (10% EtOAc in hexanes), Rf:
8 7.70 (d, J= 8.2, 1H, CH), 7.66 (d, J= 8.3, 2H, C17 H,
C2 1H), 7.30 (app-dt, J= 1.4, 7.8, 1H, C7H), 7.23 (d, J=
8.3, 1H, Ci 8H, C20H), 7.05 (app-dt, J = 0.9, 7.5, 1H,
C6H), 6.99 (d, J = 7.6, 1H, C5 H), 5.00 (d, J = 2.8, 1H,
C14Hz), 3.99-3.95 (m, 1H, CiiHa), 3.93 (d, J= 10.8, 1H,
C2Ha), 3.75 (d, J= 10.8, 1H, C2Hb), 3.74 (d, J= 2.8, 1H,
C14HE), 3.73-3.65 (m, 1H, C,,Hb), 2.36 (s, 3H, C2 2H3),
2.01 (ddd, J= 8.3, 10.9, 12.8, 1H, Ci0 Ha), 1.91 (ddd, J=
2.0, 6.2, 12.8, 1H, CiOHb).
6 148.2 (C13), 144.8 (C19), 142.4 (C9), 133.6 (CIs),
133.5 (C4), 130.0 (C 8, C20), 129.8 (C8 ), 127.5 (C17,
C2 1), 124.7 (C), 124.5 (C), 120.5 (q, J = 325.3,
SO2CF 3), 115.2 (C), 95.4 (C 14), 62.5 (C2 ), 55.0 (C3 ),
49.5 (C,,), 36.5 (C1o), 21.7 (C2 2).
6-74.0.
2919 (w), 1656 (m), 1599 (m), 1478 (m), 1405 (s), 1359
(s), 1229 (s), 1199 (s), 1169 (s), 1027 (m).
calc'd for C2 0 H2 0F3N20 4S2 [M+H]*: 473.0811,
found: 473.0807.
0.13 (UV, CAM, KMnO4).
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Spirocyclic 1-methyltryptamine adduct (+)-6b:
Trifluoromethanesulfonic anhydride (220 piL, 1.31 mmol, 2.10 equiv) was added via syringe
to a solution of 1-methyl-N-acetyltryptamine 2 (1b, 135 mg, 622 jmol, 1 equiv), 2-chloropyridine
(187 pL, 1.99 mmol, 3.20 equiv) and 1-methyltryptamine (85.5 pL, 685 pimol, 1.10 equiv) in
dichloromethane (5.0 mL) at -78 *C. After 5 min, the reaction mixture was allowed to warm to 0 'C.
After 5 min, the reaction mixture was allowed to warm to 23 *C. After 4 h, saturated aqueous
potassium carbonate solution (5 mL) was added to neutralize the trifluoromethanesulfonate salts.
Brine (10 mL) was added, and the aqueous layer was extracted with dichloromethane (3 x 10 mL).
The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (25% dichloromethane in hexanes) to afford spirocyclic 1-methyltryptamine adduct (+)-6b
(219 mg, 76.0%) as a white powder. Structural assignments were made with additional information
from gCOSY, HSQC, gHMBC, and NOESY data.
H NMR (500 MHz, PhMe-d, 100 'C):
"
3 C NMR (125 MHz, PhMe-d, 100 'C):
'9F NMR (471 MHz, PhMe-ds, 100 'C):
FTIR (neat) cm 1:
HRMS (DART):
TLC (50% CH2Cl2 in hexanes), Rf:
8 7.69 (d, J= 8.1, 1H, C5,H), 7.14-7.07 (m, 2H, C7 ,H,
C7H), 7.02 (app-t, J= 7.7, 1H, C6,H), 7.00 (d, J= 8.1,
1H, C8 H), 6.91 (d, J = 7.4, 1H, C5 H), 6.72 (app-t, J=
7.5, lH, C6 H), 6.70 (s, 1H, C2'H), 6.47 (d, J= 7.9, 1H,
C8H), 5.48 (d, J= 1.7, 1H, C14Hz), 4.55 (d, J= 1.7, 1H,
C14HE), 4.54 (s, 1H, C2H), 3.19 (s, 3H, C15.H3 ), 3.15
(app-t, J = 9.1, 1H, CiiHa), 2.52-2.43 (m, 1H, CnHb),
2.48 (s, 3H, Ci5H3), 2.26-2.16 (m, 1H, CioHa), 1.52-
1.43 (m, 1H, CioHb).
6 153.3 (C9), 151.2 (C13), 138.5 (C9'), 134.1 (C4 ), 129.4
(C7), 128.9 (C2.), 128.4 (C4'), 124.0 (C5 ), 122.8 (C7 ),
121.4 (C5'), 121.3 (q, J = 325.8, SO 2CF 3), 120.6 (C61),
119.7 (C6), 110.5 (C5 .), 109.9 (C8'), 108.5 (C8), 95.5
(C14), 77.9 (C2 ), 61.4 (C3 ), 50.3 (C,1 ), 34.1 (C,5 ), 33.2
(C1O), 32.2 (Ci5').
5 -75.1.
2915 (w), 1650 (m), 1605 (m), 1485 (s), 1402 (s), 1382
(s), 1228 (s), 1197 (s), 1146 (s), 1021 (m), 744 (m).
calc'd for C23H23F3N30 2 S [M+H]*: 462.1458,
found: 462.1477.
0.42 (UV, CAM, KMnO4).
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Oxazolidinone urea le:
A solution of 1-methyltryptamine' 4 (S2, 1.66 g, 9.53 mmol, 1 equiv) in tetrahydrofuran (20
mL) was added via cannula to a solution of N-chlorocarbonyloxazolidin-2-one 1 5 (S3, 1.56 g, 10.4
mmol, 1.09 equiv) and triethylamine (3.33 mL, 23.9 mmol, 2.51 equiv) in tetrahydrofuran (40 mL) at
23 'C. After 12 h, the reaction mixture was diluted with ethyl acetate (250 mL). The organic layer
was washed with saturated aqueous ammonium chloride solution (2 x 250 mL), aqueous sodium
hydroxide solution (IN, 250 mL), saturated aqueous sodium bicarbonate solution (250 mL), and
brine (250 mL). The organic layer was dried over anhydrous sodium sulfate, was filtered, and was
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (50% ethyl acetate in hexanes) to afford oxazolidinone urea le (1.76 g, 64.3%) as a beige
powder. Structural assignments were made with additional information from gCOSY data.
'H NMR (500 MHz, CDCl 3, 20 'C):
3 C NMR (125 MHz, CDCl3, 20 *C):
FTIR (neat) cm-1:
HRMS (DART):
8 7.92-7.84 (br-m, 1H, N12H), 7.63 (d, J = 7.9, 1H,
CH), 7.30 (d, J= 8.2, 1H, C8H), 7.24 (app-dt, J= 1.1,
7.6, 1H, C7 H), 7.13 (app-dt, J= 1.1, 7.4, 1H, C6H), 6.92
(s, 1H, C2H), 4.32 (t, J = 8.2, 2H, Ci 8H2), 3.98 (t, J=
8.2, 2H, C19H2 ), 3.74 (s, 3H, C19H3 ), 3.58 (app-q, J =
7.1, 2H, C11H 2 ), 3.02 (t, J= 7.1, 1H, C10 H2).
8 155.7, 151.6, 137.1, 127.6, 126.9, 121.6, 118.8, 118.8,
111.1, 109.3, 62.3, 42.4, 40.7, 32.6, 25.4.
3349 (br-m), 2922 (m), 1755 (s), 1697 (s), 1540 (s),
1478 (s), 1400 (s), 1245 (s), 1104 (s), 1037 (m), 744 (s).
calc'd for C 5Hi 8N30 3 [M+H]*: 288.1343,
found: 288.1348.
TLC (50% EtOAc in hexanes), Rf: 0.19 (UV, CAM, KMnO 4).
" For a previous preparation of 1-methyltryptamine (S2), see Lygin, A. V.; de Meijere, A. Eur. J. Org. Chem. 2009, 5138.
" For a previous preparation of N-chlorocarbonyloxazolidin-2-one (S3), see Evans, D. A.; Johnson, D. S. Org. Lett. 1999, 1, 595.
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Spirocyclic 1-methyltryptamine adduct (0-6e:
Trifluoromethanesulfonic anhydride (25.9 gL, 154 pmol, 1.10 equiv) was added via syringe to
a solution of oxazolidinone urea le (40.2 mg, 140 pmol, 1 equiv) and 2-chloropyridine (28.9 gL, 308
pmol, 2.20 equiv) in dichloromethane (1.8 mL) at -78 *C. After 5 min, the reaction mixture was
allowed to warm to 0 0C. After 30 min, 1-methylindole (19.2 pL, 154 pmol, 1.10 equiv) was added
via syringe. After 1 min, titanium tetrachloride (1.0 M solution in dichloromethane, 154 gL, 154
pimol, 1.10 equiv) was added via syringe. After 5 min, the reaction mixture was allowed to warm to
23 'C. After 5 min, the reaction vessel was placed into an oil bath and heated to 45 *C. After 3 h, the
reaction vessel was removed from the oil bath and allowed to cool to 23 *C before saturated aqueous
sodium bicarbonate solution (15 mL) was added to quench the titanium and
trifluoromethanesulfonate salts. The aqueous layer was extracted with dichloromethane (3 x 10 mL).
The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (30 --> 70% ethyl acetate in hexanes) to afford spirocyclic 1 -methyltryptamine adduct (±)-6e
(46.6 mg, 83.2%) as a white powder. Structural assignments were made with additional information
from gCOSY, HSQC, gHMBC, and NOESY data.
IH NMR (500 MHz, PhMe-d, 100 *C):
13C NMR (125 MHz, PhMe-d, 80 *C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (70% EtOAc in hexanes), Rf:
6 7.83-7.60 (br-s, 1H, C5'H), 7.13 (app-t, J = 7.6, 1H,
C7,H), 7.09 (app-t, J = 7.8, 1H, C7 H), 7.04 (app-t, J =
8.0, 1H, C6,H), 7.01 (d, J= 8.2, 1H, C8sH), 6.79 (d, J=
7.7, lH, C5 H), 6.79-6.74 (br-s, 1H, C2,H), 6.66 (app-t, J
= 7.4, 1H, CH), 6.52 (d, J = 7.9, 1H, CH), 5.82-5.69
(br-s, 1H, C2 H), 3.78 (app-q, J = 9.0, 1H, Ci8 Ha),
3.71-3.57 (in, 1H, Ci8Hb), 3.71-3.57 (m, 1H, C17Ha),
3.53 (app-q, J= 8.3, 1H, C17Hb), 3.39 (ddd, J= 3.5, 8.6,
14.8, 1H, CiHa), 3.17 (s, 3H, C19 ,H3), 2.83 (app-dt, J=
15.0, 7.5, 1H, CuHb), 2.72 (s, 3H, C19H3 ), 2.70-2.62
(in, 1H, CioHa), 1.86 (app-dt, J= 13.0, 7.9, 1H, CIoHb).
6 163.9 (C13 ), 154.0 (C9 ), 153.0 (C15), 138.4 (C9.), 135.4
(C4 ), 129.3 (C4), 128.9 (C2'), 128.6 (C7), 122.3 (C7 '),
121.6 (C5), 120.7 (C5 ), 120.0 (C'), 118.4 (C6), 113.2
(C3 '), 109.6 (C8 '), 108.2 (C8), 69.7 (C2), 64.4 (C3), 62.1
(C 17), 54.9 (C11), 46.8 (Ci 8), 40.4 (C1o), 34.7 (C19), 32.2
(C19').
2931 (m), 1770 (s), 1611 (s), 1488 (s), 1399 (s), 1121
(in), 1066 (in), 741 (s).
calc'd for C2 4 H2 5N 40 2 [M+H]*: 401.1972,
found: 401.1972.
0.18 (UV, CAM, KMnO 4).
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lN-Dimethyl-N-pivalyltryptamine (1f):
Sodium hydride (60% dispersion in mineral oil, 1.24 g, 31.0 mmol, 8.00 equiv) was added
slowly over 5 min as a solid under an argon atmosphere to a solution of N-pivalyltryptamine 6 (S4,
946 mg, 3.87 mmol, 1 equiv) in NN-dimethylformamide (12.0 mL) at 0 *C, and the resulting mixture
was allowed to warm to 23 'C. After 30 min, iodomethane (2.42 mL, 38.7 mmol, 10.0 equiv) was
added slowly via syringe over 5 min. After 48 h, saturated aqueous ammonium chloride solution (20
mL) was added via syringe to quench the excess base, and the resulting biphasic mixture was
concentrated under reduced pressure. The residue was diluted with diethyl ether (250 mL) and was
washed with water (2 x 200 mL) and brine (200 mL). The organic layer was dried over anhydrous
magnesium sulfate, was filtered, and was concentrated under reduced pressure. The residue was
purified by flash column chromatography on silica gel (20 -+ 40% ethyl acetate in hexanes) to afford
1,N-dimethyl-N-pivalyltryptamine (1f, 993 mg, 94.1%) as a viscous yellow oil. Structural
assignments were made with additional information from gCOSY data.
1H NMR (500 MHz, CDCl 3, 20 C): 6 7.63 (d, J= 7.7, 1H, C5H), 7.28 (d, J= 8.2, 1H, CsH),
"C NMR (125 MHz, CDCl3, 20 0C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (30% EtOAc in hexanes), Rf:
(d, J = 7.7, 1H, C5 H), 7.21 (app-t, J = 7.6, 1H, C7H),
7.10 (app-t, J= 7.4, 1H, CH), 6.86 (s, 1H, C2H), 3.73
(s, 3H, C19H3 ), 3.62 (t, J= 7.3, 2H, C1 IH2), 3.05 (s, 3H,
C18H3), 2.99 (t, J = 7.3, 2H, C10 H2), 1.28 (s, 9H,
C(CH3)3).
8 177.3, 137.1, 127.9, 126.7, 121.7, 119.0, 118.9, 111.7,
109.3, 51.6, 38.9, 36.9, 32.7, 28.4, 23.4.
3054 (w), 2933 (in), 1623 (s), 1482 (s), 1403 (in), 1379
(m), 1328 (m), 1094 (m), 740 (s).
calc'd for C17H24N2NaO [M+Na]*: 295.1781,
found: 295.1771.
0.20 (UV, CAM, KMnO4).
16 For a previous preparation of amide S4, see Eichele, 0.; Mutschler, E. A rchiv der Pharmazie 1967, 300, 1038.
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Tricyclic indoline (+)-7f:
Trifluoromethanesulfonic anhydride (59.7 gL, 355 pmol, 1.10 equiv) was added via syringe to
a solution of 1,N-dimethyl-N-pivalyltryptamine (1f, 87.8 mg, 322 pmol, 1 equiv) and 2-
chloropyridine (36.3 ptL, 387 ptmol, 1.20 equiv) in acetonitrile (3.6 mL) at 0 'C. After 10 min, the
reaction mixture was allowed to warm to 23 *C. After 20 min, triethylsilane (154 pL, 967 pmol, 3.00
equiv) was added via syringe. After 8 h, the reaction mixture was cooled to 0 *C, and
tetrahydrofuran (3.0 mL) was added via syringe. After 30 sec, lithium aluminum hydride' 7 (48.9 mg,
1.29 mmol, 4.00 equiv) was added as a solid under an argon atmosphere. After 10 min, sodium
sulfate decahydrate was added to quench the unreacted aluminum hydride salts. The resulting
suspension was filtered, and the filter cake was extracted with ethyl acetate (20 mL). The combined
filtrates were concentrated under reduced pressure. The residue was purified by flash column
chromatography on alumina (0 -+ 1.5% ethyl acetate in hexanes) to afford tricyclic indoline (±)-7f
(76.1 mg, 91.4%) as a viscous, colorless oil. Structural assignments were made with additional
information from gCOSY, HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 20 'C):
"C NMR (125 MHz, CDCl3, 20 "C):
FTIR (neat) cm-1:
HRMS (DART):
8 7.20 (d, J= 7.4, 1H, C5H), 7.10 (app-t, J= 7.7, 1H,
C7H), 6.68 (app-t, J= 7.4, 1H, CH), 6.49 (d, J = 7.7,
1H, C8H), 3.37-3.24 (in, 1H, CiiHa), 3.18 (d, J= 7.9,
1H, C2Ha), 2.72 (s, 1H, CB3 H), 2.69 (s, 3H, C19H 3), 2.64
(s, 3H, C, 8H3), 2.63 (d, J= 7.9, 1H, C2Hb), 2.54 (app-dt,
J= 7.5, 12.2, 1H, CioHa), 2.42 (ddd, J= 5.9, 8.7, 12.2,
1H, C1,Hb), 1.71 (app-dd, J = 5.9, 12.0, 1H, CoHb),
0.68 (s, 9H, C(CH 3)3).
6 155.5 (C9), 134.0 (C4 ), 128.1 (C7), 125.2 (C5), 117.8
(C6), 108.0 (C8), 80.4 (C13), 74.2 (C2 ), 55.4 (C3), 55.3(C, 1), 48.1 (C,8), 37.3 (C14), 37.0 (C19), 36.5 (Cio), 27.2
(C(CH3)3).
2953 (s), 2797 (s), 1606 (s), 1484 (s),
(in), 1269 (m), 1154 (in), 1047 (in), 965
calc'd for C17H27N2 [M+H]*: 259.2169,
found: 259.2164.
1461 (in), 1365
(in), 740 (s).
TLC (A12 0 3, 10% EtOAc in hexanes), Rf: 0.76 (UV, CAM, KMnO 4).
17 The use of lithium aluminum deuteride (98 atom% D) affords the Cl3-monodeuterated analog (±)-7f-di (> 8% deuterium
incorporation at Cl 3 and <5% deuterium enrichment at C2 by 1H NMR analysis).
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Tetracyclic indoline (±)-7g:
Trifluoromethanesulfonic anhydride (10.2 pL, 60.7 pmol, 1.10 equiv) was added via syringe
to a solution of a-quaternary 1-methyltryptamine lactam 1g' 8 (15.7 mg, 55.2 pmol, 1 equiv) and 2-
chloropyridine (11.4 pL, 121 ptmol, 2.20 equiv) in dichloromethane (600 pL) at -78 'C. After 5 min,
the reaction mixture was allowed to warm to 0 'C. After 10 min, the reaction mixture was allowed to
warm to 23 'C. After 20 min, triethylsilane (26.5 piL, 166 [tmol, 3.00 equiv) was added via syringe.
After 2 h, the reaction mixture was cooled to 0 'C, and tetrahydrofuran (2.0 mL) was added via
syringe. After 30 sec, lithium aluminum hydride (8.4 mg, 221 Pmol, 4.00 equiv) was added as a solid
under an argon atmosphere. After 10 min, sodium sulfate decahydrate was added to quench the
unreacted aluminum hydride salts. The resulting suspension was filtered, and the filter cake was
extracted with ethyl acetate (20 mL). The combined filtrates were concentrated under reduced
pressure. The residue was purified by flash column chromatography on silica gel (1% triethylamine,
10% ethyl acetate in hexanes) to afford tetracyclic indoline (±)-7g (14.9 mg, 99.8%) as an off-white
powder. Structural assignments were made with additional information from gCOSY, HSQC,
gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 20 'C):
13C NMR (125 MHz, CDCl3, 20 'C):
FTIR (neat) cm-1:
HRMS (DART):
8 7.15 (d, J= 7.3, 1H, C5 H), 7.06 (app-dt, J= 1.0, 7.6,
1H, C7H), 6.61 (app-t, J 7.3, 1H, C6 H), 6.39 (d, J =
7.8, 1H, C8H), 3.50 (d, J 9.3, 1H, C2Ha), 3.29 (app-dt,
J= 4.8, 9.1, 1H, CiiHa), 3.17-3.11 (m, 1H, C17Ha), 3.09
(d, J= 9.3, 1H, C2Hb), 2.71 (s, 3H, C20H 3), 2.20 (app-dt,
J = 6.6, 9.9, 1H, CIIHb), 2.09 (ddd, J = 6.6, 8.8, 12.7,
1H, C10 Ha), 1.92 (app-dt, J = 3.1, 11.7, 1H, C17Hb),
1.87-1.79 (i, 1H, C1oHb), 1.81 (s, 1H, C1 3H),
1.69-1.56 (i, 1H, C16Ha), 1.39-1.32 (m, 1H, C16Hb),
1.20-1.13 (i, lH, C15Ha), 1.05 (app-dt, J = 3.7, 13.3,
1H, C15Hb), 1.00 (s, 3H, C18H3), 0.28 (s, 3H, C19H3).
8 153.0 (C9 ), 136.6 (C4), 127.8 (C7), 126.7 (C5), 117.4
(C), 106.6 (Cs), 82.1 (C13), 67.8 (C2), 56.0 (C17), 53.4
(C 1), 52.9 (C3 ), 43.8 (C15), 40.3 (Cio), 35.7 (C20), 34.3
(C 14), 28.8 (Ci 8), 22.3 (C16 ), 21.7 (C19).
2933 (s), 1605 (s), 1492 (s), 1386 (w),
(m), 1105 (w), 1023 (m), 740 (m).
calc'd for Ci 8H27N2 [M+H]*: 271.2169,
found: 271.2170.
1271 (m), 1163
TLC (A12 0 3, 10% EtOAc in hexanes), Rf: 0.60 (UV, CAM, KMnO 4).
" Lactam ig was prepared from the C14-didemethyl derivative by sequential treatment with excess lithium diisopropylamide and
methyl iodide in tetrahydrofuran. For a previous preparation of the C14-didemethyl derivative of lactam 1g, see Nagawa, M.; Kiuchi,
M.; Obi, M.; Tonozuka, M.; Kobayashi, K.; Hino, T.; Ban, Y. Chem. Phann. Bull. 1975, 23, 304.
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Pentacyclic indoline (±')-8h:
Trifluoromethanesulfonic anhydride (38.4 pL, 228 ptmol, 2.10 equiv) was added via syringe to
a solution of 1-methyl-N-phenylacetyltryptamine' 9 (1h, 31.8 mg, 109 pmol, 1 equiv) and 2-
chloropyridine (32.7 gL, 348 pmol, 3.20 equiv) in dichloromethane (1.0 mL) at -78 0C. After 5 min,
the reaction mixture was allowed to warm to 0 'C. After 5 min, the reaction mixture was allowed to
warm to 23 'C. After 5 min, the reaction vessel was placed into a microwave reactor and heated to
130 *C. After 5 min, the reaction vessel was removed from the microwave reactor and allowed to
cool to 23 'C before triethylamine (500 [tL) was added to neutralize the trifluoromethanesulfonate
salts. Brine (10 mL) was added, and the aqueous layer was extracted with dichloromethane (10 mL,
then 2 x 5 mL). The combined organic layers were dried over anhydrous sodium sulfate, were
filtered, and were concentrated under reduced pressure. The residue was purified by flash column
chromatography on silica gel (0 --> 20% ethyl acetate in hexanes) to afford spirocyclic indoline (±)-
8h (44.1 mg, 99.8%) as an off-white powder. Structural assignments were made with additional
information from gCOSY, HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 20 'C):
3 C NMR (125 MHz, CDCl3, 20 'C):
'
9F NMR (471 MHz, CDCl3, 20 'C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (20% EtOAc in hexanes), Rf:
8 7.43 (d, J= 6.7, 1H, C19H), 7.14-7.05 (m, 1H, C7H),
7.14-7.05 (in, 1H, C17H), 7.14-7.05 (m, 1H, C18H),
6.98-6.93 (m, 1H, C5H), 6.98-6.93 (m, 1H, Ci6H), 6.63
(app-dt, J = 0.9, 7.4, 1H, C6H), 6.49 (d, J = 7.8, 1H,
CsH), 6.38 (s, 1H, C14H), 4.80 (s, 1H, C2H), 4.04 (app-t,
J = 9.3, 1H, CiiHa), 3.94 (app-dt, J = 5.7, 10.9, 1H,
C,Hb), 3.38 (s, 3H, C2 1H3), 2.23 (app-dt, J= 8.6, 11.8,
1H, CioHa), 2.12 (app-dd, J= 5.7, 11.8, 1H, CioHb).
6 149.6 (C9), 137.4 (C1 3), 133.7 (C 20), 133.4 (C 4), 133.0
(C 15), 129.4 (C 7), 128.2 (C17), 127.6 (C,6), 127.1 (Ci8),
126.8 (C19), 121.7 (Cs), 120.4 (q, J = 324.8, SO2CF 3),
118.1 (C6 ), 108.1 (Cs), 106.1 (C14 ), 73.4 (C2), 55.0 (C3 ),
49.1 (C11), 38.7 (C1o), 37.2 (C2 1).
5-75.0.
2911 (w), 1671 (m), 1605 (m), 1485 (s), 1399 (s), 1227
(s), 1194 (s), 1147 (s), 1039 (m), 746 (m).
calc'd for C20Hi 8F3N20 2S [M+H]*: 407.1036,
found: 407.1026.
0.56 (UV, CAM, KMnO4).
'9 For a previous preparation of amide lh, see Ho, B. T.; Mclsaac, W. M.; Tansey, L. W.; Kralik, P. M. J. Pharm. Sci. 1968, 57, 1998.
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1-Methvl-N-(3,4-dimethoxvphenvl)acetyltrvtamine (i):
Sodium hydride (60% dispersion in mineral oil, 147 mg, 3.68 mmol, 1.30 equiv) was added
slowly over 5 min as a solid under an argon atmosphere to a solution of N-(3,4-
dimethoxyphenyl)acetyltryptamine20 (S5, 958 mg, 2.83 mmol, 1 equiv) in NN-dimethylformamide
(25 mL) at 23 'C. After 30 min, iodomethane (230 [tL, 3.68 mmol, 1.30 equiv) was added slowly via
syringe over 5 min. After 18 h, the reaction mixture was concentrated under reduced pressure and
then diluted with diethyl ether (125 mL). The organic layer was washed with water (2 x 125 mL),
was dried over anhydrous sodium sulfate, was filtered, and was concentrated under reduced pressure.
The residue was purified by flash column chromatography on alumina (50% ethyl acetate in hexanes)
to afford 1-methyl-N-(3,4-dimethoxyphenyl)acetyltryptamine (1i, 536 mg, 53.7%) as a white powder.
Structural assignments were made with additional information from gCOSY, HSQC, and gHMBC
data.
'H NMR (500 MHz, CDCl3, 20 'C):
3 C NMR (125 MHz, CDCl 3, 20 'C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (50% EtOAc in hexanes), Rf:
6 7.50 (d, J= 7.9, 1H, C5H), 7.26 (d, J= 8.2, 1H, C8H),
7.21 (app-t, J= 7.6, 1H, C7H), 7.07 (app-t, J= 7.4, 1H,
CH), 6.74 (d, J= 8.1, 1H, CI 9H), 6.65 (dd, J= 1.5, 8.1,
1H, C20H), 6.62 (d, J = 1.5, 1H, CIH), 6.57 (s, IH,
C2 H), 5.61-5.42 (br-s, 1H, N 12H), 3.85 (d, 3H, C2 3H3),
3.73 (s, 3H, C2 2H3 ), 3.66 (s, 3H, C2 1 H 3), 3.49 (app-q, J
= 6.3, 2H, CI1 H2), 3.44 (s, 2H, C14H 2), 2.86 (t, J= 6.6,
2H, CioH 2).
6 171.3 (C13), 149.3 (C 17), 148.3 (C, 8 ), 137.2 (C9 ),
127.8 (C4), 127.6 (C, 5), 126.8 (C2 ), 121.9 (C7 ), 121.8
(C20), 119.1 (C), 118.9 (C), 112.5 (C,6 ), 111.5 (C19),
111.3 (C3 ), 109.4 (C), 56.0 (C23), 56.0 (C22 ), 43.6
(C14), 40.0 (CI1), 32.6 (C 2 1), 25.0 (C10 ).
3293 (br-m), 2934 (m), 1645 (s), 1514 (s), 1465 (m),
1328 (m), 1262 (s), 1235 (s), 1156 (m), 1027 (s), 742
(m).
calc'd for C21H24N2NaO3 [M+Na]*: 375.1679,
found: 375.1687.
0.64 (UV, CAM, KMnO4 ).
20 For a previous preparation of amide S5, see Onda, M.; Kawanishi, M. Yakugaku Zasshi 1956, 76, 966.
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Pentacyclic indoline ( )-8i:
Trifluoromethanesulfonic anhydride (417 gL, 2.48 mmol, 2.10 equiv) was added via syringe
to a solution of 1 -methyl-N-(3,4-dimethoxyphenyl)acetyltryptamine (1i, 416 mg, 1.18 mmol, 1 equiv)
and 2-chloropyridine (355 pL, 3.78 mmol, 3.20 equiv) in dichloromethane (12.0 mL) at -78 'C.
After 5 min, the reaction mixture was allowed to warm to 0 'C. After 5 min, the reaction mixture was
allowed to warm to 23 'C. After 5 min, the reaction vessel was placed into an oil bath and heated to
45 *C. After 3 h, the reaction vessel was removed from the oil bath and allowed to cool to 23 *C
before triethylamine (1.0 mL) was added to neutralize the trifluoromethanesulfonate salts. Brine (60
mL) was added, and the aqueous layer was extracted with dichloromethane (60 mL, then 2 x 30 mL).
The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (10 -+ 30% ethyl acetate in hexanes) to afford pentacyclic indoline (±)-8i (540 mg, 98.1%)
as a tan powder. Structural assignments were made with additional information from gCOSY,
HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 20 *C):
"C NMR (125 MHz, CDCl3, 20 'C):
'
9F NMR (282 MHz, CDCl3 , 20 'C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (50% EtOAc in hexanes), Rf:
6 7.11 (app-dt, J= 1.2, 7.7, 1H, C7H), 6.96 (d, J= 7.3,
1H, C5H), 6.94 (s, 1H, C19H), 6.64 (app-dt, J= 1.0, 7.5,
1H, C6H), 6.51 (d, J = 7.7, 1H, C8H), 6.48 (s, 1H,
CIAH), 6.29 (s, 1H, C14H), 4.76 (s, 1H, C2H), 4.03 (app-
t, J= 9.2, 1H, CIIHa), 3.93 (app-dt, J= 5.9, 11.0, 1H,
C1LHb), 3.84 (s, 3H, C22H3), 3.79 (s, 3H, C2 3H3), 3.37 (s,
3H, C2 1H3), 2.24 (app-dt, J= 8.4, 11.8, 1H, CioHa), 2.11
(app-dd, J= 5.6, 11.9, 1H, CIoHb).
6 149.5 (C9), 148.7 (C 1 7), 147.9 (C18), 1
133.8 (C4), 129.4 (C7), 126.1 (C15), 125.6 (
(C5), 120.5 (q, J = 325.3, SO2CF3), 118.4
(C 16), 110.7 (C19), 108.5 (Cs), 105.7 (C 14),
56.3 (C22), 56.0 (C23), 55.0 (C 3), 49.1 (C11 ),
37.4 (C21).
6-75.0.
2935 (m), 1670 (m), 1603 (m), 1516 (m),
1396 (s), 1256 (s), 1225 (s), 1212 (s), 1148
(m), 666 (s).
calc'd for C22H22F3N2 0 4S [M+H]*: 467.1247,
found: 467.1232.
36.2
C20),
73.6
38.6
(C 13),
121.7
110.7
(C2 ),
(C10 ),
1489 (m),
(m), 1040
0.64 (UV, CAM, KMnO4).
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N-(4-nitrophenvDacetyltryptamine (1j):
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrogen chloride (EDC-HCl, 4.81 g, 25.1
mmol, 1.50 equiv) was added under an argon atmosphere to a solution of tryptamine (S1, 2.95 g, 18.4
mmol, 1.10 equiv), 4-nitrophenylacetic acid (3.03 g, 16.7 mmol, 1 equiv), N-hydroxybenzotriozole
(HOBT, 3.39 g, 25.1 mmol, 1.50 equiv), and powdered 4 A molecular sieves (3.0 g) in
dichloromethane (100 mL) at 23 'C. After 48 h, the reaction mixture was concentrated under
reduced pressure. The residue was diluted with ethyl acetate (275 mL) and was washed with aqueous
hydrogen chloride solution (IN, 250 mL), saturated aqueous ammonium chloride solution (250 mL),
saturated aqueous sodium bicarbonate solution (2 x 250 mL), and brine (250 mL). The organic layer
was dried over anhydrous sodium sulfate, was filtered, and was concentrated under reduced pressure
to afford N-(4-nitrophenyl)acetyltryptamine (1j, 4.71 g, 87.1%) as a tan powder. Structural
assignments were made with additional information from gCOSY data.
'H NMR (500 MHz, CDCl 3, 20 'C):
13 C NMR (125 MHz, CDCl3, 20 'C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (70% EtOAc in hexanes), Rf:
8 8.29-8.18 (br-s, 1H, N1H), 8.05 (d, J= 8.6, 2H, C17 H,
C19H), 7.52 (d, J= 7.8, 1H, C5 H), 7.35 (d, J= 8.1, 1H,
C8H), 7.25 (d, J = 8.6, 2H, C16 H, C2oH), 7.21 (t, J =
7.6, 1H, C7H), 7.10 (t, J= 7.5, 1H, C6H), 6.89 (s, 1H,
C2H), 5.62-5.48 (br-s, 1H, N 12H), 3.59 (app-q, J= 6.3,
2H, C1 H2), 3.53 (s, 2H, C1 4H2), 2.95 (t, J= 6.6, 2H,
CioH 2).
8 169.3, 147.2, 142.5, 136.5, 130.3, 127.4, 124.0, 122.5,
122.3, 119.8, 118.7, 112.6, 111.6, 43.5, 40.3, 25.0.
3403 (br-s), 3293 (br-s), 2929 (w), 1652 (s), 1517 (s),
1457 (m), 1346 (s), 1109 (w), 743 (m).
calc'd for C1 8H1 7N3NaO3 [M+Na]*: 346.1162,
found: 346.1150.
0.25 (UV, CAM, KMnO 4).
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Pentacyclic indoline ()-8i:
Trifluoromethanesulfonic anhydride (110 pL, 652 pmol, 3.10 equiv) was added via syringe to
a solution of N-(4-nitrophenyl)acetyltryptamine (1j, 68.0 mg, 210 pmol, 1 equiv) and 2-
chloropyridine (82.9 pL, 883 imol, 4.20 equiv) in dichloromethane (2.1 mL) at -78 *C. After 5 min,
the reaction mixture was allowed to warm to 0 'C. After 5 min, the reaction mixture was allowed to
warm to 23 *C. After 5 min, the reaction vessel was placed into a microwave reactor and heated to
130 "C. After 10 min, the reaction vessel was removed from the microwave reactor and allowed to
cool to 23 *C before triethylamine (500 RL) was added to neutralize the trifluoromethanesulfonate
salts. Brine (10 mL) was added, and the aqueous layer was extracted with dichloromethane (10 mL,
then 2 x 5 mL). The combined organic layers were dried over anhydrous sodium sulfate, were
filtered, and were concentrated under reduced pressure. The residue was purified by flash column
chromatography on silica gel (0 --> 10% ethyl acetate in hexanes) to afford pentacyclic indoline (+)-
8j (63.7 mg, 53.2%) as a white powder. Structural assignments were made with additional
information from gCOSY, HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 20 'C):
13C NMR (125 MHz, CDCl3, 20 *C):
19 F NMR (282 MHz, CDCl 3, 20 0C):
FTIR (neat) cm-1:
HRMS (DART):
TLC (10% EtOAc in hexanes), Rf:
6 8.54 (s, 1H, CI 9H), 8.05 (dd, J = 2.0, 8.2, 1H, C17H),
7.59 (d, J= 8.1, 1H, C8H), 7.33 (app-dt, J= 1.2, 7.8, 1H,
C7H), 7.22 (app-dt, J = 0.8, 7.6, 1H, C6 H), 7.18-7.10
(m, 1H, C5H), 7.18-7.10 (m, 1H, CIH), 6.55 (s, 1H,
C14H), 5.74 (s, 1H, C2H), 4.20 (app-t, J = 9.5, 1H,
CiiHa), 4.01 (app-dt, J = 5.7, 11.1, 1H, C1Hb), 2.51
(app-dt, J= 8.8, 11.9, 1H, CioHa), 2.22 (app-dd, J= 5.7,
12.1, lH, CoHb).
6 147.3 (C,8 ), 140.3 (C, 3), 138.8 (C15 ), 137.8 (C9),
134.5 (C4), 130.7 (C7), 130.1 (C20), 128.1 (C, 6), 127.7
(C), 125.0 (C17), 123.1 (C19), 122.6 (C5), 120.4 (q, J=
325.3, SO2CF3), 120.3 (q, J = 324.8, SO2CF 3), 117.5
(Cs), 105.1 (C14), 72.4 (C2 ), 54.8 (C3), 49.3 (C,,), 37.1
(C1O).
6 -73.9, -75.0.
2918 (w), 1666 (m), 1582 (m), 1524 (s), 1404 (s), 1340
(s), 1229 (s), 1203 (s), 1145 (s), 1077 (m), 666 (m).
calc'd for C20H 14F6N3 0 6 S2 [M+H]*: 570.0223,
found: 570.0220.
0.15 (UV, CAM, KMnO4).
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Tetracyclic indoline (0-8k:
Trifluoromethanesulfonic anhydride (199 p.L, 1.18 mmol, 3.10 equiv) was added via syringe
to a solution of N-vinylacetyltryptamine2 1 (1k, 87.0 mg, 381 pmol, 1 equiv) and 2-chloropyridine
(150 [tL, 1.21 mmol, 4.20 equiv) in dichloromethane (19.1 mL) at -78 *C. After 2 min, the reaction
mixture was allowed to warm to 0 'C. After 5 min, the reaction mixture was allowed to warm to 23
'C. After 5 min, the reaction vessel was placed into an oil bath and heated to 45 *C. After 3 h, the
reaction vessel was removed from the oil bath and allowed to cool to 23 'C before saturated aqueous
sodium bicarbonate solution (30 mL) was added to neutralize the trifluoromethanesulfonate salts.
Brine (40 mL) was added, and the aqueous layer was extracted with ethyl acetate (3 x 60 mL). The
combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (0 -- 5% ethyl acetate in hexanes) to afford tetracyclic indoline (±)-8k (102 mg, 56.4%) as
an off-white powder. Structural assignments were made with additional information from gCOSY,
HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 53 C): 6 7.55 (d, J= 8.1, 1H, CH), 7.34 (app-dt, J= 1.4, 7.8,
3 C NMR (125 MHz, CDCl3, 53 'C):
19F NMR (471 MHz, CDC 3, 53 'C):
FTIR (neat) cm'1:
HRMS (DART):
TLC (20% EtOAc in hexanes), Rf:
1H, C7 H), 7.20 (app-dt, J= 1.0, 7.5, 1H, C6H), 7.14 (d,
J= 7.5, 1H, C5H), 5.97-5.91 (m, 1H, Ci5H), 5.87 (d, J=
6.3, 1H, C14 H), 5.43 (dd, J = 2.2, 9.5, 1H, CIAH), 5.39
(s, 1H, C2H), 4.06 (app-t, J= 9.6, 1H, C 1Ha), 3.92 (app-
dt, J= 6.1, 10.8, 1H, CIIHb), 2.33 (app-q, J= 10.9, 1H,
CioHa), 2.11 (app-dd, J= 5.8, 12.2, 1H, CIoHb).
6 137.9 (C13), 137.7 (C9), 135.3 (C4 ), 130.2 (C7), 126.7
(C6), 125.8 (Ci5 ), 122.8 (Cs), 121.1 (Ci6 ), 120.5 (q, J=
324.8, SO2 CF3), 120.4 (q, J = 324.3, SO2CF 3), 116.2
(Cs), 101.6 (C14), 72.4 (C2 ), 53.6 (C3), 48.7 (C11), 37.3
(C1O).
6 -75.0, -75.5.
2918 (w), 1671 (m), 1603 (m), 1474 (m), 1463
1405 (s), 1229 (s), 1205 (s), 1146 (s), 1077 (m),
(m), 666 (s).
calc'd for C16H13F6N204S2 [M+H]*: 475.0215,
found: 475.0226.
(m),
1048
0.51 (UV, CAM, KMnO4).
21 For a previous preparation of amide 1k, see Airiau, E.; Spangenberg, T.; Girard, N.; Schoenfelder, A.; Salvadori, J.; Taddei, M.;
Mann, A. Chem. Eur. J. 2008, 14, 10938.
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Pentacyclic indoline (+)-9i:
Sodium metal ingot (25.0 mg, 1.09 mmol, 9.91 equiv) was added as a solid under an argon
atmosphere to a solution of pentacyclic indoline (±)-8i (51.3 mg, 110 pmol, 1 equiv) and methanol
(31.4 gL, 776 pmol, 7.05 equiv) in tetrahydrofuran (2.0 mL) and ammonia (2.5 mL) at -78 'C. After
4.25 h, ammonium chloride (150 mg) was added as a solid to quench the sodium salts, and the
resulting mixture was allowed to warm to 23 'C over 1 h. Saturated aqueous potassium carbonate
solution (60 mL) was added, and the aqueous layer was extracted with diethyl ether (3 x 50 mL).
The combined organic layers were dried over anhydrous potassium carbonate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (1.4% ammonium hydroxide [40% aqueous solution], 12.6% methanol, 30%
dichloromethane in chloroform) to afford pentacyclic indoline (±)-9i (35.0 mg, 94.6%) as a yellow
powder. Structural assignments were made with additional information from gCOSY, HSQC,
gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 20 'C):
13C NMR (125 MHz, CDCl3, 20 *C):
FTIR (neat) cm-1:
HRMS (DART):
6 7.16 (d, J= 7.2, 1H, C5 H), 7.12 (app-t, J= 7.6, 1H,
C7H), 6.80-6.75 (in, 1H, C6H), 6.79 (s, 1H, C19H), 6.77
(s, 1H, C16 H), 6.47 (d, J = 7.6, 1H, CH), 3.91 (s, 3H,
C2 2 H 3), 3.88 (s, 3H, C2 3H3), 3.81 (s, 1H, C2H), 3.37 (br-
s, 1H, C13H), 3.07 (dd, J= 3.7, 14.7, 1H, C14Ha), 3.03-
2.87 (in, 2H, C1 1H2), 2.80 (d, J = 14.7, 1H, C14Hb),
2.57-2.47 (in, 1H, CioHa), 2.53 (s, 3H, C2 1H 3), 1.69
(app-dt, J= 12.8, 8.3, 1H, CIoHb).
5 152.8 (C9), 149.1 (C18 ), 147.4 (C 17), 136.0
(C20 ), 128.0 (C7 ), 125.7 (C15), 122.8 (C),
114.3 (C 19), 113.6 (C16), 107.5 (Cs), 76.8
(C 13 ), 56.4 (C22), 56.1 (C2 3), 54.7 (C3 ), 48.1
(C1o), 33.6 (C21), 31.8 (C 14).
(C 4),
119.1
(C2 ),
(C 11),
128.9
(C6),
68.4
43.7
3335 (br-w), 2952 (in), 1606 (in), 1515 (s), 1486 (s),
1294 (m), 1250 (in), 1119 (s), 1022 (m), 742 (m).
calc'd for C2 1H25N2 0 2 [M+H]*: 337.1911,
found: 337.1924.
TLC (2% NH40H [40% aqueous solution], 18% MeOH in CHCl 3), Rf: 0.59 (UV, CAM, KMnO 4).
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Spirocyclic enimine (0-10a:
1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU, 257 pL, 1.72 mmol, 15.0 equiv) was added via
syringe to a solution of spirocyclic indoline 3a (41.3 mg, 115 pmol, 1 equiv) in acetonitrile (4.0 mL)
at 23 'C. After 5 min, the reaction vessel was placed into a microwave reactor and heated to 125 "C.
After 10 min, the reaction vessel was removed from the microwave reactor and allowed to cool to 23
'C and concentrated under reduced pressure. The residue was purified by flash column
chromatography on alumina (0 -- 10% ethyl acetate in hexanes) to afford spirocyclic enimine (±)-
10a (18.3 mg, 70.6%) as a white powder. Structural assignments were made with additional
information from gCOSY, HSQC, gHMBC, and ROESY data.
1H NMR (500 MHz, CDC13, 20 0C):
13C NMR (125 MHz, CDC13, 20 0C):
FTIR (neat) cm-1:
HRMS (DART):
6 7.09 (app-dt, J= 1.3, 7.7, 1H, C7H), 6.86 (dd, J= 1.3,
7.3, 1H, C5H), 6.63 (app-dt, J= 0.9, 7.4, 1H, C6H), 6.48
(d, J= 7.8, 1H, CH), 5.30 (s, 1H, C15HE), 5.19 (s, 1H,
Ci5Hz), 4.05 (ddd, J= 4.5, 8.4, 16.6, 1H, CiiHa), 3.86
(app-dt, J= 16.6, 7.4, 1H, C11Hb), 3.61 (d, J= 9.4, 1H,
C2Ha), 3.35 (d, J= 9.4, 1H, C2Hb), 2.80 (s, 3H, C17H3),
2.32 (ddd, J= 4.5, 7.8, 12.9, 1H, CioHa), 2.18 (ddd, J
7.2, 8.4, 12.9, 1H, CioHb), 1.97 (s, 3H, C16H3).
8 176.0 (C 13), 151.8 (C9 ), 137.7 (C 14 ), 135.4 (C4 ), 128.5
(C7), 123.2 (C5), 122.5 (C15), 118.3 (C), 107.3 (Cs),
65.1 (C3 ), 61.1 (C2 ), 57.9 (CO), 43.3 (C10 ), 35.7 (C 17),
21.6 (C16).
2918 (s), 2849 (s), 1679 (m), 1605 (s), 1493 (s), 1463
(s), 1377 (m), 744 (m), 666 (s).
calc'd for C15H19N 2 [M+H]: 227.1543,
found: 227.1554.
TLC (30% EtOAc in hexanes), Rf: 0.38 (UV, CAM, KMnO 4).
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Chapter III
A Concise and Versatile Double-Cyclization Strategy for the Highly
Stereoselective Synthesis and Novel Arylative Dimerization of
Aspidosperma Alkaloids
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Introduction and Background
The monoterpene-indole alkaloids represent the largest family of alkaloid natural
products, whose more than 2,000 members display a broad range of chemical diversity and
potent biological activity.' The structural challenges presented by this family have long been a
source of interest, resulting in the development of a variety of inventive synthetic strategies to
access various family members. The biogenetically related natural alkaloids N-
methylaspidospermidine (1), N-methylquebrachamine (2), and tabernaebovine (3) represent the
aspidosperma subfamily of indole-monoterpene alkaloids (Figure 1). 2,3,4,5,6,7,8,9 The desmethyl
X
N 6
8 
-"'\ 21
10 N D 6 2N 6 15 19 4 Me N X
E ."\ 1 1 \ e1
15 1 C 4 Me 21 15 19 4 Me 21 / ' 19'
1A B \2. 2' Me
1N H 1 N N17 R R Me H
R = Me, (-)-N-methylaspidospermidine (1) R = Me, (+)-N-methylquebrachamine (2) X = 0, (+)-tabemaebovine (3)
R = H, (-)-aspidospermidine (1a) R = H, (+quebrachamine (2a) X = H2, (+)-dideepoxytabernaebovine (4)
OH
Me
N\Me2l e2
N 6 N N N N 6Me21
15 19 Me 21 15 19 Me 21 1 19 OAc 9 OAc
~~-,OH / 1| OH~~~ 2C5(.~1 NH'
1N H 1N 2CO 2Me X 1NHCO2Me N 1N H 'C 2Me
OMe Ac H Meie Me
(-)-aspidospermine (5) (-)-tabersonine (6) X = H, (-)-vindorosine (7) X = CO 2Me: (-)-vinblastine (9)
X = OMe, (-)-vindoline (8)
Figure 1. Representative aspidosperma alkaloids.
derivatives of 1 and 2, aspidospermidine (1a) and quebrachamine (2a), are also natural products
of the aspidosperma family. Aspidospermine (5) and tabersonine (6) represent further
monomeric derivatives of 1; tabersonine (6) is a key intermediate in the biosynthesis of the
aspidosperma alkaloids (Scheme 1). Vindorosine (7) and vindoline (8) are skeletally
functionalized derivatives of 1, while dimeric alkaloid vinblastine (9), a potent oncolytic agent, is
an dimeric natural product containing an aspidosperma alkaloid derived subunit. The dimeric
alkaloid tabernaebovine (3), isolated from Tabernaemontana bovina in 1 9 9 8 ,2n has a fascinating
molecular constitution that exhibits a unique C2-C 15' linkage between two pentacyclic
aspidosperma skeletons. While elegant strategies for synthesis of other dimeric indole-
monoterpene alkaloids have been reported,9 no synthetic solution to the distinctive C2-C15'
union present in 3 existed prior to our work. As an outgrowth of our laboratory's studies
concerning electrophilic amide activationo and of our results discussed in chapter II, we were
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inspired to develop a concise and convergent strategy for the enantioselective synthesis of
alkaloids (-)-1, (+)-2, and dimeric (+)-dideepoxytabernaebovine (4).
The biosynthesis' of the aspidosperma alkaloids is known to begin from tryptamine (10)
and geraniol derivative secologanin (11), and proceeds through the skeleton of the related
corynanthe family of indole-monoterpene alkaloids followed by several structural
rearrangements (Scheme 1). The first step in the biosynthetic route is the strictosidine synthase
11 8 CHO strictosidine 1121 strictosidine 1121
NH2  '9Glc synthase NH /OGIc deglusosidase NH 1C
I+ 6 i9 8 I8 CH
N  O - O N OH
H MeO 2C 4 H 6 4 H 6 4
tryptamine (10) secologanin (11) strictosidine (12) MeO 2C MeO 2CGc = glucosyl
N 6 Me N 19 5 N+19
19 N Me Me 8 Me N 21
0 -OH I N 6 MeI 2 C 2 3 4 eH 6
1N CO 2Me N CO2Me 1N CO 2Me MeO2C 4 OHH H H M0
(-)-tabersonine (6) dehydroscodine (16) preakuammicine (15) dehydrogeissoschizine (14)
Scheme 1. Proposed biosynthesis of the aspidosperma alkaloids.
catalyzed Pictet-Spengler reaction between tryptamine (10) and secologanin (11), which affords
strictosidine (12). Strictosidine deglucosidase acts on 12 to reveal an aldehyde intermediate 13,
which undergoes condensative N9-C19 double bond formation and isomerization of the C20-
C21 olefin to give key intermediate dehydrogeissoschizine (14), an alkaloid of the corynanthe
type. While the enzymes responsible for the remaining biosynthetic steps are not known,
previous studies have allowed for a proposed sequence involving a retro-Pictet-Spengler
reaction of 14 and subsequent C2-C3 bond formation to furnish preakuammicine (15), which
undergoes a series of rearrangements to give dehydrosecodine (16). The final step is proposed to
be an intramolecular Diels-Alder reaction to give tabersonine (6), which serves as a gateway into
the biosynthesis of related aspidosperma alkaloids.
Review of Prior Total Syntheses of Aspidosperma Alkaloids
The first total synthesis of aspidosperma alkaloids related to 1 and 2 was the seminal
collective syntheses of (±)-aspidospermine (5) and (±)-quebrachamine (2a) reported by Stork6b
in 1963 (Scheme 2). The synthetic route exploits the potential for interconversion of the
aspidospermidine- and quebrachamine-type skeletons, allowing for the collective syntheses of
both targets through late-stage divergence. Michael addition of enamine 17 onto methyl acrylate
and in situ enamine hydrolysis, followed by enamine formation and a subsequent Robinson
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annulation with methyl vinyl ketone, afforded C-ring containing enone (±)-18 in 32% yield over
three steps. Enone (±)-18 was converted to bicyclic chloroacetamide (±)-19 in five steps.
Treatment of (±)-19 with potassium tert-butoxide in benzene effected smooth Cl1-C12
cyclization to afford tricycle (±)-20. Reduction of the C1O-amide over 3 steps
N 6
19 -Et g,h
0 0 151 1
MeO2C CI N&1 10 N N e,1fN
N a-c 19 steps 3 steps ~ (±)-22
191 'Et '19 Et 12 19 -'E 12 -E6t t jIrEti Q tOeN 6
Et 0 2 O 2 0 i,fN E4 N
17 (1)-18 (_)-19 ( -20 (±)-2119 151
1N(±)-23
Scheme 2. Stork's seminal syntheses of (2)-aspidospermine (5) and (±)-quebrachamine (2a): a) methyl
acrylate, 67%. b) pyrrolidine. c) methyl vinyl ketone; AcOH, 48% (2 steps). d) KOtBu, PhH. e) 2-
methoxyphenylhydrazine. f) AcOH, heat. g) LiAlH4 . h) Ac 20. i) phenylhydrazine. j) KBH 4.
afforded key tricyclic ketone (±)-21. A two-step Fischer indoleninization sequence between (±)-
21 and 2-methoxyphenylhydrazine afforded pentacycle (±)-22 with inversion of the C19-
stereocenter to the more stable natural configuration via a reversible C12-C19 retro-Mannich
reaction; reduction of (±)-22 with lithium aluminum hydride and subsequent acetylation of NI
afforded (±)-aspidospermine (5). Alternatively, Fischer indoleninization of (+)-21 with phenyl
hydrazine afforded pentacycle (±)-23, which, upon treament with potassium borohydride,
underwent C12-C19 bond cleavage and reduction of a putative C19-iminium ion to afford (±)-
quebrachamine (2a). The judicious exploitation of late-stage divergence to form both natural
products from a common intermediate highlights the strategic sophistication of Stork's synthetic
route.
Following Stork's seminal work, over two decades would pass before the first
enantioselective total synthesis of la, the aspidosperma alkaloid most directly related to (-)-1,
was achieved by Fuji in 1987 (Scheme 3).5' Enantioenriched chiral lactone 2411 was converted
in six steps to key acetal 25 in 57% overall yield. An acetic acid mediated Picter-Spengler
reaction of 25 with tryptamine (10) at elevated temperature and subsequent basic hydrolysis
afforded corynanthe related tetracycle 26 in 42% overall yield. Trifluoromethanesulfonic acid
mediated rearrangement of 26 afforded aspidosperma type pentacycle 27 in 60% yield, and
subsequent reduction with lithium aluminum hydride afforded (-)-aspidospermidine (la) in 81%
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Scheme 3. Enantioselective total syntheses of (-)-la and (+)-2a by Fuji: a) tryptamine (10), AcOH, A. b)
NaOH, MeOH, 42% (2 steps). c) TfOH, 60%. d) LiAlH4 , Et 20, 81%. e) TiCl 3 , MeOH, pH 5. f) tryptamine
(10), AcOH, A, 84% (2 steps). g) LiAlH4 , THF. h) MsCl, Et3N, CHCl 3. i) Na, NH 3 , EtOH, 53% (3 steps).
yield, completing the first enantioselective total synthesis of this alkaloid. Additionally,
reduction of nitroolefin 24 with titanium trichloride afforded acetal 28, which underwent a
Pictet-Spengler reaction with tryptamine (10) to afford tetracycle 29 as a diastereomeric mixture
in 84% yield. Conversion of 29 to quaternary ammonium salt 30 over two steps, followed by
reductive cleavage of the C3-N9 bond under Birch conditions, afforded (+)-2a in 53% yield
from 29, thus completing the total synthesis. While Fuji's collective approach to (-)-la and (+)-
2a does not benefit from the strategic late-stage divergence employed by Stork, the completion
of the first enantioselective synthesis of (-)-la in biomimetic fashion was a substantial step
forward in aspidosperma alkaloid synthesis.
Two more recent examples of aspidosperma alkaloid syntheses demonstrate efficient
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Scheme 4. Rawal's enantioselective total syntheses of (+)-la and (-)-2a: a) ethacrolein, catalyst 32
(5.0 mol %), 4A-MS, CH 2Cl2 , 84%, 95% ee. b) Ph3PCH3I, "BuLi, THF. c) Grubbs' lst generation
catalyst (7.5 mol %), CH2Cl2, A. d) (2-nitrophenyl)(phenyl)iodonium fluoride, THF, DMSO, 57-62%
(3 steps). e) TiCl3 , NH40Ac, acetone, H20, 90%. f) Me 3Sil, CH2Cl2 , A. g) Br(CH2)2OH, Na 2CO 3 ,
EtOH, A. h) MsCl, NEt3 ; KOtBu, 79% (3 steps). i) NaBH 4 , EtOH. j) H2, PtO2 , EtOH, 73% (2 steps).
k) H2 , PtO2 , AcOH, 69%.
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approaches for asymmetric synthesis. Rawal's 5 2002 collective syntheses of (+)-la and (-)-2a
(Scheme 4) commenced with a catalytic enantioselective Diels-Alder reaction between super-
diene 31 and ethacrolein promoted by Jacobsen's 1 2 chiral chromium salen catalyst 32, affording
monocyclic compound 33 in 84% yield and 95% ee. Elaboration of 33 to nitroarene 34 through
Wittig olefination, ring-closing olefin metathesis and arylation, followed by reductive
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Scheme 5. MacMillan's enantioselective total synthesis of (+)-la: a) propynal, catalyst 41 (20 mol %),
PhMe, 83%, 97% ee. b) Ph3PCH 31, nBuLi, THF; NaBH 3CN, AcOH. c) TFA, CH2Cl2 . d) (Z)-3-bromo-
1 -iodopropene, K2CO 3 , DMF, 73% (3 steps). e) (Ph3P)4Pd, Et3N, PhMe, 80 'C, 65%. f) H2 (200 psi),
Pd(OH) 2 , MeOH, EtOAc, 98%.
indolization of 34, afforded tetracycle 35 in 51-56% overall yield. The C 10-C 11 ethylene group
was installed in 79% yield over 3 steps in a sequence reminiscent of Stork's strategy to afford
indolenine 36. Reduction of indolenine 36 with sodium borohydride and subsequent catalytic
hydrogenation afforded (-)-la in 73% yield, completing a 12-step total synthesis. Catalytic
hydrogenation of 36 in acetic acid afforded (+)-2a in 69% yield via a putative C19-iminium ion.
Additionally, Rawal was able to access (+)-tabersonine (6) and other aspidosperma alkaloids via
his route, highlighting the utility of late-stage synthetic divergence in a modem, asymmetric
setting. MacMillan's 5 1 2009 synthesis of (+)-la (Scheme 5) centered on a key organocatalytic
enantioselective Diels-Alder reaction/Michael addition cascade between 2-vinylindole 38 and
propynal promoted by catalyst 39 afforded tetracycle 40 in 83% yield and 97% ee. Elaboration
of 40 to vinyl iodide 42 and subsequent Heck cyclization afforded pentacyclic triene 43 in 47%
yield over four steps. Exhaustive catalytic hydrogenation and hydrogenolysis afforded (+)-la in
98% yield, completing a nine-step synthesis from tricycle 37. Their strategy was also applied to
the synthesis of related kopsia and strychnos alkaloids through a similar key Diels-Alder
reaction/Michael addition cascade.
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Despite numerous previous total syntheses of aspidosperma alkaloids, prior to our work,
no total synthesis of N-methquebrachamine (2) had been reported, and no enantioselective
synthesis of N-methylaspidospermidine (1) had been reported.13 The only synthesis of 1 was
reported by Boger3 in 2006 in the context of his groups' total synthesis of (+)-vindoline (8).
Oxadiazole 45, synthesized in three steps from N-methyltryptamine (44), was acylated with 4-
methylenehexanoic acid in the presence of EDC-HCl to afford achiral intermediate 46 in 87%
yield. Heating of 46 in refluxing 1,2-dichlorobenzene effected a unique [4+2]/[3+2]
cycloaddition cascade to secure hexacycle (±)-47 in 74% yield; separation of the enantiomers by
chiral HPLC afforded (+)-47, which was reduced in a single step or through a higher yielding
two step sequence to pentacyclic diol 48. Oxidative diol cleavage with sodium periodate, ketone
reduction with sodium borohydride, and a two step Barton-McCombie deoxygenation afforded
(+)-1 in 68% yield over four steps, completing a nine or ten step synthesis from N-
methyltryptamine (44).
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Scheme 6. Boger's total synthesis of (+)-N-methylaspidospermidine (1): a) 4-methylenehexanoic acid,
4-DMAP, EDCeHCl, CH2Cl2, 87%. b) 1,2-dichlorobenzene, 180 *C, 74% of (t)-47; 37% of (+)-47
after chiral HPLC separation of enantiomers. c) LiAlH4, 31%. d) NaBH 3CN, HCl, MeOH, 96%. e)
LiAIH4, 99%. f) NaIO4, 93%. g) NaBH 4, 99%. h) LiHMDS, CS2; Mel, 77%. i) AIBN, "Bu 3SnH, 96%.
In chapter II, we discussed the development of a methodology for the interruption of the
Bischler-Napieralski reaction by intra- and intermolecular trapping of spirocyclic indoleninium
ions. In this chapter, we discuss the development of a double-cyclization cascade based on our
interrupted Bischler-Napieralski reaction methodology and its application to the previously
unprecedented C2-C15' union of aspidosperma alkaloids in the enantioselective total synthesis
of dimeric decacyclic product (+)-4 in addition to enantioselective total syntheses of (-)-1 and
(+)-2.
102
Results and Discussion
Inspired by precedence in biogenetically relevant dimerizations of other monoterpene-
indole alkaloids, ', we posited the biogenesis of (+)-tabemaebovine (3) to involve late-stage
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Scheme 7. Retrosynthetic analysis of the aspidosperma alkaloids.
union of two aspidosperma fragments at the C2-C15' linkage. This retrobiosynthetic analysis14
prompted the development of a regio- and diastereoselective C2-arylation of pentacycle 51
(Scheme 7) en route to decacycle (+)-4. Based on our results discussed in chapter II, we
envisioned that a highly electrophilic diiminium ion 51 would allow for stereo- and
regioselective transformations that provide divergent access to dideepoxytabemaebovine (+)-4 as
well as monomeric aspidosperma alkaloids (-)-N-methylaspidospermidine (1) and (+)-N-
methylquebrachamine (2) (Scheme 7). We expected reduction of the diiminium ion 51 would
afford (-)-1, whereas hydrative Grob fragmentation followed by reduction would afford (+)-2.
We hypothesized that the diiminium ion 51 could be generated from lactam (-)-53 via a novel,
stereoselective double-cyclization cascade. We envisioned a transformation involving
spirocyclization of an electrophilically activated lactam intermediate onto the 2-chloroindole and
subsequent interruption of the Bischler-Napieralski reaction by cyclization of an unactivated
C3-C4 vinyl group onto the C2-position of the putative 2-chlorospiroindoleninium intermediate
52, a bond formation uniquely favored by the relative stereochemistry in 52. The overall
stereochemical outcome of the process would be secured from the resident stereochemistry of the
C5-quaternary center. The requisite lactam (-)-53 could be simplified via N-acylation and N-
alkylation transforms to 2-chlorotryptamine sulfonamide 54 and a-quaternary amide (+)-55, the
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latter of which could be synthesized diastereoselectively via alkylative quaternization of an
amide enolate.
The concise enantioselective synthesis of the key tryptamine-lactam (-)-53 is illustrated
in Scheme 8. Regioselective methylation of sulfonamide 5615 via its disodium dianion provided
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Scheme 8. Enantioselective synthesis of lactam (-)-53: a) NaH, DMF, 23 'C; Mel, 0 -+ 23 'C, 91%. b) N-
chlorosuccinimide, MeCN, 23 'C, 76%. c) E-crotonyl chloride, Et3N, THF, -30 -+ 23 *C, 97%. d) lithium
2,2,6,6-tetramethylpiperidide, LiCl, THF, 0 -+ -78 *C; 3-chloro-1-iodopropane, -78 -+ 0 'C, 83%. e) lithium
diisopropylamide, LiCl, THF, -78 -- 0 'C; N,N-dimethylpropylene urea, -40 OC; EtI, -50 OC, 72%, >29:1 dr.
f) triethylsilyl triflate, 2,6-lutidine, CH 2Cl 2 , 23 'C, 100%. g) (+)-60, 54, KH, "Bu 4NI, DMF, 100 *C, 86%. h)
PhSH, K2CO 3, DMSO, 23 0C; KOEt, Et 3Ne3HF, EtOH, 85 OC, 95%, 94% ee, 99% recovery of (-)-57. DMF
= N-dimethylformamide, Ns = 2-nitrobenzenesulfonyl, TES = triethylsilyl.
the requisite Ni-methylated derivative in 91% yield.16  Subsequent treatment with N-
chlorosuccinimide afforded C2-chlorotryptamine 54 in 76% yield. The C5-quaternary
stereogenic center that we envisioned would enable stereocontrolled introduction of all
stereocenters found in alkaloids (-)-1, (+)-2, and (+)-4 was secured by successive
diastereoselective a-alkylations of crotonamide (+)-58. Acylation of (-)-pseudoephenamine
(57)17 with E-crotonyl chloride gave the enamide (+)-58 in 97% yield. Chemoselective y-
deprotonation of enamide (+)-58 with lithium 2,2,6,6-tetramethylpiperidide in the presence of
lithium chloride,' 8 followed by electrophilic trapping of the resulting enolate with 3-chloro-1-
iodopropane afforded c-vinyl amide (+)-59 as a single diastereomer in 83% yield. Inspired by
Myers' alkylative quaternizations19 of pseudoephedrine amides and precedent for a-alkylation of
a-methyl crotonimides,20 we reasoned that deprotonation of a-vinyl amide (+)-59 would afford
the corresponding enolate with the sterically less demanding vinyl group cis to the amide
nitrogen. Alkylation from the less sterically shielded face of the enolate 1',1 would secure the
desired C5-quaternary stereocenter. Gratifyingly, deprotonation of amide (+)-59 with lithium
diisopropylamide in the presence of lithium chloride, followed by electrophilic trapping with
104
iodoethane at -50 'C in the presence of N,N-dimethylpropylene urea provided the a-quatemary
amide (+)-55 in 72% yield with an excellent level of stereoselection (>29:1 dr).16,2 1,22
Attempts to hydrolyze amide (+)-55 to the corresponding carboxylic acid were
unsatisfactory due to competitive lactone formation under either basic or acidic conditions.
Initial efforts to couple a-quatemary amide (+)-55 with sulfonamide 54 via nucleophilic
displacement of the C8-chloride proved inefficient; fast N---O acyl transfer of amide (+)-55 led
to intramolecular N-alkylation. This propensity of amide (+)-55, however, could be used to our
advantage for the synthesis of lactam (-)-53 and recovery of the chiral auxiliary. Sequential
treatment of sulfonamide 54 with potassium hydride and O-silyl derivative (+)-60 in DMF in the
presence of tetrabutylammonium iodide followed by heating to 100 'C afforded N-alkylated
sulfonamide (+)-61 in 86% yield. Desulfonylation 23 of (+)-61 to the corresponding secondary
amine and in situ desilylation and heating in ethanol afforded the key lactam (-)-53 in 95% yield
and 94% ee. 16  This single-step transformation, which occurs via a desilylation/N--O acyl
transfer/lactam cyclization cascade, also leads to efficient recovery of the chiral auxiliary (-)-57
in 99% yield (Scheme 8).24
We next focused on the development of a unified strategy to access a versatile
intermediate en route to alkaloids (-)-1, (+)-2, and (+)-4. Electrophilic activation of lactam (-)-
53 with trifluoromethanesulfonic anhydride'' 2 5 initiated a double-cyclization cascade leading to
the versatile diiminium ion 51 (Scheme 9). Guided by our methodology for the interrupted
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Scheme 9. Synthesis of aspidosperma alkaloids by interception of diiminium ion 51: a) Tf20, 3-
cyanopyridine, MeCN, 85 'C. i) NaBH 3CN, THF, 50%. ii) 4-(Me2N)-C6H4MgBr, -40 'C; Red-Al, 40%.
iii) trifluoroacetic acid, sodium trifluoroacetate, H20, 70 'C, 57%. b) H2 , Pt/C, THF, 100%. c) H2, Pt/C,
THF. d) LiAlH4 , THF, 65 0C, 82% (two steps). Tf2O = trifluoromethanesulfonic anhydride.
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Bischler-Napieralski reaction discussed in chapter II and by our prior methodologies for
azaheterocycle syntheses employing electrophilic amide activation,' 0 we recognized the optimal
conditions for conversion of lactam (-)-53 to diiminium ion 51 involve the use of mildly basic
additive 3-cyanopyridine in acetonitrile followed by warming. This transformation relies on
C19-electrophilic activation of lactam (-)-53 and rapid C12-nucleophilic spirocyclization
affording the putative 2-chlorospiroindoleninium intermediate 52 (Scheme 7) that undergoes C2-
addition by the vinyl group and loss of hydrogen chloride. The ability to employ an unactivated
C3-C4 olefin as the nucleophile in the second cyclization is likely due to the enhanced C2-
electrophilicity of intermediate 52 imparted by the chlorine atom,26 together with a high
27,28resilience of 52 toward an undesired Wagner-Meerwein rearrangement. Consistent with the
sensitivity of this double-cyclization step, the use of less basic 2-chloropyridine or more
nucleophilic pyridine as the additive gave the desired diiminium ion 51 with reduced efficiency
as evidenced by the presence of singly cyclized side-products, recovered starting material, and
significant decomposition.29 The synthetic versatility of diiminium ion 51 is illustrated by its
conversion to alkaloids (-)-1, (+)-2, and (-)-63 (Scheme 9). In situ reduction of intermediate 51
with sodium cyanoborohydride furnished (-)-N-methyldehydroaspidospermidine (62) in 50%
yield as a single diastereomer. Catalytic hydrogenation of cis-alkene (-)-62 with a carbon-
supported platinum catalyst afforded (-)-N-methylaspidospermidine (1) {[a] 24 D= -23 (c 0.17,
CHCl3); lit. [a] 25D = -23 (c 1.1, CHCl 3);3 for (+)-1, [c] 20 D = +24 (c 1.25, CHCl 3)2 1} in
quantitative yield (Scheme 9). All spectroscopic data for our synthetic (-)-1 was consistent with
those reported in the literature.3  The concise enantioselective synthesis of lactam (-)-53
combined with the double-cyclization strategy described above enables rapid access to useful
intermediates with highly reactive C2- and C19-iminium functions.
The unique reactivity of diiminium ion 51 is demonstrated by its utility in a C2-arylation
reminiscent of the C2-C15' bond adjoining the two halves of the complex natural alkaloid (+)-
tabernaebovine (3, Figure 1). We reasoned that the vicinal C19-iminium ion of intermediate 51
would enhance the electrophilicity of the C2-iminium ion both inductively and by reducing the
steric environment through the flattening of the DE-ring system. Gratifyingly, treatment of in
situ generated diiminium ion 51 with 4-(NN-dimethylamino)phenylmagnesium bromide at -40
'C for 30 seconds followed by addition of Red-Al afforded hexacyclic C2-aniline adduct (-)-63
in 40% yield as a single diastereomer (Scheme 9).16 The steric congestion about C2 in adduct
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(-)-63 is evidenced by the ~20 kcal/mol barrier to rotation16 about the C2-C23 T -bond as
measured through NMR coalescence temperature experiments. Also, heating an acidic aqueous
solution of diiminium ion 51 to 70 'C effected Grob fragmentation to give the tetracyclic lactam
(-)-6430 in 57% yield in a single step from lactam (-)-53. Platinum catalyzed hydrogenation31 of
the C3-C4 olefin and subsequent C19-carbonyl reduction with lithium aluminium hydride at 60
C provided (+)-N-methylquebrachamine (2) {[a]2 4D= +102 (c 0.22, CHCl 3); lit. [a]24D +110
(CHCl 3)2 g} in 82% yield over two steps.16
With particular interest in evaluating this chemistry as a general entry to the synthesis of
complex aspidosperma alkaloids, we investigated a series of C2-addition reactions of relevance
in synthetic planning. Importantly, lactam (-)-64, requiring mild activation conditions, proved to
be an excellent precursor to diiminium ion 51. Treatment of lactam (-)-64 with Tf2O-2-
chloropyridine reagent combination 0 in acetonitrile (23 'C, 10 min) resulted in rapid stereo- and
regioselective electrophilic transannular spirocyclization to 51 en route to various C2-adducts
62-69 (Table 1). Introduction of sodium cyanoborohydride afforded (-)-N-
methyldehydroaspidospermidine (62) in 95% yield (Table 1, entry 1) consistent with efficient
generation of the same electrophilic intermediate 51 accessed from lactam (-)-53 (Scheme 9).
The greater reactivity at C2 compared to C19 of diiminium ion 51 can be used for regioselective
addition of the first nucleophile at the former.32  For example, treatment of 51 with
tributylstannane, followed by introduction of sodium borodeuteride, afforded C19-deuterated
pentacycle (-)-65 in 94% yield with no deuterium enrichment at C2 and 93% deuterium
incorporation at C19 (Table 1, entry 2). Notably, the C2-arylated product (-)-63 could be
prepared efficiently from lactam (-)-64 using 4-(NN-dimethylamino)phenylmagnesium bromide
as the first nucleophile followed by in situ C19 reduction (Table 1, entry 3, 76% yield).
Alternatively, hexacyclic iminium triflate (-)-66 could be isolated then reduced with sodium
cyanoborohydride to (-)-63 in a subsequent step (Table 1, entries 4 and 9). That this C19-
reduction of pentacycle (-)-66 occurs in the absence of an acidic additive is consistent with its
spectroscopic data revealing its iminium ion structure.16 It is notable that the ~12 kcal/mol
barrier to rotation' 6 about the C2-C23 -bond in iminium ion (-)-66 is significantly lower than
in the reduced product (-)-63 (vide supra), consistent with the aforementioned structural
flattening effect of the C19-iminium ion. The high electrophilicity of diiminium ion 51 allows
107
Table 1. Regio- and stereoselective transformations of lactam (-)-64.
Tf2O
2-CIPyr
MeCN
Entry Nuc-1a
N R2
Nuc-1; 19 Me
-'- 2/Nuc-2 NRI
62 -69 Me
Nuc-2 Product Yieldb
1 NaBH3CN
2 "Bu 3SnH
BrMg
3e
NMe2
Me
5 BrMg
Me
Me
6 JSiMe3,
OMe
7
OSiMe2tBu
8
9 aNMe2
NaBD4
Red-Al
Red-Al
NaHB(OMe) 3
NaHB(OMe)3
NaHB(OHMe)3
(-)-62
N D
19 Me
2/
NNH
(-)-65 Me
N H
S1 9 
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Me /
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NYH
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(-)-66
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95%
94%
76%
76%
59%
92%
79%
74%
73%
aGrignard reagents at -40 'C. Other nucleophiles at 23 C. blsolated
yield of single diastereomer. c93% Deuterium incorporation at C19.
2-ClPyr = 2-chloropyridine.
BrMg z
NMe2
for C-C bond formation at C2 with highly hindered and mildly nucleophilic species. Treatment
of intermediate 51 with 2,6-dimethylphenylmagnesium bromide followed by hydride reduction
afforded the highly congested xylene adduct (-)-67 in 59% yield (Table 1, entry 5). The high
degree of steric congestion about C2 in (-)-67 is evidenced by the complete lack of observable
C2-C23 a -bond rotation on the 'H NMR timescale, even at 140 'C. Reaction of 51 with 2-
methallyltrimethylsilane or 1-(tert-butyldimethylsilyloxy)-1-methoxyethene and subsequent
hydride reduction afforded methallyl adduct (-)-68 (Table 1, entry 6, 92% yield) or methyl
acetate adduct (-)-69 (Table 1, entry 7, 79% yield), respectively. The utility of this strategy to
access C2-arylated derivatives is highlighted by a Friedel-Crafts reaction of 51 with NN-
dimethylaniline (23 'C, 90 min) and either in situ C19-reduction to provide C2-arylated amine
(-)-63 or isolation of the pentacyclic C19-iminium salt (-)-66 (Table 1, entries 8 and 9, 74% and
73% yield, respectively).
With insight gained from these studies, in particular entries 8 and 9 of Table 1, we
sought to implement this chemistry in effecting the dimerization of two pentacyclic
aspidosperma type molecular frameworks at the challenging C2-C15' linkage (Scheme 10). In
the event, electrophilic activation of tetracyclic lactam (-)-64 followed by treatment with
equimolar (-)-N-methyldehydroaspidospermidine (62) and heating to 85 'C afforded the
decacyclic iminium triflate (+)-70 in 80% yield. Subsequent C19-reduction of (+)-70 gave (-)-
didehydrodideepoxytabemaebovine (71), which upon hydrogenation provided (±)-
(-)-62 N
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Me 19 Me N 19 Me
N N + TfO- N 15- \ N
(-)-64 Me 51 Me Me /Me
N
b MeH
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2 N C 2/ N
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(+)4 MeH _H.71 MeH
Scheme 10. Synthesis of (+)-dideepoxytabernaebovine (4): a) Tf2O, 2-CiPyr, MeCN,
23 OC. i) (-)-62 (1.0 equiv), 85 0C, 80%. ii) (-)-62, 85 'C; NaHB(OMe) 3, THF,
73%. b) Ied-Al, THF, 0 0C, 73%. c) H2, Pt/C, THF, 84%.
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dideepoxytabernaebovine (4) in 64% yield over two steps. Alternatively, in situ C19-reduction
of dimeric iminium ion (+)-70, formed through the union of lactam (-)-64 with (-)-N-
methyldehydroaspidospermidine (62) as described above, with sodium trimethoxyborohydride
directly afforded product (-)-71 from (-)-64 in 73% yield. Apart from increasing the
electrophilicity of the vicinal C2-iminium ion, the C19-iminium ion may be responsible for
reducing the nucleophilicity of the dimeric intermediate (+)-70, as no oligomerized products
could be observed even when only one equivalent of (-)-62 was employed as nucleophile.
Conclusion
We have developed a concise synthetic strategy to access the aspidosperma type
molecular framework employing a double-cyclization cascade that sets up to three contiguous
stereogenic centers and forms up to three carbon-carbon bonds with complete regio- and
stereochemical control in a single step. The use of the chiral auxiliary (-)-5717 was critical in
enabling our concise and enantioselective synthesis of the key intermediate (-)-63. The ability
to use an unactivated olefin as a pendant nucleophile minimizes the need for functional group
removal and allows for concise and convergent access to complex aspidosperma alkaloids. We
have shown putative diiminium ion 51 to be a highly reactive and versatile intermediate,
allowing the rapid enantioselective total syntheses of (-)-N-methylaspidospermidine (1) and (+)-
N-methylquebrachamine (2) in 8 and 9 steps, respectively, from E-crotonyl chloride and (-)-
pseudoephenamine (57), as well as previously unprecedented C-C bond formations onto the
highly congested C2-position of the aspidosperma skeleton. The power of this synthetic strategy
has been demonstrated in the first example of a C2-C15' dimerization of two aspidosperma type
systems, a complex assembly drawing on biogenetic considerations of (+)-3, in the synthesis of
(+)-dideepoxytabernaebovine (4).33
1 For reviews, see: (a) Brown, R. T. Indoles, The Monoterpenoid Indole Alkaloids. In The
Chemistry of Heterocyclic Compounds; Saxton, J. E., Weissberger, A., Taylor, E. C., Eds.;
Wiley: New York, 1983; Vol. 25, Part 4, pp 85. (b) Saxton, J. E. In The Alkaloids. Chemistry and
Biology; Cordell, G. A., Ed.; Academic Press: San Diego, 1998; Vol. 51, pp 1. (c) Dewick, P. M.
In Medicinal Natural Products: A Biosynthetic Approach, 2nd ed.; Wiley: Chichester, 2001; pp
350. (d) O'Connor, S. E.; McCoy, E. Recent Adv. Phytochem. 2006, 40, 1. (e) O'Connor, S. E.;
Maresh, J. J. Nat. Prod. Rep. 2006, 23, 532. (f) O'Connor S. E. In Plant-Derived Natural
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Takeda, H.; Takemoto, Y. Chem. Pharm. Bull. 2008, 56, 1567.
28 An elegant report involving a functional pendant nucleophile (ref. 6h) requires additional steps
for synthetic simplification.
29 The use of less electrophilic dehydrating agents (e.g., trifluoroacetic anhydride, POCl3, POBr 3,
the Hendrickson reagent or the Burgess reagent) provided none of the desired cyclization
products.
30 For semisynthesis of a similar tetracyclic lactam, see Yates, P.; MacLachlan, F. N.; Rae, I. D.
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31 Hydrogenation was carried out at 400 psi: the C3-C4 olefin in 3,4-dehydroquebrachamine
systems is resilient to hydrogenation (see ref. 7b).
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Experimental Section
General Procedures. All reactions were performed in oven-dried or flame-dried round bottomed
flasks, modified Schlenk (Kjeldahl shape) flasks or glass pressure vessels. The flasks were fitted
with rubber septa and reactions were conducted under a positive pressure of argon. Stainless steel
gas-tight syringes or cannulae were used to transfer air- and moisture-sensitive liquids. Flash column
chromatography was performed as described by Still et al. using silica gel (60 A pore size, 32-63 pm,
standard grade) or non-activated alumina (80-325 mesh, chromatographic grade).1 Analytical thin-
layer chromatography was performed using glass plates pre-coated with 0.25 mm 230-400 mesh
silica gel or neutral alumina impregnated with a fluorescent indicator (254 nm). Thin layer
chromatography plates were visualized by exposure to ultraviolet light and/or by exposure to an
ethanolic solution of phosphomolybdic acid (PMA), an acidic solution of p-anisaldehyde (anis), an
aqueous solution of ceric ammonium molybdate (CAM), an aqueous solution of potassium
permanganate (KMnO 4), or an ethanolic solution of ninhydrin followed by heating (<1 min) on a hot
plate (-250 'C). Organic solutions were concentrated on rotary evaporators at -20 Torr (house
vacuum) at 25-35 'C, then at -1 Torr (vacuum pump) unless otherwise indicated.
Materials. Commercial reagents and solvents were used as received with the following exceptions:
Dichloromethane, diethyl ether, tetrahydrofuran, acetonitrile, toluene, and triethylamine were
purchased from J.T. Baker (Cycletainer TM) and were purified by the method of Grubbs et al. under
positive argon pressure .2 2-Chloropyridine, NN-diisopropylamine and N,N'-dimethylpropylene urea
were distilled from calcium hydride and stored sealed under argon atmospheres. Lithium chloride was
dried by the method of Myers et al.3 and stored in a chemical glovebox. The molarity of n-
butyllithium solutions was determined by titration against diphenylacetic acid4 (average of three
titrations). Trifluoromethanesulfonic anhydride was purchased from Oakwood Products, Inc.; all
other solvents and chemicals were purchased from Sigma-Aldrich.
Instrumentation. Proton nuclear magnetic resonance ('H NMR) spectra were recorded with Varian
inverse probe INOVA-500 and Varian INOVA-500 spectrometers, are reported in parts per million
on the 6 scale, and are referenced from the residual protium in the NMR solvent (CDCl3 : 8 7.24
(CHCl 3), benzene-d: 6 7.16 (benzene-d5), CD3CN: 6 1.94 (CD2HCN), toluene-d: 6 2.09
(C6D5CD 2H), DMSO-d: 6 2.50 (DMSO-d)). Data are reported as follows: chemical shift
[multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet, br = broad), coupling constant(s) in
Hertz, integration, assignment]. Carbon-13 nuclear magnetic resonance (13C NMR) spectra were
recorded with a Varian INOVA-500 spectrometer, are reported in parts per million on the 6 scale,
and are referenced from the carbon resonances of the solvent (CDCl3 : 6 77.23, benzene-d: 6 128.39,
CD 3CN: 6 1.39, toluene-d: 6 20.4, DMSO-d: 6 39.51). Data are reported as follows: chemical shift
(assignment). Fluorine-19 nuclear magnetic resonance ('9F NMR) spectra were recorded with a
Varian Mercury 300 spectrometer, are reported in parts per million on the 6 scale, and are referenced
from the fluorine resonance of neat trichlorofluoromethane (CFCl3 : 6 0). Data are reported as
follows: chemical shift (assignment). Infrared data (IR) were obtained with a Perkin-Elmer 2000
FTIR, and are reported as follows: frequency of absorption (cm-1), intensity of absorption (s = strong,
'Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978,43,2923.
2 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518.
3 Myers, A. G.; Yang, B. H.; Chen, H.; McKinstry, L.; Kopecky, D. J.; Gleason, J. L. J. Am. Chem. Soc. 1997, 119, 6496.
' Kofron, W. G.; Baclawski, L. M. J. Org. Chem. 1976,41, 1879.
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m = medium, w = weak, br = broad). Optical rotations were measured on a Jasco-1010 polarimeter.
We are grateful to Dr. Li Li for obtaining the mass spectrometric data at the Department of
Chemistry's Instrumentation Facility, Massachusetts Institute of Technology. High resolution mass
spectra (HRMS) were recorded on a Bruker Daltonics APEXIV 4.7 Tesla FTICR-
MS using a direct analysis in real time (DART) ionization source.
Positional Numbering System. At least two numbering systems exist in the literature for the
aspidosperma alkaloids.' For direct comparison between structures, the system employed by Yates
for (-)-aspidophytine is optimal and is used throughout this report. In the case of dimeric structures
such as (+)-tabernaebovine (3), the subunit bearing C15' substitution is given primed numbers.
8
10 N D 620
2 C 4 Me 21
IA B
16 BN H
Me 22
(-)-N-methylaspidospermidine (1)
8
16 N#7N
Me 22
(+)-N-methylquebrachamine (2)
8 0
10 N 20
""19 \ 21 8'14N 19 4 Me O
S 2 N
16 1 N 19' 21'
Me 4. Me
H
Me
(+)-tabernaebovine (3)
'(a) Yates, P.; Maclachlan, F. N.; Rae, I. D.; Rosenberger, M.; Szabo, A. B.; Willis, C. R.; Cava, M. P.; Behforouz, M.;
Lakshmikantham, M. V.; Zeiger, W. J. Am. Chem. Soc. 1973,95,7842. (b) J. E. Saxton, The Alkaloids, Chem. and Biol. 1998,51, 1.
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14 NHNs NaH, DMF;
16 2 Mel
H 91%
56
10
14 NHNs
16 N 2
Me
SI
1-Methyltryptamine nosylamide (S1):
Sodium hydride (60% dispersion in mineral oil, 1.06 g, 26.5 mmol, 3.52 equiv) was added as
a solid under an argon atmosphere to a solution of sulfonamide 566 (2.60 g, 7.53 mmol, 1 equiv) in
N,N-dimethylformamide (28 mL) at 23 *C. After 20 min, the reaction mixture was cooled to 0 *C.
lodomethane (470 pL, 7.53 mmol, 1.00 equiv) was added dropwise via syringe over 5 min. After 3
h, the reaction mixture was allowed to warm slowly to 23 *C. After 6 h, saturated aqueous
ammonium chloride solution (20 mL) was added via syringe to quench the sodium salts. The
resulting biphasic mixture was concentrated under reduced pressure. The residue was diluted with
ethyl acetate (500 mL) and was washed with brine (2 x 500 mL). The organic layer was dried over
anhydrous sodium sulfate, was filtered, and was concentrated under reduced pressure. The residue
was purified by flash column chromatography on silica gel (30 -> 40% ethyl acetate in hexanes) to
afford sulfonamide S1 (2.46 g, 90.9%) as a yellow powder. Structural assignments were made with
additional information from gCOSY data.
'H NMR (500 MHz, CDCl3, 20 *C):
3C NMR (125 MHz, CDCl3, 20 *C):
FTIR (neat) cm-:
6 8.00-7.95 (m, 1H, PhNs-H), 7.65-7.60 (m, 1H, PhNs~
H), 7.59-7.53 (m, 2H, PhNs-H), 7.29 (d, J = 7.6, 1H, C14 -
H), 7.20 (d, J = 8.2, 1H, C17-H), 7.17-7.12 (m, 1H, C,6 -
H), 6.96-6.91 (m, 1H, C,5-H), 6.84 (s, 1H, C2-H), 5.36-
5.30 (br-m, 1H, N,-H), 3.68 (s, 3H, C22-H3), 3.41 (app-q,
J = 6.6, 2H, C10-H2), 2.97 (app-t, J = 6.6, 2H, CII-H 2 )-
6 147.5, 137.4, 133.4, 133.4, 132.7, 131.0, 127.8, 127.2,
125.5, 121.9, 119.1, 118.5, 109.7, 109.6, 44.0, 32.8,
25.5.
3339 (br-m), 3095 (w), 2934 (m), 1538 (s), 1407 (s),
1344 (s), 1167 (s), 739 (s).
HRMS (DART):
TLC (50% EtOAc in hexanes),
calc'd for C17HI8 N 30 4S
found: 360.1007.
Rf: 0.38 (UV, CAM).
[M+H]*: 360.1013,
6 The 2-nitrobenzenesulfonyl amide 56 was prepared in 1-step, see Matsuda, Y.; Kitajima, M.; Takay ama, H . Org. Lett. 2008, 10, 125.
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76%
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I ci2 CI16 -N2
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54
2-Chloro-1-methyltryptamine nosylamide (54):
N-Chlorosuccinimide (1.01 g, 7.57 mmol, 1.10 equiv) was added as a solid under an argon
atmosphere to a solution of sulfonamide S1 (2.47 g, 6.88 mmol, 1 equiv) in acetonitrile (120 mL) at
23 *C. After 1 h, saturated aqueous sodium thiosulfate solution (20 mL) was added to quench excess
N-chlorosuccinimide. The mixture was diluted by addition of brine (125 mL) and dichloromethane
(125 mL), and the layers were separated. The aqueous layer was further extracted with
dichloromethane (2 x 125 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The residue was purified by
flash column chromatography on silica gel (20% ethyl acetate in hexanes) to afford sulfonamide 54
(2.06 g, 76.1%) as a yellow powder. Structural assignments were made with additional information
from gCOSY data.
'H NMR (500 MHz, CDC13, 20 *C):
3C NMR (125 MHz, CDC13, 20 *C):
FTIR (neat) cm-':
HRMS (DART):
5 7.96-7.91 (m, 1H, PhNs-H), 7.67-7.64 (m, 1H, PhNs-
H), 7.59-7.53 (m, 2H, PhNs-H), 7.29 (d, J = 7.9, 1H, C14 -
H), 7.16-7.14 (m, 1H, C16-H), 7.16-7.14 (m, 1H, C17-
H), 7.01-6.97 (m, 1H, C 5-H), 5.38-5.30 (br-m, 1H, N9-
H), 3.63 (s, 3H, C22-H3), 3.44 (app-q, J = 6.8, 2H, CO-
H 2), 2.98 (app-t, J= 6.8, 2H, C1,-H 2)-
8 147.6, 135.8, 133.8, 133.3, 132.8, 130.9, 126.2, 125.5,
125.0, 122.2, 120.2, 117.9, 109.4, 106.5, 43.6, 30.1,
24.8.
3354 (br-m), 2937 (m), 1537 (s), 1468 (s), 1332 (s),
1163 (s), 738 (s).
calc'd for C, 7HI,7ClN30 4 S [M+H]*: 394.0623,
found: 394.0610.
TLC (30% EtOAc in hexanes), Rf: 0.35 (UV, CAM).
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97%
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Ph N1Me
OH Me
(+)-58
Crotonamide (+)-58:
An ice-cooled solution of E-crotonyl chloride (S2, 1.28 mL, 13.2 mmol, 1.00 equiv) in
tetrahydrofuran (7.0 mL) was added slowly via cannula to a solution of amine (-)-57 (3.00 g, 13.2
mmol, 1 equiv) and triethylamine (2.21 mL, 15.8 mmol, 1.20 equiv) in tetrahydrofuran (40 mL) at
-30 *C. The resulting mixture was allowed to warm slowly to -10 *C over 80 min and then allowed
to warm to 23 *C. After 2 h, saturated aqueous sodium bicarbonate solution (20 mL) was added to
quench the amine hydrochloride salts. The mixture was diluted with ethyl acetate (600 mL), and the
layers were separated. The organic layer was washed successively with aqueous hydrogen chloride
solution (IN, 400 mL), saturated aqueous potassium carbonate solution (400 mL), and brine (400
mL). The organic layer was dried over anhydrous sodium sulfate, was filtered, and was concentrated
under reduced pressure. The residue was recrystallized from 40% ethyl acetate in hexanes to afford
crotonamide (+)-58 (3.78 g, 97.0%) as lustrous yellow needles.' Structural assignments were made
with additional information from gCOSY data.
'H NMR (500 MHz, CDCl3, 20 *C, 6:1 atropisomer mixture, * denotes minor atropisomer): 8 7.43-
7.15 (m, 1OH, Ph-H), 7.43-7.15 (m, 1OH, Ph-H*), 6.92
(dq, J = 15.0, 6.9, 1H, C4-H), 6.72-6.60 (m, 1H, C4-H*),
6.21 (d, J = 15.0, 1H, C5-H), 6.20-6.13 (m, 1H, C5 H*),
5.70 (d, J = 8.4, 1H, NC-H), 5.41-5.35 (m, 1H, OC-
H*), 5.34 (app-t, J = 7.8, 1H, OC-H), 5.24-5.18 (m, 1H,
NC-H*), 4.45 (d, J = 6.9, 1H, O-H), 3.18-3.10 (m, 1H,
0-H*), 2.93 (s, 3H, NC-H 3*), 2.91 (s, 3H, NC-H 3), 1.87
(d, J= 6.9, 3H, C3-H3), 1.82-1.76 (m, 3H, C3-H3 .*)
"C NMR (125 MHz, CDCl 3, 20 *C, 6:1 atropisomer mixture, * denotes minor atropisomer): 8 168.9,
168.9*, 143.1, 142.1, 141.3*, 140.8*, 137.2, 136.6*,
128.7, 128.6, 128.5, 128.3*, 127.9*, 127.8*, 127.8,
127.7, 127.2*, 127.1, 127.0*, 126.8*, 122.7*, 122.3,
73.9,73.4*, 66.0, 65.8*, 34.3, 30.1*, 18.5, 15.4*.
FTIR (neat) cm-:
HRMS (DART):
3395 (br-s), 3031 (w), 1656 (s), 1597 (s), 1062 (m), 699
(n).
calc'd for C,9H22NO2 [M+H]*: 296.1645,
found: 296.1640.
[a D24:
TLC (50% EtOAc in hexanes), Rf:
+199 (c = 0.41, CHCl3)-
0.20 (UV, KMnO 4).
For a synthesis of a related unsaturated pseudoephedrine amide, see Yang, B. H. Ph.D. thesis, Harvard University, 1997.
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Ph 4  N9 Me3
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(+)-58
LTMP, LiCI, THF
0 -- 78 *C;
I(CH 2)3Cl
-78 - 0 *C
83%
Ph 0 H
Phy N C
OH Me
(+)-59 3
Vinyl tertiary amide (+)-59:
2,2,6,6-Tetramethylpiperidine (2.12 mL, 12.5 mmol, 2.30 equiv) was added via syringe to a
suspension of lithium chloride (1.39 g, 32.7 mmol, 6.00 equiv) in tetrahydrofuran (6.0 mL) at -78 *C.
A solution of n-butyllithium (2.01 M in hexanes, 5.56 mL, 11.2 mmol, 2.06 equiv) was added via
syringe, and the resulting mixture was warmed to 0 *C. After 20 min, an ice-cooled solution of
crotonamide (+)-58 (1.61 g, 5.45 mmol, 1 equiv) in tetrahydrofuran (15 mL) was added via cannula.
The transfer was quantitated with additional tetrahydrofuran (2 x 2.5 mL). After 10 min, the reaction
mixture was cooled to -78 *C. After 10 min, 3-chloro-1-iodopropane (1.17 mL, 10.9 mmol, 2.00
equiv) was added via syringe. After 40 min, the reaction mixture was warmed to 0 'C. After 4.5 h,
saturated aqueous ammonium chloride solution (40 mL) was added to quench the lithium alkoxide
salts. Brine (85 mL) and ethyl acetate (125 mL) were added, and the layers were separated. The
aqueous layer was further extracted with ethyl acetate (2 x 125 mL). The combined organic layers
were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The residue was purified by flash column chromatography on silica gel (20 --> 30% ethyl
acetate in hexanes) to afford vinyl tertiary amide (+)-59 (1.69 g, 83.4%) as a colorless gum.
Structural assignments were made with additional information from gCOSY data.
'H NMR (500 MHz, CDCl 3, 20 *C, 4.6:1 atropisomer mixture, * denotes minor atropisomer): 8 7.47-
7.22 (m, 1OH, Ph-H), 7.47-7.22 (m, IH, Ph-H*), 5.88-
5.79 (m, 1H, C4 H*), 5.79-5.72 (m, 1H, C4-H), 5.65 (d,
J= 7.4, 1H, NC-H), 5.49 (dd, J= 1.6, 6.5, 1H, OC-H*),
5.40 (app-t, J = 7.2, 1H, OC-H), 5.34 (d, J = 6.5, 1H,
NC-H*), 5.19 (app-d, J= 10.3, 1H,C 3-HE),5.15, (app-d,
J = 17.2, 1H, C3-Hz), 5.14-5.08 (m, 2H, C3 H2*), 4.05
(br-s, 1H, O-H), 3.59-3.53 (m, 2H, C8 -H2 ), 3.51-3.44
(m, 2H, C8-H2 *), 3.22 (app-q, J = 7.1, 1H, C5-H), 3.15
(app-q, J = 7.3, 1H, C5 H*), 2.94 (s, 3H, NC-H 3), 2.90,
(s, 3H, NC-H 3*), 2.34 (br-d, J = 1.6, 1H, 0-H*), 1.96-
1.82 (m, 2H, C6 -H2), 1.96-1.82 (m, 2H, C7-H2), 1.77-
1.59 (m, 2H, C6-H2*), 1.77-1.59 (m, 2H, C7 H2 *)-
3C NMR (125 MHz, CDC13, 20 *C, 4.6:1 atropisomer mixture, * denotes minor atropisomer):
8 174.9, 174.2*, 142.0, 141.8*, 137.8*, 137.1, 137.0*,
136.2, 129.0*, 128.8*, 128.7, 128.5, 128.4, 127.9, 127.8,
127.1*, 126.8, 117.8*, 117.7, 73.8, 73.5*, 66.1, 64.2*,
47.4, 47.2*, 45.1*, 44.9, 34.6, 31.0*, 30.4*, 30.3, 30.0*,
29.8.
FTIR (neat) cm-': 3382 (s), 3031 (w), 2958 (w), 1619 (s), 1451 (m), 1403
(m), 1063 (m), 700 (s).
S For c-alkylation of related pseudoephedrine amides, see Yang, B. H. Ph.D. thesis, Harvard University, 1997.
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calc'd for C2 2H27ClN0 2 [M+H]*: 372.1725,
found: 372.1738.
+122 (c = 0.37, CHCl 3)-
TLC (40% EtOAc in hexanes), Rf: 0.51 (UV, KMnO 4).
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HRMS (DART):
Ph O LDA, LiCI, THF Ph Me
Ph CI 6 0 ; Ph CI
OH Me DMP, -0 C; OH Me N
(+)-59 3 72% (+)-55 3
>29:1 dr
a-Quaternary amide (+)-55:
N,N-Diisopropylamine (531 pL, 3.79 mmol, 2.26 equiv) was added via syringe to a
suspension of lithium chloride (428 mg, 10.1 mmol, 6.01 equiv) in tetrahydrofuran (3.0 mL) at -78
*C. A solution of n-butyllithium (2.25 M in hexanes, 1.55 mL, 3.48 mmol, 2.07 equiv) was added via
syringe, and the resulting mixture was warmed to 0 *C. After 5 min, the resulting solution was
cooled to -78 *C. An ice-cooled solution of vinyl tertiary amide (+)-59 (625 mg, 1.68 mmol, 1
equiv) in tetrahydrofuran (5.0 mL) was added via cannula.9 The transfer was quantitated with
additional tetrahydrofuran (2 x 1.0 mL), and the resulting mixture was warmed to 0 *C. After 1 h,
the reaction mixture was cooled to -40 C, and NN'-dimethylpropylene urea (507 pL, 4.21 mmol,
2.51 equiv) was added via syringe. After 10 min, the reaction mixture was cooled to -60 *C, and
iodoethane (1.01 mL, 12.6 mmol, 7.50 equiv) was added slowly via syringe. After 5 min, the
reaction mixture was warmed to -50 *C. After 42 h, saturated aqueous ammonium chloride solution
(5 mL) was added to quench the lithium alkoxide salts, and the resulting biphasic mixture was
allowed to warm to 23 *C. Brine (55 mL) and dichloromethane (60 mL) were added, and the layers
were separated. The aqueous layer was further extracted with dichloromethane (3 x 60 mL). The
combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
silica gel (10 -- 18% ethyl acetate in hexanes) to afford a-quaternary amide (+)-55 (484 mg, 72.0%)
as a colorless gum. Structural assignments were made with additional information from gCOSY
data. The diastereomeric ratio of the purified a-quaternary amide (+)-55 was determined to be >29:1
by 'H NMR analysis of the oxazolinium trifluromethanesulfonate derivative S3.'0
'H NMR (500 MHz, C6D6, 73 *C): 8 7.32 (d, J = 7.6, 2H, Ph-H), 7.28 (d, J = 7.5, 2H, Ph-
H), 7.10-7.02 (m, 4H, Ph-H), 7.02-6.95 (m, 2H, Ph-H),
9 We are grateful to professor Myers and co-workers for sharing their new asymmetric alkylation methodology in advance of
publication: (a) Personal communication, Myers, A. G. 2011. (b) Morales, M. R.; Mellem, K. T.; Myers, A. G. Angew. Chem., Int. Ed.
2012,51,4568.
'4 The diastereomeric ratio of the product (+)-55 was determined by its conversion to the corresponding a-quaternary oxazolinium
trifluoromethanesulfonate S3; see Chain, W. J.; Myers, A. G. Org. Lett. 2007, 9, 355.
21 8
21 Me CI
Ph 0 .Me Tf2O, pyridine, Ph
Ph 8 CH 2CI 2, /Ph . 66 CI 19 3OH Me N.0~2t POH Me 0 - 23 *C P + ,Me F3CSO 3(+)-55 3 S3
>29:1 dr
A sample of S3 was prepared as follows: Trifluoromethanesulfonic anhydride (2.3 pL, 14 Rmol, 1.5 equiv) was added via
syringe to a solution of a-quaternary amide (+)-55 (3.7 mg, 9.3 imol, 1 equiv) and pyridine (2.2 pL, 28 ptmol, 3.0 equiv) in
dichloromethane (1.0 mL) at 0 *C. After 10 min, the solution was allowed to warm to 23 *C. After 10 min the reaction mixture was
concentrated under reduced pressure. The residue was dissolved in CDC13 for 'H NMR analysis. Structural assignments were made
with additional information from gCOSY experiments. 'H NMR (500 MHz, CDCl3 , 20 *C, >29:1 diastereomer mixture, * denotes
minor diastereomer): 6 7.21-7.10 (m, 6H, Ph-H), 7.21-7.10 (m, 6H, Ph-H*), 6.98-6.92 (m, 2H, Ph-H), 6.98-6.92 (m, 2H, Ph-H*),
6.98-6.92 (m, 1H, NC-H), 6.98-6.92 (m, IH, NC-H*), 6.88-6.83 (m, 2H, Ph-H), 6.88-6.83 (m, 2H, Ph-H*), 6.32 (d, J = 11.9, IH,
OC-H*), 6.24 (d, J = 10.9, 1H, OC-H), 6.18 (dd, J = 10.8, 17.7, 1H, C4-H), 6.10 (dd, J = 10.9, 17.7, 1H, C4-H), 5.69 (d, J = 10.8, 1H,
C3-HE), 5.68 (d, J = 10.9, 1 H, C3-HE*), 5.52 (d, J = 17.7, 1 H, C3-Hz), 5.50 (d, J = 17.7, 1H, C3-Hz*), 3.76-3.68 (m, I H, C8-Ha), 3.76-
3.68 (m, IH, C8 -Ha*), 3.67-3.59 (m, IH, C8-Hb), 3.67-3.59 (m, 1H, C8-Hb*), 3.39 (s, 3H, NC-H 3), 3.37 (s, 3H, NC-H 3*), 2.30-2.04
(m, 2H, C6-H2), 2.30-2.04 (m, 2H, C6-H 2 *), 2.30-2.04 (m, 2H, C7-H 2), 2.30-2.04 (m, 2H, C7-H2*), 2.04-1.94 (m, 1H, C 2-Ha), 2.04-
1.94 (m, 1H, C2-Ha*), 1.92-1.82 (m, 1H, C2-Hb), 1.92-1.82 (m, 1H, C 2-Hb*), 1.15 (t, J = 7.5, 3H, C21-H 3*), 1.06 (t, J = 7.5, 3H, C2 1-
H3).
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"C NMR (125 MHz, C6D6 , 73 C):
FTIR (neat) cm-':
HRMS (DART):
5.91 (d, J = 8.1, 1H, NC-H), 5.69 (dd, J = 10.9, 17.8,
1H, C4-H), 5.22 (d, J = 8.1, 1H, OC-H), 4.92 (app-d, J =
10.9, 1H, C 3-HE), 4.84 (app-d, J = 17.8, 1H, C3-Hz),
3.38-3.27 (br-s, 1H, O-H), 3.27-3.16 (m, 2H, C8-H2),
2.74 (s, 3H, NC-H 3), 1.89-1.79 (m, 1H, C6-Ha), 1.73-
1.49 (m, 1H, C6-Hb), 1.73-1.49 (m, 2H, C7-H2), 1.73-
1.49 (m, 2H, C20-H2), 0.76 (t, J = 7.4, 3H, C2 -H3)-
5 175.8, 143.4, 142.6, 138.9, 129.6, 128.8, 128.7, 128.1,
128.0, 127.8, 114.2, 74.2, 66.4, 53.2, 46.1, 34.8, 34.2,
29.3, 28.5, 9.0.
3407 (br-s), 2965 (m), 1607 (s), 1451 (m), 1391 (m),
1083 (m), 699 (s).
calc'd for C24H31ClN02 [M+H]*: 400.2038,
found: 400.2056.
laD 2 4 :
TLC (30% EtOAc in hexanes), Rf:
+92 (c = 0.44, CH2Cl 2 )-
0.39 (UV, KMnO4).
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CH 2CI2
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Ph 0 Me
S 8
Ph N 6 CI
TESO Me
(+)-60 3
O-Silylated a-quaternary amide (+)-60:
Triethylsilyltrifluoromethanesulfonate (535 pL, 2.37 mmol, 2.00 equiv) was added via
syringe to a solution of a-quaternary amide (+)-55 (473 mg, 1.18 mmol, 1 equiv) and 2,6-lutidine
(343 pL, 2.96 mmol, 2.50 equiv) in dichloromethane (8.0 mL) at 0 *C. After 5 min, the solution was
allowed to warm to 23 *C. After 4.5 h, the reaction mixture was poured into -saturated aqueous
sodium bicarbonate solution (15 mL). Brine (25 mL) was added, and the layers were separated. The
aqueous layer was further extracted with dichloromethane (4 x 40 mL). The combined organic layers
were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The residue was purified by flash column chromatography on silica gel (0 -- 5% ethyl
acetate in hexanes) to afford O-silylated a-quaternary amide (+)-60 (608 mg, 100%) as a viscous
colorless oil. Structural assignments were made with additional information from gCOSY data.
'H NMR (500 MHz, CDC13, 20 *C, 4.5:1 atr
13C NMR (125 MHz, CDCl3, 20 *C, 4.5:1
FTIR (neat) cm-':
HRMS (DART):
TLC (20% EtOAc in hexanes), Rf:
opisomer mixture, * denotes minor atropisomer): 8 7.46-
7.04 (m, 1OH, Ph-H), 7.46-7.04 (m, 8H, Ph-H*), 6.94-
6.77 (m, 2H, Ph-H*), 6.24-6.03 (br-m, 1H, NC-H),
5.92-5.80 (m, 1H, C4-H*), 5.85 (dd, J = 10.7, 17.6, 1H,
C4-H), 5.66-5.56 (br-m, 1H, NC-H*), 5.36 (d, J = 7.0,
1H, OC-H), 5.18-5.11 (m, 1H, C3-Ha*), 5.14 (d, J =
10.7, 1H, C3-HE), 5.11-5.02 (br-m, 1H, OC-H*), 5.00-
4.92 (m, 1H, C3-Hb*), 4.96 (d, J = 17.6, 1H, C3-Hz),
3.47-3.35 (m, 2H, C8-H2 ), 3.30 (s, 3H, NC-H 3*), 3.09
(s, 3H, NC-H 3), 3.04-2.92 (m, 1H, C8-Ha*), 2.88-2.75
(m, 1H, C8-Hb*), 1.90-1.16 (m, 2H, C6 -H2), 1.90-1.16
(m, 2H, C6-H2 *), 1.90-1.16 (m, 2H, C7-H2 ), 1.90-1.16
(m, 2H, C7-H2 *), 1.90-1.16 (m, 2H, C20-H2), 1.90-1.16
(m, 2H, C2 0-H2*), 0.86-0.71 (m, 9H, Si(CH 2CH 3)3*),
0.79 (t, J = 7.7, 9H, Si(CH2CH 3)3), 0.78-0.73 (m, 3H,
C2 1-H3*), 0.64 (t, J = 7.1, 3H, C21-H3), 0.46-0.32 (m,
6H, Si(CH 2CH3)3*), 0.39 (q, J = 7.7, 6H, Si(CH 2CH3)3)-
atropisomer mixture, * denotes minor atropisomer): 6
175.1*, 174.0, 143.4*, 142.3, 142.1, 141.9*, 139.3*,
138.6, 128.8, 128.6*, 128.2, 128.1, 128.0*, 127.7,
127.6*, 127.4, 127.2, 113.9, 113.3*, 78.0*, 75.3, 66.0*,
63.2, 52.2, 52.1*, 46.1, 45.2*, 33.8, 33.2, 31.3*, 29.9*,
28.4*, 27.7, 27.5, 8.5, 8.4*, 7.0, 6.9*, 5.1, 5.0*.
3031 (w), 2957 (s), 2877 (m), 1624 (s), 1454 (m), 1384
(m), 1088 (m), 1005 (m), 699 (s).
calc'd for C3oH44ClNNaO 2Si [M+Na]*: 536.2722,
found: 536.2706.
+72 (c = 0.52, CHCl3).
0.61 (UV, KMnO4).
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Tertiary sulfonamide (+)-61:
Potassium hydride (47.4 mg, 1.18 mmol, 1.10 equiv) was added as a solid under an argon
atmosphere to a solution of O-silylated a-quatemary amide (+)-60 (553 mg, 1.08 mmol, 1 equiv),
sulfonamide 54 (466 mg, 1.18 mmol, 1.10 equiv), and tetrabutylammonium iodide (392 mg, 1.08
mmol, 1.00 equiv) in NN-dimethylformamide (2.5 mL) at 23 *C. After 5 min, the solution was
warmed to 100 *C. After 24 h, the solution was allowed to cool to 23 *C. Saturated aqueous
ammonium chloride solution (20 mL) was added to quench the sulfonamide salts. Brine (40 mL) and
dichloromethane (60 mL) were added, and the layers were separated. The aqueous layer was further
extracted with dichloromethane (2 x 60 mL). The combined organic layers were dried over
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure. The residue
was purified by flash column chromatography on silica gel (80% dichloromethane in hexanes -+ 30%
ethyl acetate in hexanes) to afford tertiary sulfonamide (+)-61 (806 mg, 86.0%) as a beige foam.
Structural assignments were made with additional information from gCOSY data.
'H NMR (500 MHz, CDCl 3, 20 *C, 4.4:1 atropisomer mixture, * denotes minor atropisomer): 8 7.93-
7.85 (m, 1H, PhNs-H), 7.85-7.75 (m, 1H, PhNs-H*),
7.65-7.53 (m, 3H, PhNs-H), 7.65-7.53 (m, 3H, PhNs-H*),
7.53-7.05 (m, 14H, Ar-H), 7.53-7.05 (m, 12H, Ar-H*),
6.96-6.84 (m, 2H, Ar-H*), 6.21-6.07 (br-m, 1H, NC-
H), 5.93-5.81 (m, 1H,C 4-H*), 5.86 (dd, J = 11.0, 18.1,
1H, C4-H), 5.66-5.56 (br-m, 1H, NC-H*), 5.36 (d, J =
6.8, 1H, OC-H), 5.17-5.09 (m, 1H, C3 -Ha*), 5.12 (d, J =
11.0, 1H, C3-HE), 5.08-5.02 (br-m, 1H, OC-H*), 4.98-
4.88 (m, 1H, C3-Hb*), 4.93 (d, J = 18.1, 1H, C3-Hz),
3.66 (s, 3H, C22-H3), 3.66 (s, 3H, C2 2-H3 *), 3.45 (app-t, J
= 7.3, 2H, Cio-H 2), 3.45 (app-t, J = 7.3, 2H, Co-H2*),
3.42-3.32 (m, 2H, C8-H2), 3.30 (s, 3H, NC-H3*), 3.07
(s, 3H, NC-H 3), 3.03-2.92 (m, 1H, C8 -Ha*), 2.97 (app-t,
J = 7.3, 2H, Cl 1-H2), 2.97 (app-t, J = 7.3, 2H, C,1-H 2 *),
2.93-2.75 (m, 1H, C8-Hb*), 1.88-1.06 (m, 2H, C6 -H2 ),
1.88-1.06 (m, 2H, C6-H2 *), 1.88-1.06 (m, 2H, C7-H2 ),
1.88-1.06 (m, 2H, C7-H2 *), 1.88-1.06 (m, 2H, C2 0 -H2 ),
1.88-1.06 (m, 2H, C20 -H 2 *), 0.88-0.73 (m, 9H,
Si(CH2 CH 3)3 *), 0.80 (t, J = 7.8, 9H, Si(CH2CH 3)3),
0.73-0.65 (m, 3H, C21-H3 *), 0.60 (t, J = 7.0, 3H, C2 1-
H3), 0.49-0.32 (m, 6H, Si(CH 2CH 3)3*), 0.40 (q, J = 7.8,
6H, Si (CH 2CH3)3)-
3C NMR (125 MHz, CDCl3, 20 C): 6 173.9, 147.9, 142.3, 142.1, 138.5, 135.7, 133.9, 133.1,
131.5, 130.8, 128.9, 128.2, 128.1, 127.7, 127.5, 127.2,
126.4, 124.4 124.1, 122.1, 120.2, 118.3, 114.0, 109.2,
107.5, 75.1, 63.2, 52.3, 48.3, 46.6, 34.0, 33.1, 30.0, 27.2,
23.8, 23.0, 8.7, 7.0, 5.1.
126
FTIR (neat) cm-':
HRMS (DART):
2955 (m), 1622 (s), 1544 (s), 1468 (m), 1372 (s), 1091
(m), 741 (m).
calc'd for C4 7H6oClN 40 6SSi [M+H]*: 871.3686,
found: 871.3678.
+49 (c = 0.38, CH 2 Cl2).
TLC (50% EtOAc in hexanes), Rf: 0.87 (UV).
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10 21lme 0 Ph
14 N 8 619J P
Ss Me OTES
16 N 
2
Me (+)-61
21
0 Me
PhSH, K2C0 3  14 N 19
.
0  1 \ cI 6
NEt 3*3HF, KOEt 16 ' N
EtOH, 85 *C Me (-)-53
95%, 94% ee
P h
+ Ph NH
OH Me
(-)-57
99%
Lactam (-)-53:
Thiophenol (203 pL, 1.98 mmol, 3.00 equiv) was added via syringe to a suspension of tertiary
sulfonamide (+)-61 (574 mg, 0.658 mmol, 1 equiv) and potassium carbonate (455 mg, 3.29 mmol,
5.00 equiv) in dimethylsulfoxide (3.6 mL) at 23 *C. After 3 h, triethylamine trihydrofluoride (716
pL, 4.39 mmol, 6.67 equiv) was added via syringe. After 1 min, potassium ethoxide (2.25 M solution
in ethanol, 17.1 mL) was added via syringe. After 5 min, the solution was warmed to 85 *C. After 24
h, the solution was allowed to cool to 23 *C. Saturated aqueous ammonium chloride solution (20
mL) was added to quench the potassium ethoxide, and the resulting biphasic mixture was
concentrated under reduced pressure. Saturated aqueous sodium bicarbonate (60 mL) and
dichloromethane (60 mL) were added, and the layers were separated. The aqueous layer was further
extracted with dichloromethane (2 x 60 mL). The combined organic layers were dried over
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure. The residue
was purified by flash column chromatography on silica gel (10 -> 20% ethyl acetate in hexanes) to
afford lactam (-)-53 (216 mg, 95.1%) as a viscous light orange oil. Further elution (0.5% ammonium
hydroxide, 4.5% methanol, 20% chloroform in dichloromethane) afforded amine (-)-57 (148 mg,
98.9%) as a white powder. Structural assignments were made with additional information from
gCOSY data. Lactam (-)-7 was determined to be of 94% ee by chiral HPLC analysis (Chiralpak IC,
25% 'PrOH / 75% hexanes, 0.5 ml/min, 230 nm, tR(minor)= 19.8 min, tR(major) = 22.7 min).
'H NMR (500 MHz, CDCl3, 20 *C):
3C NMR (125 MHz, CDCl3, 20 *C):
FTIR (neat) cm-':
HRMS (DART):
TLC (30% EtOAc in hexanes), Rf:
8 7.64 (d, J = 7.8, 1H, C14-H), 7.24-7.15 (m, 1H, C17-H),
7.24-7.15 (m, 1H, C16-H), 7.10 (app-t, J = 7.8, 1H, C 5 -
H), 5.90 (dd, J = 10.7, 17.6, 1H, C4-H), 5.11 (dd, J =
1.0, 10.7, 1H, C3-HE), 5.01 (dd, J = 1.0, 17.6, 1H, C3-
Hz), 3.69 (s, 3H, C2 2 -H3 ), 3.63-3.55 (m, 1H, CiO-Ha),
3.54-3.46 (m, 1H, CIo-Hb), 3.29-3.20 (m, 1H, C8 -Ha),
3.20-3.13 (m, 1H, C8-Hb), 3.07-2.95 (m, 2H, CI-H 2),
1.96-1.56 (m, 2H, C6-H 2), 1.96-1.56 (m, 2H, C7-H 2 ),
1.96-1.56 (m, 2H, C20-H2), 0.80 (t, J = 7.5, 3H, C21-H3).
8 172.8, 142.7, 135.8, 126.9, 124.0, 122.0, 120.0, 118.8,
113.9, 109.1, 108.8, 49.3, 49.2, 48.3, 31.7, 30.0, 28.7,
22.4, 19.6, 8.6.
2937 (m), 1629 (s), 1467 (s), 1328 (m), 1199 (m), 740
(n).
calc'd for C20H26ClN 20 [M+H]*: 345.1728,
found: 345.1721.
-5 (c = 0.19, CHCl3)-
0.70 (UV, CAM, KMnO4).
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Me (-)-53
Tf2O, 3-CNPyr
MeCN, 85*C;
NaBH3CN
THF, 23 *C
50%
N 6
14 19
N /4 Me 21
16 1 N H
(-)-62 Me
(-)-N-Methyldehydroaspidospermidine (62):
Trifluoromethanesulfonic anhydride (18.5 p.L, 110 pmol, 1.10 equiv) was added via syringe
to a solution of lactam (-)-53 (34.6 mg, 100 pmol, 1 equiv) and 3-cyanopyridine (12.5 mg, 120 [imol,
1.20 equiv) in acetonitrile (6.5 mL) at 23 *C. After 5 min, the solution was warmed to 85 'C. After 3
h, the solution was allowed to cool to 0 *C. A solution of sodium cyanoborohydride (62.8 mg, 1.00
mmol, 10.0 equiv) in tetrahydrofuran (4 mL) was added via cannula, and the resulting mixture was
allowed to warm to 23 *C. After 6 h, saturated aqueous sodium bicarbonate solution (15 mL) was
added to quench the trifluoromethanesulfonate salts. Dichloromethane (15 mL) was added, and the
layers were separated. The aqueous layer was further extracted with dichloromethane (2 x 15 mL).
The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
alumina (0 -> 3% ethyl acetate in hexanes) to afford (-)-N-methyldehydroaspidospermidine (62, 14.7
mg, 49.8%) as a light tan gum. Structural assignments were made with additional information from
gCOSY, HSQC, gHMBC, and ROESY data.
'H NMR (500 MHz, C6D6, 20 'C):
3 C NMR (125 MHz, C6D6, 20 'C):
FTIR (neat) cm-':
HRMS (DART):
TLC (A12 0 3, 10% EtOAc in hexanes), R,:
6 7.11 (app-t, J = 7.8, 1H, C16-H), 7.02 (d, J= 7.8, 1H,
C14-H), 6.74 (app-t, J = 7.8, 1H, C15-H), 6.25 (d, J = 7.8,
1H, C17-H), 5.80 (dd, J = 4.0, 10.3, 1H, C3-H), 5.59 (d, J
= 10.3, 1H, C4-H), 3.68 (d, J = 4.0, 1H, C2-H), 2.97 (dt,
J = 3.3, 8.5, 1H, CoI-Ha), 2.88 (m, 1H, C8-Ha), 2.53 (s,
3H, C22-H3), 2.25-2.18 (m, 1H, ClO-Hb), 2.23 (s, 1H, C19-
H), 2.03 (dt, J = 12.2, 8.5, 1H, Ci-Ha), 1.94-1.82 (m,
1H, Cs-Hb), 1.94-1.82 (m, 1H, CII-Hb), 1.68-1.57 (m,
1H, C7-Ha), 1.57-1.49 (m, 1H, C6 -Ha), 1.40-1.29 (m,
1H, C7-Hb), 1.40-1.29 (m, 1H, C20 -Ha), 1.12-1.03 (m,
1H, C2 0 -Hb), 1.03-0.95 (m, 1H, C6-Hb), 0.61 (t, J = 7.5,
3H, C21-H 3).
6 151.6 (C18), 137.8 (C4 ), 136.0 (C1 3), 128.4 (C16), 124.6
(C3), 123.8 (C14), 117.5 (C15), 106.1 (C17), 73.3 (C19),
71.5 (C2), 53.0 (C8), 52.9 (CIO), 52.9 (C12 ), 43.9 (C11),
39.4 (C5), 35.6 (C20), 34.9 (C6), 32.6 (C22), 23.8 (C7 ), 8.2
(C 21).
2931 (s), 1605 (m), 1492 (m), 1264 (m), 1121 (m), 736
(s).
calc'd for C20H27N2 [M+H]*: 295.2169,
found: 295.2165.
-28 (c = 0.30, CH 2 C12 )-
0.40 (UV, CAM, KMnO 4 ).
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Alternate Synthesis:
8 8
N O 6 Tf2O, 2-CIPyr N 6
14 19 M"\ MeCN, 23 *C; -'14 
_9_4 Me 21 14 19 4 Me 21
16 1 N NaBH 3CN 1 N H
(-)-64 Me 95% (-)-62 Me
Synthesis of (-)-N-Methyldehydroaspidospermidine (16) from tetracyclic lactam (-)-64:
Trifluoromethanesulfonic anhydride (18.0 pL, 107 imol, 1.10 equiv) was added via syringe
to a solution of tetracyclic lactam (-)-64 (29.9 mg, 96.9 pmol, 1 equiv) and 2-chloropyridine (10.9
pL, 116 pmol, 1.20 equiv) in acetonitrile (3.0 mL) at 23 *C. After 10 min, a solution of sodium
cyanoborohydride (36.6 mg, 582 gmol, 6.00 equiv) in tetrahydrofuran (1.0 mL) was added via
cannula. After 6 h, saturated aqueous sodium bicarbonate solution (15 mL) was added via syringe to
quench the trifluoromethanesulfonate salts. Dichloromethane (15 mL) was added, and the layers
were separated. The aqueous layer was further extracted with dichloromethane (2 x 15 mL). The
combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
alumina (0 -- 3% ethyl acetate in hexanes) to afford (-)-N-methyldehydroaspidospermidine (62, 27.1
mg, 94.9%) as a light tan gum. See page 129 for characterization data for (-)-N-
methyldehydroaspidospermidine (62).
8 8
N 6 Tf20, 2-CIPyr N , 6
14 19 Me2 MeCN, 23* 14 19 me 21
16 1 N BusSnH; 16 N H(}64 Me NaBD4, MeOH (-)-65 Me94%
Synthesis of C19-deuterated pentacycle (-)-65 from tetracyclic lactam (-)-64:
Trifluoromethanesulfonic anhydride (2.4 VL, 14 pmol, 1.1 equiv) was added via syringe to a
solution of tetracyclic lactam (-)-64 (4.0 mg, 13 pmol, 1 equiv) and 2-chloropyridine (1.5 jL, 16
jimol, 1.2 equiv) in acetonitrile (0.8 mL) at 23 *C. After 10 min, tributylstannane (5.2 pL, 20 [tmol,
1.5 equiv) was added via syringe. After 30 min, a solution of sodium borodeuteride (98 atom% D,
2.2 mg, 52 pmol, 4.0 equiv) in methanol (0.8 mL) was added via cannula. After 30 min, saturated
aqueous sodium bicarbonate solution (15 mL) was added via syringe to quench the
trifluoromethanesulfonate salts. Dichloromethane (15 mL) was added, and the layers were separated.
The aqueous layer was further extracted with dichloromethane (2 x 15 mL). The combined organic
layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The residue was purified by flash column chromatography on alumina (0 -> 3% ethyl
acetate in hexanes) to afford pentacycle (-)-65 (3.6 mg, 94%) as a light tan gum. 'H NMR analysis
of the purified pentacycle (-)-65 showed 0% deuterium incorporation at C2 and 93% deuterium
incorporation at C19. See page 129 for characterization data for (-)-N-
methyldehydroaspidospermidine (62).
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4 Me 21
16 1 N H
(-)-1Me
(-)-N-Methylaspidospermidine (1):
Platinum on charcoal (10% w/w, 10.0 mg, 5.13 pmol, 0.130 equiv) was added as a solid to a
solution of (-)-N-methyldehydroaspidospermidine (62, 11.6 mg, 39.4 Rmol, 1 equiv) in
tetrahydrofuran (2.0 mL) at 23 *C. The opened reaction vessel was placed in a Fischer-Porter tube
and sealed under an atmosphere of hydrogen gas (80 psi). After 48 h, the Fischer-Porter tube was
opened in air, and the suspension was filtered over Celite. The solids were extracted with ethyl
acetate, and the combined filtrates were concentrated under reduced pressure. The residue was
purified by flash column chromatography on alumina (0 -> 3% ethyl acetate in hexanes) to afford
(-)-N-methylaspidospermidine (1, 11.7 mg, 100%) as a pale off-white powder. Structural
assignments were made with additional information from gCOSY, HSQC, gHMBC, and NOESY
data.
'H NMR (500 MHz, CDC13, 20 'C):
13C NMR (125 MHz, CDC13 , 20 *C):
FTIR (neat) cm-':
HRMS (DART):
TLC (A12 03, 20% EtOAc in hexanes), Rf:
6 7.04 (app-t, J = 7.3, 1H, C16-H), 7.00 (d, J = 7.1, 1H,
C14-H), 6.61 (app-t, J = 7.3, 1H, C15-H), 6.35 (d, J = 7.7,
1H, C17-H), 3.40 (dd, J = 5.8, 11.0, 1H, C2-H), 3.15-
3.06 (m, 1H, CIo-Ha), 3.06-2.99 (m, 1H, C8-Ha), 2.72 (s,
3H, C22 -H3), 2.35-2.17 (m, 1H, Ci;-Ha), 2.35-2.17 (m,
1H, CS-Hb), 2.17 (s, 1H, C,9-H), 1.99-1.81 (m, 1H, CIO-
Hb), 1.99-1.81 (m, 1H, C4-H), 1.80-1.65 (m, 1H, C3 -
Ha), 1.80-1.65 (m, 1H, C7-Ha), 1.64-1.56 (m, lH, C6-
Ha), 1.53-1.37 (m, 1H, C7-Hb), 1.53-1.37 (m, 1H, C11-
Hb), 1.53-1.37 (m, 1H, C20-Ha), 1.26-1.16 (m, 1H, C3-
Hb), 1.15-1.03 (m, 1H, C4-Hb), 1.15-1.03 (m, 1H, C6-
Hb), 0.90-0.80 (m, 1H, C20-Hb), 0.60 (t, J = 7.5, 3H, C21-
H3).
8 150.8 (CI8), 137.1 (C13), 127.4 (CI6 ), 122.4 (C14),
117.3 (CI), 106.6 (C17), 72.0 (C2), 71.4 (C19), 54.1 (C8),
53.3 (CIO), 52.8 (C12), 39.3 (C11), 35.7 (C), 34.7 (C6 ),
31.7 (C22), 30.3 (C20), 23.1 (C 4), 22.2 (C3 ), 22.0 (C), 7.0
(C 21)-
2929 (s), 1606 (m), 1485 (m), 1446 (m), 1376 (m), 1265
(s), 1122 (m), 737 (m).
calc'd for C20H29N2 [M+H]*: 297.2325.
found: 297.2317.
-23 (c = 0.17, CHCl3)-
0.63 (UV, CAM, KMnO4 ).
" Literature value: [C]D25= -23 (c 1.1, CHCl3) for (-)-1, Ishikawa, H.; Elliott, G. I.; Velcicky, J.; Choi, Y.; Boger, D. L. J. Am. Chem.
Soc. 2006, 128, 10596. [a]D20= +24 (c 1.25, CHCl3) for (+)-1, Mokry, J.; Kompis, I.; Spiteller, G. Collect. Czech. Chem. Commun.
1967,32,2523.
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Table S1. Comparison of our 'H NMR data for (-)-N-methylaspidospermidine (1) with
literature data for (+)-N-methylaspidospermidine (1):
r\6N .6
14 '19
4 Me 21
16 N H
Me
(+)-N-methylaspidospermidine (1)
8
N 6
44 1 Me 21
16 1N H
Me
(-)-N-methylaspidospermidine (1)
Assignment Boger's Report" This Work
(+)-N-Methylaspidospermidine (1) (-)-N-Methylaspidospermidine (1)
'H NMR, 400 MHz, 'H NMR, 500 MHz,
CDC13  CDC13, 20 *C
C2 3.40 (dd, J= 5.8, 10.7, 1H) 3.40 (dd, J= 5.8, 11.0, 1H)
C3 1.80-1.65 (m, 1H) 1.80-1.65 (m, 1H)
1.29-1.20 (m, 1H) 1.26-1.16 (m, 1H)
C4 2.00-1.80 (m, 1H) 1.99-1.81 (m, 1H)
1.20-1.10 (m, 1H) 1.15-1.03 (m, 1H)
C5 -
C6 1.65-1.60 (m, 1H) 1.64-1.56 (m, 1H)
1.20-1.10 (m, 1H) 1.15-1.03 (m, 1H)
C7 1.80-1.65 (m, 1H) 1.80-1.65 (m, 1H)
1.55-1.40 (m, 1H) 1.53-1.37 (m, 1H)
C8 3.20-3.05 (m, 1H) 3.06-2.99 (m, 1H)
2.35-2.20 (m, 1H) 2.35-2.17 (m, 1H)
C1O 3.20-3.05 (m, 1H) 3.15-3.06 (m, 1H)
2.00-1.80 (m, 1H) 1.99-1.81 (m, 1H)
C1l 2.35-2.20 (m, 1H) 2.35-2.17 (m, IH)
1.55-1.40 (m, IH) 1.53-1.37 (m, 1H)
C12 -_ -
C13 -_ -
C14 7.02 (d, J= 7.7, 1H) 7.00 (d, J= 7.1, 1H)
C15 6.63 (t, J= 7.3, 1H) 6.61 (app-t, J= 7.3, 1H)
C16 7.05 (t, J= 7.7, 1H) 7.04 (app-t, J= 7.3, 1H)
C17 6.37 (d, J= 7.7, 1H) 6.35 (d, J= 7.7, 1H)
C18 -_ -
C19 2.21 (s, 1H) 2.17 (s, 1H)
C20 1.55-1.40 (m, 1H) 1.53-1.37 (m, 1H)
0.90-0.80 (m, 1H) 0.90-0.80 (m, 1H)
C21 0.62 (t, J= 7.4, 3H) 0.60 (t, J = 7.5, 3H)
C22 2.74 (s, 3H) 2.72 (s, 3H)
12 Ishikawa, H.; Elliott, G. I.; Velcicky, J.; Choi, Y.; Boger, D. L. J. Am. Chem. Soc. 2006, 128, 10596.
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Table S2. Comparison of our 13C NMR data for (-)-N-methylaspidospermidine (1) with
literature data for (+)-N-methylaspidospermidine (1):
8 8
6 6N N
14 4 Me21 14 19 4 Me 21N N
16 N 'H 16 1 N H
Me Me
(+)-N-methylaspidospermidine (1) (-)-N-methylaspidospermidine (1)
Assignment Boger's Report 12  This Work Chemical Shift
(+)-N-Methylaspidospermidine (1) (-)-N-Methylaspidospenmidine (1) Difference
13C NMR, 100 MHz, "C NMR, 125 MHz, Ab =
CDCl 3  CDC13, 20 *C 6 (this work) -6 (Ref. 12)
C2 71.7 72.0 0.3
C3 22.0 22.2 0.2
C4 22.9 23.1 0.2
C5 35.5 35.7 0.2
C6 34.5 34.7 0.2
C7 21.7 22.0 0.3
C8 53.8 54.1 0.3
C1O 53.0 53.3 0.3
C11 39.0 39.3 0.3
C12 52.5 52.8 0.3
C13 136.9 137.1 0.2
C14 122.1 122.4 0.3
C15 117.0 117.3 0.3
C16 127.2 127.4 0.2
C17 106.4 106.6 0.2
C18 150.5 150.8 0.3
C19 71.2 71.4 0.2
C20 30.1 30.3 0.2
C21 6.8 7.0 0.2
C22 31.5 31.7 0.2
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21
.Me
16
Tf2O, 3-CNPyr
MeCN, 85 'C;
NaF3CCOO
F3CCOOH
H20, 70 *C
57%
8
NO 6
14 1 4 Me 21
16 N 
(-)_64 Me
Tetracyclic lactam (-)-64:
Trifluoromethanesulfonic anhydride (115 pL, 686 pmol, 1.10 equiv) was added via syringe to
a solution of lactam (-)-53 (215 mg, 623 gmol, 1 equiv) and 3-cyanopyridine (77.9 mg, 748 Pmol,
1.20 equiv) in acetonitrile (25 mL) at 23 *C. After 5 min, the solution was warmed to 85 *C. After 3
h, the solution was allowed to cool to 23 *C. Sodium trifluoroacetate (254 mg, 1.87 mmol, 3.00
equiv) was added as a solid under an argon atmosphere. After 2 min, water (12.5 mL) was added via
syringe. After 5 min, trifluoroacetic acid (382 pL, 4.99 mmol, 8.00 equiv) was added via syringe, and
the solution was warmed to 70 *C. After 12 h, the solution was allowed to cool to 23 *C. Saturated
aqueous potassium carbonate solution (20 mL) was added to quench the trifluoroacetic acid. Brine
(100 mL) and dichloromethane (120 mL) were added, and the layers were separated. The aqueous
layer was further extracted with dichloromethane (2 x 120 mL). The combined organic layers were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
The residue was purified by flash column chromatography on silica gel (1.5% acetone in
dichloromethane -> 30% ethyl acetate in hexanes) to afford tetracyclic lactam (-)-64 (110.4 mg,
57.4%) as a beige powder. Structural assignments were made with additional information from
gCOSY, HSQC, and gHMBC data.
'H NMR (500 MHz, CD 3CN, 73 *C):
3C NMR (125 MHz, CD 3CN, 73 *C):
FTIR (neat) cm-':
HRMS (DART):
5 7.55 (d, J = 7.9, 1H, C14-H), 7.30 (d, J = 7.9, 1H, C 17-
H), 7.17 (app-t, J = 7.9, 1H, C16-H), 7.06 (app-t, J = 7.9,
1H, C15-H), 6.37 (d, J = 11.9, lH, C3-H), 6.21 (d, J =
11.9, 1H, C4-H), 4.29-4.22 (m, 1H, Cio-Ha), 3.59 (s, 3H,
C22-H 3), 3.06-2.95 (m, 2H, C8-H 2), 3.06-2.95 (m, 1H,
Ci-Ha), 2.89 (ddd, J = 2.9, 6.0, 12.7, 1H, CIo-Hb), 2.74-
2.66 (m, 1H, ClI-H), 1.92-1.58 (m, 2H, C6-H 2 ), 1.92-
1.58 (m, 2H, C7-H2), 1.92-1.58 (m, 2H, C20 -H 2 ), 0.94 (t,
J = 7.5, 3H, C21-H3).
5 176.1 (C19), 149.2 (C4), 138.4 (C18), 135.1 (C2), 129.1
(CI), 122.7 (C16), 121.2 (C3), 120.0 (C,5), 119.2 (C14 ),
112.0 (C12), 110.3 (C, 7 ), 52.3 (CIO), 49.8 (C5), 48.3 (C),
32.5 (C6 ), 32.0 (C20), 31.0 (C2 2), 23.4 (C11), 21.6 (C),
9.5 (C 2 1).
2926 (m), 1638 (s), 1469 (m), 1321 (m), 1245 (w), 742
(mn).
calc'd for C20H 25N 20 [M+H]*: 309.1961,
found: 309.1971.
TLC (50% EtOAc in hexanes), Rf:
-200 (c = 0.38, CHCl3).
0.45 (UV, CAM, KMnO4).
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6 1. H2 , Pt/C
2\ THF, 23 *C.
4 Me 21
2. LiAIH 4, THF
60 *C
82% (two steps)
21
16
(+)-N-Methylquebrachamine (2):
Platinum on charcoal (10% w/w, 10.0 mg, 5.13 jmol, 0.0806 equiv) was added as a solid to a
solution of tetracyclic lactam (-)-64 (19.6 mg, 63.6 pmol, 1 equiv) in tetrahydrofuran (2.0 mL) at 23
*C. The opened reaction vessel was placed in a Parr bomb and sealed under an atmosphere of
hydrogen gas (400 psi). After 48 h, the Parr Bomb was opened in air, and the suspension was filtered
over Celite. The solids were further extracted with ethyl acetate (30 mL), and the combined filtrates
were concentrated under reduced pressure. The residue was dissolved in tetrahydrofuran (1.5 mL) at
23 'C. Lithium aluminum hydride (2.0 M solution in tetrahydrofuran, 160 pL, 320 pmol, 5.0 equiv)
was added via syringe. After 5 min, the reaction mixture was warmed to 60 *C. After 12 h, the
reaction mixture was allowed to cool to 23 *C. Sodium sulfate decahydrate was added as a solid to
quench the aluminum hydride salts. The resulting suspension was filtered over Celite. The solids
were further extracted with ethyl acetate (30 mL), and the combined filtrates were concentrated under
reduced pressure. The residue was purified by flash column chromatography on alumina (0 -- 5%
ethyl acetate in hexanes) to afford (+)-N-methylquebrachamine (2, 15.3 mg, 81.7% over two steps) as
a white gum. Structural assignments were made with additional information from gCOSY, HSQC,
and gHMBC data.
'H NMR (500 MHz, CDC13, 20 *C): 8 7.51 (d, J = 7.8, 1H, C 4-H), 7.28 (d, J = 7.8, 1H, C 7 -
13 C NMR (125 MHz, CDCL3, 20 *C):
FTIR (neat) cm-1:
HRMS (DART):
laD 24 :
TLC (Al2O3, 5% EtOAc in hexanes), Rf:
H), 7.15 (app-t, J = 7.8, 1H, C,6-H), 7.07 (app-t, J = 7.8,
1H, C15-H), 3.70 (s, 3H, C22-H3), 3.36 (d, J = 11.9, 1H,
C19-Ha), 3.03-2.82 (m, 1H, CII-Ha), 3.03-2.82 (m, 1H,
Cl,-Hb), 2.79 (app-dd, J = 10.8, 15.3, 1H, C3-Ha), 2.65
(app-dd, J = 6.8, 15.6, 1H, C3-H), 2.51-2.40 (m, 1H,
Cio-Ha), 2.51-2.40 (m, 1H, C8-Ha), 2.34-2.21 (m, 1H,
CIo-Hb), 2.34-2.21 (m, 1H, C8-Hb), 1.81 (app-dd, J =
6.8, 13.7, 1H, C4-Ha), 1.64 (app-t, J = 12.1, 1H, C4 -Hb),
1.61-1.54 (m, 1H, C7-Ha), 1.5 1 (d, J = 11.9, 1 H, C I -Hb),
1.35-1.24 (m, 1H, C7-Hb), 1.35-1.24 (m, 1H, C6 -Ha),
1.35-1.24 (m, 1H, C20-Ha), 1.24-1.10 (m, 1H, C2 0 -Hb),
1.24-1.10 (m, 1H, C6-Hb), 0.90 (t, J= 7.5, 3H, C21-H3)-
5 142.2 (C2), 136.4 (C18), 127.9 (C13), 119-9 (C16), 118.4
(C15 ), 117.5 (C,4), 108.7 (C,), 108.4 (C12), 56.8 (C,9),
55.4 (C8 ), 53.7 (CIO), 37.8 (C), 35.0 (C6 ), 32.5 (C4),
32.2 (C20), 29.7 (C 2 2), 22.8 (C7), 22.7 (C,), 19.2 (C3),
8.1 (C21).
3051 (w), 2928 (s), 2782 (m), 1472 (s), 1371 (s), 1299
(n), 1191 (m), 1140 (m), 1012 (w), 736 (s).
calc'd for C20H29N2 [M+H]*: 297.2325,
found: 297.2329
+102 (c = 0.22, CHC 3)-13
0.59 (UV, CAM, KMnO4).
" Literature value: [C]D2 4 = +110 (CHCI3), Mokry, J.; Kompis, I.; Dubravkova, L.; Sefcovic, P. Tetrahedron Lett. 1962,25, 1185.
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Table S3. Comparison of our 'H NMR data for (+)-N-methylquebrachamine (2) with literature
data for (-)-kopsiyunnanine D (S4) and (+)-quebrachamine (2a):
Though early reports concerning (+)-N-methylquebrachamine (2) have not reported 'H or "C
NMR spectra, later reports14 have included 'H and "C NMR data for the structural analog (-)-
kopsiyunnanine D (S4) and have made assignments based on gCOSY, HSQC and gHMBC data.
Furthermore, 'H and "C NMR spectra have been reported for (+)-quebrachamine (2a), though
assignments based upon 2D NMR data were not reported. A comparison of the 'H data for the three
compounds is presented below; a comparison of the "C NMR data is presented on page 137.
N .. 6
14 19 4 Me 21
16 1 N Me
22 0 24
(-)-kopsiyunnanine D (S4)
8
N 6
14 19 4 Me 21
16 N
H
(+)-quebrachamine (S5)
8
6
4 Me 2j
16
(+)-N-methylquebrachamine (2)
Assignment Takayama's Report" Schrock's Report" This Work
(-)-Kopsiyunnanine D (S4) (+)-Quebrachamine (2a) (+)-N-Methylquebrachamine (2)
'H NMR, 500 MHz, 'H NMR, 400 MHz, 'H NMR, 500 MHz,
CDC13  CDC13  CDC13, 20 *C
NI 7.70 (br-s, IH)
C2
C3 2.79 (m, 1H) 2.74 (ddd, J= 2.0, 10.4, 15.6, 1H) 2.79 (app-dd, J= 10.8, 15.3, 1H)
2.55 (ddd, J= 1.5, 7.5, 7.5, 1H) 2.67 (ddd, J= 2.0, 7.2, 15.2, 1H) 2.65 (app-dd, J= 6.8, 15.6, 1H)
C4 1.74 (dd, J= 6.0, 13.0, 1H) 1.92 (ddd, J= 2.0, 6.8, 14.0, 1H) 1.81 (app-dd, J= 6.8, 13.7, 1H)
1.55 (m, IH) 1.65-1.53 (m, IH) 1.64 (app-t, J= 12.1, 1H)
C5
C6 1.18 (m, 1H) 1.33-1.08 (m, 2H) 1.35-1.24 (m, 1H)
1.09 (m, 1H) 1.24-1.10 (m, 1H)
C7 1.20 (m, 2H) 1.65-1.53 (m, 1H) 1.61-1.54 (m, 1H)
1.33-1.08 (m, 1H) 1.35-1.24 (m, 1H)
C8 2.32 (dd, J = 5.5, 13.0, 1H) 2.41 (dd, J= 2.8, 4.4, 1H) 2.51-2.40 (m, 1H)
2.18 (ddd, J = 3.5, 13.0, 13.0, 1H) 2.25 (dt, J= 2.8, 11.6, 1H) 2.34-2.21 (m, 1H)
CIO 2.40 (ddd, J = 1.5, 4.5, 13.0, 1H)) 2.48-2.43 (m, 1H)) 2.51-2.40 (m, 1H)
2.22 (ddd, J = 4.5, 13.0, 13.0, 1H) 2.33 (dt, J = 4.4, 11.6, 1H) 2.34-2.21 (m, 1H)
C11 2.87 (ddd, J= 4.5, 13.0, 15.0, 1H) 2.94 (ddd, J= 4.8, 11.6,14.8, 1H) 3.03-2.82 (m, 1H)
2.77 (m, 1H) 2.84 (ddd, J= 2.8, 4.4, 14.8, 1H) 3.03-2.82 (m, 1H)
C12 -_-_-
C13 - _-_-
C14 7.41 (d, J= 7.5, 1H) 7.49-7.47 (m, 1H) 7.51 (d, J= 7.8, 1H)
C15 7.03 (ddd, J= 1.5, 7.5, 7.5, 1H) 7.06 (dt, J= 1.6, 7.2, 1H) 7.07 (app-t, J= 7.8, 1H)
C16 7.08 (ddd, J= 1.5, 7.5, 7.5, 1H) 7.09 (dt, J= 1.6, 7.2, 1H) 7.15 (app-t, J= 7.8, 1H)
C17 7.33 (d, J= 7.5, 1H) 7.29-7.26 (m, 1H) 7.28 (d, J= 7.8, 1H)
C18 -_-_-
C19 3.28 (br-d, J= 12.0, 1H) 3.25 (br-d, J= 11.6, 1H) 3.36 (d, J= 11.9, 1H)
1.41 (m, 1H) 1.50 (d, J= 11.6, 1H) 1.51 (d, J= 11.9, 1H)
C20 1.21 (m, 1H) 1.33-1.08 (m, 2H) 1.35-1.24 (m, 1H)
1.05 (m, 1H) 1.24-1.10 (m, 1H)
C21 0.80 (t, J= 7.5, 3H) 0.85 (t, J= 7.2, 3H) 0.90 (t, J = 7.5, 3H)
C22 5.39 (d, J= 11.5, 1H) 3.70 (s, 3H)
5.35 (d, J= 11.5, 1H)
C24 3.19(s,3H)
'" Wu, Y.; Suehiro, M.; Kitajima, M.; Matsuzaki, T.; Hashimoto, S.; Nagaoka, M.; Zhang, R.; Takay ama, H. J. Nat. Prod. 2009, 72,
204.
" Sattely, E. S.; Meek, S. J.; Malcolson, S. J.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 943.
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Table S4. Comparison of our 13C NMR data for (+)-N-methylquebrachamine (2) with literature
data for (-)-kopsiyunnanine D (S4) and (+)-quebrachamine (2a):
r\6N
14 19 4 Me 21
16 1 N Me
22O 24
8
N 6
9 Me 21
16 1 N
H
N 6
9 Me 21
16 1 N
Me
(-)-kopsiyunnanine D (S4) (+)-quebrachamine (S5) (+)-N-methylquebrachamine (2)
Assignment Takayama's Report" Schrock's Report" This Work Chemical Chemical
(-)-Kopsiyunnanine D (+)-Quebrachamine (2a) (+)-N-Methyl Shift Shift
(S4) "C NMR, 100 MHz, quebrachamine (2) Difference Difference
"C NMR, 125 MHz, CDC13  "C NMR, 125 MHz, Ab = Ab =
CDC13  CDC13, 20 *C 6 (this work) 6 (this work)
- 8 (Ref. 14) - 6 (Ref. 15)
C2 141.8 140.0 142.2 0.4 2.2
C3 18.5 22.1 19.2 0.7 -2.9
C4 32.4 33.6 32.5 0.1 -1.1
C5 37.5 37.3 37.8 0.3 0.5
C6 34.7 34.9 35.0 0.3 0.1
C7 22.6 22.8 22.8 0.2 0.0
C8 55.2 55.2 55.4 0.2 0.2
C1O 53.0 53.4 53.7 0.7 0.3
Cli 22.3 22.6 22.7 0.4 0.1
C12 110.2 108.9 108.4 -1.8 -0.5
C13 128.3 129.1 127.9 -0.4 -1.2
C14 117.4 117.5 117.5 0.1 0.0
C15 119.2 118.8 118.4 -0.8 -0.4
C16 120.5 120.3 119.9 -0.6 -0.4
C17 108.8 110.1 108.7 -0.1 1.4
C18 136.7 135.0 136.4 -0.3 1.4
C19 56.5 56.9 56.8 0.3 -0.1
C20 31.8 32.2 32.2 0.4 0.0
C21 7.9 7.9 8.1 0.2 0.2
C22 73.8 - 29.7 -44.1l6 17
C24 55.6 -18 19
16 Significant difference in chemical shift is due to oxygenation of C22 in (-)-kopsiyunnanine D (S4).
"7 No difference in chemical shift is reported due to absence of C22 in (+)-quebrachamine (2a).
18 No difference in chemical shift is reported due to absence of C24 in (-)-N-methylquebrachamine (2).
'9 No difference in chemical shift is reported due to absence of C24 in (+)-N-methylquebrachamine (2) and (+)-quebrachamine (2a).
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21
10 O Me
14 N 1
ci 6
16 eN 2
Me (-)-53
Tf20, 3-CNPyr
MeCN, 85 *C;
(4-(dimethylamino)phenyl)-
magnesium bromide
-40 *C;
Na(MeO(CH 2)20)2AIH 2
40%
Hexacyclic aniline adduct (-)-63:
Trifluoromethanesulfonic anhydride (4.8 pL, 29 pmol, 1.1 equiv) was added via syringe to a
solution of lactam (-)-53 (9.0 mg, 26 gmol, 1 equiv) and 3-cyanopyridine (3.3 mg, 32 pmol, 1.2
equiv) in acetonitrile (1.0 mL) at 23 *C. After 5 min, the solution was warmed to 85 *C. After 3 h,
the solution was cooled to -40 *C, and (4-(dimethylamino)phenyl)magnesium bromide (0.50 M
solution in tetrahydrofuran, 130 pL, 65 pimol, 2.5 equiv) was added via syringe. After 30 sec, sodium
bis(2-methoxyethoxy)aluminum hydride (65% w/v solution in toluene, 80 PL, 260 gmol, 10 equiv)
was added via syringe. After 2 min, acetic acid (50 pL) was added via syringe to quench the
aluminum hydride salts, and the solution was allowed warmed to 23 *C. Saturated aqueous
potassium carbonate solution (15 mL) and ethyl acetate (15 mL) were added, and the layers were
separated. The aqueous layer was further extracted with ethyl acetate (2 x 15 mL). The combined
organic layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under
reduced pressure. The residue was purified by flash column chromatography on alumina (0 -> 1.5%
ethyl acetate in hexanes) to afford hexacyclic aniline adduct (-)-63 (4.3 mg, 40%) as a white powder.
Structural assignments were made with additional information from gCOSY, HSQC, gHMBC, and
ROESY data. The connectivity and relative stereochemistry of hexacyclic aniline adduct (-)-63 were
secured by X-Ray diffraction of a single crystal of its bis-(hydrogen chloride) salt (-'-)-63*2HC 20
(page 164, vide infra).
'H NMR (500 MHz, CDC13, 20 *C): 6 7.44 (dd, J = 2.2, 8.7, 1H, C28-H), 7.27 (dd, J = 2.2,
8.6, 1H, C24-H), 7.06 (app-t, J = 7.7, 1H, C16-H), 6.97
(d, J = 7.7, 1H, C14-H), 6.69 (dd, J = 2.7, 8.7, 1H, C27 -
H), 6.64 (dd, J = 2.7, 8.6, 1H, C25-H), 6.56 (app-t, J =
7.7, 1H, C15-H), 6.30 (d, J= 7.7, 1H, C17-H), 5.77 (d, J =
10.4, 1H, C3-H), 5.70 (dd, J = 1.4, 10.4, 1H, C4-H), 2.94
(s, 6H, C3 0-(H3)2), 2.88-2.82 (m, lH, CO-Ha), 2.66 (s,
3H, C22-H3), 2.46 (s, lH, C19-H), 2.19-2.11 (m, lH, C10-
Ha), 2.07-2.00 (m, 1H, ClO-Hb), 2.00-1.91 (m, 1H, C8-
Hb), 1.81-1.72 (m, lH, Cii-Ha), 1.70-1.64 (m, 1H, C6 -
Ha), 1.64-1.56 (m, 1H, C7-Ha), 1.56-1.41 (m, 1H, C7-
H), 1.56-1.41 (m, lH, CIl-Hb), 1.20 (app-dt, J = 4.2,
12.9, 1H, C6 -Hb), 1.02-0.83 (m, 2H, C20-H2), 0.65 (t, J=
7.5, 3H, C21-H3)-
20 A sample of the corresponding bis-(hydrogen chloride) salt (+)-63e2HCl was prepared from hexacyclic aniline adduct (t)-63 as
follows: Hydrogen chloride (2.0 M in diethyl ether, 9.6 pL, 19 gmol, 2.0 equiv) was added via syringe to a solution of hexacyclic
aniline adduct (±)-63 (4.0 mg, 9.7 pmol, 1 equiv) in diethyl ether-chloroform (3:1, 500 pL) at 23 *C. A white solid precipitated
immediately. The resulting slurry was concentrated under reduced pressure, and the residue was dissolved in chloroform (200 pL).
Vapor diffusion of diethyl ether into this solution provided crystals of hexacyclic aniline adduct bis-(hydrogen chloride) salt (±)-
63e2HCl suitable for X-Ray diffraction. For a thermal ellipsoid representation of (±)-63-2HCl, see page 164.
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"C NMR (125 MHz, CDCl3, 20 'C):
FTIR (neat) cm-1:
HRMS (DART):
8 150.7 (C18), 149.2 (C26), 136.1 (C4), 134.2 (C13), 132.1
(C 28 ), 131.6 (C 23), 128.9 (C 24), 128.6 (C 3), 127.8 (C 16),
123.5 (CI), 116.0 (C15), 112.3 (C 27), 111.1 (C25), 104.3
(C17), 73.8 (C2), 72.3 (C19), 57.4 (C12), 52.4 (C), 51.5(CIO), 40.9 (C30), 38.6 (C1,), 38.3 (C), 35.6 (C20), 34.4
(C6), 29.8 (C22), 23.6 (C7), 7.8 (C21).
2929 (s), 2791 (m), 1603 (s), 1517 (s), 1497 (s), 1315
(m), 1186 (m), 1121 (m), 734 (s).
calc'd for C28H36N 3 [M+H]*: 414.2904,
found: 414.2912.
TLC (Al20 3, 5% EtOAc in hexanes), Rf:
8
16
Tf2O, 2-CIPyr
MeCN, 23 *C;
21 (4-(dimethylamino)pheny)-
magnesium bromide
-40 *C;
Na(MeOEtO) 2AIH2
76%
Synthesis of hexacyclic aniline adduct (-)-63 from tetracyclic lactam (-)-64 and (4-
(dimethylamino)phenyl)magnesium bromide:
Trifluoromethanesulfonic anhydride (19.7 pL, 117 pmol, 1.10 equiv) was added via syringe
to a solution of tetracyclic lactam (-)-64 (32.7 mg, 106 jmol, 1 equiv) and 2-chloropyridine (11.9
pL, 127 [mol, 1.20 equiv) in acetonitrile (4 mL) at 23 *C. After 10 min, the reaction mixture was
cooled to -40 *C, and (4-(dimethylamino)phenyl)magnesium bromide (0.50 M solution in
tetrahydrofuran, 320 pL, 160 gmol, 1.5 equiv) was added via syringe. After 30 sec, sodium bis(2-
methoxyethoxy)aluminum hydride (65% w/v solution in toluene, 323 PL, 1.06 mmol, 10.0 equiv)
was added via syringe. After 2 min, acetic acid (500 [LL) was added via syringe to quench the
aluminum hydride salts, and the solution was allowed warmed to 23 *C. Saturated aqueous
potassium carbonate solution (15 mL) and ethyl acetate (15 mL) were added, and the layers were
separated. The aqueous layer was further extracted with ethyl acetate (2 x 15 mL). The combined
organic layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under
reduced pressure. The residue was purified by flash column chromatography on alumina (0 -+ 1.5%
ethyl acetate in hexanes) to afford hexacyclic aniline adduct (-)-63 (33.1 mg, 75.5%) as a white
powder. See page 138 for characterization data for hexacyclic aniline adduct (-)-63.
139
-186 (c = 0.16, CH 2 Cl2 )-
0.65 (UV, CAM, KMnO 4).
16
88 6
8 N 6
N O 6 Tf20, 2-CIPyr 14 1 \MeCN, 23 C; /
14 19 4 Me 21 |
9 4 Me / N,N-dimethylaniline; 16 1 Ne /23\ 27
16 1 ~ N Na(OMe)3BH, THF (-)-63
(-)-64 Me 74% 25 NMe 2
Synthesis of hexacyclic aniline adduct (-)-63 from tetracyclic lactam (-)-64 and N-
dimethylaniline:
Trifluoromethanesulfonic anhydride (5.6 pL, 34 pmol, 1.1 equiv) was added via syringe to a
solution of tetracyclic lactam (-)-64 (9.4 mg, 31 gmol, 1 equiv) and 2-chloropyridine (3.4 pL, 37
gmol, 1.2 equiv) in acetonitrile (0.7 mL) at 23 *C. After 10 min, N,N-dimethylaniline (4.6 pL, 37
gmol, 1.2 equiv) was added via syringe. After 90 min, a solution of sodium trimethoxyborohydride
(39.0 mg, 305 pmol, 10.0 equiv) in tetrahydrofuran (1.0 mL) was added via cannula. After 2 h,
saturated aqueous sodium bicarbonate solution (15 mL) was added to quench the
trifluoromethanesulfonate salts. Dichloromethane (15 mL) was added, and the layers were separated.
The aqueous layer was further extracted with dichloromethane (2 x 15 mL). The combined organic
layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The residue was purified by flash column chromatography on alumina (0 -> 1.5% ethyl
acetate in hexanes) to afford hexacyclic aniline adduct (-)-63 (9.3 mg, 74%) as a white powder. See
page 138 for characterization data for hexacyclic aniline adduct (-)-63.
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14
16
(-)-63 Me '/232 30
25 NMe 2
Activation energy calculation for hexacyclic aniline adduct (-)-63 C2-C23 bond rotation:
The rate constant for rotation about the C2-C23 bond of hexacyclic aniline adduct (-)-63 in
dimethyl sulfoxide-d6 was approximated from changes in the 'H NMR peak separation of the
resonances corresponding to the C24 and C28 protons. Data were collected at temperatures
sufficiently below the coalescence point of the two resonances. In this regime, defined by k : Av
where k is the exchange rate constant and Av = 102.03 Hz is the peak separation of the resonances of
the C24 and C28 protons at a temperature where negligible exchange is occurring, the rate constant
for rotation can be approximated by k = (Av2 - Ai), where Ave is the separation of the
resonances of the C24 and C28 protons at the experimental temperature, T.
Ea
The activation energy Ea was calculated from the Arrhenius equation k = Ae r, where R is
the Boltzmann constant (1.98 cal/mol) and A is a constant factor. This can be written in form
suitable for application of linear least squares regression: In k = - + C, where C is a constant.RT
T (*C) Ave (Hz) T' (mK') In(k)
52.0 100.98 3.08 3.48
56.0 100.52 3.04 3.66
60.0 97.46 3.00 4.21
64.0 93.27 2.97 4.52
68.0 80.93 2.93 4.93
ln(k)
R0 09811
3.05 3.12.9 2.95
T' (mK-')
Linear least squares gives Ea = 20.1 - 0.1 kcal/mol.
(a) Gasparro, F. P.; Kolodny, N. H. J. Chem. Ed. 1977,54, 258. (b) Johnson, E. S. In Advances in Magnetic Resonance, Waugh, J.S.,
Ed.; Academic Press: New York, 1956, Vol. 1, Chapter 2, pp. 64-68. (c) Gutowsky, H. S.; Holm, C. H. J. Chem. Phys. 1956,25, 1228.
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8 Tf2O, 2-CIPyr F3CSO 3 + 6
N O 6 MeCN, 23 *C; 14
14 1914* 19 4 Me 21 (4-(dimethylamino)pheny)- /
magnesium bromide 16 Ne 23 27
16 1 N -40 *C; AcOH (-)-66 30
(-)-64 Me 76% 25 NMe 2
Hexacyclic iminium trifluoromethanesulfonate (-)-66:
Trifluoromethanesulfonic anhydride (6.0 pL, 36 pmol, 1.1 equiv) was added via syringe to a
solution of tetracyclic lactam (-)-64 (10.0 mg, 32.4 pmol, 1 equiv) and 2-chloropyridine (3.7 pL, 39
pmol, 1.2 equiv) in acetonitrile (1.5 mL) at 23 *C. After 10 min, the reaction mixture was cooled to
-40 *C, and (4-(dimethylamino)phenyl)magnesium bromide (0.50 M solution in tetrahydrofuran, 97
pL, 49 pmol, 1.5 equiv) was added via syringe. After 30 sec, acetic acid (20 pL) was added via
syringe to quench the arylmagnesium bromide salts, and the solution was allowed warmed to 23 *C.
Saturated aqueous sodium bicarbonate solution (15 mL) and dichloromethane (15 mL) were added,
and the layers were separated. The aqueous layer was further extracted with dichloromethane (2 x 15
mL). The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and
were concentrated under reduced pressure. The residue was purified by flash column
chromatography on alumina (20 -+ 80% acetone in hexanes) to afford hexacyclic iminium
trifluoromethanesulfonate (-)-66 (13.9 mg, 76.3%) as a yellow oil. Structural assignments were
made with additional information from gCOSY, HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, C6D6 , 72 *C): 6 7.76 (d, J = 7.5, 1H, C14-H), 7.06 (d, J = 7.5, 1H, C16 -
H), 7.01 (br-d, J = 8.3, 2H, C24-H, C28-H), 6.80 (app-t, J
=7.5, 1H, Ci5-H), 6.74 (d, J = 8.3, 2H, C2 5-H, C27-H),
6.29 (d, J =7.5, 1H, C17-H), 5.53 (d, 1H, J = 9.9, C4-H),
5.43 (d, J = 9.9, 1H, C3-H), 4.25 (app-dd, 1H, J = 5.6,
16.6, Cio-Ha), 4.17-4.07 (m, 1H, C8-Ha), 3.57-3.44 (m,
2H, CIO-Hb), 2.68 (s, 6H, C30 -(H3)2), 2.68-2.55 (m, 1H,
C8-Hb), 2.44 (s, 3H, C22-H3), 2.20-2.10 (m, 1H, C7-Ha),
2.10-2.02 (m, 1H, Ci-Ha), 2.10-2.02 (m, 1H, C20-Ha),
2.02-1.93 (m, 1H, Cl,-Hb), 1.86-1.73 (m, 1H, C7-Hb),
1.86-1.73 (m, 1H, C6-Ha), 1.67-1.55 (m, 1H, C20-Hb),
1.33-1.21 (m, 1H, C6-Hb), 0.52 (t, J = 7.5, 3H, C2 1-H 3)-
13C NMR (125 MHz, C6D6, 72 *C): 8 192.0 (C19), 151.8 (C26), 150.6 (C18), 132.7 (C4), 130.9
(C13), 130.5 (C16), 129.2 (C24 , C28), 127.5 (C14), 125.9
(C3), 123.2 (C23), 122.9 (q, J = 322.4, F3CS0 3-), 120.1
(C 15), 113.5 (C25, C27), 108.1 (C, 7), 82.8 (C 2), 69.4 (C12),
59.3 (C), 50.7 (CIO), 43.5 (C), 40.4 (C30), 32.8 (C 1),
31.8 (C 20), 30.2 (C 22), 27.8 (C 6), 17.7 (C 7), 7.8 (C 2 1)-
'
9F NMR (300 MHz, C6D6 , 20 *C): 6-78.6
FTIR (neat) cm-': 2925 (m), 1670 (m), 1609 (s), 1521 (m), 1489 (m), 1262
(s), 1157 (s), 1031 (s), 638 (s).
HRMS (DART): calc'd for C28H34N3 [M-CF 30 3S-]*: 412.2747,
found: 412.2745.
[a] 24: -85 (c = 0.25, CH2Cl2).
TLC (A120 3, 75% acetone in hexanes), Rf: 0.26 (UV, CAM, KMnO4).
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14 19 4 Me 21 N,N-dimethylaniline I
74% 16 1 N /23N 27
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(-)-64 Me (-)-66 25 NMe 2
Synthesis of hexacyclic iminium trifluoromethanesulfonate (-)-66 from tetracyclic lactam (-)-
64 and NN-dimethylaniline:
Trifluoromethanesulfonic anhydride (17.2 pL, 102 gmol, 1.10 equiv) was added via syringe
to a solution of tetracyclic lactam (-)-64 (28.7 mg, 93.1 pmol, 1 equiv) and 2-chloropyridine (10.5
pL, 112 pmol, 1.20 equiv) in acetonitrile (3.5 mL) at 23 *C. After 10 min, NN-dimethylaniline (14.2
VL, 112 pmol, 1.20 equiv) was added via syringe. After 90 min, a solution of sodium bicarbonate
(150 mg) in water (15 mL) was added to quench the trifluoromethanesulfonic acid salts.
Dichloromethane (15 mL) was added, and the layers were separated. The aqueous layer was further
extracted with dichloromethane (2 x 15 mL). The combined organic layers were dried over
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure. The residue
was purified by flash column chromatography on alumina (20 -- 80% acetone in hexanes) to afford
hexacyclic iminium trifluoromethanesulfonate (-)-66 (37.9 mg, 72.5%) as a yellow oil. See page 142
for characterization data for hexacyclic iminium trifluoromethanesulfonate (-)-66.
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Activation energy calculation for hexacyclic iminium trifluoromethanesulfonate (-)-66 C2-C23
bond rotation:
The rate constant for rotation about the C2-C23 bond of hexacyclic iminium
trifluoromethanesulfonate (-)-66 in acetonitrile-d3 was approximated from changes in the 'H NMR
peak separation of the resonances corresponding to the C24 and C28 protons. Data were collected at
temperatures sufficiently below the coalescence point of the two resonances. In this regime, defined
by k * Av where k is the exchange rate constant and Av = 327.89 Hz is the peak separation of the
resonances of the C24 and C28 protons at a temperature where negligible exchange is occurring, the
rate constant for rotation can be approximated by k = T(v2 - Av where Ave is the separation
of the resonances of the C24 and C28 protons at the experimental temperature, T.
The activation energy Ea was calculated from the Arrhenius equation k = Ae~i, where R is
the Boltzmann constant (1.98 cal/mol) and A is a constant factor. This can be written in form
suitable for application of linear least squares regression: In k = - + C, where C is a constant.
RT
V T 3.72
T ('C) Ave (Hz) T-1 (mK~1) In(k)
-2.0 318.41 3.69 5.16
1.0 311.86 3.65 5.42
4.0 300.67 3.61 5.67
7.0 287.73 3.57 5.86
10.0 256.17 3.53 6.12
3.7
3.68
36
3.64RI097
In(k) 3.62 R 97
3.6
3.S8
3.56
3.54
3.52
5 5.2 5.4 5-6 58S 6 6.2
T-'(inK')
Linear least squares gives Ea = 11.7 ± 0.2 kcal/mol.
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Reduction of hexacyclic iminium trifluoromethanesulfonate (-)-66:
Sodium cyanoborohydride (10.1 mg, 161 jmol, 7.89 equiv) was added as a solid under an
argon atmosphere to a solution of hexacyclic iminium trifluoromethanesulfonate (-)-66 (11.5 mg,
20.4 [tmol, 1 equiv) and acetic acid (42.9 gL, 533 Rmol, 26.1 equiv) in methanol (2.0 mL) at 23 *C.
After 2 h, saturated aqueous sodium bicarbonate solution (15 mL) was added via syringe to quench
the trifluoromethanesulfonate salts. Dichloromethane (15 mL) was added, and the layers were
separated. The aqueous layer was further extracted with dichloromethane (2 x 15 mL). The
combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
alumina (0 - 1.5% ethyl acetate in hexanes) to afford hexacyclic aniline adduct (-)-63 (8.2 mg,
97%) as a white powder. See page 138 for characterization data for hexacyclic aniline adduct (-)-63.
If the reaction is run in the absence of acetic acid, hexacyclic aniline adduct (-)-63 is afforded in 92%
yield.
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Hexacyclic xylene adduct (-)-67:
Trifluoromethanesulfonic anhydride (10.5 pL, 62.4 pmol, 1.10 equiv) was added via syringe
to a solution of tetracyclic lactam (-)-64 (17.5 mg, 56.7 pimol, 1 equiv) and 2-chloropyridine (6.4 pL,
68 pmol, 1.2 equiv) in acetonitrile (1.5 mL) at 23 *C. After 10 min, the reaction mixture was cooled
to -40 *C, and (2,6-dimethylphenyl)magnesium bromide (1.0 M solution in tetrahydrofuran, 85.1 pL,
85 pmol, 1.5 equiv) was added via syringe. After 10 min, sodium bis(2-methoxyethoxy)aluminum
hydride (65% w/v solution in toluene, 104 pL, 340 pmol, 6.00 equiv) was added via syringe. After 2
min, acetic acid (100 VL) was added via syringe to quench the aluminum hydride salts, and the
solution was allowed warmed to 23 *C. Saturated aqueous potassium carbonate solution (15 mL) and
ethyl acetate (15 mL) were added, and the layers were separated. The aqueous layer was further
extracted with ethyl acetate (2 x 15 mL). The combined organic layers were dried over anhydrous
sodium sulfate, were filtered, and were concentrated under reduced pressure. The residue was
purified by flash column chromatography on silica gel (0 -> 2% ethyl acetate in hexanes) to afford
hexacyclic xylene adduct (-)-67 (13.4 mg, 59.2%) as a white powder. Structural assignments were
made with additional information from gCOSY, HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3 , 20 *C):
3C NMR (125 MHz, CDCl3, 20 *C):
FTIR (neat) cm-':
HRMS (DART):
[a] 4 E
TLC (2% EtOAc in hexanes), Rf:
8 7.03 (t, J = 7.8, 1H, C16-H), 7.01-6.95 (m, 1H, C25-H),
7.01-6.95 (m, 1H, C26-H), 7.01-6.95 (m, 1H, C14-H),
6.91 (m, 1H, C27-H), 6.50 (app-t, J = 7.8, 1H, C,5-H),
6.06 (d, J = 10.5, 1H, C3-H), 6.03 (d, J = 7.8, 1H, C17 -
H), 5.44 (dd, J = 1.5, 10.5, 1H, C4-H), 2.89-2.83 (m,
1H, C8-Ha), 2.72 (s, 3H, C29-H3), 2.56-2.50 (m, 1H, CO-
Ha), 2.49 (s, 3H, C22-H3), 2.27 (s, 1H, C1,9-H), 2.17 (ddd,
J = 5.7, 8.6, 10.5, 1H, CIO-Hb), 2.02-1.95 (m, 1H, C8-
Hb), 1.95-1.88 (m, 1H, CI-Ha), 1.92 (s, 3H, C30-H3 ),
1.82 (ddd, J = 4.4, 10.5, 14.0, 1H, CI,-Hb), 1.65-1.59
(m, 1H, C6-Ha), 1.57-1.42 (m, 2H, C7-H2), 1.29-1.13
(m, IH, C6 -Hb), 0.81-0.66 (m, 2H, C20-H2 ), 0.55 (t, J =
7.5, 3H, C21-H3)-
8 149.9 (C18 ), 142.0 (C 23), 140.1 (C24), 139.7 (C 28),
134.2 (C13), 132.5 (C3), 131.6 (C4), 131.5 (C25), 130.6
(C27), 128.5 (C16), 126.3 (C26), 123.0 (C14), 115.1 (Ci1),
103.0 (C17), 74.5 (C2), 74.0 (C1,9), 57.8 (C,2), 52.3 (C8),
51.8 (CIO), 38.4 (C5), 36.9 (C,1 ), 34.9 (C6 ), 34.4 (C20),
28.7 (C22), 25.5 (C30), 23.6 (C29), 23.2 (C 7), 7.9 (C 21).
2929 (s), 1603 (s), 1503 (s), 1457 (m), 1382 (m), 1188
(m), 666 (s).
calc'd for C28H35N2 [M+H]*: 399.2795,
found: 399.2790.
-145 (c = 0.14, CH2Cl2)-
0.26 (UV, CAM, KMnO 4).
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Pentacyclic methallyl adduct (-)-68:
Trifluoromethanesulfonic anhydride (6.0 VL, 36 gmol, 1.1 equiv) was added via syringe to a
solution of tetracyclic lactam (-)-64 (10.0 mg, 32.4 pmol, 1 equiv) and 2-chloropyridine (3.7 pL, 39
gmol, 1.2 equiv) in acetonitrile (1.3 mL) at 23 *C. After 10 min, trimethyl(2-methallyl)silane (8.5 pL,
49 pmol, 1.5 equiv) was added via syringe. After 90 min, a solution of sodium
trimethoxyborohydride (24.9 mg, 195 gmol, 6.00 equiv) in tetrahydrofuran (1.0 mL) was added via
cannula. After 2 h, saturated aqueous sodium bicarbonate solution (15 mL) was added to quench the
trifluoromethanesulfonate salts. Dichloromethane (15 mL) was added, and the layers were separated.
The aqueous layer was further extracted with dichloromethane (2 x 15 mL). The combined organic
layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The residue was purified by flash column chromatography on silica gel (10 --> 20% ethyl
acetate in hexanes) to afford pentacyclic methallyl adduct (-)-68 (10.4 mg, 92.0%) as a viscous
yellow oil. Structural assignments were made with additional information from gCOSY, HSQC,
gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 20 *C):
3C NMR (125 MHz, CDCl3, 20 *C):
FTIR (neat) cm-1:
HRMS (DART):
8 7.03-6.93 (m, 1H, C16-H), 7.03-6.93 (m, 1H, C,4-H),
6.51 (app-t, J = 7.8, 1H, C15-H), 6.10 (d, J = 7.8, 1H,
C17-H), 5.80 (d, J = 10.3, 1H, C3-H), 5.64 (d, J = 10.3,
1H, C4-H), 4.87-4.76 (m, 2H, C25 -H2 ), 3.03-2.94 (m,
1H, CiO-Ha), 3.03-2.94 (m, 1H, C8-Ha), 2.69 (s, 3H, C2 2-
H3 ), 2.65-2.55 (m, 1H, Ci-Ha), 2.47 (s, 2H, C2 3-H 2),
2.28 (app-q, J = 8.5, 1H, CIo-Hb), 2.06 (s, 1H, CI9-H),
1.96-1.86 (m, lH, C8-Hb), 1.86-1.76 (m, 1H, CI,-Hb),
1.72 (s, 3H, C26-H3), 1.70-1.61 (m, 1H, C6 -Ha), 1.54-
1.43 (m, 2H, C7-H 2), 1.16-1.06 (m, 1H, C6-Hb), 1.06-
0.96 (m, 1H, C2 0 -Ha), 0.84-0.74 (m, 1H, C20-Hb), 0.53 (t,
J = 7.5, 3H, C21-H3)-
8 150.3 (C,8), 143.2 (C24), 137.2 (C4 ), 136.3 (C,3), 129.5
(C3), 128.0 (C16), 123.2 (C,4), 115.8 (C,5), 114.4 (C25),
104.1 (C17), 77.4 (C, 9), 68.4 (C2), 57.4 (C, 2), 53.9 (CO),
53.0 (C8), 45.6 (C23), 39.0 (C), 36.3 (C,), 34.7 (C6),
33.7 (C20), 30.0 (C22), 25.4 (C26), 23.2 (C7), 7.7 (C21)-
2927 (s), 1604 (s), 1501 (s), 1462 (s), 1376 (m), 736 (s).
calc'd for C2 4 H 33 N 2 [M+H]*: 349.2638,
found: 349.2645.
TLC (A12 0 3, 5% EtOAc in hexanes), Rf:
-130 (c = 0.15, CH 2Cl2)-
0.63 (UV, CAM, KMnO 4).
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Pentacyclic methyl acetate adduct (-)-69:
Trifluoromethanesulfonic anhydride (12.0 pL, 71.3 jmol, 1.10 equiv) was added via syringe
to a solution of tetracyclic lactam (-)-64 (20.0 mg, 64.8 pmol, 1 equiv) and 2-chloropyridine (7.3 pL,
78 pmol, 1.2 equiv) in acetonitrile (2.5 mL) at 23 *C. After 10 min, tert-butyl((1-
methoxyvinyl)oxy)dimethylsilane (21.2 pL, 97.3 pmol, 1.50 equiv) was added via syringe. After 90
min, the reaction mixture was cooled to -30 *C, and a solution of sodium trimethoxyborohydride
(49.8 mg, 389 gmol, 6.00 equiv) in tetrahydrofuran (1.0 mL) was added via cannula. After 30 min,
the reaction mixture was allowed to warm slowly to 0 *C. After 30 min, saturated aqueous sodium
bicarbonate solution (15 mL) was added to quench the trifluoromethanesulfonate salts, and the
resulting biphasic mixture was allowed to warm to 23 *C. Dichloromethane (15 mL) was added, and
the layers were separated. The aqueous layer was further extracted with dichloromethane (2 x 15
mL). The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and
were concentrated under reduced pressure. The residue was purified by flash column
chromatography on alumina (5 -> 10% ethyl acetate in hexanes) to afford pentacyclic methyl acetate
adduct (-)-69 (18.8 mg, 79.1%) as a yellow oil. Structural assignments were made with additional
information from gCOSY, HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl 3, 20 *C):
"C NMR (125 MHz, CDCl3, 20 *C):
FTIR (neat) cm-:
HRMS (DART):
TLC (A120 3, 10% EtOAc in hexanes), Rf:
8 7.04-6.93 (m, 1H, C14-H), 7.04-6.93 (m, 1H, C16-H),
6.54 (app-t, J = 7.8, 1H, C15-H), 6.16 (d, J = 7.8, 1H,
C17-H), 5.84 (d, J = 10.3, 1H, C3-H), 5.70 (d, J = 10.3,
1H, C4-H), 3.46 (s, 3H, C26-H3), 3.07-2.99 (m, 1H, CIO-
Ha), 2.99-2.90 (m, 1H, Cs-Ha), 2.80 (d, J = 14.1, 1H,
C2 3-Ha), 2.75 (d, J = 14.1, 1H, C23-Hb), 2.72 (s, 3H., C22-
H3), 2.55-2.45 (m, 1H, CII-Ha), 2.30 (app-q, J = 8.4, 1H,
Clo-Hb), 2.12 (s, 1H, C19-H), 1.98-1.81 (m, 1H, C8-Hb),
1.98-1.81 (m, 1H, CII-Hb), 1.73-1.64 (m, 1H, C6-Ha),
1.53-1.42 (m, 2H, C7-H2), 1.19-1.02 (m, 1H, C6 -Hb),
1.19-1.02 (m, lH, C2 0-Ha), 0.92-0.80 (m, lH, C20-Hb),
0.56 (t, J = 7.4, 3H, C2 1-H3).
8 171.7 (C24), 149.9 (C18), 138.3 (C4), 135.7 (C13), 127.9
(C14), 127.8 (C3 ), 123.0 (C6 ), 116.6 (C15), 104.8 (C27),
76.3 (C1,9), 68.9 (C2), 57.1 (C12), 53.4 (CIO), 52.7 (C),
51.5 (C2 6), 42.1 (C2 3), 39.0 (C5), 36.6 (C11), 34.8 (C6 ),
33.8 (C20), 29.6 (C22), 23.0 (C7), 7.8 (C2 1)-
2934 (s), 1733 (s), 1603 (s), 1494 (s), 1304 (m), 1189
(m), 1156 (m), 737 (m).
calc'd for C23H3IN20 2 [M+H]*: 367.2380,
found: 367.2377.
-95 (c = 0.17, CH 2Cl 2)-
0.26 (UV, CAM, KMnO 4).
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Decacyclic iminium trifluoromethanesulfonate (+)-70:
Trifluoromethanesulfonic anhydride (16.3 pL, 97.0 pmol, 1.10 equiv) was added via syringe
to a solution of tetracyclic lactam (-)-64 (27.2 mg, 88.2 Rmol, 1 equiv) and 2-chloropyridine (10.0
pL, 106 gmol, 1.20 equiv) in acetonitrile (2.0 mL) at 23 *C. After 10 min, a solution of (-)-N-
methyldehydroaspidospermidine (62, 26.0 mg, 88.2 gmol, 1.00 equiv) in acetonitrile (2.0 mL) was
added via cannula. After 5 min, the reaction mixture was warmed to 85 *C. After 90 min, the
reaction mixture was allowed to cool to 23 *C, and a solution of sodium bicarbonate (150 mg) in
water (15 mL) was added to quench the trifluoromethanesulfonic acid salts. Dichloromethane (15
mL) was added, and the layers were separated. The aqueous layer was further extracted with
dichloromethane (2 x 15 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The residue was purified by
flash column chromatography on alumina (10 --> 85% acetone in hexanes) to afford decacyclic
iminium trifluoromethanesulfonate (+)-70 (51.8 mg, 79.9%) as an amorphous orange solid.
Structural assignments were made with additional information from gCOSY, HSQC, gHMBC, and
NOESY data.
'H NMR (500 MHz, PhMe-ds, 80 *C): 8 7.86 (d, J = 7.5, 1H, C 4-H), 7.01 (app-t, J = 7.5, 1H,
C16-H), 7.01-6.96 (br-s, 1H, C4,-H), 6.78 (app-t, J = 7.5,
1H, C15-H), 6.77-6.66 (br-m, 1H, C,6-H), 6.30-6.21 (m,
1H, C17-H), 6.30-6.21 (m, 1H, C,7-H), 5.69 (dd, J = 3.8,
10.3, 1H, C3-H), 5.56 (d, J = 10.0, 1H, C4-H), 5.51 (d, J
= 10.3, 1H, C4-H), 5.46 (d, J = 10.0, 1H, C3-H), 4.38-
4.25 (m, 1H, C8-Ha), 4.38-4.25 (m, 1H, CiO-Ha), 3.68 (d,
J = 3.8, 1H, C2-H), 3.38-3.27 (m, 1H, C8-Hb), 3.07-2.98
(m, 1H, Ci0eHa), 2.86-2.79 (m, 1H, Cg-Ha), 2.72-2.64
(m, 1H, CIo-Hb), 2.64 (s, 3H, C22 -H3), 2.49 (s, 3H, C2 2 -
H3 ), 2.35-2.26 (m, 1H, CIo-Hb), 2.26-2.15 (m, 1H, C7-
Ha), 2.26-2.15 (m, 2H, C,-H 2), 2.15 (s, 1H, C,9-H),
2.14-2.04 (m, 1H, C20-Ha), 2.14-2.04 (m, 1H, Cti-Ha),
1.95-1.88 (m, 1H, C6 -Ha), 1.88-1.74 (m, 1H, C7-Hb),
1.88-1.74 (m, 1H, C8-Hb), 1.88-1.74 (m, 1H, CuI-Hb),
1.68 (dq, J = 6.3, 7.5, 1H, C20-Hb), 1.58-1.47 (m, 1H,
C7 Ha), 1.58-1.47 (m, 1H, C6-Ha), 1.39-1.31 (m, 1H,
C7 -Hb), 1.25-1.17 (m, 1H, C6-Hb), 1.13-1.04 (m, 1H,
C20-Ha), 1-01-0-91
C20 -Hb), 0.59 (t, J
3H, C21-H3).
"C NMR (125 MHz, PhMe-d8, 80 *C):
(m, 1H, C6'-Hb), 1.01-0.91 (m, 1H,
= 7.5, 3H, C2 1-H3), 0.56 (t, J = 7.5,
5 192.2 (C19), 152.0 (C,8), 150.4 (C18), 137.4
136.9 (C4 ), 132.7 (C 4), 130.8 (C,3 ), 130.3 (C, 6 ),
(C1,6 ), 127.7 (C14 ), 125.9 (C3), 124.0 (C3,), 123.2
122.8 (C14 ), 122.5 (q, J = 322.4, F3CSO 3-), 120.0
(C, ),
128.6
(C1,5),
(C15),
149
'
9F NMR (300 MHz, CDCl 3, 20 'C):
FTIR (neat) cm-1:
HRMS (DART):
107.9 (C 17), 105.6 (C17,), 83.1 (C2), 73.0 (C1 g,), 71.5
(C2), 69.6 (C 12), 59.2 (CIO), 52.9 (C12), 52.6 (C8,), 52.4(C1 O,), 50.7 (C8), 44.4 (CI 1 ), 43.6 (C), 39.3 (C,), 36.2
(C2 0 ,), 34.6 (C,), 32.4 (C11), 31.7 (C 22), 31.4 (C20), 29.9
(C22), 28.1 (C6 ), 23.5 (C,), 17.6 (C), 7.7 (C21), 7.6
(C 21 )-
6 -78.9
2933 (s), 1672 (m), 1608 (s), 1489 (s), 1454 (m), 1262
(s), 1155 (s), 1031 (s), 752 (m).
calc'd for C40H4qN4 [M-CF 30 3S ]*: 585.3952,
found: 585.3941.
TLC (Al2O 3, 75% acetone in hexanes), Rf:
+9 (c = 0.076, CH2Cl 2).
0.48 (UV, CAM, KMnO 4).
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Decacyclic dimer (-)-71:
Trifluoromethanesulfonic anhydride (7.2 VL, 42 pmol, 1.1 equiv) was added via syringe to a
solution of tetracyclic lactam (-)-64 (11.8 mg, 38.2 pmol, 1 equiv) and 2-chloropyridine (4.3 VL, 46
pmol, 1.2 equiv) in acetonitrile (0.6 mL) at 23 *C. After 10 min, a solution of (-)-N-
methyldehydroaspidospermidine (62, 13.5 mg, 45.9 Rmol, 1.20 equiv) in acetonitrile (1.2 mL) was
added via cannula. After 5 min, the reaction mixture was warmed to 85 *C. After 90 min, the
reaction mixture was allowed to cool to 23 *C, and a solution of sodium trimethoxyborohydride (29.3
mg, 229 gmol, 6.00 equiv) in tetrahydrofuran (1.8 mL) was added via cannula. After 3 h, saturated
aqueous sodium bicarbonate solution (15 mL) was added to quench the trifluoromethanesulfonate
salts, and the resulting biphasic mixture was allowed to warm to 23 *C. Dichloromethane (15 mL)
was added, and the layers were separated. The aqueous layer was further extracted with
dichloromethane (2 x 15 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The residue was purified by
flash column chromatography on silica gel (0.5% acetic acid, 20% methanol, 20% tetrahydrofuran in
dichloromethane -+ 30% methanol in dichloromethane) to afford decacyclic dimer (-)-71 as its acetic
acid salt, which was dissolved in ethyl acetate (30 mL) and washed with saturated aqueous potassium
carbonate solution (30 mL) and brine (30 mL). The organic layer was dried over anhydrous sodium
sulfate, was filtered, and was concentrated under reduced pressure to afford decacyclic dimer (-)-71
(16.3 mg, 72.6%) as a colorless gum. Structural assignments were made with additional information
from gCOSY, HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl3, 20 *C, 1.7:1 atropisomer mixture, * denotes minor atropisomer): 8 7.36
(d, J = 1.7, 1H, C1 ,-H*), 7.28 (d, J = 8.3, 1H, C16,-H),
7.11-7.07 (m, 1H, C16,-H*), 7.09-7.06 (m, 1H, C16-H),
7.08 (d, J = 1.8, 1H, C14-H), 7.04 (app-dt, J = 1.1, 7.5,
1H, C16-H*), 6.97 (d, J = 7.7, 1H, C14-H), 6.97-6.94 (m,
1H, C14 -H*), 6.58 (app-t, J = 7.2, 1H, C15-H), 6.55 (app-
t, J = 7.3, 1H, C15-H*), 6.33 (d, J = 7.7, 1H, C17-H), 6.30
(d, J = 7.7, 1H, C17-H*), 6.23 (d, J = 8.3, 1H, C,-H),
6.17 (d, J = 8.2, 1H, C17,H*), 5.98 (dd, J = 4.5, 10.2,
1H, C3,-H), 5.98-5.95 (m, 1H, C3,-H*), 5.74 (d, J = 10.2,
1H, C,-H), 5.73-5.63 (m, 1H, C4'-H*), 5.73-5.63 (m,
1H, C3-H), 5.73-5.63 (m, 1H, C4-H), 5.73-5.63 (m, 1H,
C4-H*), 5.73-5.63 (m, 1H, C3-H*), 3.76-3.71 (m, 1H,
CT-H), 3.76-3.71 (m, 1H, C2,-H*), 3.16-3.00 (m, 1H,
CIo0 -Ha*), 3.16-3.00 (m, 1H, CIt0 Ha), 3.16-3.00 (m, 1H,
C8 -Ha*), 3.16-3.00 (m, 1H, C8-Ha), 2.84 (s, 3H, C22-
H3 ), 2.82 (s, 3H, C2 2 ,-H 3*), 2.80-2.73 (m, 1H, C8-Ha),
2.80-2.73 (m, 1H, C8-Ha*), 2.62 (s, 3H, C22-H3), 2.61 (s,
3H, C22-H 3*), 2.54 (s, 1H, C19-H*), 2.52 (s, 1H, C19-H),
2.34-2.26 (m, 1H, CIO'-Hb), 2.26-2.19 (m, 1H, CIocHb*),
2.17 (s, 1H, Cg,-H*), 2.12 (s, 1H, C19-H), 2.15-1.83 (m,
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8A
1H,
1H,
1H,
CI,-Ha), 2.15-1.83
Co-H2*),2.15-1.83
Ci-Ha*), 2.15-1.83
(m
(m
1H, CIo-H 2), 2.15-1.83 (m,
1H, Cg-Hb*), 2.15-1.83 (m,.
1H,
1H,
1H,
2H,
1H,
1H,
1H,
1H,
1H,
1H,
1H,
1H,
3H,
7.4,
1H, C8-Hb), 2.15-1.83 (m,
1H, C8,-Hb*), 2.15-1.83 (m,
1H, Cl,,-Hb), 2.15-1.83 (m,
1H, C8,-Hb), 2.15-1.83 (m,
1H, C I ,-Hb*), 2.15-1.83 (m,
CI-Ha), 2.15-1.83 (m, 1H, CII-Ha*), 1.77-1.60 (m,
C 6,-Ha*), 1.77-1.60 (m, 1H, C6-Ha*), 1.77-1.60 (m,
C 6-Ha), 1.77-1.60 (m, 1H, C6,-Ha), 1.67-1.48 (m,
C7,-H2*), 1.67-1.48 (m, 1H, C7-Ha*), 1.67-1.48 (m,
C7-Ha), 1.67-1.48 (m, 1H, C,-Ha), 1.67-1.48 (m,
C7-Hb), 1.67-1.48 (m, 1H, C7-Hb*), 1.67-1.48 (m,
C7 ,-Hb), 1.53-1.39 (m, 1H, CII-Hb), 1.53-1.39 (m,
Cl,-Hb*), 1.32-1.15 (m, 1H, C6-Hb*), 1.32-1.15 (m,
C6 -Hb), 1.32-1.15 (m, 1H, C6,-Hb), 1.32-1.15 (m,
C6 ,-Hb*), 1.15-0.83 (m, 2H, C20-H 2*), 1.15-0.83 (m,
C20'-Ha), 1.15-0.83 (m, 2H, C20 ,-H 2 *), 1.15-0.83 (m,
C20-H2), 1.15-0.83 (m, 1H, C2 o,-Hb), 0.66 (t, J = 7.4,
C2 r,-H 3*), 0.65 (t, J = 7.5, 3H, C21-H3 ), 0.62 (t, J =
3H, C2 1-H3 *), 0.50 (t, J = 7.5, 3H, C2,r-H3)-
13C NMR (125 MHz, CDC13, 20 C, 1.7:1
FTIR (neat) cm-':
HRMS (DART):
TLC (A120 3, 10% EtOAc in hexanes), Rf:
atropisomer mixture, * denotes minor atropisomer): 8
150.8 (CI8), 150.8 (C18 *), 149.4 (C,8 ), 149.3 (C,8,*),
139.1 (C4,*), 137.9 (C4.), 135.5 (C 4), 135.4 (C4 *), 134.8
(C,3 '*), 134.6 (C,3 ,), 134.0 (C,3 ), 133.9 (C3*), 131.8
(C ,6 ), 131.5 (C ,), 131.2 (C ,5 *), 128.7 (C 3*), 128.4
(C3), 127.7 (C16 ), 127.7 (C16 *), 127.7 (C 6,*), 127.1
(C ,4 *), 125.1 (C3 ,), 124.6 (C 3,*), 123.5 (C 4 ), 123.5
(C 4 *), 123.2 (C 4.), 116.2 (C15*), 116.1 (C, 5 ), 104.7
(CI.), 104.7 (C,7*), 104.6 (C, 7), 103.4 (C17,*), 75.3
(Cg,), 74.4 (C2 *), 74.3 (C 2), 74.0 (Cg,*), 71.7 (C2.), 71.5
(C2,*), 71.3 (C,9), 71.2 (C1,*), 57.0 (C12*), 57.0 (C12),
53.3 (CIO,*), 53.0 (CIO,), 52.9 (C8,*), 52.8 (C8.), 52.3
(C*), 52.3 (C12.), 52.1 (C8), 52.1 (C12 '*), 51.2 (C10*),
50.7 (CIO), 45.4 (CI,.), 44.5 (Cl,,*), 39.1 (CO,), 39.1
(C5,*), 38.5 (C), 38.4 (C*), 38.2 (C,,*), 38.1 (C,,),
36.1 (C20), 36.0 (C2 0*), 35.4 (C20,), 34.4 (C6 ,*), 34.3
(C6.), 34.3 (C6), 34.2 (C6*), 34.1 (C 20,*), 33.4 (C22.), 33.2
(C 22,*), 29.9 (C 2 2*), 29.5 (C 2 2), 23.7 (C*), 23.6 (C 7),
23.3 (C7,), 23.3 (C 7,*), 8.0 (C2 ,*), 7.9 (C21), 7.9 (C21*),
7.7 (C 21.)-
2928 (s), 2781 (m), 1603 (s), 1494 (s), 1373 (m), 1263
(m), 1190 (m), 1122 (m), 736 (m), 666 (m).
calc'd for C40H5,N4 [M+H]*: 587.4108,
found: 587.4111.
-240, (c = 0.10, CH2Cl 2)-
0.40 (UV, CAM, KMnO 4).
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Table S5. Comparison of our 'H NMR data for decacyclic dimer (-)-71 with literature data for
(+)-tabernaebovine (3):22,23
Blue arrows in the figure below represent key NOESY correlations:
key NOESY
correlations:
For clarity most 16
methines are
omitted; arrows
point to the carbon of
the methines of interest.
(+)-tabernaebovine (3) (-)-71
major rotamer
(-)-71
minor rotamer
Assignment Ripperger's Report2 2  This Work
(+)-Tabernaebovine (3) (-)-71
'H NMR, 500 MHz, 'H NMR, 500 MHz,
CDC13  CDC13, 20 *C
* denotes minor atropisomer resonance
C2 --
C3 2.83 (dd, J= 3.7, 13.4, 1H) 5.73-5.63 (m, 1H)
1.83 (m, IH) 5.73-5.63* (m, IH)
C4 2.08 (m, 1H) 5.73-5.63 (m, 1H)
1.43 (m, 1H) 5.73-5.63* (m, IH)
C5 -_ -
C6 2.98 (d, J= 3.9, 1H) 1.77-1.60 (m, 1H)
1.32-1.15 (m, 1H)
1.77-1.60* (m, 1H)
1.32-1.15* (m, 1 H)
C7 3.30 (m, 1H) 1.67-1.48 (m, 2H)
1.67-1.48* (m, 2H)
C8 3.49 (dd, J= 13.0, 1.5, 1H) 2.80-2.73 (m, 1H)
2.27 (d, J = 12.8, 1H) 2.15-1.83 (m, 1H)
2.80-2.73* (m, 1H)
2.15-1.83* (m, 1H)
C1O 2.78 (dt, J= 3.4, 8.5, 1H) 2.15-1.83 (m, 2H)
2.07 (m, 1H) 2.15-1.83* (m, 2H)
C11 1.59 (m, 1H) 2.15-1.83 (m, 1H)
1.50 (m, IH) 1.53-1.39 (m, 1H)
2.15-1.83* (m, 1H)
1.53-1.39* (m, 1H)
C12 -_ -
C13 -_ -
C14 6.90 (d, J= 6.7, 1H) 6.97 (d, J= 7.7, 1 H)
6.97-6.94* (m, IH)
C15 6.54 (dt, J= 0.7, 7.3, 1H) 6.58 (app-t, J= 7.2, 1H)
6.55* (app-t, J= 7.3, 1H)
C16 7.09 (dt, J = 1.2, 7.6, 1H) 7.09-7.06 (m, IH)
7.04* (app-dt, J= 1.1, 7.5, 1H)
C17 6.27 (d, J= 7.9, 1H) 6.33 (d, J= 7.7, 1H)
6.30* (d, J= 7.7, 1H)
C18
C19 2.04 (s, 1H) 2.52 (s, 1H)
2.54* (s, IH)
C20 1.07 (m, 2H) 1.15-0.83 (m, 2H)
1.15-0.83* (m, 2H)
22 Lim, T. P.; Kamperdick, C.; Sung, T. V.; Adam, G.; Ripperger, H. Phytochemistry 1998,49, 1797.
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16
C21 0.68 (t, J = 7.4, 3H) 0.65 (t, J= 7.5, 3H)
0.62* (t, J 7.4, 3H)
C22 2.46 (s, 3H) 2.62 (s, 3H)
2.61 * (s, 3H)
C2' 3.34 (br-d, J= 5.2, 1H) 3.76-3.71 (m, 1H)
3.7 6-3.7 1* (m, 1 H)
C3' 1.74 (m, I H) 5.98 (dd, J= 4.5, 10.2, 1H)
1.10 (m, 1H) 5.98-5.95* (m, 1H)
C4' 1.76 (m, IH) 5.74 (d, J= 10.2, 1 H)
1.37 (m, 1H) 5.73-5.63* (m, 1H)
C5'
C6' 2.88 (br-s, 1H) 1.77-1.60 (m, 1H)
1.32-1.15 (m, 1H)
1.77-1.60* (m, 1H)
1.32--1.15* (m, 1 H)
C7' 3.30 (m, I H) 1.67-1.48 (m, 2H)
1.67-1.48* (m, 2H)
C8' 3.53 (br-d, J= 12.8, 1H) 3.16-3.00 (m, 1H)
ca. 2.30 (m, 1H) 2.15-1.83 (m, 1H)
3.16-3.00* (m, 1H)
2.15-1.83* (m, 1H)
CIO' 3.15 (t, J= 7.6, 1H) 3.16-3.00 (m, 1H)
2.07 (m, I H) 2.34-2.26 (m, IH)
3.16-3.00* (m, 1H)
2.26-2.19* (m, 1 H)
C1l' 2.23 (m, 1H) 2.15-1.83 (m, 2H)
1.50 (m, 1 H) 2.15-1.8 3*m 2H)
C1 2'--
Cl3'-
C14' not observed 7.08 (d, J= 1.8, 1 H)
7.36* (d, J= 1.7, 1H)
C15'
C16' 6.93 (br, 1H) 7.28 (d, J= 8.3, 1H)
7.11-7.07* (m, 1 H)
C17' 6.24 (br-d, J= 7.0, 1H) 6.23 (d, J= 8.3, 1H)
6.17* (d, J= 8.2, 1H)
C18' --
C19' 2.05 2.12 (s, IH)
2.17* (s, 1 H)
C20' 1.11 (m, 2H) 1.15-0.83 (m, 2H)
1.15-0.83* (m, 2H)
C2 1' O.68 (t, J = 7.4, 3H) 0.50 (t, J= 7.5, 3H)
0.66* (t, J= 7.4, 3H)
C22' 2.70 (s, 3H) 2.84 (s, 3H)
2.82* (s, 3H)
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Table S6. Comparison of our 13C NMR data for decacyclic dimer (-)-71 with literature data for
(+)-tabernaebovine (3):23
8
16
16
(+)-tabernaebovine (3) (-)-71
major rotamer
(-)-71
minor rotamer
Ripperger's This Work Chemical
Report" (-)-71 Shift
(+)-tabemaebovine "C NMR, 125 MHz, Difference
(3) CDC13, 20 -C Ab =
"C NMR, * denotes minor atropisomer resonance 8 (this work)
125 MHz, - 6 (Ref. 22)
CDCl3
Assign Chemical Chemical Key gHMBC
-ment Shift Shift Correlations
C2 74.8 74.3 C3, C4, C11, C19, C22, C14', C16' -0.5
74.4* C3*, C4*, C1I*, C19*, C22*, C14'*, C16'* -0.4*
C3 26.0 128.4 102.424
128.7* 102.7*24
C4 28.4 135.5 C6, C19, C20 107.124
135.4* C6*,C19*,C20* 107.0*24
C5 32.8 38.5 C3,C4,C7,C19,C20,C21 5.7
38.4* C3*,C4*,C7*,C19*,C20*,C21* 5.6*
C6 60.2 34.3 C4,C7,C8,C19,C20 -25.925
34.2* C4*,C7*,C8*,C19*,C20* -26.0*25
C7 53.12 23.6 C6,C8 -29.5225
23.7* C6*,C8* -29.4225
C8 52.2 52.1 C6,C7,C1O,C19 -0.1
52.3* C6*,C7*,CIO*,C19* 0.1*
C1O 53.6 50.7 C8,CI,C19 -2.9
51.2* C8*, C11*, C19* -2.4*
CI 36.2 38.1 C10,C19 1.9
38.2* C10*,C19* 2.0*
C12 56.8 57.0 C3,C1O,CI1,C14,C19 0.2
57.0* C3*,C1O*,C11*,C14*,C19* 0.2*
C13 135.1 134.0 C11, C15, C17, C19 -1.1
133.9* C11*, C15*, C17*, C19* -1.2*
C14 123.0 123.5 C15,C16 0.5
123.5* C15*,C16* 0.5*
C15 115.6 116.1 C16,C17 0.5
116.2* C16*,C17* 0.6*
C16 128.1 127.7 C14,C15 -0.4
127.7* C14*,CI5* -0.4*
C17 102.7 104.6 C15,C16 1.9
104.7* C15*,C16* 2.0*
C18 152.4 150.8 C14,C16,C22 -1.6
150.8* C14*, C16*, C22* -1.6*
23 The lack of epoxides and the presence of alkenes in dimer
tabernaebovine (3).
)-71 results in greater C2-C 15' atropisomerism compared to (+)-
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C19 72.8 71.3 C4,C6, C8, C1O, C11, C20 -1.5
71.2* C4*, C6*, C8*, C1O*, C11*, C20* -1.6*
C20 32.9 36.1 C4,C6,C19,C21 3.2
36.0* C4*,C6*,C19*,C21* 3.1*
C21 8.1 7.9 C20 -0.2
7.9* C20* -0.2*
C22 29.0 29.5 0.5
29.9* - 0.9*
C2' 73.3 71.7 C3', C4', C11', C19', C22' -1.6
71.5* C3'*, C4'*, C11'*, C19'*, C22'* -1.8*
C3' 20.1 125.1 C2' 105.026
124.6* C2'* 104.5*26
C4' 24.3 137.9 C2', C6', C19', C20' 113.626
139.1* C2'*, C6'*, C19'*, C20'* 114.8*26
CS 34.5 39.1 C3', C4', C7', C19', C20', C21' 4.6
39.1* C3'*, C4'*, C7'*, C19'*, C20'*, C21* 4.6*
C6' 57.6 34.3 C4', C7', C8', C19', C20' -23.327
34.4* C4'*, C7'*, C8'*, C19'*, C20'* -23.2*27
CT 53.1 23.3 C6', C8' -29.827
23.3* C6'*, C8'* -29.8*27
C8' 53.06 52.8 C6',C7',C1O',C19' -0.26
52.9* C6'*, C7'*, C10'*, C19'* -0.16*
C1O' 53.6 53.0 C8', CI1', C19' -0.6
__ _ _53.3* C8'*,C11'*,C19'* -0.3*
C11' 41.1 45.4 C2',C1O',C19' 4.3
44.5* C2'*, C1O'*, C19'* 3.4*
C12' 51.2 52.3 C2', C3', C10', C11', C14', C19' 1.1
52.1* C2'*, C3'*, C10'*, C11'*, C14'*, C19'* 0.9*
C13' 136.4 134.6 Cl1',C17',C19' -1.8
C14____ _134.8* C11'*, C17'*, C19'* -1.6*
C14' 120.7 123.2 C16' 2.5
127.1* C16'* 6.4*
C15' 132.2 131.5 C3,C17' -0.7
131.2* C3*,C17'* -1.0*
C16' 126.9 131.8 C14' 4.9
127.7* C14'* 0.8*
CIT 105.9 104.7 C16' -1.2
103.4* C16'* -2.5*
C18' 148.8 149.4 C14', C16', C22' 0.6
149.3* C14'*, C16'*, C22'* 0.5*
C19' 66.7 75.3 C2', C4', C6', C8', C10', CI', C20' 8.6
74.0* C2'*, C4'*, C6'*, C8'*, C10'*, C11'*, C20'* 7.3*
C20' 27.9 35.4 C4', C6', C19', C21' 7.5
34.1* C4'*, C6'*, C19'*, C21'* 6.2*
C21' 7.5 7.7 C20' 0.2
1 8.0* C20'* 0.5*
C22' 31.5 33.4 C2' 1.9
1_ 1 33.2* C2'* 1.7*
2 Difference in chemical shift is due to presence and absence of C3-C4 double bond in (-)-71 and (+)-tabemaebovine (3),
respectively.
25 Difference in chemical shift is due to absence and presence of C6-C7 epoxide in (-)-71 and (+)-tabernaebovine (3), respectively.
26 Difference in chemical shift is due to presence and absence of C3'-C4' double bond in (-)-71 and (+)-tabemaebovine (3),
respectively.
27 Difference in chemical shift is due to absence and presence of C6'-C7' epoxide in (-)-71 and (+)-tabemaebovine (3), respectively.
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F3 CSO 3 + 6 N 6N N
14 19 \21 8' \14 19 8'4 Me N ' Na(MeOEt(CH 2)20)2AH 2  4 N 6'N 6'IH N
16 1 \ 19'"\ THF, 0 *C 16 1N \ 19'
- /4' Me2l' 76% e /4- Me2l'(+)-70 1'N H (-)-71 'N H
Me MeH
Synthesis of decacylic dimer (-)-71 by reduction of decacyclic iminium trifluoromethane-
sulfonate (+)-70:
Sodium bis(2-methoxyethoxy)aluminum hydride (65% w/v solution in toluene, 91.2 jiL, 299
pmol, 5.00 equiv) was added via syringe to a solution of decacyclic iminium
trifluoromethanesulfonate (+)-70 (43.9 mg, 59.7 pmol, 1 equiv) in tetrahydrofuran (4.0 mL) at 0 *C.
After 30 min, aqueous hydrogen chloride solution (2.0 mL) was added to quench the aluminum
hydride salts, and the reaction mixture was allowed to warm to 23 *C. Saturated aqueous potassium
carbonate solution (15 mL) and ethyl acetate (15 mL) were added, and the layers were separated.
The aqueous layer was further extracted with ethyl acetate (2 x 15 mL). The combined organic
layers were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The residue was purified by flash column chromatography on alumina (3 -> 7% ethyl
acetate in hexanes) to afford decacyclic dimer (-)-71 (26.6 mg, 75.9%) as a colorless gum. See page
151 for characterization data for decacyclic dimer (-)-71.
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86
14
6
H2 , Pt/C
6'
THF 23*C
14 8'
6'
me 4Me 84% Me Me21'v MN1 'e2l' 1~~~4 eN
(-)-71 (+)-4 MeH
(+)-Dideepoxytabernaebovine (4):
Platinum on charcoal (10% w/w, 50.0 mg, 25.6 pmol, 2.00 equiv) was added as a solid to a
solution of decacyclic dimer (-)-71 (7.5 mg, 13 pmol, 1 equiv) in tetrahydrofuran (1.4 mL) at 23 *C.
The opened reaction vessel was placed in a Parr bomb and sealed under an atmosphere of hydrogen
gas (900 psi). After 72 h, the Parr Bomb was opened in air, and the suspension was filtered over
Celite. The solids were further extracted with ethyl acetate, and the combined filtrates were
concentrated under reduced pressure. The residue was purified by flash column chromatography on
alumina (0 --> 2% ethyl acetate in hexanes) to afford (+)-dideepoxytabernaebovine (4, 6.3 mg, 84%)
as a colorless gum. Structural assignments were made with additional information from gCOSY,
HSQC, gHMBC, and NOESY data.
'H NMR (500 MHz, CDCl 3, 53 *C): 6 7.19 (br-d, J = 8.2, 1H, C,-H), 7.16 (br-s, 1H, C,4 -H),
7.08 (app-t, J = 7.5, 1H, C16-H), 6.94 (d, J = 7.1, 1H,
C14-H), 6.57 (app-t, J = 7.4, 1H, C15-H), 6.30 (d, J = 7.6,
1H, C17-H), 6.24 (d, J = 8.2, 1H, C 7,-H), 3.37 (dd, J =
6.0, 10.6, 1H, CT-H), 3.07 (app-dt, J = 2.9, 8.9, 1H, C 1,
-
Ha), 2.99 (app-d, J = 10.8, 1H, C8,-Ha), 2.86 (app-d, J =
9.5, 1H, C8-Ha), 2.73 (s, 3H, C22-H3), 2.60-2.51 (m, 1H,
C3-Ha), 2.50 (s, 3H, C22-H3), 2.32-2.20 (m, 1H, C,,-Ha),
2.32-2.20 (m, lH, CIo-Ha), 2.17 (s, 1H, C,9-H), 2.17-
2.06 (m, 1H, Cio,-Hb), 2.17-2.06 (m, 1H, C4-Ha), 2.03 (s,
1H,
1H,
1H,
1H
1H,
1H,
1H,
1H,
lH,
1H,
lH,
1H,
C1g,-H),
C8,-H), I
C4,-Ha),
C3-Hb),
C7-Ha),
C6,-Ha),
C7-Hb),
CII,-Hb)
C4-Hb),
C20-Ha),
C6'-Hb),
1.98-1.82 (m,
1.98-1.82 (m,
1.98-1.82 (m,
1.82-1.64 (m,
1.82-1.64 (m,
1.63-1.28 (m,
1.63-1.28 (m,
,1.63-1.28 (m,
1.63-1.28 (m,
1.28-1.17 (m,
1.16-0.98 (m,
0.98-0.82 (m,
1H, Cio-Hb),
1H, C8-Hb),
1H, Ci-Ha),
1H, C3,-Ha),
1H, C,-Ha),
1H, C6-Ha),
1H, C7 -Hb),
1H, CIl-Hb),
1H, C 2 0 '-Ha),
1H, C3 -Hb),
1H, C4,-Hb),
1H, C2 0-Hb),
1.98-1.82
1.98-1.82
1.82-1.64
1.82-1.64
1.63-1.28
1.63-1.28
1.63-1.28
1.63-1.28
1.28-1.17
1.16-0.98
1.16-0.98
0.78-0.65
(mn,
(in,
(in,
(in,
(in,
(in,
(in,
(in,
(in,
(mn,
(in,
(mn,
1H, C20,-Hb), 0.57 (t, J
7.3, 3H, C21,-H3)-
= 7.5, 3H, C21-H3), 0.53 (t, J =
13C NMR (125 MHz, CDC13, 20 *C): 8 151.4 (C,8), 149.1 (C1,8
133.4 (C1,5), 127.8 (C16), 1
(C,4 ), 116.5 (C,5), 105.4 (
74.1 (C2), 72.0 (C2), 71.6
53.5 (C8), 53.3 (CIO,), 52.7
37.3 (C1,), 35.6 (C6), 35.3
), 135.9 (C13), 135.8 (C13,),
27.7 (C1,6 ), 123.4 (C,4), 123.3
CI,), 105.1 (C,7), 74.5 (C,9),
(Clg,), 57.1 (C12), 54.1 (C8 ,(CIO), 51.9 (CI), 39.5 (C,,),
(C,), 34.6 (C.), 31.8 (C20),
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31.8 (C), 31.7 (C 22,), 30.3 (C 20 ), 29.3 (C 22), 28.8 (C3),
26.4 (C4), 23.2 (C4,), 22.4 (C 3,), 22.3 (C7), 22.0 (C,), 7.6
(C 21), 6.8 (C 2 )-
2929 (s), 1604 (s), 1490 (s), 1375 (m), 1262 (m), 1181
(m), 1122 (m), 801 (m), 737 (m), 666 (m).
FTIR (neat) cm-':
HRMS (DART): calc'd for C40H 55N 4 [M+H]*: 591.4421,
found: 591.4420.
TLC (A12 0 3, 10% EtOAc in hexanes), Rf:
+144, (c = 0.10, CHCl3).
0.48 (UV, CAM, KMnO4).
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Table S7. Comparison of our 'H NMR data for (+)-dideepoxytabernaebovine (4) with literature
data for (+)-tabernaebovine (3):21
Blue arrows in the figure below represent key reported NOESY correlations:
8
key NOESY
correlations:
For clarity most
methines are 16
omitted; arrows
point to the carbon of
the methines of interest.
8
6'
16
Me2l'
(+)-tabernaebovine (3) (+)-dideepoxytabernaebovine (4)
Assignment Ripperger's Report" This Work
(+)-Tabernaebovine (3) (+)-Dideepoxytabemaebovine (4)
'H NMR, 500 MHz, 'H NMR, 500 MHz,
CDC1, CDC13,53 *C
C2 -
C3 2.83 (dd, J= 3.7, 13.4, 1H) 2.60-2.51 (m, 1H)
1.83 (m, 1H) 1.82-1.64 (m, 1H)
C4 2.08 (m, 1H) 2.17-2.06 (m, 1H)
1.43 (m, 1H) 1.63-1.28 (m, 1H)
C5 -_ -
C6 2.98 (d, J= 3.9, 1H) 1.63-1.28 (m, 1H)
1.16-0.98 (m, 1H)
C7 3.30 (m, 1H) 1.82-1.64 (m, 1H)
1.63-1.28 (m, 1H)
C8 3.49 (dd, J= 13.0, 1.5, 1H) 2.86 (app-d, J= 9.5, 1H)
2.27 (d, J= 12.8, 1H) 1.98-1.82 (m, 1H)
C1O 2.78 (dt, J = 3.4, 8.5, 1H) 2.32-2.20 (m, 1H)
2.07 (m, IH) 1.98-1.82 (m, 1H)
Cli 1.59 (m, 1H) 1.98-1.82 (m, 1H)
1.50 (m, 1H) 1.63-1.28 (m, 1H)
C12
C13
C14 6.90 (d, J= 6.7, 1H) 6.94 (d, J= 7.1, 1H)
C15 6.54 (dt, J= 0.7, 7.3, 1H) 6.57 (app-t, J= 7.4, 1H)
C16 7.09 (dt, J= 1.2, 7.6, 1H) 7.08 (app-t, J= 7.5, 1H)
C17 6.27 (d, J= 7.9, 1H) 6.30 (d, J= 7.6, 1H)
C18 -_ -
C19 2.04 (s, 1H) 2.17 (s, 1H)
C20 1.07 (m, 2H) 1.28-1.17 (m, 1H)
0.98-0.82 (m, 1H)
C21 0.68 (t, J= 7.4, 3H) 0.57 (t, J= 7.5, 3H)
C22 2.46 (s, 3H) 2.50 (s, 3H)
C2' 3.34 (br-d, J= 5.2, 1H) 3.37 (dd, J= 6.0, 10.6, 1H)
C3' 1.74 (m, 1H) 1.82-1.64 (m, 1H)
1.10 (m, 1H) 1.28-1.17 (m, 1H)
C4' 1.76 (m, 1H) 1.98-1.82 (m, 1H)
1.37 (m, 1H) 1.16-0.98 (m, 1H)
C5' - _-
C6' 2.88 (br-s, 1H) 1.63-1.28 (m, 1H)
1.16-0.98 (m, 1H)
C7 3.30 (m, 1H) 1.82-1.64 (m, 1H)
1.63-1.28 (m, 1H)
C8' 3.53 (br-d, J = 12.8, 1H) 2.99 (app-d, J = 10.8, 1 H)
ca. 2.30 (m, 1H) 1.98-1.82 (m, 1H)
2 The lack of epoxides in (+)-dideepoxytabernaebovine (4) results in local variation compared to (+)-tabernaebovine (3).
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CIO' 3.15 (t, J= 7.6, 1 H) 3.07 (app-dt, J= 2.9, 8.9, 1H)
2.07 (m, I H) 2.17-2.06 (m, 1 H)
C1l' 2.23 (m, IH) 2.32-2.20 (m, I H)
1.50 (m, IH) 1.63-1.28 (m, I H)
C12' --
C13' -
C14' not observed 7.16 (br-s, 1H)
C15'
C16' 6.93 (br, IH) 7.19 (br-d, J= 8.2, 1 H)
C17' 6.24 (br-d, J= 7.0, 1H) 6.24 (d, J= 8.2, 1 H)
C18' -
C19' 2.05 2.03 (s, 1H)
C20' 1.11 (m, 2H) 1.63-1.28 (m, 1H)
0.78-0.65 (m, 1 H)
C21' 0.68 (t, J= 7.4, 3H) 0.53 (t, J= 7.3, 3H)
C22' 2.70 (s, 3H) 2.73 (s, 3H)
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Table S8. Comparison of our 13C NMR data for (+)-dideepoxytabernaebovine (4) with
literature data for (+)-tabernaebovine (3):29
16 16
(+)-tabernaebovine (3) (+)-dideepoxytabemaebovine (4)
Ripperger's This Work Chemical
Report" (+)-Dideepoxytabernaebovine (4) Shift
(+)-Tabernaebovine "C NMR, 125 MHz, Difference
(3) CDCl 3, 20 *C Ab =
"3C NMR, 125 MHz, 6 (this work)
CDCl3  - 6 (Ref. 22)
Assign- Chemical Chemical Key gHMBC
ment Shift Shift Correlations
C2 74.8 74.1 C4, C11, C22, C19, C14', C16' -0.7
C3 26.0 28.8 - 2.8
C4 28.4 26.4 C6, C19, C20 -2.0
C5 32.8 31.8 C3, C7, C19, C21 -1.0
C6 60.2 35.6 C4, C8, C19, C20 -24.630
C7 53.12 22.3 - _-30.8234
C8 52.2 53.5 C6,C1O,C19 1.3
CIO 53.6 52.7 C8,C19 -0.9
Cli 36.2 37.3 C19 1.1
C12 56.8 57.1 C3,C1O,C14 0.3
C13 135.1 135.9 C11, C15, C17, C19 0.8
C14 123.0 123.4 C16 0.4
C15 115.6 116.5 C17 0.9
C16 128.1 127.8 C14 -0.3
C17 102.7 105.1 C15 2.4
C18 152.4 151.4 C14,C16,C22 -1.0
C19 72.8 74.5 C4,C6,C8,C1O,C11,C20 1.7
C20 32.9 31.8 C4, C6, C19, C21 -1.1
C21 8.1 7.6 -0.5
C22 29.0 29.3 - 0.3
C2' 73.3 72.0 C4', C11', C19', C22' -1.3
C3 20.1 22.4 2.3
C4' 24.3 23.2 C2', C6', C19', C20' -1.1
C5' 34.5 35.3 C3',C7',C19',C21' 0.8
C6' 57.6 34.6 C4', C8',C19',C20' -23.031
CT 53.1 22.0 -31.131
C8' 53.06 54.1 C6',C1O',C19' 1.04
C10' 53.6 53.3 C8',C19' -0.3
C1l' 41.1 39.5 C2', C19' -0.6
C12' 51.2 51.9 C3', C10', C14', C19' 0.7
C13' 136.4 135.8 C11',C17',C19' -0.6
C14' 120.7 123.3 C16' 2.6
C15' 132.2 133.4 C3, C17' 1.2
C16' 126.9 127.7 C14' 0.8
C17' 105.9 105.4 - -0.5
29 The lack of epoxides in (+)-dideepoxytabemaebovine (4) results in local variation compared to (+)-tabemaebovine (3).
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C18' 148.8 149.1 C14', C16', C22' 0.3
C19' 66.7 71.6 C2', C4', C6', C8', C10', C11', C20' 4.9
C20' 27.9 30.3 C4', C6', C19', C21' 2.4
C21' 7.5 6.8 
-0.7
C22' 31.5 31.7 C2' 0.2
30 Difference in chemical shift is due to absence and presence of C6-C7 epoxide in (+)-dideepoxytabernaebovine (4) and (+)-
tabernaebovine (3), respectively.
" Difference in chemical shift is due to absence and presence of C6'-C7' epoxide in (+)-dideepoxytabernaebovine (4) and (+)-
tabernaebovine (3), respectively.
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Crystal structure of diammonium dichloride (*)-63*2HC .
Structural parameters for diammonium dichloride (±)-63-2HCl are freely available from the
Cambridge Crystallographic Data Center under CCDC 862060.
View 1:
0
4: S
View 2:
*-4.
* 0
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Table S9. Crystal data and structure refinement for (±)-63-2HC.
Identification code x8_11133
Empirical formula C28 H38.66 C12 N3 01.33
Formula weight 509.50
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2(1)/n
Unit cell dimensions a = 12.4338(15) A
b = 12.6833(16) A
c = 17.824(2) A
Volume 2706.6(6) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 28.910
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F 2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
a= 90'.
@= 105.660(2)0.
y = 900 .
4
1.250 Mg/m3
0.267 mm-1
1089
0.30 x 0.09 x 0.02 mm3
1.79 to 28.91*.
-16<=h<=16, -17<=k<= 17, -24<=l<=24
57036
7129 [R(int) = 0.0547]
100.0 %
Semi-empirical from equivalents
0.9947 and 0.9243
Full-matrix least-squares on F2
7129 / 29 / 356
1.017
RI =0.0413, wR2=0.0954
R1 =0.0706, wR2= 0.1113
0.530 and -0.242 e.A- 3
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Table S10. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 101)
for ( )-63 2HC. U(eq) is defined as one third of the trace of the orthogonalized UUi tensor.
x y z U(eq)
Cl(l)
CI(2)
N(l)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
N(9)
C(10)
C(l 1)
C(12)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
C(27)
C(28)
N(29)
C(30)
C(31)
O(lS)
O(1T)
O(2T)
-1713(1)
-1102(1)
3463(1)
2326(1)
1564(1)
1454(1)
2043(1)
1396(1)
318(1)
553(1)
1053(1)
1318(2)
1920(2)
2550(1)
3812(1)
4484(2)
5641(2)
6097(2)
5431(1)
4278(1)
2155(1)
3235(1)
3260(2)
3675(2)
1891(1)
2624(1)
2253(1)
1124(1)
376(1)
759(1)
708(1)
843(2)
1230(2)
-1326(5)
-1036(8)
-1118(4)
8982(1)
7643(1)
9333(1)
8847(2)
9560(2)
9523(2)
8717(2)
8504(2)
7880(2)
6844(2)
7108(1)
6207(2)
6774(2)
7728(1)
7622(2)
6756(2)
6844(2)
7794(2)
8674(2)
8572(2)
7688(1)
9104(2)
10052(2)
10317(2)
8722(2)
8446(2)
8296(2)
8430(2)
8705(2)
8845(2)
8276(1)
7166(2)
9023(2)
5786(5)
5537(9)
6723(4)
-1123(1)
-4549(1)
-3315(1)
-3539(1)
-4134(1)
-4896(1)
-5265(1)
-6125(1)
-6225(1)
-5791(1)
-4951(1)
-4396(1)
-3645(1)
-3886(1)
-3586(1)
-3593(1)
-3281(1)
-2965(1)
-2934(1)
-3255(1)
-4798(1)
-5248(1)
-5772(1)
-2890(1)
-2813(1)
-2099(1)
-1437(1)
-1497(1)
-2194(1)
-2855(1)
-803(1)
-513(1)
-157(1)
-3361(3)
-3607(8)
-1925(2)
29(1)
30(1)
23(1)
22(1)
24(1)
23(1)
23(1)
25(1)
27(1)
26(1)
23(1)
27(1)
26(1)
22(1)
23(1)
28(1)
31(1)
30(1)
27(1)
23(1)
22(1)
26(1)
33(1)
31(1)
23(1)
25(1)
26(1)
24(1)
28(1)
28(1)
25(1)
34(1)
30(1)
72(2)
63(3)
35(1)
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Table S1I. Bond lengths [A] and angles [0]
N(1)-C(18)
N(1)-C(22)
N(1)-C(2)
C(2)-C(3)
C(2)-C(23)
C(2)-C( 12)
C(3)-C(4)
C(4)-C(5)
C(5)-C(19)
C(5)-C(6)
C(5)-C(20)
C(6)-C(7)
C(7)-C(8)
C(8)-N(9)
N(9)-C( 10)
N(9)-C( 19)
C(10)-C(l 1)
C(1 1)-C(12)
C(12)-C(13)
C(12)-C( 19)
C(13)-C( 14)
C(1 3)-C(18)
C(14)-C(15)
C(15)-C(16)
C(16)-C(17)
C(17)-C(1 8)
C(20)-C(2 1)
C(23)-C(24)
C(23)-C(28)
C(24)-C(25)
C(25)-C(26)
C(26)-C(27)
C(26)-N(29)
C(27)-C(28)
N(29)-C(30)
N(29)-C(3 1)
1.383(2)
1.447(2)
1.494(2)
1.517(2)
1.539(2)
1.602(2)
1.327(2)
1.510(2)
1.533(2)
1.549(2)
1.554(2)
1.525(2)
1.513(3)
1.497(2)
1.489(2)
1.514(2)
1.526(2)
1.564(2)
1.521(2)
1.567(2)
1.382(3)
1.396(3)
1.400(3)
1.384(3)
1.400(3)
1.399(2)
1.528(3)
1.395(2)
1.397(2)
1.392(2)
1.388(2)
1.380(2)
1.478(2)
1.397(2)
1.493(3)
1.496(2)
C(1 8)-N(1)-C(22)
C(1 8)-N(1)-C(2)
C(22)-N(1)-C(2)
N(1)-C(2)-C(3)
N(1)-C(2)-C(23)
C(3)-C(2)-C(23)
N(1)-C(2)-C( 12)
C(3)-C(2)-C( 12)
C(23)-C(2)-C( 12)
C(4)-C(3)-C(2)
C(3)-C(4)-C(5)
C(4)-C(5)-C( 19)
122.32(15)
110.73(14)
121.41(14)
107.90(14)
109.91(13)
110.77(13)
102.59(12)
113.51(13)
111.76(14)
124.57(16)
122.78(16)
108.87(13)
C(4)-C(5)-C(6)
C(19)-C(5)-C(6)
C(4)-C(5)-C(20)
C(1 9)-C(5)-C(20)
C(6)-C(5)-C(20)
C(7)-C(6)-C(5)
C(8)-C(7)-C(6)
N(9)-C(8)-C(7)
C(1 0)-N(9)-C(8)
C(I 0)-N(9)-C(19)
C(8)-N(9)-C(19)
N(9)-C(10)-C(1 1)
C(10)-C(1 1)-C(12)
C(I 3)-C(1 2)-C( 11)
C(1 3)-C(I 2)-C( 19)
C( 11)-C(1 2)-C( 19)
C(I 3)-C(1 2)-C(2)
C( 11)-C(1 2)-C(2)
C(1 9)-C(1 2)-C(2)
C(1 4)-C(1 3)-C( 18)
C(1 4)-C(1 3)-C(12)
C(1 8)-C(1 3)-C( 12)
C(1 3)-C(1 4)-C( 15)
C(16)-C(15)-C(14)
C(1 5)-C(1 6)-C( 17)
C(1 8)-C(1 7)-C(16)
N(1)-C(1 8)-C( 13)
N(1)-C(1 8)-C(17)
C(I 3)-C(1 8)-C( 17)
N(9)-C(19)-C(5)
N(9)-C(1 9)-C( 12)
C(5)-C(1 9)-C(12)
C(2 1)-C(20)-C(5)
C(24)-C(23)-C(28)
C(24)-C(23)-C(2)
C(28)-C(23)-C(2)
C(25)-C(24)-C(23)
C(26)-C(25)-C(24)
C(27)-C(26)-C(25)
C(27)-C(26)-N(29)
C(25)-C(26)-N(29)
C(26)-C(27)-C(28)
C(27)-C(28)-C(23)
C(26)-N(29)-C(30)
C(26)-N(29)-C(3 1)
C(30)-N(29)-C(3 1)
111.43(14)
109.62(15)
110.45(15)
108.16(14)
108.24(12)
114.33(13)
110.41(14)
106.72(15)
116.73(15)
103.14(13)
113.58(13)
100.84(14)
106.73(13)
112.40(14)
111.49(12)
102.70(13)
102.28(13)
115.30(13)
113.03(14)
120.44(16)
129.47(17)
110.07(15)
119.44(18)
119.71(18)
121.84(17)
117.56(18)
110.92(15)
128.08(17)
120.98(17)
111.76(13)
102.52(12)
119.53(14)
114.44(15)
118.46(15)
120.07(15)
121.44(14)
121.59(16)
118.45(15)
121.55(15)
118.90(15)
119.55(15)
119.29(16)
120.65(16)
112.52(14)
112.56(14)
110.23(14)
Symmetry transformations used to generate equivalent
atoms.
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for (t)-63e2HCl.
Table S12. Anisotropic displacement parameters (A2x 103) for (+)-63e2HC. The anisotropic
displacement factor exponent takes the form: -2jT2[ h2 a*2 U"l + ... + 2 h k a* b* U 12 ]
U " U22 U 33 U23 U1 3 U12
Cl(1)
Cl(2)
N(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
N(9)
C(10)
C(1 1)
C(12)
C(13)
C( 14)
C(15)
C(16)
C(17)
C(18)
C( 19)
C(20)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
C(27)
C(28)
N(29)
C(30)
C(31)
O(lS)
O(1T)
O(2T)
21(1)
21(1)
21(1)
20(1)
22(1)
19(1)
19(1)
21(1)
19(1)
21(1)
20(1)
25(1)
26(1)
20(1)
19(1)
27(1)
26(1)
19(1)
22(1)
23(1)
16(1)
21(1)
31(1)
32(1)
22(1)
19(1)
21(1)
22(1)
19(1)
21(1)
20(1)
32(1)
30(1)
58(3)
25(3)
31(2)
39(1)
47(1)
31(1)
33(1)
33(1)
32(1)
35(1)
40(1)
42(1)
38(1)
31(1)
31(1)
32(1)
31(1)
36(1)
38(1)
49(1)
55(1)
42(1)
34(1)
32(1)
39(1)
45(1)
34(1)
33(1)
40(1)
41(1)
36(1)
46(1)
45(1)
38(1)
39(1)
43(1)
64(3)
47(5)
45(3)
28(1)
24(1)
19(1)
14(1)
19(1)
18(1)
15(1)
15(1)
18(1)
20(1)
19(1)
25(1)
20(1)
16(1)
14(1)
19(1)
18(1)
18(1)
17(1)
13(1)
17(1)
19(1)
25(1)
28(1)
15(1)
19(1)
16(1)
16(1)
21(1)
16(1)
17(1)
35(1)
18(1)
72(3)
105(8)
27(2)
1(1)
-2(1)
-2(1)
-1(1)
0(1)
2(1)
0(1)
0(1)
-2(1)
-7(1)
-1(1)
0(1)
2(1)
0(1)
1(1)
-3(1)
0(1)
3(1)
2(1)
2(1)
-1(1)
-2(1)
1(1)
-4(1)
-1(1)
1(1)
2(1)
-1(1)
-1(1)
2(1)
1(1)
7(1)
-1(1)
27(2)
29(5)
3(2)
10(1)
8(1)
7(1)
6(1)
8(1)
5(1)
7(1)
5(1)
4(1)
5(1)
7(1)
7(1)
8(1)
7(1)
6(1)
5(1)
7(1)
8(1)
7(1)
9(1)
5(1)
7(1)
10(1)
9(1)
7(1)
8(1)
4(1)
9(1)
8(1)
5(1)
8(1)
16(1)
10(1)
-19(2)
-1(4)
6(2)
1(1)
-3(1)
1(1)
2(1)
4(1)
2(1)
0(1)
0(1)
-1(1)
-3(1)
-1(1)
-1(1)
-1(1)
0(1)
3(1)
6(1)
13(1)
4(1)
-3(1)
1(1)
-1(1)
-4(1)
-8(1)
0(1)
2(1)
3(1)
3(1)
0(1)
4(1)
7(1)
1(1)
0(1)
-2(1)
-18(2)
-7(3)
3(2)
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Table S13. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3) for (+)-63-2HCI.
x y z U(eq)
H(3)
H(4)
H(6A)
H(6B)
H(7A)
H(7B)
H(8A)
H(8B)
H(9N)
H(1OA)
H(1OB)
H(11A)
H(I1B)
H(14)
H(15)
H(16)
H(17)
H(19)
H(20A)
H(20B)
H(21A)
H(21 B)
H(21C)
H(22A)
H(22B)
H(22C)
H(24)
H(25)
H(27)
H(28)
H(29N)
H(30A)
H(30B)
H(30C)
H(31A)
H(31B)
H(31C)
H(lSA)
H(lSB)
H(ITA)
H(1TB)
H(2TA)
H(2TB)
1137
983
1214
1889
-217
-25
-147
1080
536(15)
1809
631
2455
1376
4163
6111
6885
5750
2687
3634
3646
2989
4028
2781
3791
3033
4344
3394
2760
-393
246
-42(13)
1636
429
550
2032
884
1114
-1270(60)
-1900(40)
-1110(90)
-1620(60)
-1400(70)
-1300(40)
10069
10026
9189
8114
8297
7743
6439
6414
7531(15)
5685
5850
6293
7024
6106
6256
7849
9316
7223
9293
8515
9839
10313
10611
10179
10788
10649
8360
8105
8799
9025
8455(16)
6976
6692
7102
8879
8929
9749
6270(40)
5400(40)
6130(50)
5180(70)
7330(30)
6470(40)
-3949
-5222
-6396
-6380
-6024
-6786
-5856
-5992
-4792(11)
-4553
-4347
-3296
-3369
-3807
-3287
-2763
-2704
-4977
-4705
-5408
-6319
-5670
-5662
-2333
-3075
-2974
-2064
-954
-2223
-3337
-941(12)
-368
-924
-56
30
272
-349
-3660(30)
-3510(40)
-3820(70)
-3690(70)
-1900(40)
-2386(17)
29
27
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30
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32
32
32
28
32
32
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31
34
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26
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47
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31
31
34
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30
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44
44
44
108
108
94
94
70(30)
18(14)
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Appendix A
Spectra for Chapter I
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.100 sec
Pulse 73.1 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4294973 MHz
DATA PROCESSING
FT size 262144
Total time 1 min, 21 sec
0
MeO Ph
N
3aa
11 10 9
it~ iLl
8 7
I -I- I I I I I -- T - I 'T
6
0.89 1.02.10 1.16
1.01 1.07 6.18 1.13
12 5 34
3.22
2.91
2 1 ppm
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz NO, r- W,0M
221 repetitions M C' 0 n
OBSERVE C13, 125.7822234 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
cont i nuous ly on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 45 hr, 39 min, 31 sec
c"00
,.cn
0) ~o '('3
4CD
U, ~
-4-4-4
CD0 ,
co
0
MeO N P
MeON -
3aa
00
LnDD
CYD
-4 -
-4 -
-4
NJ~
cii
220 140 120 
100 80 60 40
200 180 160 20 0 ppm
cn
140 120 100 80 60 40
84.4
80
75
70
65
60
55
2252.67
0
MeO -Ph
MN 
"~ N 
,
N
I I
3aa
50
45 I,
II
1075.9R
'i177.65
1137.79
1023
'2 4.67
1515.73
1660.79
2000
1337.4k
1303.16
1268.09
1500
cm-I
1000
I I
I837.80
3060.501
2935.73
71.3I
.83
40
6.301
14
t5.98
752.44
731.13
35
30
913.38
828.
25
23.1
4000.0 3000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.100 sec
Pulse 78.7 degrees
Acq. time 4.999 sec
Width 12012.0 H7
16 repetitions
OBSERVE H1, 500.4294975 MHz
DATA PROCESSING
FT size 262144
Total time 1 min, 21 sec
0
MeO Ph
N
3ac
-_ -------- - ----------
_ - ----
_ _
T-'---7-- V - - --- T- -- ---- F r 7 -----T rF 7 T --- 7----- T ---- ----- -7- F - - -
12 1110 9 8 7 6 5 4 3 2 1 ppm
0.82 2.0.69 1.07
1.00 1.8B.99
13C OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.500 sec
Pulse 46.2 degrees
Acq. time 1.500 sec
Width 22624.4 Hz
512 repetitions
OBSERVE C13, 75.4615184 MHz
DECOUPLE H1, 300.1067546 MHz
Power 39 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Sq. sine bell 1.500 sec
Shifted by -1.500 sec
FT size 262144
Total time 17 min, 8 sec
0
MeO NPh
MeO N
3ac
-
1-
oU')
LON
0N
A..J~~~~~~~~~~~ W.L. JA AiJ 1.. . . - -A-I .- i~L"
I I'..I. .I . .r I I I
220 200 180 160
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40
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-.iL I . I II .
o N
L. I 1 1
S8 0 4I I I I
80 60 40
I I T T 1. 1 1 1 1 1 f T I I - I I I T 1 1 1 1 1 1 r T 1 1 1 1 1 1 , I [ I , I , I -
20 0 PPM
T--T-T
-4
Cq
CD
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I I I I I I II I
140 120
86.5
80
75
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65-
60
55
50
45 ,
0
MeO N',Ph
MeO N
3ac
II
I'
1~75.3
3059.1I
3006.71
837.73
2935.710
1732 .9
1
1 i 151
1660 47
1584.53
2000
cm-i
I
2
6 6.46
38
.7 '
869.26'
810.18
7 3. 6
700.30
590.90
.13
1213.2
1176.60
I 1138.26
024.08
1269.39
1 8.76
1500 1000 500 400.0
768.88
I I
I I
40
35
30
25
20
15
10
5
0.3 K
4000.0 3000
I
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: DMSQ
Ambient temperature
INOVA-500 "Zippy"
Relax. delay 0.100 sec
Pulse 78.7 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4318716 MHz
DATA PROCESSING
FT size 262144
Total time 1 min, 21 sec
0
Ph N Ph
N /
3ba
14 13 12 11 10 9 8 7 6 5 4 3
1. O0 .091.183.32
1.10 2.211.95.33
2T
1 ppm
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: DMSO
Temp. 100.0 C / 373.1 K
INOVA-500 "zippy'
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
296 repetitions
OBSERVE C13, 125.7829573 MHz
DECOUPLE H1, 500.2315969 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 22 hr, 49 min, 46 sec
a
Cq
to M C in c
-" - 3- -YC') C" U1 N L
Nl N N CS
0. 2 2
0 N
M
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1
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0
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T -' _ _r- - -T
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-- . I . 1 -1-- . . I . I . -_ 7
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I -Ulz,
0091 000z OOoK 0*00017
t7Of99 I
17,68 E fI
0f
9O,9LZI ZI 'V61t1
89,E851,
Z9M1
58TLO I
98S911l
RULLI
f6*890f
eqg
S N
q~d- N qAd
0
WL661
6Z'616Z
81O58Z, 08'I1 ZE
8I~O~t~
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STANDARD 1H OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE H1, 300.1052783 MHz
DATA PROCESSING
FT si ze 131072
Total time 1 min, 4 sec
00-
0
0
Ph N
N
/ 3bb
- ' ' ' ' 
9 8 7 6 5 4
1.00 1.14 9.29
1.92 .98
I ' 
------ | ' I I I | 1 '
3 211 10 1 ppm
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13C. OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.500 sec
Pulse 46.2 degrees
Acq. time 1.500 sec
Width 22624.4 Hz
512 repetitions
OBSERVE C13, 75.4615196 MHz
DECOUPLE H1, 300.1067546 MHz
Power 39 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Sq. sine bell 1.500 sec
Shifted by -1.500 sec
FT size 262144
Total time 17 min, 8 sec
00
N71
i,~~~~~~~ ~ ~   iNj ii wL~L h9Aj"1 iAA .I U.1. A-iW j1.
LN Cno CUi
C. N -4 C
aa) O' ao
NN N C. C,
00 U: ,
CO .q
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Ph )N Ph
N
.'3b b
to 0
1 C'
IL~L4MM1L~k..~I in. IJ~~~hALu~ ~i41it~ii .&i Li .ih.Lan ili~J, .nI&~ L*kIMI*4 nn.iAJUi.J Iii IAinL .i..Li ,i..LJ~ .Mi&. ~ .~ hAiL
160 140 120 100 80 60 40 20
I. -, dlatinm
TrITW -R1filI Mv~f T 1
ppmr'
240 220
I I
200
I ! | 4 .
180
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2246.52
80 91 .06
0 1 16875
Ph 1 00.41 938
Ph N 61643 26 1 $62.11
70 306 6N2oii 1073.69 912.01
1 05.9,3 1027.03
65 1178.4
lo- 3bb 4i. 1131.9260 S7.46 616.4
118.5 7. 1 1218.79
784.41
50
45
%T
00 40 1427.53 753.49
1348.23
35
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30 1501.68 697.99
25
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20
15
10
5
0.9
4000.0 3000 2000 1500 1000 500 400.0
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
INOVA-500 "zippy"
Relax. delay 2.000 sec
Pulse 94.4 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417199 MHz
DATA PROCESSING
FT size 262144
Total time 1 min, 20 sec
8 7 6 5 4 3 2 1 -O ppm
Y L"I Y
2.18.2318
1.173.2518
0
Ph N
N'
3bc
V
11 10 9
1.00
I
Li
13C OBSERVE
Pulse Sequence: s2pul
Solvent: CDCl3
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.500 sec
Pulse 46.2 degrees
Acq. time 1.500 sec
Width 22624.4 Hz
512 repetitions
OBSERVE C13, 75.4615190 MHz
DECOUPLE H1, 300.1067546 MHz
Power 39 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Sq. sine bell 1.500 sec
Shifted by -1.500 sec
FT size 262144
Total time 17 min, 8 sec
00
Ln
160 140 120 1'
-rT-~TT 1T-TT TT-r T-- " - rT TT-j
0
Ph N,Ph
N/
o N
N *
.- 4fl
COTL t00 00
mo eLn M a
U) C')O
Cv)
00
N
3bc
U)
(0
0) C
v0
N"
220
Ln
I , I - I
al
180 00 80 60 40200 20 0 ppm
0
K .Ph
Ph N
N 
3bc
j
2851.7760 1
55
50
45
40
35j
30
25
20
15
10
5
1582.54
17 17.03
67.6
65
1 24
149 9
1467.7
1661.45
2000 1500 1000
cm-I
8 3.3i
26.09
093 859.06
179.57 9 3.88
1232.78 F 1*8. 8 908.04
1152. 8 9 4.98
118A
1075.24
1027.58
1282.49
3d 6.84
2924.94
3059.81
00
1432.98
1341.09
0.8
4000.0 3000 500 400.0
788314 6
780.99
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: DMSO
Temp. 80.0 C / 353.1 K
INOVA-500 "zippy"
Relax. delay 0.100 sec
Pulse 73.1 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
32 repetitions
OBSERVE Hi, 500.4318712 MHz
DATA PROCESSING
FT size 262144
Total time 2 min, 43 sec
0
Me N Ph
N 
3ca
00
L '1 1 I
12 11 10 9
1.
8
Y Y Y VYY Y'T Y
00 1.07.102.0.12
1.01.82142.21
7 6 5 4 3
I F I --- 7 - - T F i I F I I I
2 1 -0 ppm
Y
3.09
@IL--
.. ........ .... 'IQ I'll 11 ......... &
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: DMSO
Temp 100.0 C / 373.1 K
INOVA-500 "zippy'
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
168 repetitions
OBSERVE C13, 125.7829567 MHz
DECOUPLE H1, 500.2315969 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 22 hr, 49 min, 46 sec
InV U- W r . 1V) M
r" U) CO mn e
0,. 00 00 CWC (P
(n MV V c'i 
" N TJQ
-~ ~4 ~0-
[K)
11,-a
0
Me N Ph
N
3ca
co C
C'J I
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T Ti r - I T
160 140 120 100 80 60 40 20
00
r- C75
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I
, I I . L
-11 jfr- r i w -- -r - -- i - --N I-ele r 1 1 v- , ", -- ,. J .- , -- , -
240 220 200 180 0 -20 PPM
1959.19 1796.25
15 .44
80
75
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65.
60
%T
55
50-
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35
153.41
15{52
1 09.,
120.61
1158. 0
1
1325.66 1 C
1141.55
.01
1274.73
1494.92 130.1
3.7
7.6
829.95
48.71
696.44
755.59
1370.11
1301.83
30-
26.6-
4000.0
90.2
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0
Me ANPh
N ;-
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1 1$60
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00
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2000
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1500 1000 600.0
STANDARD 1H OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE Hi, 300.1052818 MHz
DATA PROCESSING
FT size 131072
Total time 1 min, 4 sec
00
0
Me N
N
3 c b
12 11 10 9 8 7 6 5 4 3 2 1
1.091.12.11
1.04 .166 .25
-0 ppm
3.00
13C OBSERVE
Pulse Sequence: s2pul
Solvent: CDCl3
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.500 sec
Pulse 46.2 degrees
Acq. time 1.500 sec
Width 22624.4 Hz
256 repetitions
OBSERVE C13, 75.4615215 MHz
DECOUPLE H1, 300.1067546 MHz
Power 39 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Sq. sine bell 1.500 sec
Shifted by -1.500 sec
FT size 262144
Total time 8 min, 34 sec
N.
CD~
4 
a
MD~ C
U) CnU
aa, .C
0
Me N
N
3| c
(Cn
U)C
0
(00
U)n
-4 CD
220 200 160 140 120
1 60F 1 C F T I'-FF7 40, 20 -'- pp mFFT
100 80 60 40 20 0 PPM
-4J
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'.4
180
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1618.ti
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92.81
43.32 7 6.?3j
1073.44
11199.56 1034.971
1143.$2 985.68
1118.86
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45.61
698.85
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1321.51:
1427.14
1368.22
1501.36
55
1681.66
2000 1500
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1000
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0
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3583.26
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60
50
45
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4000.0 3000 600.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
INOVA-500 "zippy"
Relax. delay 2.000 sec
Pulse 59.1 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417203 MHz
DATA PROCESSING
FT size 262144
Total time 1 min, 20 sec
0
Me N
N'
3cc
V ~~ - V F TT r -------- r j I 1-
12 11 10 9 8 7 6 5 4 3 2 1 ppm
0.83 0.838r.00
0.971.BB99 2.96
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
4096 repetitions
OBSERVE C13, 125.7822090 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 2 hr, 51 min, 15 sec
C')
(0
N
co
U)
CN
(I
L.
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4000.0 3000 1000 600.0
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambi ent temperature
INOVA-500 "zippy'
Relax. delay 0.100 sec
Pulse 78.7 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
Single scan
OBSERVE H1, 500.4294965 MHz
DATA PROCESSING
FT si ze 262144
Total time 0 min, 5 sec
0
Ph N'
3da
11 10 9 8
Y Y Y Y-y
0.95 1.l4M11.931.76
1.02111.5)1 1.08
12 7 6 5 4 3 2
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1 -0 ppm
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13C OBSERVE
Pulse Sequence: s2pul
Solvent: COC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.500 sec
Pulse 46.2 degrees
Acq. time 1.500 sec
Width 22624.4 Hz
256 repetitions
OBSERVE C13, 75.4615277 MHz
DECOUPLE H1, 300.1067546 MHz
Power 39 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Sq. sine bell 1.500 sec
Shifted by -1.500 sec
FT size 262144
Total time 8 min, 34 sec
M
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Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.100 sec
Pulse 78.7 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4294963 MHz
DATA PROCESSING
FT size 262144
Total time 1 min, 21 sec
0
,kMePh N
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00
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Y Y YYrYY Y
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13C OBSERVE
Pulse Sequence: s2pul
Solvent: CDCl3
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.500 sec
Pulse 46.2 degrees
Acq. time 1.500 sec
Width 22624.4 Hz
256 repetitions
OBSERVE C13, 75.4615208 MHz
DECOUPLE H1, 300.1067546 MHz
Power 39 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Sq. sine bell 1.500 sec
Shifted by -1.500 sec
FT size 262144
Total time 8 min, 34 sec
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Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
INOVA-500 "zippy'
Pulse 88.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
16 repetitions
OBSERVE H1, 500.2272164 MHz
DATA PROCESSING
FT size 131072
Total time 0 min, 54 sec
0
Ph N'Me
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- -- r1 1 
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STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
INOVA-500 "zippy"
Relax. delay 3.000 sec
Pulse 33.6 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
435 repetitions
OBSERVE C13, 125.6601347 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
Total time 91 hr, 11 min, 2 sec
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STANDARD 1H OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy'
Relax. delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE H1, 300.1052785 MHz
DATA PROCESSING
FT size 131072
Total time 1 min, 4 sec
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STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: DMSO
Temp. 100.0 C 7 1 K
INOVA-500 "zippy"
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.136 sec
Width 37735.8 Hz
271 repetitions
OBSERVE C13, 125.7829573 MHz
DECOUPLE H1, 500.2315969 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 22 hr, 49 min, 46 sec
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STANDARD 1H OBSFRVF
Pulse Sequence: s2pul
Solvent: CDCl3
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax . delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE H1, 300.1052821 MHz
DATA PROCESSING
FT size 131072
Total time 1 min, 4 sec
o - OMe
N
3eb
-~~- r~T y-
12 11 10 9 8 7 6 5
0.82 0.975.71 2.28
1.64.37 2.00
4 3 2 1 ppm
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13C OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
Mercury-300 "mrhat"
Relax. delay 0.500 sec
Pulse 46.2 degrees
Acq. time 1.500 sec
Width 22624.4 Hz
1756 repetitions
OBSERVE C13, 75.4615196 MHz
DECOUPLE H1, 300.1067546 MHz
Power 39 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Sq. sine bell 1.500 sec
Shifted by -1.500 sec
FT size 262144
Total time 41 hr, 47 min, 0 sec
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STANDARD 1H OBSERVE
Pulse Sequence: s2pul
Solvent: CDCl3
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE H1, 300.1052821 MHz
DATA PROCESSING
FT size 131072
Total time 1 min, 4 sec
0 - OMe
NBr N
3ec
I,
10 9 8 7
3.913.00
1.10 1.45 2.05
0
11
J I
T T- -1 T - ---- T T
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1 .00 3.04
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
512 repetitions
OBSERVE C13, 125.7822136 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 21 min, 26 sec
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambi ent temperature
INOVA-500 ''zippy"
Relax. delay 2.000 sec
Pulse 94.4 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE h1, 499.741/185 MHz
DATA PROCESSING
FT si ze 262144
Total time 1 min, 20 sec
0
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1110 9
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STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
256 repetitions
OBSERVE C13, 125.7822113 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 10 min, 44 sec
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STANDARD 1H OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE H1, 300.1052786 MHz
DATA PROCESSING
FT size 131072
Total time 1 min, 4 sec
f
0
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STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambi ent temperature
INOVA-500 "zippy"
Relax. delay 0.763 se.
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
2124 repetitions
OBSERVE C13, 125.7822072 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 44 hr, 8 min, 23 sec
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambi ent temperature
INOVA-500 "zippy"
Relax. delay 2.000 sec
Pulse 94.4 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417206 MHz
DATA PROCESSING
FT si ze 262144
Total time 1 min. 20 sec
IT-r
MeO
MeO
.1Pr
3ga
-T T
8 7
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STANDARD CARBON PARAME TERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.763 sec 0
Pulse 69.0 degrees
Acq. time 1.736 sec MeO Pr
Width 37735.8 Hz N - D to
4719 repetitions
OBSERVE C13, 125.7822078 MHz - - -N -
DECOUPLE 111, 500.2292208 MHz MeO N
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072 3ga
Total time 22 hr, 49 min, 46 sec
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STANDARD 1H OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE H1, 300.1052782 MHz
DATA PROCESSING
FT size 131072
Total time 1 min, 4 sec
k)
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STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
0
Relax . delay 0.763 sec
Pulse 69.0 degrees MeO Pr
Acq. time 1.736 sec N
Width 37735.8 Hz
480 repetitions
OBSERVE C13, 125.7822130 MHz MeO N
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz o ,-e.in
FT size 131072 - 'Z
Total time 22 hr, 49 min, 46 sec O C> _ ,
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STANDARD 1H OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE H1, 300.I0522789
DATA PROCESSING
FT size 131072
Total time 1 min, 4 sec
0
MeO Pr
N
MeO NMHz
3gc
I / I
~ kA ~iJ'JI______________ I ______ ______ ____ 
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5 4
.99
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STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.763 sec M
Pulse 69.0 degrees N' P
Acq. time 1.736 sec N
Width 37735.8 Hz to 0o
644 repetitions DoM, r' a
OBSERVE C13, 125.7822084 MHz MeO N
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING 3gC
Line broadening 0.3 Hz
FT size 131072
Total time 45 hr, 39 min, 31 sec
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: DMSO
Temp. 100.0 C / 373.1 K
INOVA-500 "zippy"
Pulse 79.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
16 repetitions
OBSERVE H1, 500.2295896 MHz
DATA PROCESSING
FT size 131072
Total time 0 min, 54 sec
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STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: DMSO
Temp. 100.0 C / 373.1 K
INOVA-500 "zippy"
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
1272 repetitions
OBSERVE C13, 125.7829550 MHz
DECOUPLE H1, 500.2315969 MHz
Power 37 dB
continuously on
WALT2-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 22 hr, 49 min, 46 sec
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STANDARD 1H OBSERVE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.050 sec
Pulse 34.3 degrees
Acq. time 4.003 sec
Width 6002.4 Hz
16 repetitions
OBSERVE H1, 300.1052790 MHz
DATA PROCESSING
FT size 131072
Total time 1 min, 4 sec-
_ 11
0
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7'
/' 7
- ,-.--.-----.~.--------
8 7 6
1 15 1 2M.883 .40
2.01). 2.17
5 4
l.11
1.11
3 2 1
1.21.89 2.702.71
2.18 2.01 13.61 2.793.40
12 11 10 9 -0 ppm
13C OBSERVE
Pulse Sequence: s2pul
Solvent: CDCl3
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.500 sec
Pulse 46.2 degrees
Acq. time 1.500 sec
Width 22624.4 Hz
512 repetitions
OBSERVE C13, 75.4615227 MHz
DECOUPLE H1, 300.1067546 MHz
Power 39 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Sq. sine bell 1.500 sec
Shifted by -1.500 sec
FT size 262144
Total time 17 min, 8 sec
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Pulse 79.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
16 repetitions
OBSERVE H1, 500.2272157 MHz
DATA PROCESSING
FT size 131072
Total time 0 min, 54 sec
0
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STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Temp. 20.0 C / 293.1 K
INOVA-500 "zippy"
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
12712 repetitions
OBSERVE C13, 125.7821446 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 45 hr, 39 min, 31 sec
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MWD1 D, Sig=254,16 Ref=360,100
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67.5 70 72.5 75 77.5 80 82.5 85 min
Area Percent Report
Sorted By
Multiplier
Di ltion
Use MuItipl ir & Dilution
Signal
1.0000
1.0000
Factor with ISTDs
Sigal i.: MWDI D, Sig=254,16 Ref=360,100
Peak RetTime Typ
# [inn
I 69.292 PV
74.489 VB
Totals :
e Width
[min I
1.4743
2.4760
Area
mAU* s
143 .10532
1.32871e4
1.34302e4
Height
[mAU]
1.15119
72.98418
74.13538
Area
1.0655
98.9345
Resul : s obtained with enhanced integrator!
End of Report
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0Me N
MeN....
(+)-3ha
MWD1 D, Sig=254,16 Ref=360,100
mAU
8
6
4
C\4 Co
00f
68 70
Area Percent Report
Sorted By
D K u t I LP
Use~ Mult>p ier
: Signal
: 1.0000
: 1.0000
& Dilution Factor with ISTDs
Signal 1: MWDi D, Sig=254,16 Ref=360,100
I
RetTime Type
1-.2 4 MM
75.665 MM
Width
min]
2.3878
2.6063
Totals :
Area
[mAU* s]
422.22662
421.07855
843.30518
Height
[mAU]
2.94713
2.69268
5.63980
P-sul:.- ob.tained wirh enhanced integrator!
End of Report
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C)
-4
64 66 7 772 74 76 78 80 min
Area
50.0681
49.9319
Me N
Me H
1h
MWD1 B, Sig=230,16 Ref=360,100
'I
0
Ci
2-- --
42 44
Area Percent Report
Sr t-ed By
Mu t ipl1er
D lution
Use0 Multriplier
Signal
1.0000
1.0000
& Dilution Factor with ISTDs
Signal 1: MWDI B, Sig=230,16 Ref=360,100
Pak RT ime
S37.719
2 .340
Type
LBB
MM
Width Area Height
[min] [mAU*s] [mAU]
-- --- I---------I - - - - -
0.9076 6347.98145 102.34804
0.9913 77.54951 1.30385
Area
-
98.7931
1.2069
Tot-als : 6425.53096 103.65188
Results obtained with enhanced integrator!
* End of Report ***
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mAU
100
0)
80
60
40
20
34 36 38 40
Me N
Me
1h
MWD1 B, Sig=230,16 Ref=360,100
mAU
15
10
0
0)
N-(~)
-5
-15
34 36
Area Percent Report
:rtec e y
M-u t 1p0 ier
Dilut ion
Use Multipl~ir
: Signal
: 1.0000
: 1.0000
& Dilution Factor with ISTDs
n I:WD1 B, Sig=230,16 Ref=360,100
Peadk RetTiine Type
37.9L0 LBB
4 2.231 BB
Width
[min]
0.7657
0.7854
Area
[mAU * s]
323.57190
327.61554
651.18744
Height
[mAU]
5.65401
5.28346
10.93746
Area
49.6895
50.3105
Resulls obtained with enhanced integrator!
* End of Report *
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-10
CVi
38 40 42
-4
44 min~
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
INOVA-500 "zippy"
Relax. delay 2.000 sec
Pulse 89.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417195 MHz
DATA PROCESSING
FT size 262144
Total time 1 min, 20 sec
O
Ph N'
OMe
3dd
9 8 7 6 5 4 3 2 1 ppm
1.00 1.98 0.93
2.81 0.98 6.25
12 11 10
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
52 repetitions
OBSERVE C13, 125.7822142 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 45 hr, 39 min, 31 sec
C"
LO
1
C"
IT
41,
0
cli
W
UDI
to
-4
-4
'I..
C',
C" Cn
C;)
LI
0
Ph N Me
N /10
OMe
3dd
00
C3
Cv)
N000
MC)
Mv
7 r-r.77iiL.-'7,i
20 0 -20 ppm0 120 10014 80 60 40240 220 200 180 160
87.4
85
80
75
70
65-
60-
55 -
1500
929.41 151.35
3583.20 3060.91
2941.42
N
3dd
%T 50
45
40
35
30
25
20
15.8
4000.0
,Me
j 10.4
j 1482.2)
1446.79
1362
1 6.64
1 63.
294.46
9 0.46
74.14'
11223
1093.12
1619.44
1044.03
1232.98
04
1651.82
1594.99
3000 2000 1000
cm-I
829.0w
792. 50
728.
6 16
564.29
711.93
600.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDClY
Amb i ent temperature
INOVA-500 "Zippy"
Relax. delay 2.000 sec
Pulse 89.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417195 MHz
DATA PROCESSING
FT si ze 262144
Total time 1 min, 20 sec
0
Ph N'
%- 
NO
2
3de
- I -
8
Y Y4-
0.98 2.27
0.81 3.16
6 5 4 3 2 1 ppm
1.00
3.49
1 11T10 9
12 11 10 9
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
INOVA-500 "zippy"
Relax. delay 0.763 se.
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
255 repetitions
OBSERVE C13, 125.7822118 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Total time 45 hr, 39 min, 31 sec
0
40-0
0 M
-
0- co
QU
(Z
Lr)
U")
Lr)
CY)
0
Ph N'Me
N 
1
NO2
3de
01
Cn
-4
cli
to
NCIO
22020018016014012010080 0 4 20ppml,
a)
Ln
1;
Lr)
220 200 180 160 140 120 100 80 60 40 20 PPM
87.2
85
80
75
70
65
60
13 4.5
282.9
4-
ii I
1393.116!
1663.03
1534.31
2000 1500
1356.43
1000
cm-1
90.02
1191.31
1132.3
1101.411
1080.
1048.41
1021.99
3
0
)Me
P h N'
N
NO2
3de
3089.82
2923.40
55
50CIS
885.87
:829.24
643.23
45
40
35
30
25
22.4
4000.0 3000 600.0
IIA 1
Appendix B
Spectra for Chapter II
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 72.4 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE 11, 500.4252875 MHz
DATA PROCESSING
FT size 262144
0
Me
Me
Sla
00
1 1 T
1211 8 7 654 32 1 PPM10 9
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
65536 repetitions
OBSERVE C13, 125.7822245 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
0
N
H Me
Me
Sla
4 T 2 0 ppm200 180 160 140 120 100 80 
60 40 20 0 ppmI I ! I
200 180 160 140 120 100 80 60
84.9
80
75
70
65
60
55
50-
45
%T 40
35
30
25
20
15
Sla
0
3405.3$
3057.5k
i3.00
29 1.04
2969.38
13
1525.34
1457.41
1528.733285.74
40.65
1229.08
928.14
8 805.5
1010.22
665.58
1098.28
742.51
1651.87
10
5
0.0 - ,- -0i 
-0.0 3020
4000.0 3000 2000 1500
cm-1
1000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 72.4 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4252862 MHz
DATA PROCESSING
FT size 262144 I
12 11 10 9 8 7 6 5 
4 3 2 1 -O ppm
0
N MeH Me
Me
Me
1a
3 2 1 -0 ppm 11 10 9 8 7 6 5
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
65536 repetitions
OBSERVE C13, 125.7822245 MHZ
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
120 100 80 60
0
H Me
Me
1a
- - - - . . - -, - i - -- . - -. - -- 10 - ft% - -, - -j No -- - - I
I
200 180 40 20 0 ppn140160
100.0
95
90
85
80
927.17
75
0
70- MeNII
703055.4 He1 8959 101265
65.N Me ;1157. 9
M p 665.67e
60
3.58 i 1130. 01a
552 1097.5
3301.34 I378.1
50 1
%T21327.16 1071.20
4 I 2931.04 1472 .00 1236.69
40
1548.04
35 740.01
30
1646.83
25
20
15
10
5
0.0- - -- - -
4000.0 3000 2000 1500 1000 500 400.0
cm-I
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417347 MHz
DATA PROCESSING
FT size 262144
1 1 10
12 11 10 9
S02 CF3N Me
0 '' Me
:LN
Me(±)-3a
8 7 6 5 4 3 
2 1 ppm
k)
3 2 1 PPM87 6 5 4
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCIS
Ambient temperature
Relax. delay 3.000 sec SO 2CF 3Pulse 35.0 degrees
Acq. time 2.000 sec N ME
Width 31397.2 Hz
302 repetitions
OBSERVE C13, 125.6601362 MHz
DECOUPLE H1, 499.7442194 MHz '' Me
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING Me
Line broadening 1.0 Hz (±).3a
FT size 131072
200 180 160 140 120 100 80 60 40 
20 0 ppir
120 100 80 60 40 20 0 ppnr 180 160 140
19F SENSITIVITY
0.05X TRIFLUOROTOLUENE
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 2.000 sec
Pulse 90.0 degrees 2 3
Acq. time 0.232 sec N MeWidth 140.8 kHz
12 repetitions
OBSERVE FI, 470.2272133 MHz
DATA PROCESSING Me
Line broadening 1.0 Hz
FT size 131072 N
Me(±)-3a
in
C!
Ln
F T --T - F -r TI f I I 1 7 T
0 -20 -40 60 -80 -100 -120
-140 -160 PPM
SO 2CF 3
N Me
e.. Me
N
Me(t)-3a
85
80
75-
70-
65-
60-
55
50
45
40
35
30j
25
20
15
10
3O.
856.76
i67.9
665.55
786.30,
738.42
599.77
- , 4
500 400.0
100.0
95
90
2919.08
2860.40
1~J
1298.0 95
1 53 24 1278.
1255.'0
1606.13 1023.79
1493.48
K 1133.63
1222.A2
1377.94 1191.45
0.0 4--
4000.0 3000 2000
cm-I
1500 1000
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE Hi, 499.7417336 MHz
DATA PROCESSING
FT size 262144
S02CF3N
N
Me
(±)-3b
TTI IIIIIIIT I I Ii -I_ _ _ _ _ __ _ _ _ _
00
2 1 pp7 6 54 3
- I I
9 812 1110
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
142 repetitions
OBSERVE C13, 125.6601405 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
SO2 CF3N
Me
1-~
200 180 160 140 120 100 
80 60 40 20 0 ppi
40 20 0 ppi
I I II I . I I I . I I f 1 1 1 1 1 1
I 1 1 1 1,
 160 140 120 100 80 60
19F SENSITIVITY
0.05% TRIFLUOROTOLUENE
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 2.000 sec
Pulse 90.0 degrees
Acq. time 0.232 sec
Width 140.8 kHz
16 repetitions
OBSERVE F19, 470.2272133 MHz
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
S02 CF3N
Me
(±)-3b
C',
I k .. kh -Lj... -i;~ f L2,:.hJ- -k- "2 A.;... -It J j iN1. 1 fl~ v LL..T~
-40 -60 -80 -100 140 -160 pN
I . I . I . I I I I . . . . . I I . I . I I1 1 1 1 j j--T--r- j ] j -F -T T T j ; ' 1 1 1 1 1 1 , 1 - . 1 1 1 1 1 1
0 -20 -120
100.0
95
90-
85
80
S02CF3  o J
75 2953.64 N 2
772
70 286. 7 13 .78  66.906
65 28.3 66 1299.1 F 865.88 665.541
( )-3 b 05.8 5160-
1656.7I
1093.72
1607.79 1022.34 747.57
50-
T 1492.11
45 13 i78
40-
1404.36 1j47.16 614.i9
35 593.24
30 1 7.96
25-
20
1227.46
15
10 1
5 .
0 .0--- ---
4000.0 3000 2000 1500 1000 500 400.0
cm-1
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 1.800 sec
Pulse 90.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
5 repetitions
OBSERVE Hi, 500.2272318 MHz
DATA PROCESSING
FT size 131072
S0 2CF 3N
( )-3c /
12 11 10 I 8 7 6 I I I I i Ipp -T--I  I I I I I--T I I T I I3 2 1pplI I11 10 9 8 712
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
397 repetitions
OBSERVE C13, 125.7822193 MHz
DECOUPLE Hi, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
S02CF3N
(±)-3c
200 180 160 140ZOO  160 140 120 100 
80 60 40 20 0 ppmI I I I I I I I
120 100 80 60 40 20 0 PPM
19F OBSERVE
STANDARD PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 4.000 sec
Pulse 45.0 degrees
Acq. time 0.300 sec
Width 100.0 kHz
6 repetitions
OBSERVE F19, 282.3814158 MHz
DATA PROCESSING
Line broadening 0.3 Hz
FT size 262144
SO2CF 3N
(±)-3c
0 -20-40 60 -0 -10 -10 -10 -10 pp
wCD
-80 -100 -120 -140 -160 ppt0 -20 -40 -60
100.9
90
80]
70-
S02CF 3  013.3I
60 303 8 N 45.94
50 2912.1- N 5.74
2831.11 ( )-3C 866.46
40
13 9.75 i1, 527 768.8
30~ 1656.1 1. 499.50
%T 20 1605.98 082.43 742.04 04
1489 39 1028.93 612.A6
10
1404.3 1198.351 591.60
0 ]1382.07 1146.70
-10 1227.81
-20
-30
-40
-50
-55.7 
-
4000.0 3000 2000 1500 1000 500 400.0
cm-1
I
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 0.100 sec
Pulse 72.4 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4252873 MHz
DATA PROCESSING
FT size 262144
SO 2CF 3N
N
(±)-3d 02 0 Me
~I IL I Ll I
12 I1 10 I 8 T 6 5 I f I I Ipp - - I I I I I I I I I I
k.)
3 1~ PpH12 1110 9 8 7 6 5 4 2
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
534 repetitions
OBSERVE C13, 125.7822118 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
SO2CF 3N
0 2 S(+)-3d /Me
L 1j J LP) ~ U P~P I Ni
I I 1-T-
40 20 0 ppn200 180 160 120 100 80 60140
19F OBSERVE
STANDARD PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 4.000 sec
Pulse 45.0 degrees
Acq. time 0.300 sec
Width 100.0 kHz
27 repetitions
OBSERVE F19, 282.3814158 MHz
DATA PROCESSING
Line broadening 0.3 Hz
FT size 262144
SO2CF 3N
-02S
(±)-3d /28Me
C)
00
w
0)
C
I I I I
-160 PPM
0 ' ' ' ' I ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' I I ' ' ' I ' ' ' ' I ' ' ' ' I ' ' ' ' I I - 1 p
-40 -60 -80 -100 -120 -140
. I'~~ ~~ ~~~~ ' ' ' ' '' ' ' 'I '
0 -20
165
90
88
86
84
82
80-
78
76
74
72
0 2S Me
11 9.96
.091.05
1 7.92
1359.31 102
1228.9b
I 199. 9
939.73
869.48
815.12
757.86
735.
699.2
1169.04
665.11.
613.33
1500 1000
cm-I
2285.21
338679
3583.21
92.5
6.201 1+47
1598.87 1
1478.44
14
2919.46
S02CF 3N
-N
(±)-3d
70
68
66
65.1
4000.0 2000 500 400.03000
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: toluene
Temp. 100.0 C / 373.1 K
Relax. delay 2.000 sec
Pulse 84.1 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
12 repetitions
OBSERVE H1, 499.7418474 MHz
DATA PROCESSING
FT size 262144
I2 I 1 10 I f I 6 5 4 3 2T-r 1- ppm I I I I I I I I I I ; I I I
SO 2CF 3
NMe
(±)-6b
I ktI .1 K I
12 11 10 9 8 7 654 3 21PPM
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent; toluene
Temp. 100.0 C / 373.1 K
Relax. delay 3.000 sec
Pulse 37.8 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
1581 repetitions
OBSERVE C13, 125.6600986 MHz
DECOUPLE H1, 499.7442944 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 2.0 Hz
FT size 131072
1 0 . I 1 1 0 1 6 1 4 1 2 1 0 8 0 6 0 4 0 2 0 0I. . . I . I I I ; , , 1 , - i . I I I I I I . I . I Pp p m 1 7 ; T ji I
S02CF3
(±)-6b
Ii ii L +~jIt"~J~P 1-01 -m- MONO
- - - - - I - -04011^10 - - - 0 , MI 10 . lb - 4-011-004
I
200 180 160 140 120 100 80 60 40 20 0 PPM
19F SENSITIVITY
0.05% TRIFLUOROTOLUENE
Pulse Sequence: s2pul
Solvent: toluene
Temp. 100.0 C / 373.1 K
Relax. delay 2.000 sec
Pulse 90.0 degrees
Acq. time 0.232 sec
Width 140.8 kHz
17 repetitions
OBSERVE F19, 470.2272838 MHz
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
SO2CF 3N
| / NMeK-N
Me -
(±)-6b
L,
C
U,
kP)
T IT I f
-40 -60 -80 -100 -120 -140 -160 ppi0 -20
92.2
90
85
80 {953.78
550.93 861.53
SO2CF3
75 103583.16 2915.2 N 39. 802.36
1649.8ll
70 ''N e 1605.25 331.2 092.27 665.60
NIMe
S N I 1021.08
Me - 13 2.87
65 (±)-6b \ / 1485.45 1289.0
1402.304 743.56
60-10
55
1227.58
50
45
40
35
30
24.1 - - -
4000.0 3000 2000 1500 1000 500 400.0
cm-1
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 1.800 sec
Pulse 90.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
32 repetitions
OBSERVE H1, 500.2272234 MHz
DATA PROCESSING
FT size 131072
12 11 10 9 
8 7 6 5 4 3 2 1 ppm
0
N
(X0
le
rj
7 611 10 9 8
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 3.000 sec
Pulse 37.8 degrees
Acq. time 2.000 sec (
Width 31397.2 Hz
320 repetitions N
OBSERVE C13, 125.6601534 MHz
DECOUPLE H1, 499.7442194 MHz H N
Power 34 dB o
continuously on
WALTZ-16 modulated
DATA PROCESSING Me
Line broadening 3.0 Hz
FT size 131072 le
2I i
200 180 160 140 120 100 
80 60 40 20 0 pp~
40 20 0 ppn120 100 80 60
124.2
120
io.
100-4
90
80
70
60-
50,
1696.
1705.01
*1*
2000
70.78
40.0 1244.68
i3.00
0. O46
1157.7U
1973.8>
111326.86
1104.77
1478.02 1284.94 1037.29
1500
cm-1
1000
3348.90
0
H N4
N (X
Me
le40-
30-
20-
10
0-
-10
-20-
-30 -
3053 88
2921.74
743.99
-40.0
4000.0 3000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: toluene
Temp. 100.0 C / 373.1 K
Relax. delay 2.000 sec
Pulse 84.1 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417947 MHz
DATA PROCESSING
FT size 262144
................. . I J . A A
1 -0 ppm8 7 6 5 4 3 212 11 10 9
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: toluene
Temp. 80.0 C / 353.1 K
Relax. delay 3.000 sec
Pulse 37.8 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
10368 repetitions
OBSERVE C13, 125.6600952 MHz
DECOUPLE H1, 499.7442944 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 3.0 Hz
FT size 131072
c
0
N 0
(±)-6e
I I
200 180 16 I4 12 1 80 60 40 20 
0Ip
%.ww-- SA
40 20 0 ppr200 140 120 100 80180 160 60
88
86
84
82-
80-
78
76
74
72
70
68
66
64
62
60
58
56.9
4000.0
3583.15
Me
(±)-6e
3000
0 1487.90
1611.37 1398.54
1770.05
665.54
2000 1500
cm-1
90.4
1121.391
1065.70 740.952931.01
1000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 1.800 sec
Pulse 90.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
16 repetitions
OBSERVE Hi, 500.2272299 MHz
DATA PROCESSING
FT size 131072
0
N
Me Me
MeMe
;N
Me
if
00
A-- X
S 1 1 1 0 p p 4 1 0 pp12 11 1
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
464 repetitions
OBSERVE C13, 125.7822280 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
0
-Me
if
I
iI g~ 4J
60 40
1 I8 I
100 80 20 0 ppm160
I
200 180 140 120
100
80
60
40-
20
0.-
-20 -
1623.22 1379.1)
1327.68
740.34
1152.35
1094.38
.- ....
1500 1000 500 400.0
cm-I
124.3-
3053. 0
2933.23
O0
if
1233.1 8 1 70
2.1208.
1403.96 1168.8
1482.46 13P3.12 111 1.4p
00
-40
-60-
-80-
-100_
-120
-140
-161.4 z
4000.0 3000 2000
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 2.000 sec
Pulse 84.1 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417505 MHz
DATA PROCESSING
FT size 262144
NMe Me
"" 1(Me
' H Me
Me
(±)-7f
12 11 0 I 8 7h 6-5-4-3-2 1ppmI I
6 5 4 3 2 1 PPM12 11 10 9 8 7
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 3.000 sec
Pulse 37.8 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
358 repetitions
OBSERVE C13, 125.6601405 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 d8
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 3.0 Hz
FT size 131072
NMe Me
'' H Me
Me
(±)-7f
200 180 160 140 120
i 8 i
100 80 60 40 20 0 ppm
00
I 
I I I ,
NMe Me
-""6Me
H Me
NI
Me
(±)-7f
91.2
80
70
30-
%T 20-
10
0
-10
-20-1
-30
-40
-46.1
4000.0
cm-I
14 1
390.16
1365.27
1483.2
1461.62
269.39
1208.
11
1500
877.3
102.47 842.50
19.10 964.68
1046.54
1606.23
1000
53.76
60.
50
40 -
00
2952.69
2796.74
2000
740.37
3000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 2.000 sec
Pulse 84.1 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
17 repetitions
OBSERVE H1, 499.7417322 MHz
DATA PROCESSING
FT size 262144
00
(±)-7g
FT ~II 1
12 11 10 9 8 7 6 
5 4 3 2 1 pp
 10 9 8 7 6 5 4 32 1 pp
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
2165 repetitions
OBSERVE C13, 125.7822072 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz N
FT size 131072
(-)-79
200 180 160 140 120 100 80 
60 40 20 0 ppi1 - , I
40 20 0 ppi200 180 160 140 120 100 80 60
93.6
92
90
88
86
84
82 35
80.
78-
76
74
1385.94
83.22
1605.43
2933.22
2803.20
1492.18
1163.701
1271.14 1104.77
1022.92
'Me
X N
Me
(±)-7g
72
70
68
66-
64
62
60..
58
56
54.7
4000.0 3000 2000
cm-1
1500
740.16
665 .60
1000 500 400.0
t-00
00
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 2.000 sec
Pulse 81.5 degrees S0 2 CF3Acq. time 3.001 sec
Width 10504.2 Hz
4 repetitions
OBSERVE H1, 499.7417343 MHz
DATA PROCESSING
FT size 262144
N H
Me
(±)-8h
12 11 10 9 8 7 6 5 3 2 1 ppF
I I - 111111 k I I
4
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
1995 repetitions
OBSERVE C13, 125.6601328 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
140 120 100 60 40 20 0
S02CF 3
(±)-8h
200 180 160 80 PPM
19F SENSITIVITY
0.05% TRIFLUOROTOLUENE
Pulse Sequence: s2pul
Solvent: COC13
Ambient temperature
Relax. delay 2.000 sec
Pulse 90.0 degrees
Acq. time 0.232 sec
Width 140.8 kHz
11 repetitions
OBSERVE F19, 470.2272133 MHz
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
T I i i . I T T- - T f T I i I T T - I IT T 1
-60 -80 -100
SO2CF 3
.N
(±)-8h
a!
0 -20 -120 -140 -160 PPM-40
9?086-
84,
82 -
80-
78
76 -
74
309.62
lr$1 .59
1 5.44
1605.52
1670.88
1485.41
124
1399.47
2 ' 846'
12.8
6.401
910.56
800.39
745.56
1226.67
cm-1
10001500
89.0
88
3583.15
094.161
II I
1039.32
147.19
2911.37 SO2CF 3
t'J
(±)-8h
72-
70
68
66
64-
61.9
4000.0
665.4
621.8$
3000 2000 500 400.0
I ,
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 1.800 sec
Pulse 90.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
3 repetitions
OBSERVE H1, 500.2272281 MHz
DATA PROCESSING
FT size 131072
OMe
0
N OMe
H
Me 11
I ~i1 A lii
I I 1 1 . . , , I I , I12 11 10 I 8 .6 5 4 I I 1 -0 Ippn I IIIIIII i II I I I i I
1 1 10 9 8 7 6 54 3 212 1 -0 ppn
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
108 repetitions
OBSERVE C13, 125.7822170 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 2.0 Hz
FT size 131072
OMe
0
s 
--'OMeN
H
VP
140 120 100 80 60200 180 160 40 20 0 PPM
1327.791
t65.O1 1156.45
1 64.89 1027.47
1645.40 1262.00
1513.64
1500
cm-I
1000
1
3293.06
2933.96
92.4
90
88
86J
84..
82
80
78-
76
74-
72
70
68
66
64
62
60
58
0
OMe
i
742.53
665.64
55.2
4000.0 3000 2000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 73.1 degrees
Acq. time 4.999 sec 2 3
Width 12012.0 Hz N
16 repetitions
OBSERVE 11, 500.4295125 MHz
DATA PROCESSING
FT size 262144 /\-OMe
N H
Me OMe(±)-8i
1 2 1 1 0 I 8 -- - 6 5 4 3 I I. p p lI I I I I I I I I i T -T --3 2 1 PPI
i I I I I
12 10 9 8 76 5 411 I
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
1272 repetitions
OBSERVE C13, 125.7822107 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
SO2CF 3N
OMe
fN H
Me OMe(±)-8i
160 140 120 100 80 60 40200 180 20 0 ppt
19F OBSERVE
STANDARD PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 4.000 sec
Pulse 45.0 degrees
Acq. time 0.300 sec
Width 100.0 kHz
11 repetitions
OBSERVE F19, 282.3814158 MHz
DATA PROCESSING
Line broadening 0.3 Hz
FT size 262144
SO2CF 3N
OMe
N H
Me OMe
(±)-8i
-140 -160 ppm
-40 -60 -80 -100
00
- I
0 -200 -120
2935.22
SO2CF 3
3583.21
1670.01
59
.
0
1603.41
1516. 9
1488.69
13
91.1
90
89
88
944.61
910.25
832.03
740.90
665.69
cm-I
1500 1000
-OMe
87
86-
85-
84-
83-
82-
81-
%T 80 -
79
78
77
76
75
74
73
72
71
(*)-8i OMe
69.5 2-
4000.0 3000 2000 500 400.0
J339.45
1062. 4
1 48. 6
1118.61
96.00 1039.77
1256. j
1225 121
12 12. 13
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 1.800 sec
Pulse 90.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
4 repetitions
OBSERVE H1, 500.2272224 MHz
DATA PROCESSING
FT size 131072 N N0 2
H
Ij
12 11 10 9 8 7 6 5 4 3 
2 1 ppm
3 2 1 PPM 11 10 9 8 7
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
65536 repetitions
OBSERVE C13, 125.7822130 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
0
N NO 2
H
N 
H ij
200 180 160 140 20 0 PPM120 100 80 60 40
89.0-
88
86
84-
82
80
78-
76-
2929.35
N N0 2H
H lj
14521
14t4.98
457.09
1229.A0
1200.94
11
10
08.53
16.11 9.45
855.94
742.81
665.56
1651.82
1516.86
1345.76
1500
cm-1
1000 500 400.0
3078.393583.17
w
3403.081
3292.3774
72
70
68
66
64
61.5 4_
4000.0 3000 2000
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 72.4 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
20 repetitions
OBSERVE H1, 500.4252876 MHz
DATA PROCESSING
FT size 262144
I
S02 CF3N
'N H
SO2CF 3  NO2(±)-8j
J
I [ i1
12I 1 9 I 7
12 11 10 9 8 7 6 5 4 3 2 1 -0 ppm
I 
.
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
448 repetitions
OBSERVE C13, 125.7822049 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
S0 2CF3
N
N H
SO 2CF 3  NO2(±)-8j
I
200 180
14 I I i10 I 6
140 120 100 80 60
-up- _1 111, 11k 0_0
I T I I i I I I I r--T--= T F-T-7- I F T_ -T--T--T-
h, I
40160 20 0 PPM
19F OBSERVE
STANDARD PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 20.0 C / 293.1 K
Relax. delay 4.000 sec
Pulse 45.0 degrees
Acq. time 0.300 sec
Width 100.0 kHz
16 repetitions
OBSERVE F19, 282.3812074 MHz
DATA PROCESSING
Line broadening 0.3 Hz
FT size 262144
S02CF 3N
H' NH2
SO2CF 3  NO2(±)-8j
C!J
0n
CV)
-160 ppm0-- -F 40 -6 -8 
-10 -1T -140FII! I;IT
-120 -140-80 -100
i I II , , 1 1 1
40 -600 -20
SO2CF 3N
SNH 
-
SO 2CF 3(±)-8j
606. 2
1666.22 74
1582.19!
1524.081
7
1404.46 14.37
00.
.24
3 P67. 8
941.39 774.2i
916.66 746. 0
845.12 641.52
4 728.73
665.6
1228.47
1203.36
701,
68
66
64.1
4000.0 3000 2000 1500
cm-I
94.3
92
90
88
86
84
82-
80-
78-
2918.15
3428.94
3583.19
0
76
74
72
6 .01
623 1
1000 500 400.0
~~~-2274.34
96. 2:
1077- 7
1045.0NO2
STANDARD PROTON PARAMETERS
Pulse Sequence:
Solvent: CDCl3
Temp. 53.0 C /
s2pul
326.1 K
Relax. delay 2.000 sec
Pulse 84.1 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417326 MHz
DATA PROCESSING
FT size 262144
SO 2 CF3N
(±)-8k
U
12 11 10 9 16 5 4 3 28 7 PPM
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 53.0 C / 326.1 K
Relax. delay 3.000 sec
Pulse 37.8 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
1331 repetitions
OBSERVE C13, 125.6601151 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 2.0 Hz
FT size 131072
2 0 0 1 8 T0 1 6 1 4 1 2 0 T T 10 8 0 6 0 4 02 
p
SO2CF 3
(±)-8k
00
I I At A
Tr' -
I I I I i
200 180 160 140 120 100 80 60 40 20 0 PPM
19F SENSITIVITY
0.05% TRIFLUOROTOLUENE
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 53.0 C / 326.1 K
Relax, delay 2.000 sec
Pulse 90.0 degrees
Acq. time 0.232 sec
Width 140.8 kHZ
23 repetitions
OBSERVE F19, 470.2272133 MHz
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
S02CF 3N
0
0
(±)-8k
-60 -80 -100
N, i A- VIA I
-120 -140 P p10 -20 -40
88-
86
84
82-
80
78
76
74
72
70-
P80.00 78
922.88
1256.00 851.81
2 1 04. 8
1076.
1229. 6 1048. 1
1205.41
1146.34
1500
756.37
732.40
65 .77
665.61
1029.66
1000
90.9
1474.291
3.4 57.9
1558.82
1462.78
1404.67
2917.71
o )
1670.82
16(
S02CF 3
.N
3583.23 F 3
(±)-8k
68
66
64
62
60
58
56
53.5 _
4000.0 3000 2000
cm-I
500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 1.800 sec
Pulse 90.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
16 repetitions
OBSERVE H1, 500.2272302 MHz
DATA PROCESSING
FT size 131072
H
N
OMe
NH
Me OMe
(±)-9i
12 11 10 9
1I I1 1 8 7i ! 5 4 3 2 IppN I I I I I I . I I T TI 6 5 4 3 2 1 ppn8 7
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CODC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
516 repetitions
OBSERVE C13, 125.7822176 MHz
DECOUPLE H1, 500.2292208 MHz
Power 46 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
H
IN
OMe
N H
Me OMe
(±)-9i
20 I8 16 14 120 IIII. 1 0 80 60 40 20 0 ,ppn 1.iIIII17' I-TT7IIIII200 180 160 20 0 ppn80 60 40140 120 100
(±)-9i
15 14.7$
1463.86
1155.06 697.87
086.02 865.41
122.87 947.39 '665.39
1191.27 1021.69 827.4
56. 1 790.481
1312 . 6 742.01
1294.001
12
I 250. 30
1453.64 1232.58
11948
1000
100.0
95
90
85
80
75 -
70
65
60
55.
501
%T
45-
40
35
3583.19
3334.90
2833.07
2952.11
-OMe
Me OMe
1606.01
I3.25
13
30
~1
25
20
15
10
5i
0.0
4000.0 3000 2000
cm-I
1500 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 72.4 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
17 repetitions
OBSERVE H1, 500.4252875 MHz
DATA PROCESSING
FT size 262144
Me
(t)-1 Oa
12 11 10 9 8 7 
6 5 4 3 2 1 
-fl ppm
IF,
3 1-0 PPM7
I ! !
5 48 612 9
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 3.000 sec
Pulse 37.8 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
226 repetitions
OBSERVE C13, 125.6601333 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 3.0 Hz
FT size 131072
N
Me
44
Me
(-1Oa
A i
-,~~~ ~~~~~~ " i.I.ihj.a.. kik W~U
jaill ijil" &4"AirL lwmA IdT
200~~~~~~~, 18 6 4T10 10 8 6 02
ppm20 0120 100 80 60180 160 140200 40
83.9
82
80
781 743.67
76
1377.48
74
72 1678.95 1492.1
1604.97
70 N 665.53
68 1462.92
Me
,66-N
3583.19 Me
64 3387.05 (±)-lOa
62
60j
58 2:49.46
56! 2917.76
54
52
50
48.5
4000.0 3000 2000 1500 1000
cm-1
500 400.0
Appendix C
Spectra for Chapter III
317
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Pulse 76.1 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
16 repetitions
OBSERVE H1, 500.2272311 MHz
DATA PROCESSING
FT size 131072
02 NO 2
N'
H
N
Me
S1
I L~i
10 9 8 7 6 5
o
A Ai
i IA" I
4 3 2 1 0 PPM12 11
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 69.8 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
65536 repetitions
OBSERVE C13, 125.7822130 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
02 NO 2
N 'S
H
N
Me
S1
I I I I I I I I I i I F I I T I T -;I I I 1 ;FI I
200~ ~~~~~~ 180 16 401010 0604 0 p
180 160 140 120 100 80 60 40 20 0 PPM200
95-
901
85-1
80-
75-
70-
65
60
55
50
45-
40
35
30.-
25
20
3339.17
NO 2
SI
1615.09 13
1593.2 250.50 \
. 061
474.26 5.03
1406.5
1343.99
1167.00
1538.01
1500
IT
1 12.07 16.3
928.69 7 0.
854.10
8.53 783.
655.43
591A7
569.441
1000
5 4
500 400.0
100.0
3094.99
2935.76
w
15
10
5-
0.0
4000.0 3000 2000
cm-I
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 78.3 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
32 repetitions
OBSERVE H1, 500.4252887 MHz
DATA PROCESSING
FT size 262144
I ii iJt~ A
4 3 2 1 -o ppm
NO 2
54
±1
I I ! I . I I I . . I I I .
12 11 10 9
I I
8 76 5
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 0.763 sec
Pulse 69.8 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
20631 repetitions
OBSERVE C13, 125.7822090 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
I 18 16 140 12 10 80 60 40 20 I II
02 NO 2
-S
54
k)
0 PPM
I I
200 180 160 140 120 100 80 60 40 20
928.08
853.59
30
%T 25
1773 87
45
40
35
782.22
066/>3
649.47
590.9Q
738.19
549.40
1013.70
41.951
I .7 1 I1 4
1089.5
1071.09
1053.82
1163.30
1752.80 1538.20
1500
cm-I
51.7
50
713.22 534.84
02 NO 2
-S
54
20 T 2918.43
1605.65
1441.08
140947
15
3201.19
1467.92
1357.34
10
5
0.8
4000.0
1308.30
3000 2000 1000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Pulse 76.1 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
16 repetitions
OBSERVE H1, 500.2272196 MHz
DATA PROCESSING
FT size 131072
Ph 0
Ph
N Me
OH Me
(+)-58
6.0:1.0 mixture of atropisomers
7 6 5 4 3 2 1 ppm
I I . I
812 11 10 9
STANDARD CARBON PARANETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 69.8 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
5151 repetitions
OBSERVE C13, 125.7822147 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
Ph 0
Ph N Me
OH Me
(+)-58
6.0:1.0 mixture of atropisomers
.1
_____I______________J6.__h_____A___ I
160 140 120 100 80 40 20 0 ppm
I I - T I 1 7-7 1 F I I I I I I t f T 7- ---r-7--7--T--T-T--7- i i I
60200 180
95-
90
85
80
75-
70-
65
60-
55 -
50-
45
Ph
Ph N Me
OH Me
(+)-58
6.0:1.0 mixture of atropisomers
2000
1062.42 761.33
699.20
| |
1656.231
1597.43
cm-I
1500 1000
100.0
402.07
1448.22
1~~
OIN
3394.69
40
35
30
25
20
15-
10
5
0.0 
4000.0 3000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 0.100 sec
Pulse 78.3 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4252632 MHz
DATA PROCESSING
FT size 262144 Ph 0 HPh CI
OH Me
(+)-59
4.6:1.0 mixture of atropisomers
12 I  1 9 8 7 6 2 1 ppm -- I I I I I I I . I I I I 1 T -
5 4 31211 10 9 8 7 6 2 1 P PM
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 69.8 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
23066 repetitions
OBSERVE C13, 125.7822009 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
0C
Ph 0
= HPh N "7 CI
OH Me
(+)-59
4.6:1.0 mixture of atropisomers
i T I T f I I I I i I I I I I I I I . I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I f I 1 1 1 1 1 1 1 1 1 7 t I I I I T T I I I -l I I I
200 180 160 140 120 100 80 60 40 20 0 PPM
100.0-
95
90
85
80
75-
70-
65
60-
55
50-
45
40
35
30
25
20
15
10-
5
Ph 0 H
Ph
N CI
OH Met
(+)-59
4.6:1.0 mixture of atropisomers
3000 2000
1495.74
1451.14
1619.36
cm-I
1000.67
1288.06 1097.84 921.43
1197.88 1
1062.73
1403.09
10001500
3381.76
3062431
3030.6P
2957.56
761.5
730.9
699.64
0.0
4000.0 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: Benzene
Temp. 73.0 C / 346.1 K
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417485 MHz
DATA PROCESSING
FT size 262144 Ph O -,MePhO
Ph N CI
OH Me
(+)-55
101 9 8 7 6 5 4 3 2 1 ppm12 1
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: Benzene
Temp. 73.0 C / 346.1 K
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
341 repetitions
OBSERVE C13, 125.6600618 MHz
DECOUPLE H1, 499.7442644 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
Ph O Me
Ph N CI
OH Me
(+)-55
200- 180 160 14 12 10 80 60ol I It
40 20 0 ppm120200 180 160 140 100 80 60
100.0
95
90
85
80
751
70
65-
60-
55
50-
rT
45-
40
35
30-
25
20
1305.53
1451.22
1390.96
3407.03 2965.23
Ph 0 Me
Ph<N 
c
OH Me"I
(+)-55
5
0.0-
4000.0 3000 2000 1500
cm-1
1606.53
15-
10-
917.43
1083.5
1061.95
761.641.
5.56
699.00
1000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 0.100 sec
Pulse 78.3 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4252874 MHz
DATA PROCESSING
FT size 262144 Ph 0 Me
Ph
h N CI
TESO Me
(+)-60
4.5:1.0 mixture of atropisomers
I* ' I12 1 10 8 76 54 3 1 
- ppI T .I I i~~ ~ I I I I I I I I I I I I I I I
12 11 10 9 8 7 6 5 4 3 2 1 -0 PPM
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
10016 repetitions
OBSERVE C13, 125.6601328 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
.1gII .1
Ph 0 Me
Ph N C1
TESO Me
(+)-60
4.5:1.0 mixture of atropisomers
Li j I Ii
200 180 160 140 120 40 20 0 ppm
,,II~I
LA- LIIII-,
10 0 80 6 0
100.0
95
90
85
80 3062.f6 1495.94 1239.48
915.86
75 3030.95 1412.91 1196.42 881.66 647.55
701 Ph 0 Me
2912.54 - 1453.75 803.94
PhN CI
65 2876.97 1383.93 1087197 764.29
i TESO Me
60 (+)-60
2957.45 1296.40 1072.17 741.86
4.5:1.0 mixture of atropisomers 6 8 1551624.84 10.0699.26
50
T
45
40
35
30
25
20
15
10
5
0.0
4000.0 3000 2000 1500 1000 500 400.0
cm-I
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 78.3 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE Hi, 500.4252879 MHz
DATA PROCESSING
FT size 262144
Me 0 Ph
N N Ph
Ns I
Ns Me OTES
NC
Me (+)-61
4.4:1.0 mixture of atropisomers
12 11 10 9 8 7 6 5 4
. . . . . . . . . . . . . . . . . .
3 21PPM
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
5312 repetitions
OBSERVE C13, 125.6601362 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
Me 0 Ph
N N Ph
Ns I
Cs Y Me OTES
(+)-61
140 120 100 80
I I . I I . I I I 1 1 1 T I ;
200 180 160 60 40 20 0 PPM
100.0-
95
90
85
80
75-
70
651
60-
55
50-
%T
4500
40
35
30
25
20
15
10
5
0.0
4000.0
2955.46
1621.63 1372.35
1544.53
Me 0 PhI
1467.55
ll Me OTES
1004.02
1161.34
1090.79
Me (+)-61
4.4:1.0 mixture of atropisomers
3000 2000 1500
cm-1
1000
00.07
740.89
500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 75.4 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE Hi, 500.4295113 MHz
DATA PROCESSING
FT size 262144
Me
N
Me
(-)-53
6 5 4 3 2 1 0 ppm
I I I I
12 1110 9
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 0.763 sec
Pulse 69.8 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
1095 repetitions
OBSERVE C13, 125.7822101 MHz
DECOUPLE Hi, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
0
N
Me
(-)-53
M im
20 18 160 14 120 0 pp100I I I I 2
100 80 60 40 21200 180 160 140 120 00 PPM
0 Me
N
2936.72 cI
C N
Me
(-)-53
1629.47
I1372.9
1328.38
1467.12
10
5
0.0
4000.0 3000 1500
cm-I
1000 500 400.0
100.0
95 -
90
85
80
75
70
65
60-
55-
50-
45-
40
35-
30
25
20
15
1 64.21
1199.41
914.11 665.60
740.77
2000
75%hex
Chiralpak IC
.5 mL/min
0 Me
N
N
Me
(-)-53
DADI C, Sig=230,16 Ref=360,100
mAU
250-
200-
150
100-
50
0- -- -
19 20 21 22 23 24 25 min
Area Percent Report
Sorted By : Signal
Multiplier : 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: DAD1 C, Sig=230,
Peak RetTime Type Width
# [min] [min]
--- ------ I--.-- I-------I
1 19.784 BB 0.3298
2 22.733 BB 0.5051
Totals :
16 Ref=360,100
Area Height Area
[mAU*s] [mAU] %
--- - - -I - - - - -I -----
280.11615 10.21808 3.0750
8829.24609 268.90414 96.9250
9109.36224 279.12222
342
04C4
75%hex
Chiralpak IC
.5 mL/min
o Me
N '
N
Me
(-)-53
DAD1 C, Sig=230,16 Ref=360,100
mAU
600
500-
400
300-
200-
100-
0
N
0)
S('4
S/
C-
/
19 20 21 22
Area Percent Report
Sorted By : Signal
Multiplier : 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: DADi C, Sig=230,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s) [mAU) %
---- I--------I ----I-------I---------- ---------------------I
1 19.562 BB 0.4421 1.69635e4 587.10394 49.7855
2 22.381 BB 0.5081 1.71097e4 514.37726 50.2145
3.40731e4 1101.48120
343
23 24 25 miW
Totals :
I in 21 22 23
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: Benzene
Ambient temperature
Relax. delay 0.100 sec
Pulse 78.3 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4295272 MHz
DATA PROCESSING
FT size 262144 
Me
(-)-62
12 11 10 9 8 7 
6 5 4 3 2 1 
ppm
9 8 7 6 PPM10
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: Benzene
Ambient temperature
Relax. delay 0.763 sec
Pulse 69.8 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
18234 repetitions
OBSERVE C13, 125.7821556 MHz
DECOUPLE H1, 500.2292658 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
I I- - * *
200 180 140 120 100 
80 60 40 20 0 ppm
160
Me
L
 180
I
140 100 80 60120 40 20 0 PPM
100.0
95
90
85I-
80-
1605.28 1264.09
149 213 112127
736.61
70 2930.51 N
65 Me
60 NH
55 (-)-62 Me
50
%T
45
40
35
30
25
20
15
10
5
0.0
4000.0 3000 2000 1500 1000 500 400.0
cm-I
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Pulse 76.1 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
16 repetitions
OBSERVE Hi, 500.2272319 MHz
DATA PROCESSING N
FT size 131072 .. ,
Me
12 11 10 9 8 7 6 
5 4 3 2 1 -o ppmI I I I II I I I I I I I I I I I I I I I 1 1
 10 9 1 -0 ppm
I i I I I I I I i , I
8 7 6 5 4 3 2
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 0.763 sec
Pulse 69.8 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
16226 repetitions
OBSERVE C13, 125.7822078 MHz
DECOUPLE H1, 500.2292208 MHz
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 0.3 Hz
FT size 131072
00
j
200 180 160 140 120 40 20 0 ppm
Me
100 80 60
I i M i I ;
100.0
95
90
85
80 J
75
70
65
60
55
50
45
1112.99
1202. 3
.71
2780.41
2931.55
021.8?
1 33.20
1605.81 1374.96
5 126
1484.20
1500
cm-I
902~.21
977.41
5.5666
737.10
1181.12
40
35
30
25
20
15
10
5
0.0
4000.0
Me
Me
20003000 1000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CD3CN
Temp. 72.0 C / 345.1 K
Pulse 76.1 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
42 repetitions
OBSERVE H1, 500.2298782 MHz
DATA PROCESSING
FT size 131072
9 8
. I I I . I . I t I I I I I I I I I I I I I I T - - -- -- r i I ; I I I I i I I I I I
7 6 5 3
Me
(-)-64
3 2 1PPM4
I I I I I I I I I . . . . I
11 1012
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CD3CN
Temp. 73.0 C / 346.1 K
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
3711 repetitions
OBSERVE C13, 125.6606536 MHz
DECOUPLE H1, 499.7468631 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
200 180 160 140 120 100 
80 60 40 20 0 ppm
Me
(-)-64
I1. Lj
I I
160 140 120 100 80
1 ; ; 1 ; 1
60 40 20 0 PPM
& -
I , -
6-1TM- 
I 1 1-0-411 
014 
1
100.0-
95
90
85
80-
75~
70
65 -
60
55
50
45
40
35
30
25
20 J
15
10
5.
0.0
4000.0
1638.25
N O
Me
(-)-64 Me
cm-1
1500 1000 500 400.0
V 1245.35
1321.04
1469.13
741.58
3000 2000
mlmw
2926.03
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 60.3 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
32 repetitions
OBSERVE H1, 500.4252688 MHz
DATA PROCESSING
FT size 262144
12 11 I0 I T I I I 4 3-T 2- T1 ppmII I10 9 5 4 3 21PPM8 7 612 11
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
1332 repetitions
OBSERVE C13, 125.6601314 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
200 180 160 140 120 
100 81 60 40 
20 0 ppm
Me
1 1 1I11 1 1 1 I f I 1 1 1
180 0 60 40 20 0 PPM
1 1.i I I I I I I - . I I . I I I I I I I I I I I I I I I i . I I 1 1
 120 100 8
3583.24
95.-
90
85
80
751
70
65-
60-
55
50
%T
45
40
35
30
25
20
1'5
10
5
0.0
4000.0
\e
Me
1611.71
20.16
l 1298.91
1472.35
066.13
1139.89 I72.50
1038.49
1190.79
1252.66
1011.89
913.64
N
Me
3000 2000
cm-I
1500 1000
100.0
(3'
3051.4
848.80
,2782.18
2927.78
785.05
665.54
736.26
500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDCl3
Ambient temperature
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
32 repetitions
OBSERVE H1, 499.7417341 MHz
DATA PROCESSING
FT size 262144
9 8 7 6 5 4
Me
(-)-63
U.
I I I t I I - I I I . . I I I I f I I T T I f I I T I T- I I I ; I .I I I i I I I I I
2 1 PPM12 11 10 3
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: COC13
Ambient temperature
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
264 repetitions
OBSERVE C13, 125.6601333 MHz
DECOUPLE Hi, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
s<Am-LA~ L--t-f It -:11r1 h.14.&-s~ a i2.'
1 0I 1 1
180 160 140
1 100I I I I I I p I m
120 100 80 60 40 20 0 PPM
Me
NMe 2
200
d'IK. L~. 1,1.- L
137
45 30
1603.28
1517.62
1496.97
cm-1
85
80
75-
70
65
601
55
50
%T
45
40
35
30
25
20
15-1
10
5
0.0
4000.0
14
3.J51
1261.8h
347.5
1314.70
1228.0(
87.82 19.01I
3 77.73
1025.19 866.
12 .00 945. 18
809.
04
58
734.46
1186.49
10T - - 400.
1000 500 400.0
100.0
95
90
0 5.21
2 53.7F
2929.36
2790.95
00
15003000 2000
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: Benzene
Temp. 72.0 C / 345.1 K
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417469 MHz
DATA PROCESSING
FT size 262144
F3CS0 3 +
Me
(-)-66 Me
I I
la 11 'a 9 B 7 6 5 4 3 2 1 
ppm
12 11 10 9 7 6 5 4 3 2 1 PPM8
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: Benzene
Temp. 72.0 C / 345.1 K
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
13063 repetitions
OBSERVE C13, 125.6600613 MHz
DECOUPLE H1, 499.7442644 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
~k~J..~hhLd~A
4
~iILkL
I I I f I T-7 7 I I i i i I i i I I i I I I I I I I I I I I I I I I i I I I j 1 1 1 1 1 j I j I i I I I I I. .I.I I.I.I I.I. .I.I I.I.I I.T.. . .I I.I.I I.I. .I.I I.. .I I.. . .1. ... I
100 80 6 C
F3CS0 3 +
Me
(-)-66
-. 1 A A L-.- - t . hIJ ..L7
L-!-'i -A. 11L-A1 i.1-- LALM"hW AN,"
II I
1 11 --
200 180 120
I f I 1 ; 1 ; 1 1 1 ; ; ; i
160 140 40 20 0 PPM
19F OBSERVE
STANDARD PARAMETERS
Pulse Sequence: s2pul
Solvent: Benzene
Ambient temperature
Relax. delay 4.000 sec
Pulse 45.0 degrees
Acq. time 0.300 sec
Width 100.0 kHz
4 repetitions
OBSERVE F19, 282.3816196 MHz
DATA PROCESSING
Line broadening 0.3 Hz
FT size 262144
F3CSO 3 +
C
Me
(-)-66 Me
I I I
150 100 50 0 
-50 -100 -150 ppmI I I I
-100 -150 PPM50 0 -50
92.8
90
882
86
84-
82-
80-
78-
76
74
72-
3583.22
3420.62
F3CSO 3
Me
NMe 2
16'
152 1.16
1609.44
1488.52
1356.04 8
'1264.11
1156.83
1030.80
1262.02
1000 500 400.0
2925.20
945 12
827.59
754.0
70 -
68
66-
64-
62
60
58
56
54
'4
665.
637.74
51.6 1
4000.0 3000 2000
cm-1
1500
I
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 22.0 C / 295.1 K
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417327 MHz
DATA PROCESSING
FT size 262144
Me,(-)-67
12 I1 1 8 I 6 5 4 I I 1 ppmII . I I I I I I I I I
i-LA - I
I I I I I I I I 2 1 PPM5 4 310 9 8 7 612 11
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 22.0 C / 295.1 K
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
709 repetitions
OBSERVE C13, 125.6601290 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
Me-
(-)-67
ON
I.
ppm80 60 40 20 0
M'K'7 111 , - "1wr"7-r-
- -
I i I
I
I~~  ~ I i-rT T ,- -r r rT T T rT r r- I I I I I I I I I I | Ii i 1 |
200 180 160 140 120 100
1023.73 93.95
261. jg81 3 940.11
3052.82 2726.33
2784.40
2928.57
Me
Me
2000
1602.91
1502.54
cm-I
103.2
100
95
90
85
80-
75
3583.25
768.81
732.21
665.59
70
65 J
60
55.]
53.0 1
4000.0 3000 1500 1000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 22.0 C / 295.1 K
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions
OBSERVE H1, 499.7417347 MHz
DATA PROCESSING N
FT size 262144
Me
(-)-68 Me
ONA
12 1 98 7 6 5 4 3 p
i -k. IA,
12 1110 9 2 1 PPM
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 22.0 C / 295.1 K
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
11977 repetitions
OBSERVE C13, 125.6601290 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
(-)-68 Me
.-I
.A I J- L .1.1 -1. - 0 -rJ
140 120 40 20 0 ppm
. I F " I
- r r - -I - -- !- -i
200 180 160 100 80 60
1061.68
1603.66 1376.37
\ Ar 1500.65
62
59.9 - -
3000 2000 1500 1000 500 400.0
cm-I
87.3
86
84
82
80
78
76-
74
--
2927.46
00
736.19
72
(-)-68 Me
70
68
66
64
4000.0
V
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 60.3 degrees
Acq. time 4.999 sec
Width 12012.0 Hz
16 repetitions
OBSERVE H1, 500.4252861 MHz
DATA PROCESSING
FT size 262144
I I
12 11 10 9 8 7 6 
5 4 3 2 1 ppm
10 9 2 1 PPM7 6 5 4 38
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 65.4 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
3524 repetitions
OBSERVE C13, 125.7822101 MHz
DECOUPLE H1, 500.2292208 MHz N
Power 37 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 2.0 Hz
FT size 131072
N
Me
PPM
1 14I I I I80 6 4 2 III
160 140 120 100 80 60 40 20220 200
OMe
iILI A ~ I i
A. 11 - , ""M """ : 111, 1- 1 ji, A" IVA Jli".Ik -J, lukaWLA. L d ku LA J L-1
I - 1 11
L
240 180 0 -20
2361.53
3048 25
2727.48
2934.39
374.02
1 0.9 1
1435.21
1603.72 13274
II 1304
75
70
65-
60
55
50
%T
45-
40
35
30
25
20
15
10
3000 2000
cm-I
1494.29
95
90
85
80
61.74
1224.
9 1156.2b
.29 1120.63
1189.06
1500
100.0
108i8< 91
062.6i
1023. 8
3583.21
680. 8
665.46
1733.46
7  91
868.14
838.49
989.07
737.45
5.
0.0
4000.0 1000 500 400.0
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: toluene
Temp. 80.0 C / 353.1 K
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
16 repetitions F3CSO3 +OBSERVE H1, 499.7418438 MHz
DATA PROCESSING
FT size 262144 \
(+)-70
7 6 5 4 3 2 1 ppm
7- 1 --F---T-I I 1 1 4 1 1
.11
12 1110 9 8
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: toluene
Temp. 80.0 C / 353.1 K
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 sec
Width 31397.2 Hz
10625 repetitions
OBSERVE C13, 125.6601082 MHz
DECOUPLE H1, 499.7442944 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
F3CSO 3 +
Me
Li
I"' 
0-m~ " 4T'ii L IIL..I v,~LA r4
I I0 PPM
20 I8 16 14 12 10 806T02
100200 180 160 140 120 80 60 40 20
19F OBSERVE
STANDARD PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temDerature
Relax. delay 4.000 sec
Pulse 45.0 degrees
Acq. time 0.300 sec
Width 100.0 kHz
8 repetitions
OBSERVE F19, 282.3815086 MHz
DATA PROCESSING
Line broadening 0.3 Hz
FT size 262144
Me
N
150 100
I I
50 0 -100 -150 ppm
F3CS0 3
-50
982.05 803.06
902.55
1671.991
54.1
1607.77
1488.98
188.p
8 1 46.95
375.95
1355.12
123i60
1155.46
Me
cm-I
1261.80
1500
92.1
91
90-
89
Iq85.19
36081 4
486.06
3583.26
2786.56
2 19.34
2933.04
752.81
F3CSO 3 +
88
87-
86 -
85 -
%T 84
83
82
81 ~
80
79
78
77
030.84
eH
76.2
4000.0 3000
665 5
6I486
2000 1000 500 400.0
I
STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.100 sec
Pulse 60.3 degrees
Acq. time 4.999 sec
Width 12012.0 HZ
32 repetitions
OBSERVE H1, 500.4252873 MHz
DATA PROCESSING
FT size 262144
(-)-71 N
MeH
1.7:1.0 mixture of atropisomers
8 7 6 5 4 3 2 1 ppm12 11 10 9
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 21.0 C / 294.1 K
Relax. delay 3.000 sec
Pulse 35.0 degrees
Acq. time 2.000 Sec
Width 31397.2 Hz
9729 repetitions
OBSERVE C13, 125.6601314 MHz
DECOUPLE H1, 499.7442194 MHz
Power 34 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
Me Me
(-)-71 N
MeH
1.7:1.0 mixture of atropisomers
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STANDARD PROTON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Temp. 54.0 C / 327.1 K
Relax. delay 2.000 sec
Pulse 81.5 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
354 repetitions
OBSERVE H1, 499.7417334 MHz
DATA PROCESSING
FT size 262144
Me
12 11 10 9 8 7 6 5 4
"I I , I I I k)
3 2 1 -0 ppm
STANDARD CARBON PARAMETERS
Pulse Sequence: s2pul
Solvent: CDC13
Ambient temperature
Relax. delay 0.763 sec
Pulse 60.9 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
31639 repetitions
OBSERVE C13, 125.7822055 MHz
DECOUPLE H1, 500.2292208 MHz
Power 45 dB
continuously on
WALTZ-16 modulated
DATA PROCESSING
Line broadening 3.0 Hz
FT size 131072
240 220 200
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